Sentence,class,file
4    http://www.jcancer .org 59  IL-10 uses heterodimeric receptor complexes  for  signaling.,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 60  IL-22 and gut  epithelial cell regeneration   The role of IL -22 in gut homeostasis is well  studied and reviewed elsewhere (33;34) .,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 61    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 62  proinflammatory and tissue protective role s (49).,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 63  hol or Conconavalin- A induced liver injury (56 -58).,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 64  15.,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 65  64.,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
"4      http://www.jcancer .org 66  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 66-83. doi: 10.7150/ jca.5112   Review  The Tumor Microenvironment Contribution to      Development, Growth, Invasion and Metastasis of Head  and Neck Squamous Cell Carcinomas   Sittichai Koontongkaew1,2   1.",Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
"4    http://www.jcancer .org 67  cerization’ was proposed to explain the high prope n- sity of HNSCC to develop local recurrences after  treatment, and the high like lihood that multiple in- dependent tumors can develop in the head and neck region [5].",Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 68    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
"4    http://www.jcancer .org 69  solid tumors including HNSCC exploit methods to  induce neo- angiogenesis, usually by producing a n- giogenic factors.",Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 70  tem to reject the tumor.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
"4    http://www.jcancer .org 71  HPV or norma l controls [74, 75] .",Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 72  motility and inhibiting anoikis [98] .,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 73  strongly influences the host immune system.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 74  growth [137] .,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 75    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 76  activating HIF- 1α in oral squamous cell carcinoma  [169] .,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 77  tion.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 78      Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 79  References   1.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 80  53.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 81  98.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 82  140.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
4    http://www.jcancer .org 83  188.,Non-OADS,/arxiv_data1/oa_pdf/5c/fa/jcav04p0066.PMC3564248.pdf
"4      http://www.jcancer .org 84  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 84-95. doi: 10.7150/ jca.5482   Review  Tumor -Infiltrating Immune Cells Promoting Tumor   Invasion  and Metastasis: Existing Theories  Yan-gao Man1,2, Alexander Stojadinovic3, Jeffrey Mason4, Itzhak Avital5, Anton Bilchik6, Bjoern Bruecher7,  Mladjan Protic8, Aviram Nissan9, Mina Izadjoo1, Xichen Zhang2, Anahid Jewett10  1.",Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 85  cer-related mortality [5 -8].,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 86  sive front by expression of tumor -derived chemotactic  factors and in response to the disruption of the bas e- ment membrane.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 87  subset of human clinical tumor samples [92 -97].,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 88  to drive differentiation of stem cells.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
"4    http://www.jcancer .org 89  lying the basal cell layer and the BM, a focal capsul e  disruption at the site of genetically- altered stem cells  may favor their exit from quiescence.",Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 90  and immunohistochemical findings on tissue sections.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 91    Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 92  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 93  tumor infiltrating lymphocytes by HPV16 and HPV18 E7 -pulsed auto l- ogous dendritic cells in patients with cancer of the uterine cervix.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 94  94.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
4    http://www.jcancer .org 95  138.,Non-OADS,/arxiv_data1/oa_pdf/e8/59/jcav04p0084.PMC3564249.pdf
The method to analyze splicing described here is converted into a stand-alone java-application and R package and freely available at: http://www.bioinf.fbb.msu.ru/ Bmazin.,OADS,/arxiv_data1/oa_pdf/0e/df/msb201267.PMC3564255.pdf
"For each sample, 2 mg of isolatedpooled RNA was used for sample preparation, followed by hybridiza-tion to Affymetrix Human Exon 1.0 ST arrays, according to the standard protocol with no modiﬁcations (http://www.affymetrix.",Non-OADS,/arxiv_data1/oa_pdf/0e/df/msb201267.PMC3564255.pdf
"Functional enrichment analysis The KEGG pathway annotation (Kanehisa et al, 2010) and the Gene Ontology (GO) annotation (Ashburner et al, 2000) for humans were downloaded from the KEGG (http://www.genome.jp/kegg/) andEnsembl (version 56) databases, respectively.",OADS,/arxiv_data1/oa_pdf/0e/df/msb201267.PMC3564255.pdf
"Enrichment analysis of SFBMs Sequences of 29 SFBMs were obtained from http://sfmap.technion.a- c.il and another 7 SFBM were collected from previous studies (Faustinoand Cooper, 2005; Galarneau and Richard, 2005; Sanford et al, 2009; Bolognani et al, 2010) (Supplementary Table S11).",OADS,/arxiv_data1/oa_pdf/0e/df/msb201267.PMC3564255.pdf
Data availability The following data have been deposited in the Dryad repository: http://dx.doi.org/10.5061/dryad.35h8v.,OADS,/arxiv_data1/oa_pdf/e1/c3/msb201272.PMC3564256.pdf
The expression data were submitted tothe NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE42135.,OADS,/arxiv_data1/oa_pdf/c8/88/msb201265.PMC3564263.pdf
"The estimations of expression level, foldchange between two samples, and the FDR were calculated based on the methodology developed by Johnson and Wong (see http://www.stanford.edu/group/wonglab/doc/NewGeneScoreBiostatDraft.pdf).",OADS,/arxiv_data1/oa_pdf/c8/88/msb201265.PMC3564263.pdf
"GO analysis The Gene Expression Data Analysis tool within the PANTHER resource(http://www.pantherdb.org/tools/genexAnalysis.jsp) (Thomas et al, 2003) was used to identify functional categories in our microarrayresults.",OADS,/arxiv_data1/oa_pdf/c8/88/msb201265.PMC3564263.pdf
"However, new design tools and software suites such as J5 (Hillson et al, 2012), Clotho (Xia et al, 2011), and Genome Compiler (http://www.genomecompiler.com/)provide better data management and user interfaces for the design of large operons and whole genomes.",Non-OADS,/arxiv_data1/oa_pdf/86/a3/msb201266.PMC3564264.pdf
(b ) Predicted secondary structures of  aptamers using Mfold (http://mfold.rna.albany.edu/?q=mfold/RNA-Folding-Form).,OADS,/arxiv_data1/oa_pdf/3b/66/mtna201259a.PMC3564417.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/3b/66/mtna201259a.PMC3564417.pdf
"BLAST analysis of  the AS sequence was conducted against the National Cen- ter for Biotechnology Information human RefSeq database (http://www.ncbi.nlm.nih.gov/Refseq/), with a hit defined as a high-scoring segment pair of ≥15 contiguous nucleotides  between the siRNA sequence and nontarget sequence.",OADS,/arxiv_data1/oa_pdf/5b/86/mtna201257a.PMC3564418.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/5b/86/mtna201257a.PMC3564418.pdf
Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)Molecular Therapy–Nucleic Acids is an open-access jour- nal published by Nature Publishing Group.,OADS,/arxiv_data1/oa_pdf/5b/1c/mtna201260a.PMC3564419.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/5b/1c/mtna201260a.PMC3564419.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/a9/27/mtna201256a.PMC3564420.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/5e/c9/mtna201255a.PMC3564421.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 31 August 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101570 / ijic2011-123Copyrig ht:  Submitted: 27 November 2010, revised 28 June 2011, accepted 29 July 2011 Research and Theory Providers’ perspectives on collaboration Patricia Bruner, PhD, LPC, Couple and Family Therapist, Department Couple and Family Therapy, Drexel University,  Philadelphia, P A, USA Roberta Waite, EdD, MSN, RN, Nurse Scientist, Associate Professor, College of Nursing and Health Professions, Drexel  University, Philadelphia, P A, USAMaureen P .",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ collaborative networking [11–12].",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3  3serve these vulnerable patient populations.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ tion, self-efficacy programs, nutrition education, fit- ness, cooking classes, and behavioural health group  support are the core program elements of the Healthy  Living Centre.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5between the self-report measures of collaboration.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ cussions, with more collaboration reported at time two:  Collaboration and Satisfaction about Care Decisions Scale Level of Collaboration (t(29)=–2.087, p=0.046), Question eight – Satisfaction with Decision Making (t(30)=0.361, p=0.720), Question nine – Decisions for Patient (t(30)=–0.839, p=0.408), Interprofessional Learning Scale (t(29)=0.358, p=0.723), and Interpro-fessional Relationship Scale (t(30)=0.809, p=0.425.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7whilst those with either a high school degree or a bach- elor’s degree had the most negative views of interpro - fessional relationships.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ rience because of their disadvantaged social status  (e.g.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  9This study adds to the developing literature on colla- boration care models in primary care by providing insight into the diverse perspectives of support staff, practitioners, and administrators in a federally qualified nurse managed community based primary health care centre.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 10International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ on the interactions within diverse provider groups.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
Available from: http://books.google.com/books/about/Population_Health.html?id=-X2HAWROnEQC.,Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
Available from http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
Available from: http://www.integratedprimarycare.com/organizing_the_evidence.pd f. 11.,OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101570 / ijic2011-123 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  1115.",Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7174.2011.00129.x/abstrac t. 20.,Non-OADS,/arxiv_data1/oa_pdf/78/c0/ijic2011-2011123.PMC3564422.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, 25 July 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101518 / ijic2011-81Copyrig ht:  Submitted: 9 February 2010, revised 27 May 2011, accepted 8 June 2011 Research and Theory Professionals’ views on interprofessional stroke team   functioning Jane M. Cramm, PhD, Institute of Health Policy and Management (iBMG), Erasmus University, Rotterdam, The Netherlands Anna P .",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ Although the success of integrated stroke services  relies heavily on interprofessional team functioning,  professionals’ perspectives on the factors influenc - ing such functioning remain largely unexamined.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3  3agreement on a 4-point scale.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ Table 1.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5leadership at the outset to assist in the acquisition of a  clear, shared and attainable vision, creating a sense of  belonging within each team member.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ Reviewers Sandra Dunn, RN, PhD, Perinatal Consultant, Cham- plain Maternal Newborn Regional Program (CMNRP), 2305 St. Laurent Blvd., Ottawa, Ontario, CanadaMirella M.N.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  729.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101518 / ijic2011-81 – http://www.ijic.org/ There is little evidence of conflict between team members on the stroke team.4.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/ijic2011-2011081.PMC3564423.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, 31 August 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101569 / ijic2011-122Copyrig ht:  Submitted: 14 January 2011, revised 7 July 2011, accepted 11 July 2011 Research and Theory Motivation to take part in integrated care—an assessment   of follow-up home visits to elderly persons Ulf Hjelmar, PhD, Research Programme Director, Danish Institute of Governmental Research, Købmagergade 22, DK-1150  Copenhagen, Denmark Carsten Hendriksen, PhD, Associate Professor, Institute of Public Health, University of Copenhagen, Øster Farimagsgade 5,   DK-1014 Copenhagen, DenmarkKirsten Hansen, PhD, Project Manager, Health and Care Administration, City of Copenhagen, Sjœllandsgade 40, DK-2200  Copenhagen, DenmarkCorrespondence to: Ulf Hjelmar, AKF , Danish Institute of Governmental Research, Købmagergade 22, DK-1150 Copenhagen,  Denmark, E-mail: ulf@akf.dk Abstract Objectives: The aim of follow-up visits by the general practitioner and district nurse (within a week after discharge from hospital) is  to reduce hospital readmissions and improve the overall wellbeing of the patient.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ the Copenhagen programme will be reported in 2012  by the Danish Institute of Health Services Research.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"International Journal of Integrated Care – Volume 11 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3  3a result, follow-up home visits and other cross-sector  interventions, such as ‘follow-home arrangements’  and ‘case managers’ have been quite regularly imple - mented on an experimental basis as a possible alter-native to hospital-based measures.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ Five individual interviews were held with GPs involved  in the project.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
International Journal of Integrated Care – Volume 11 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5hospital the general view was that this patient group is  very relevant for the programme.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ is the most annoying —that we are not told what the  results of follow-up home visits are” (nurse, hospital).",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"International Journal of Integrated Care – Volume 11 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7for follow-up home visits and, as a result, increase the  motivation to make these visits.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care – Volume 11, 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ References 1.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
Avail- able from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
International Journal of Integrated Care – Volume 11 31 August – URN:NBN:NL:UI:10-1-101569 / ijic2011-122 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  926.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijic2011-2011122.PMC3564424.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/ab/bgs345.PMC3564441.pdf
Supplementary material Supplementary Figures 1–6 can be found at http://carcin.oxfordjour - nals.org/ Funding L.M.B.,Non-OADS,/arxiv_data1/oa_pdf/a6/ab/bgs345.PMC3564441.pdf
"Advances in lens implant technology Daniel Kook1*, Anselm Kampik1, Alois K. Dexl2, Nicole Zimmermann3, Adrian Glasser4, Martin Baumeister5and Thomas Kohnen5 Addresses:1Department of Ophthalmology, Ludwig Maximilians University Munich, Germany;2Department of Ophthalmology, Paracelsus Medical University Salzburg, Austria;3Max Planck Institute of Psychiatry, Chaperone Research Group, Munich, Germany;4University of Houston, College of Optometry, Houston, United States;5Department of Ophthalmology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany * Corresponding author: Daniel Kook (daniel.kook@med.uni-muenchen.de)F1000 Medicine Reports 2013, 5:3 (doi:10.3410/M5-3) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/3 Abstract Cataract surgery is one of the oldest and the most frequent outpatient clinic operations in medicine performed worldwide.,Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Page 2 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Page 3 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Page 4 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Page 5 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Page 6 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Schumacher S, Oberheide U, Fromm M, Ripken T, Ertmer W, Gerten G, Wegener A, Lubatschowski H: Femtosecond laser Page 7 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"Page 8 of 8 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:3 http://f1000.com/prime/reports/m/5/3",Non-OADS,/arxiv_data1/oa_pdf/6a/56/medrep-05-03.PMC3564471.pdf
"* Corresponding author: Judith A. Brebner (j.a.brebner@bham.ac.uk) F1000 Medicine Reports 2013, 5:4 (doi:10.3410/M5-4) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/4 Abstract Free light chains are proteins produced by B lymphocytes during the process of antibody synthesis.,Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
"Page 2 of 6 (page number not for citation purposes) F1000 Medicine Reports 2013, 5:4 http://f1000.com/prime/reports/m/5/4 ’ ‘ ‘ ’",Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
"Free light chains have been shown to exert a variety of biological activities, and as our knowledge of their Page 3 of 6 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:4 http://f1000.com/prime/reports/m/5/4",Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
"Page 4 of 6 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:4 http://f1000.com/prime/reports/m/5/4",Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
"Braber S, Thio M, Blokhuis BR, Henricks PAJ, Koelink PJ, Groot Kormelink T, Bezemer GFG, Kerstjens HAM, Postma DS, Garssen J, Page 5 of 6 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:4 http://f1000.com/prime/reports/m/5/4",Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
"Page 6 of 6 (page number not for citation purposes)F1000 Medicine Reports 2013, 5:4 http://f1000.com/prime/reports/m/5/4",Non-OADS,/arxiv_data1/oa_pdf/84/f8/medrep-05-04.PMC3564472.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e4418 | Page 1 of 8Video Article Dual Electrophysiological Recordings of Synaptically-evoked Astroglial and Neuronal Responses in Acute Hippocampal Slices Ulrike Pannasch*1, Jérémie Sibille*1,2, Nathalie Rouach1 1Neuroglial Interactions in Cerebral Physiopathology, Center for Interdisciplinary Research in Biology, CNRS UMR 7241, INSERM U1050, Collège de France 2Paris Diderot University *These authors contributed equally Correspondence to: Ulrike Pannasch at ulrike.pannasch@charite.de , Nathalie Rouach at nathalie.rouach@college-de-france.fr URL: http://www.jove.com/video/4418 DOI: doi:10.3791/4418 Keywords: Neuroscience, Issue 69, Physiology, Anatomy, Medicine, hippocampus preparation, acute brain slice, electrophysiology, patch-clamp, neurons, astrocytes, astroglial, neuroglial interactions, glutamate transporter current, potassium current, paired recordings, synaptic activity, synaptically-evoked responses Date Published: 11/26/2012 Citation: Pannasch, U., Sibille, J., Rouach, N. Dual Electrophysiological Recordings of Synaptically-evoked Astroglial and Neuronal Responses in Acute Hippocampal Slices.",Non-OADS,/arxiv_data1/oa_pdf/f8/d2/jove-69-4418.PMC3564483.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4418/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/d2/jove-69-4418.PMC3564483.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e50027 | Page 1 of 9Video Article A Lightweight, Headphones-based System for Manipulating Auditory Feedback in Songbirds Lukas A. Hoffmann1,2, Conor W. Kelly1,3, David A. Nicholson1,2, Samuel J. Sober1 1Department of Biology, Emory University 2Neuroscience Graduate Program, Emory University 3Program in Neuroscience and Behavioral Biology, Emory University Correspondence to: Samuel J. Sober at samuel.j.sober@emory.edu URL: http://www.jove.com/video/50027 DOI: doi:10.3791/50027 Keywords: Neuroscience, Issue 69, Anatomy, Physiology, Zoology, Behavior, Songbird, psychophysics, auditory feedback, biology, sensorimotor learning Date Published: 11/26/2012 Citation: Hoffmann, L.A., Kelly, C.W., Nicholson, D.A., Sober, S.J.",Non-OADS,/arxiv_data1/oa_pdf/93/8e/jove-69-50027.PMC3564484.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50027/ Protocol Implementing the headphones system consists of four major steps.,Non-OADS,/arxiv_data1/oa_pdf/93/8e/jove-69-50027.PMC3564484.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f7/2e/285.PMC3564523.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8d/cc/210.PMC3564524.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/77/385.PMC3564525.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/63/46/409.PMC3564526.pdf
"Structural bioinformatics and PHSte5 model building Homologous protein sequences were retrieved by either BLASTP or  TBLASTN search (Altschul and Lipman, 1990) in the Fungal Genome  Database (www.yeastgenome.org/) and by protein domain architec - ture search in the SMART database (http://smart.embl.de/; Letunic  et al., 2006).",OADS,/arxiv_data1/oa_pdf/63/46/409.PMC3564526.pdf
"Structural fold detection for regions of representative  Ste5, Far1, and Ste11 fungal proteins was carried out at the Structure  Prediction Meta Server (http://meta.bioinfo.pl/ ), which provides a  consensus sequence–to–structure fold recognition score using the  3D-Jury meta-predictor (Ginalski and Rychlewski, 2003).",OADS,/arxiv_data1/oa_pdf/63/46/409.PMC3564526.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/15/e2/246.PMC3564527.pdf
"Cluster analysis was performed us - ing Cluster, version 3.0 (Eisen et al., 1998), and data were visualized  using Treeview, version 1.60 (http://rana.lbl.gov/EisenSoftware   .htm).",OADS,/arxiv_data1/oa_pdf/15/e2/246.PMC3564527.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/d1/274.PMC3564528.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bf/64/234.PMC3564529.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/26/7b/194.PMC3564530.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/02/89/184.PMC3564531.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ef/10/421.PMC3564532.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e3/a4/398.PMC3564533.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fd/20/308.PMC3564534.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/31/44/331.PMC3564535.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/81/e9/319.PMC3564536.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6f/71/373.PMC3564537.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2d/f4/169.PMC3564538.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ec/95/261.PMC3564539.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/79/7c/297.PMC3564540.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/99/be/342.PMC3564541.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8e/41/351.PMC3564542.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/40/1f/222.PMC3564543.pdf
"Janice M. re ichert Editor-in-Chief, mAbs; Landes Bioscience; Austin, tX U SA Keywords:  monoclonal antibodies, clinical studies, cancer Correspondence to: Janice M. Reichert; Email: Janice.reichert@landesbioscience.com Submitted: 11/19/12; Accepted: 11/19/12http://dx.doi.org/10.4161/mabs.22976listed as recruiting on clinicaltrials.gov:  ODYSSEY Mono (alirocumab compared with ezetimibe in patients with hypercho - lesterolemia), ODYSSEY Combo I and II (evaluates alirocumab in combination with lipid modifying therapy in patients with hypercholesterolemia at high cardio - vascular risk), ODYSSEY High FH (evalu - ates alirocumab in combination with lipid modifying therapy in patients with famil - ial hypercholesterolemia), ODYSSEY FHI (evaluates alirocumab in patients with familial hypercholesterolemia that is not adequately controlled), ODYSSEY Alternative (evaluates alirocumab in patients with hypercholesterolemia and cardiovascular risk who are intolerant to statins), ODYSSEY Outcomes (compares the effect of alirocumab with placebo on the occurrence of cardiovascular events in patients who have experienced an acute coronary syndrome event), and ODYSSEY Long-term (evaluated the long-term safety and tolerability of alirocumab in patients with hypercholesterolemia and cardio - vascular risk).",Non-OADS,/arxiv_data1/oa_pdf/64/b1/mabs-5-1.PMC3564874.pdf
Circulation 2012; 126:2408-17; PMID:23129602; http://dx.doi.org/10.1161/CIRCULATIONAHA.112.144055 4.,Non-OADS,/arxiv_data1/oa_pdf/64/b1/mabs-5-1.PMC3564874.pdf
J Am Coll Cardiol 2012; 60:1888-98; PMID:23083772; http://dx.doi.org/10.1016/j.jacc.2012.08.986References 1.,Non-OADS,/arxiv_data1/oa_pdf/64/b1/mabs-5-1.PMC3564874.pdf
Lancet 2012; In press; PMID:23141813; http://dx.doi.org/10.1016/S0140-6736(12)61770-X 2.,OADS,/arxiv_data1/oa_pdf/64/b1/mabs-5-1.PMC3564874.pdf
Lancet 2012; In press; PMID:23141812; http://dx.doi.org/10.1016/S0140-6736(12)61771-1,Non-OADS,/arxiv_data1/oa_pdf/64/b1/mabs-5-1.PMC3564874.pdf
"This idea has gained substantial momentum recently, as our knowledge of the endo/lysosomal system and our ability to  *Correspondence to: Nathan Scott; Email: nathan.scott@pfizer.com Submitted: 09/19/12; Revised: 11/09/12; Accepted: 11/11/12http://dx.doi.org/10.4161/mabs.22854The use of antibody-drug conjugates (ADCs) as a therapeutic  platform to treat cancer has recently gained substantial momentum.",Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Biotechnol 2005; 23:1147-57;  PMID:16151408; http://dx.doi.org/10.1038/nbt1137 2.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Rev Mol Cell Biol 2007; 8:603-12; PMID:17609668; http://dx.doi.org/10.1038/nrm2216 4.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Rev Mol Cell Biol 2005; 6:112-26; PMID:15687999; http://dx.doi.org/10.1038/nrm1571 5.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Cell 2005; 18:519-31; PMID:15916959; http://dx.doi.org/10.1016/j.molcel.2005.04.019 6.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Science 1998; 282:1327-32; PMID:9812899; http://dx.doi.org/10.1126/science.282.5392.1327 7.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Rev Mol Cell Biol 2011; 12:517-33; PMID:21779028; http://dx.doi.org/10.1038/nrm3151 8.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Dev Cell 2009; 17:811-22; PMID:20059951; http://dx.doi.org/10.1016/j.devcel.2009.11.005 10.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Cell Sci 2011; 124:133-43; PMID:21172823; http://dx.doi.org/10.1242/jcs.072686 11.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nature 2006; 441:528-31; PMID:16648839; http://dx.doi.org/10.1038/nature0471812.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Cell Biol 1999; 1:27-32; PMID:10559860; http://dx.doi.org/10.1038/8997 13.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cell 1998; 93:1021-9; PMID:9635431; http://dx.doi.org/10.1016/S0092-8674(00)81207-6 14.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Rev Mol Cell Biol 2009; 10:513-25; PMID:19603039; http://dx.doi.org/10.1038/nrm2728 15.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
T raffic 2012; 13:94-107; PMID:21973056; http://dx.doi.org/10.1111/j.1600-0854.2011.01297.x 17.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Cell Biol 1987; 105:2723-33; PMID:2447098; http://dx.doi.org/10.1083/jcb.105.6.2723 18.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat  Rev Mol Cell Biol 2004; 5:121-32; PMID:15040445; http://dx.doi.org/10.1038/nrm1315 19.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Biol Cell 2004; 15:4500-11; PMID:15292453; http://dx.doi.org/10.1091/mbc.E04-05-0432 20.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Cell Biol 1997; 139:49-61; PMID:9314528; http://dx.doi.org/10.1083/jcb.139.1.49 21.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Biol Cell 2004; 15:3542-52; PMID:15146059; http://dx.doi.org/10.1091/mbc.E04-02-0151 22.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Biol Cell 2003; 14:417-31; PMID:12589044; http://dx.doi.org/10.1091/mbc.02-04-0053 23.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
EMBO  J 2011; 30:3481-500; PMID:21878991; http://dx.doi.org/10.1038/emboj.2011.28624.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Cell Physiol 1987; 131:200-9; PMID:2438291; http://dx.doi.org/10.1002/jcp.1041310209 25.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Curr Opin Cell Biol 2006; 18:422-8; PMID:16781134; http://dx.doi.org/10.1016/j.ceb.2006.06.002 26.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Biochem Biophys Res Commun 2012; 427:185-90; PMID:22995293; http://dx.doi.org/10.1016/j.bbrc.2012.09.040 29.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Cell Sci 2006;  119:3723-31; PMID:16959902; http://dx.doi.org/10.1242/jcs.03216 30.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Oncogene 2000; 19:6102-14; PMID:11156523; http://dx.doi.org/10.1038/sj.onc.1203973 31.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Cell Biol 1983; 96:1824-8; PMID:6304116; http://dx.doi.org/10.1083/jcb.96.6.1824 32.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
T raffic 2009; 10:1115-27; PMID:19531065; http://dx.doi.org/10.1111/j.1600-0854.2009.00943.x 34.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Eur J Immunol 1999; 29:733-44; PMID:10092075; http://dx.doi.org/10.1002/(SICI)1521-4141(199903)29:03<733::AID-IMMU733>3.0.CO;2-C,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cancer Res 2006; 66:4426-33; PMID:16618769; http://dx.doi.org/10.1158/0008-5472.CAN-05-4489 64.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cancer Res 2008; 68:9280-90; PMID:19010901; http://dx.doi.org/10.1158/0008-5472.CAN-08-1776 66.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Cancer Ther 2012; 11:1133-42; PMID:22408268; http://dx.doi.org/10.1158/1535-7163.MCT-11-0727 67.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Annu Rev Med 2012; PMID:23043493; http://dx.doi.org/10.1146/annurev-med-050311-201823 68.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Curr Opin Pharmacol 2005; 5:543-9; PMID:16087399; http://dx.doi.org/10.1016/j.coph.2005.04.017 69.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Med Sci (Paris) 2009; 25:1046-52; PMID:20035677; http://dx.doi.org/10.1051/medsci/200925121046 70.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Clin Cancer Res 2011; 17:6437-47; PMID:22003071; http://dx.doi.org/10.1158/1078-0432.CCR-11-0762 71.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
N Engl J Med 2012; 367:1783-91; PMID:23020162; http://dx.doi.org/10.1056/NEJMoa1209124 72.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Bioconjug Chem 2002; 13:40-6; PMID:11792177; http://dx.doi.org/10.1021/bc0100206 74.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Blood 2010; 115:2586-91; PMID:20103782; http://dx.doi.org/10.1182/blood-2009-10-24647050.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Cancer Ther 2008; 7:2233-40; PMID:18645032; http://dx.doi.org/10.1158/1535-7163.MCT-08-0067 53.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Adv Drug Deliv Rev 2008; 60:1421-34; PMID:18541331; http://dx.doi.org/10.1016/j.addr.2008.04.012 54.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Clin Cancer Res 2011; 17:1509-20; PMID:21177408; http://dx.doi.org/10.1158/1078-0432.CCR-10-1654 55.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Mol Biol 1996; 255:28-43; PMID:8568873; http://dx.doi.org/10.1006/jmbi.1996.0004 56.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Mol Biol 1996; 263:551-67; PMID:8918938; http://dx.doi.org/10.1006/jmbi.1996.0598 57.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cancer Res 2010; 70:1595-605; PMID:20124480; http://dx.doi.org/10.1158/0008-5472.CAN-09-2724 59.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Mol Cancer Ther 2009; 8:2861-71; PMID:19825804; http://dx.doi.org/10.1158/1535-7163.MCT-09-0195 60.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cancer Res 2009; 69:2358-64; PMID:19258515; http://dx.doi.org/10.1158/0008-5472.CAN-08-2250 61.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Biotechnol 2003; 21:778-84; PMID:12778055; http://dx.doi.org/10.1038/nbt832 62.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cancer Res 2006; 66:3214-21; PMID:16540673; http://dx.doi.org/10.1158/0008-5472.CAN-05-397335.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Science 2001; 294:1307-13; PMID:11588219; http://dx.doi.org/10.1126/science.1063866 38.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Cell Biol 2002; 4:222-31; PMID:11836526; http://dx.doi.org/10.1038/ncb758 39.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Drugs Today (Barc) 2009; 45:189-97; PMID:19436841; http://dx.doi.org/10.1358/dot.2009.45.3.1343794 41.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Nat Biotechnol 2010; 28:1203-7; PMID:20953198; http://dx.doi.org/10.1038/nbt.1691 42.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Biol Chem 2012; 287:11090-7; PMID:22294692; http://dx.doi.org/10.1074/jbc.M111.319764 43.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Biochemistry 2008; 47:8638-47; PMID:18652486; http://dx.doi.org/10.1021/bi800444t 44.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Biochemistry 2007; 46:2398-410; PMID:17279774; http://dx.doi.org/10.1021/bi061958v 45.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
J Biol Chem 2010; 285:38524-33; PMID:20889499; http://dx.doi.org/10.1074/jbc.M110.172072 46.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Cancer Res 2011; 71:2250-9; PMID:21406401; http://dx.doi.org/10.1158/0008-5472.CAN-10-2277 47.,Non-OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
Ann N Y Acad Sci 1987; 507:199-210; PMID:3327413; http://dx.doi.org/10.1111/j.1749-6632.1987.tb45802.x 49.,OADS,/arxiv_data1/oa_pdf/61/59/mabs-5-13.PMC3564878.pdf
"Abuqayyas, Lubna State University of New York at Buffalo; USA Agrawal, Neeraj Massachusetts Institute of Technology;USA Alavattam, Sreedhara Genentech; USA Ambrogelly, Alexandre Merck and Co; USA Anumula, Kalyan Virdante Pharmaceuticals; USA Arbabi, Mehdi National Institute of Genetic Engineering and Biotechnology; Iran Arora, Taruna NGM Biopharmaceuticals, Inc.;USA Aucoin, Marc University of Waterloo; Canada Baecher-Allan, Clare Brigham and Women’s Hospital;USANote of appreciation to reviewers Janice M. re ichert Editor-in- ch ief, mAbs; Landes Bioscience; Austin, tX UsA *Correspondence to: Janice M. Reichert; Email: janice.reichert@landesbioscience.com Submit te d: 11/11/12; Accepte d: 11/11/12http://dx.doi.org/10.4161/mabs.22977Baeuerle, Patrick Micromet; Germany Balthasar, Joseph State University of New York at Buffalo; USA Bardwell, Philip Abbott Bioresearch Center; USA Barelle, Caroline University of Aberdeen; Scotland Beck, Alain Centre d’Immunologie Pierre Fabre; France Benhar, Itai Tel-Aviv University; Israel Berger, Scott Waters Corporation; USA Berry, Jody Becton Dickinson; USA Bhambhani, Akhilesh Merck and Co; USA Bommarius, Andreas Georgia Institute of Technology/Center for Fundamental and Applied Molecular Evolution; USA Bondarenko, Pavel Amgen; USA Brorson, Kurt Food and Drug Administration; USA Byrd, John Ohio State University; USA Carfi, Andrea Novartis; USACasacó, AngelCenter of Molecular Immunology; Cuba Chan, Laurence University of Colorado; USA Chari, Ravi ImmunoGen; USA Cheng, Kuang-Chuan Bristol-Myers Squibb; USA Cohen, Steven Waters Corporation; USA Correia, Ivan Abbott Bioresearch Center; USA Corvaia, Nathalie Centre d’Immunologie Pierre Fabre; France Cragg, Mark University of Southampton; UK Currie, Graeme Regeneron; USA Das, Tapan Pfizer; USA Deng, Rong Genentech; USA Deonarain, Mahendra Imperial College London; UK Diya, Ren Gilead Sciences Inc.; USA Doppalapudi, Venkata Pfizer; USA Feng, Yang National Institutes of Health; USA",Non-OADS,/arxiv_data1/oa_pdf/b3/19/mabs-5-171.PMC3564882.pdf
"thudium@novartis.com and Sanela.Bilic@Novartis.comSubmitted: 10/23/2012; Revised: 11/14/2012; Accepted: 11/15/2012http://dx.doi.org/10.4161/mabs.22909th e American Association of ph armaceutical Scientists  (AAp S) na tional Biotechnology Conference Short Course  “tr anslational Challenges in Developing Antibody-Drug  Conjugates (ADCs),” held May 24, 2012 in San Diego, CA,  was organized by members of the  ph armacokinetics,  ph armacodynamics and Drug Metabolism section of AA p S.  Representatives from the pharmaceutical industry, regulatory authorities, and academia in the US and  eu rope attended this  short course to discuss the translational challenges in ADC development and the importance of characterizing these molecules early in development to achieve therapeutic utility in patients.",Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
MAbs 2011; 3:61-6;  PMID:20962582;  http://dx.doi.org/10.4161/mabs.3.1.13799 2.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Clin Pharmacol Ther 2012; 92:520-7;  PMID:22968044;  http://dx.doi.org/10.1038/clpt.2012.153 3.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Blood 2012; 120:1975-84;  PMID:22665936;  http://dx.doi.org/10.1182/blood-2012-04-420968 4.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
J Clin Oncol 2011; 29:398-405; PMID:21172893 ;  http://dx.doi.org/10.1200/JCO.2010.29.58655.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
J Clin Oncol 2010; 28:2698-704;  PMID:20421541;  http://dx.doi.org/10.1200/JCO.2009.26.2071 6.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Pharm Res 2012; 29:2354-66;  PMID:22740180;  http://dx.doi.org/10.1007/s11095-012-0800-y 8.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Cancer Chemother Pharmacol 2012; 70:591-601;  PMID:22886072;  http://dx.doi.org/10.1007/s00280-012-1934-79.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Curr Drug Metab 2012; 13:901-10;  PMID:22475269 ;  http://dx.doi.org/10.2174/138920012802138598 10.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Cancer Chemother Pharmacol 2012; 69:1229-40;  PMID:22271209 ;  http://dx.doi.org/10.1007/s00280-011-1817-3 11.,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
Curr Drug Metab 2012; 13:911-22;  PMID:22475266 ;  http://dx.doi.org/10.2174/138920012802138688,Non-OADS,/arxiv_data1/oa_pdf/42/36/mabs-5-5.PMC3564886.pdf
"Do not distribute.mAbs 5:1, 70–79; January/February 2013; © 2013 Landes Bioscience Repo Rt 70 mA bs  V olume 5 Issue 1*Correspondence to: Luis Alvarez-Vallina; Email: lalvarezv.hpth@salud.madrid.org Submitted: 10/02/12; Revised: 10/26/12; Accepted: 10/28/12http://dx.doi.org/10.4161/mabs.22698Introduction Monoclonal antibodies (mAbs) are one of the fastest growing  classes of therapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
EMBO J 2003; 22:1508-17; PMID:12660158; http://dx.doi.org/10.1093/emboj/cdg150 26.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Science 1979; 206:347-9; PMID:314668; http://dx.doi.org/10.1126/sci-ence.314668 27.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Cancer Gene Ther 2007; 14:380-8; PMID:17218946; http://dx.doi.org/10.1038/sj.cgt.7701021 28.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
PLoS ONE 2009; 4:e7174; PMID:19777065; http://dx.doi.org/10.1371/journal.pone.0007174 29.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Methods Enzymol 2003; 374:461-91; PMID:14696385; http://dx.doi.org/10.1016/S0076-6879(03)74020-8 30.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
J Biol Chem 2006; 281:34610-6; PMID:16954221; http://dx.doi.org/10.1074/jbc.M603275200 31.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Nucleic Acids Res 2000; 28:235-42; PMID:10592235; http://dx.doi.org/10.1093/nar/28.1.235 32.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Nucleic Acids Res 1997; 25:3389-402; PMID:9254694; http://dx.doi.org/10.1093/nar/25.17.3389 33.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Biochem J 2000; 346:519-28; PMID:10677374; http://dx.doi.org/10.1042/0264-6021:3460519 34.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
J Mol Biol 2009; 392:787-802; PMID:19631658; http://dx.doi.org/10.1016/j.jmb.2009.07.057 35.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Proteins 1992; 14:309-23; PMID:1409577; http://dx.doi.org/10.1002/prot.34014021614.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Int J Cancer 2006; 119:455-62; PMID:16477626; http://dx.doi.org/10.1002/ijc.21851 16.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
PLoS ONE 2009; 4:e5381; PMID:19401768; http://dx.doi.org/10.1371/journal.pone.0005381 17.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
MAbs 2012; 4:226-32; PMID:22453098; http://dx.doi.org/10.4161/mabs.4.2.19140 18.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Cell 1983; 34:727-37; PMID:6605198; http://dx.doi.org/10.1016/0092-8674(83)90529-9 19.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
J Exp Med 1983; 158:988-93; PMID:6604129; http://dx.doi.org/10.1084/jem.158.3.988 20.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
PLoS ONE 2012; 7:e39097; http://dx.doi.org/10.1371/ journal.pone.0039097 22.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
FASEB J 2008; 22:3795-804; PMID:18635738; http://dx.doi.org/10.1096/fj.08-111484 23.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
MAbs 2009; 1:539-47; PMID:20073127; http://dx.doi.org/10.4161/mabs.1.6.10015 24.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Gene Ther 2002; 9:1049-53; PMID:12101437; http://dx.doi.org/10.1038/sj.gt.3301725References 1.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Acta Pharmacol Sin 2005; 26:641-8; PMID:15916728; http://dx.doi.org/10.1111/j.1745-7254.2005.00135.x 3.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
MAbs 2012; 4:182-97; PMID:22453100; http://dx.doi.org/10.4161/mabs.4.2.19000 4.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
T rends Biotechnol 2010; 28:355-62; PMID:20447706; http://dx.doi.org/10.1016/j.tibtech.2010.03.007 5.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Nat Biotechnol 2005; 23:1126-36; PMID:16151406; http://dx.doi.org/10.1038/nbt1142 6.,OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Biochemistry 1992; 31:1579-84; PMID:1737014; http://dx.doi.org/10.1021/bi00121a001 7.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Cancer Immunol Immunother 2000; 49:243-52; PMID:10941907; http://dx.doi.org/10.1007/s002620000115 8.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Nat Biotechnol 2003; 21:1486-92; PMID:14634668; http://dx.doi.org/10.1038/nbt916 11.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Blood 2003; 102:4384-92; PMID:12933583; http://dx.doi.org/10.1182/blood-2003-04-1039 12.,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Mol Immunol 2000; 37:1067-77; PMID:11399324; http://dx.doi.org/10.1016/S0161-5890(01)00023-2,Non-OADS,/arxiv_data1/oa_pdf/e7/13/mabs-5-70.PMC3564888.pdf
Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)Molecular Therapy–Nucleic Acids is an open-access jour- nal published by Nature Publishing Group.,OADS,/arxiv_data1/oa_pdf/84/52/mtna201258a.PMC3564974.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/84/52/mtna201258a.PMC3564974.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/ncomms2351.PMC3564975.pdf
"Reprints and permission information is available online atx http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Dumcenco, D.O.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/ncomms2351.PMC3564975.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2351 ARTICLE NATURE COMMUNICATIONS | 4:1351 | DOI: 10.1038/ncomms2351 | www.nature.com/naturecommunications 5 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/ncomms2351.PMC3564975.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 EDITORIAL   Medicine General & Social Medicine Chemical Castration for Sexual Offenders: Physicians’ Views Joo Yong Lee and Kang Su Cho Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2013.28.2.171   •  J Korean Med Sci 2013; 28: 171-172 For the first time in Asia, in July 2011, Korea introduced using  chemical castration on sexual offenders.",Non-OADS,/arxiv_data1/oa_pdf/27/50/jkms-28-171.PMC3565125.pdf
"• Chemical Castration for Sexual Offenders: Physicians’ Views 172  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.171cal castration is no longer effective after it is discontinued; there - fore, the spontaneity for receiving medication is prerequisite to  overcoming this limitation.",Non-OADS,/arxiv_data1/oa_pdf/27/50/jkms-28-171.PMC3565125.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 New Horizons of Acute Myocardial Infarction: From the Korea  Acute Myocardial Infarction Registry  As the first nationwide Korean prospective multicenter data collection registry, the Korea  Acute Myocardial Infarction Registry (KAMIR) launched in November 2005.",Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
"This study was supported by a grant of the  Korea Healthcare technology R&D project, Ministry for Health,  Welfare and Family Affairs (A084869), Korea.http://dx.doi.org/10.3346/jkms.2013.28.2.173  • J Korean Med Sci 2013; 28: 173-180REVIEW Cardiovascular Disorders INTRODUCTION As the first nationwide Korean prospective multicenter data  collection registry, the Korea Acute Myocardial Infarction Reg - istry (KAMIR) launched in November 2005, reflecting real-world  treatment practices and outcomes in Asian patients diagnosed  with acute myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
• New Horizons from the KAMIR 174  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.173RISK FACTORS AND CLINICAL OUTCOMES OF AMI  Well known risk factors for coronary heart disease were also  highly distributed in Korean AMI patients as well as other regis - tries (Table 1) (1-5).,OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
"• New Horizons from the KAMIR http://jkms.org   175  http://dx.doi.org/10.3346/jkms.2013.28.2.173diabetes, and dyslipidemia than male AMI patients.",Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
"• New Horizons from the KAMIR 176  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.1730.41-0.89; P= 0.010) than dual antiplatelet therapy with no dif - ference in the incidence of major bleeding, suggesting superi - ority of triple antiplatelet therapy over dual antiplatelet therapy  in STEMI patients undergoing primary PCI with DES.",Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
• New Horizons from the KAMIR http://jkms.org   177  http://dx.doi.org/10.3346/jkms.2013.28.2.173Table 3.,Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
"• New Horizons from the KAMIR 178  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.1735.9%, P= 0.032 and 3.1% vs 5.9%, P= 0.041) than BMS group  with no difference in the rate of death or MI and MACEs, sug - gesting usefulness of DES in large vessels in AMI patients over  BMS without compromising overall safety.",Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
• New Horizons from the KAMIR http://jkms.org   179  http://dx.doi.org/10.3346/jkms.2013.28.2.173stents for treatment of ST-segment elevation myocardial infarction: with  analyses for diabetic and nondiabetic subpopulation.,Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
• New Horizons from the KAMIR 180  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.1732011; 32: 2999-3054.,Non-OADS,/arxiv_data1/oa_pdf/99/ab/jkms-28-173.PMC3565126.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 The Current Situation of Treatment Systems for Alcoholism   in Korea  Alcoholism is becoming one of the most serious issues in Korea.",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"The majority of the studies described in this review were  presented in a symposium at Asia-Pacific Society for Alcohol  and Addiction Research (APSAAR) in February 2012.http://dx.doi.org/10.3346/jkms.2013.28.2.181  • J Korean Med Sci 2013; 28: 181-189REVIEW Psychiatry & Psychology INTRODUCTION Alcoholism is becoming one of the most serious issues in Korea,  and alcohol consumption and its prevalence is higher in Korea  than in the United States (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"• Treatment Systems for Alcoholism in Korea 182  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.1814.47 trillion KRW for loss of the workforce (29.92%), and 3.77  trillion KRW for other costs (21.91%).",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"We searched national epidemiologic research reports (avail - able at http://kostat.go.kr or http://stat.mw.go.kr), the NCBI  PubMed database (available at http://www.ncbi.nlm.nih.gov),  and the Korean Medical Database (available at http://kmbase.",OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"• Treatment Systems for Alcoholism in Korea http://jkms.org   183  http://dx.doi.org/10.3346/jkms.2013.28.2.181tion Psychiatry (KAAP) from presentations at conferences, ques - tionnaire surveys, and discussions among experts.",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
• Treatment Systems for Alcoholism in Korea 184  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.181peutic dose of naltrexone is 25-100 mg.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
• Treatment Systems for Alcoholism in Korea http://jkms.org   185  http://dx.doi.org/10.3346/jkms.2013.28.2.181Korea.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"• Treatment Systems for Alcoholism in Korea 186  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.181Alcohol treatment systems in Korea  In Korea, based on the forms of legal support given in Article 48  and 52 of the Korean Mental Health Law, the alcohol treatment  delivery system is primarily carried out via alcohol counseling  centers that are established and managed in the cities and sec - tions with a population of more than 200,000 people.",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
• Treatment Systems for Alcoholism in Korea http://jkms.org   187  http://dx.doi.org/10.3346/jkms.2013.28.2.181for managing the federal efforts aimed at preventing and reduc - ing underage drinking.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
SAMHSA serves as the lead ICCPUD  agency (https://www.stopalcoholabuse.gov/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"ABAM offers a rigorous certify - ing examination that was developed by an expert panel and the  National Board of Medical Examiners, as well as maintains a  certification examination to ensure that ABAM-certified physi - cians maintain life-long competence in Addiction Medicine  (http://www.abam.net/wp-content/uploads/2010/10/The- American-Board-of-Addiction-Medicine-Who-We-Are1.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"• Treatment Systems for Alcoholism in Korea 188  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.181counseling centers, which are the central organizations for the  provision of services for alcoholism treatment and rehabilita - tion in regional communities, is insufficient.",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
Available at http://stats.oecd.org/In -,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
• Treatment Systems for Alcoholism in Korea http://jkms.org   189  http://dx.doi.org/10.3346/jkms.2013.28.2.181dex.aspx?DataSetCode=HEALTH_LVNG [accessed on 1 November 2011].,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/jkms-28-181.PMC3565127.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Developing a Scoring Guide for the Appraisal of Guidelines for  Research and Evaluation II Instrument in Korea: A Modified  Delphi Consensus Process Korea has a relatively short history in the development and use of clinical practice  guidelines (CPGs).",Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
"Key Words:  Clinical Practice Guideline; Peer ReviewYou Kyoung Lee,1 Ein Soon Shin,2  Jae-Yong Shim,3 Kyung Joon Min,4  Jun-Mo Kim,5 Sun Hee Lee,6  On behalf of the Executive Committee  for CPGs, The Korean Academy of  Medical Sciences 1Department of Laboratory Medicine and Genetics,  Soonchunhyang University College of Medicine,  Bucheon; 2Department of Preventive Medicine &  Public Health, Ajou University School of Medicine,  Suwon; 3Department of Family Medicine, Gangnam  Severance Hospital, Yonsei University Health System,  Seoul; 4Department of Psychiatry, Chung-Ang  University College of Medicine, Seoul; 5Department  of Urology, Soonchunhyang University College of  Medicine, Bucheon; 6Department of Preventive  Medicine, Ewha Womans University School of  Medicine, Seoul, Korea Received: 2 October 2012 Accepted: 7 December 2012 Address for Correspondence: Ein Soon Shin, PhD Department of Preventive Medicine & Public Health,   Ajou University School of Medicine, 164 Worldcup-ro,   Yeongtong-gu, Suwon 443-721, Korea Tel: +82.31-219-5147, Fax: +82.31-219-5084 E-mail: shin2738@ajou.ac.kr This study was supported by a 201 1 research grant for health  policy from the Ministry of Health and Welfare, Republic of  Korea.http://dx.doi.org/10.3346/jkms.2013.28.2.190  • J Korean Med Sci 2013; 28: 190-194ORIGINAL ARTICLE Medicine General & Social Medicine INTRODUCTION The development of clinical practice guidelines (CPGs) in West - ern countries started in the 1980s and increased rapidly in the  1990s.",Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
• Korean Scoring Guide for the AGREE II Instrument http://jkms.org   191  http://dx.doi.org/10.3346/jkms.2013.28.2.190vant to the content and wording of CPGs (6).,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
• Korean Scoring Guide for the AGREE II Instrument 192  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.190fied Delphi  process are available on the website of the Korean  Medical Guideline Information Center (http://www.guideline.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
• Korean Scoring Guide for the AGREE II Instrument http://jkms.org   193  http://dx.doi.org/10.3346/jkms.2013.28.2.190tions of evaluators during the process of applying the AGREE in - strument in evaluations of the quality of existing CPGs is among  the most difficult problems faced by CPG developers.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
Available at http://www.guideline.or.kr/about/board/ list.php?code=pds2 [accessed on 25 September 2012] 6.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
Available at http://www.agreetrust.org.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
Available at http://www.guideline.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
• Korean Scoring Guide for the AGREE II Instrument 194  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.190or.kr/about/board/viewbody.php?code=pds2&page=1&number=31&ke yfield=&key= [accessed on 25 September 2012].,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
Available at http://www.agreetrust.org/re - source-centre/agree-ii-translations/ [accessed on 16 February 2012].,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
Available at http://www.guideline.or.kr/about/board/ viewbody.php?code=pds2&page=1&number=29&keyfield=&key= [ac - cessed on 14 September 2012]  11.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
Available at http://www.guideline.or.kr/about/ board/list.php?code=pds [accessed on 14 September 2012].12.,Non-OADS,/arxiv_data1/oa_pdf/41/bf/jkms-28-190.PMC3565128.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Seroepidemiology of Varicella-Zoster Virus in Korea This study was designed to assess the immune status of the Korean population against  varicella-zoster virus (VZV) through a seroepidemiologic study.",Non-OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
"2009-E32005-00)  and RP-Grant 2010 of Ewha Womans University to HL and KHK.http://dx.doi.org/10.3346/jkms.2013.28.2.195  • J Korean Med Sci 2013; 28: 195-199ORIGINAL ARTICLE Infectious Diseases, Microbiology & Parasitology INTRODUCTION Varicella-zoster virus (VZV) is an important cause of varicella  (chickenpox) and herpes zoster.",Non-OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
• Seroepidemiology of Varicella 196  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.195were excluded.,Non-OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
• Seroepidemiology of Varicella http://jkms.org   197  http://dx.doi.org/10.3346/jkms.2013.28.2.195DISCUSSION Total seroprevalence against VZV in subjects 1-79 yr of age was  89.6% in Korea.,Non-OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
"• Seroepidemiology of Varicella 198  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.195tries where varicella is a relatively important public health and  socioeconomic problem, where the vaccine is affordable, and  where high (85%-90%) and sustained vaccine coverage can be  achieved.",Non-OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
• Seroepidemiology of Varicella http://jkms.org   199  http://dx.doi.org/10.3346/jkms.2013.28.2.195Crovari P; Seroepidemiology Group.,OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
Available at http://apps.who.int/immunization_ monitoring/en/globalsummary/ScheduleSelect.cfm [accessed on 13  May 2011].,OADS,/arxiv_data1/oa_pdf/6f/90/jkms-28-195.PMC3565129.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Multicenter Retrospective Analysis of the Clinical Features of  Pernicious Anemia in a Korean Population To determine the approximate incidence and clinical features of pernicious anemia in a  Korean population, we retrospectively analyzed clinical data for patients with pernicious  anemia who were diagnosed between 1995 and 2010 at five hospitals in Chungnam  province.",Non-OADS,/arxiv_data1/oa_pdf/37/08/jkms-28-200.PMC3565130.pdf
"Key Words:  Anemia, Pernicious; Vitamin B 12; Anti-Intrinsic Factor Antibody; Anti-Parietal  Cell Antibody; Helicobacter PyloriIk-Chan Song,1 Hyo Jin Lee,1  Han-Jo Kim,2 Sang-Byung Bae,2 Kyu-Taek Lee,2 Young-Jun Yang,3  Suk-Young Park,3 Do-Yeun Cho,4  Nae Yu Kim,5 In-Sung Cho,5 and Deog-Yeon Jo1 1Department of Internal Medicine, Chungnam  National University Hospital, Daejeon; 2Department  of Internal Medicine, Soonchunhyang University  Hospital, Cheonan; 3Department of Internal Medicine,  Daejeon St Mary’s Hospital, Daejeon; 4Department  of Internal Medicine, Konyang University Hospital,  Daejeon; 5Department of Internal Medicine, Eulji  University Hospital, Daejeon, Korea Received: 14 May 2012 Accepted: 16 November 2012 Address for Correspondence: Deog-Yeon Jo, MD Department of Internal Medicine, Chungnam National  University Hospital, 33 Munwha-ro, Jung-gu, Daejeon 301-721,  Korea Tel: +82.42-280-7162, Fax: +82.42-257-5753 E-mail: deogyeon@cnu.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.200  • J Korean Med Sci 2013; 28: 200-204ORIGINAL ARTICLE  Oncology & Hematology INTRODUCTION Pernicious anemia is a megaloblastic anemia caused by intrin - sic factor deficiency secondary to autoimmune destruction of  the acid- and pepsin-secreting portion of the gastric mucosa.",Non-OADS,/arxiv_data1/oa_pdf/37/08/jkms-28-200.PMC3565130.pdf
"• Pernicious Anemia in a Korean Population http://jkms.org   201  http://dx.doi.org/10.3346/jkms.2013.28.2.200out Helicobacter pylori  infection, histologically confirmed severe  atrophic gastritis of the stomach body, or the presence of other  autoimmune disorders.",Non-OADS,/arxiv_data1/oa_pdf/37/08/jkms-28-200.PMC3565130.pdf
"• Pernicious Anemia in a Korean Population 202  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.200loss of > 4.5 kg or > 5% of one’s body weight over the period of  6 months (20.6%), forgetfulness (4.1%), diarrhea (2.0%), and  jaundice (1.0%).",Non-OADS,/arxiv_data1/oa_pdf/37/08/jkms-28-200.PMC3565130.pdf
"• Pernicious Anemia in a Korean Population http://jkms.org   203  http://dx.doi.org/10.3346/jkms.2013.28.2.200to normal values in 40 (90.9%) of 44 patients, and platelet counts  returned to normal values in 56 (88.9%) of 63 patients.",Non-OADS,/arxiv_data1/oa_pdf/37/08/jkms-28-200.PMC3565130.pdf
• Pernicious Anemia in a Korean Population 204  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.200ern cases.,Non-OADS,/arxiv_data1/oa_pdf/37/08/jkms-28-200.PMC3565130.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Combined Primary Tumor and Extracranial Metastasis Status   as Constituent Factor of Prognostic Indices for Predicting the  Overall Survival in Patients with Brain Metastases We retrospectively analyzed the prognostic factors on overall survival (OS) in patients with  brain metastasis (BM) and evaluated the role of combined primary tumor and extracranial  metastasis (ECM) status as a constituent factor for prognostic index.",Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
http://dx.doi.org/10.3346/jkms.2013.28.2.205  • J Korean Med Sci 2013; 28: 205-212ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION Brain metastasis (BM) is a common oncologic problem.,Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
"• Combined Primary Tumor and ECM Status as Constituent Factor  206  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.205largest lesion at the time of SRS), and SIR and GPA did not con - sider the effects of the primary tumor status partly due to diffi - culties in objective assessment and separate evaluation of pri - mary tumor and ECM status.",Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
"• Combined Primary Tumor and ECM Status as Constituent Factor  http://jkms.org   207  http://dx.doi.org/10.3346/jkms.2013.28.2.205cal tumor control of BMs, patients were divided into two treat - ment groups: the WBRT group comprised patients treated with  WBRT alone, and the Intensive Treatment (Intensive Tx) group  consisted of patients treated with surgical resection + WBRT,  SRS, FSRT, or combinations of these.",Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
"• Combined Primary Tumor and ECM Status as Constituent Factor  208  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.205tumor, controlled primary tumor without ECM, time interval to  BM > 24 months, single BM, and largest BM volume > 13 mL  occurred with significantly higher frequently in the Intensive Tx  group than in the WBRT group.",Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
• Combined Primary Tumor and ECM Status as Constituent Factor  http://jkms.org   209  http://dx.doi.org/10.3346/jkms.2013.28.2.205for each) (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
• Combined Primary Tumor and ECM Status as Constituent Factor  210  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.205DISCUSSION Recent advances in imaging and RT technical procedures have  improved the control of BMs in patients.,Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
• Combined Primary Tumor and ECM Status as Constituent Factor  http://jkms.org   21 1  http://dx.doi.org/10.3346/jkms.2013.28.2.205could be helpful to identify subgroups that would benefit from  intensive treatments for BMs and addition of the status of com - bined primary tumor and ECM to the prognostic index could  improve its discriminatory ability.,Non-OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
• Combined Primary Tumor and ECM Status as Constituent Factor  212  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.205metastases.,OADS,/arxiv_data1/oa_pdf/1a/ae/jkms-28-205.PMC3565131.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for  Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma The purpose of this study was to assess the feasibility and efficacy of stereotactic ablative  radiotherapy (SABR) for liver tumor in patients with Barcelona Clinic Liver Cancer (BCLC)-C  stage hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
"Key Words:  Carcinoma, Hepatocellular; Neoplasm Staging; Radiotherapy; Stereotactic  TechniquesSun Hyun Bae,1 Mi-Sook Kim,1  Chul Koo Cho,1 Kum Bae Kim,1  Dong Han Lee,2 Chul Ju Han,3  Su Cheol Park,3 and Young Han Kim4 1Department of Radiation Oncology, 2CyberKnife  Center, 3Department of Internal Medicine,  4Department of Radiology, Korea Institute of  Radiological & Medical Sciences, Seoul, Korea Received: 22 August 2012 Accepted: 26 November 2012 Address for Correspondence: Mi-Sook Kim, MD Department of Radiation Oncology, Korea Institute of  Radiological & Medical Sciences, 75 Nowon-ro, Nowon-gu,  Seoul 139-706, Korea  Tel: +82.2-970-1264, Fax: +82.2-970-2412 E-mail: mskim@kcch.re.kr This work was supported by the National Nuclear R & D  program of the Ministry of Education, Science and Technology,  Republic of Korea (2012).http://dx.doi.org/10.3346/jkms.2013.28.2.213  • J Korean Med Sci 2013; 28: 213-219ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION Hepatocellular carcinoma (HCC) is a highly prevalent disease  in many Asian countries including Korea, accounting for 80% of  the cases worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma 214  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.213liver tumor in patients with BCLC-C stage HCC.,Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma http://jkms.org   215  http://dx.doi.org/10.3346/jkms.2013.28.2.213Follow-up after SABR All patients were regularly followed up at 1 month after the com - pletion of SABR and then at 2-3 month intervals with CT or PET/  CT. Radiographic in-field tumor responses were evaluated by  CT performed 1 month after SABR.,Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma 216  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.213major cause of death with 15 cases.,Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
"• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma http://jkms.org   217  http://dx.doi.org/10.3346/jkms.2013.28.2.213published reports of various treatment modalities for BCLC-C  stage (9-11, 16-20).",Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
"• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma 218  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.213Child-Pugh class is generally considered as one of the most im - portant prognostic factors, because HCC is a complex neoplasm  inserted on a preneoplastic cirrhotic liver and thus variables of  both diseases leading to death should be taken into account (21).",Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
"• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma http://jkms.org   219  http://dx.doi.org/10.3346/jkms.2013.28.2.213sidered a treatment option for BCLC-C stage, especially in Asian  countries.",Non-OADS,/arxiv_data1/oa_pdf/3e/39/jkms-28-213.PMC3565132.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Hematologic Recovery after Tandem High-Dose Chemotherapy  and Autologous Stem Cell Transplantation in Children with  High-Risk Solid Tumors   Although the number of studies using tandem high-dose chemotherapy and autologous  stem cell transplantation (HDCT/autoSCT) for the treatment of high-risk pediatric solid  tumors has been increasing, documentation of hematologic recovery after tandem HDCT/ autoSCT is very limited.",Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
"Key Words:  High-Dose Chemotherapy; Autologous Stem Cell Transplantation; CD34+  Cells; Hematologic Recovery; Iron OverloadMeong Hi Son,1 Dong Hwan Kim,1  Soo Hyun Lee,1 Keon Hee Yoo,1  Ki Woong Sung,1 Hong Hoe Koo,1  Ju Youn Kim,1 Eun Joo Cho,1  Eun Suk Kang,2 and Dae Won Kim2 1Departments of Pediatrics and 2Laboratory  Medicine, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea  Received: 26 August 2012 Accepted: 26 November 2012 Address for Correspondence: Ki Woong Sung, MD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-3529, Fax: +82.2-3410-0043 E-mail: kwsped@skku.eduhttp://dx.doi.org/10.3346/jkms.2013.28.2.220  • J Korean Med Sci 2013; 28: 220-226ORIGINAL ARTICLE   Oncology & Hematology INTRODUCTION Several subsets of pediatric solid tumors have a poor prognosis  despite an initially good response to conventional chemothera - py.",Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
"• Hematologic Recovery after Tandem HDCT/autoSCT  http://jkms.org   221  http://dx.doi.org/10.3346/jkms.2013.28.2.220who underwent the first HDCT/autoSCT but were unable to  proceed to the second HDCT/autoSCT due to TRM during the  first HDCT/autoSCT, tumor progression after the first HDCT/ autoSCT, or parental refusal of the second HDCT/autoSCT were  excluded from the analysis.",Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
• Hematologic Recovery after Tandem HDCT/autoSCT  222  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.220istics with hematologic recovery after tandem HDCT/autoSCT  was performed using the Cox regression analysis.,OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
• Hematologic Recovery after Tandem HDCT/autoSCT  http://jkms.org   223  http://dx.doi.org/10.3346/jkms.2013.28.2.220partial response.,Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
"• Hematologic Recovery after Tandem HDCT/autoSCT  224  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.220eries according to the interval (< 91 days versus ≥ 91 days) be - tween the first and second HDCT/autoSCT ( P= 0.869, P=   0.308, and P= 0.864, respectively).",Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
"• Hematologic Recovery after Tandem HDCT/autoSCT  http://jkms.org   225  http://dx.doi.org/10.3346/jkms.2013.28.2.220successful hematologic recovery after SCT, a substantial num - ber of patients in the present study were transplanted with < 2  ×106 CD34+ cells/kg and consequently needed prolonged trans - fusion support.",Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
• Hematologic Recovery after Tandem HDCT/autoSCT  226  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.22020: 2284-92.,Non-OADS,/arxiv_data1/oa_pdf/2e/2e/jkms-28-220.PMC3565133.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Influence of Body Mass Index, Smoking, and Blood Pressure   on Survival of Patients with Surgically-Treated, Low Stage Renal  Cell Carcinoma: A 14-Year Retrospective Cohort Study  The association of body mass index, smoking, and blood pressure, which are related to the  three well-established risk factors of renal cell carcinoma, and survival in patients with  renal cell carcinoma is not much studied.",Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
"Key Words:  Carcinoma, Renal Cell; Body Mass Index; Smoking; Blood Pressure; SurvivalBumsoo Park,1,2,3 Byong Chang Jeong,1,2 Seong Il Seo,1,2 Seong Soo Jeon,1,2 Han Yong Choi,1 and Hyun Moo Lee1,2 1Department of Urology, 2Institute for Refractory  Cancer Research, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul; 3Department of Urology, Kangnam General  Hospital, Yongin, Korea Received: 5 September 2012 Accepted: 26 December 2012 Address for Correspondence: Hyun Moo Lee, MD Department of Urology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-3559, Fax: +82.2-3410-6992  E-mail besthml@medimail.co.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.227  • J Korean Med Sci 2013; 28: 227-236ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION Obesity, cigarette smoking, and hypertension are three well-es - tablished risk factors for developing renal cell carcinoma (RCC),  and epidemiological studies have consistently suggested evi - dence for an association between these risk factors and the eti - ology of RCC (1-3).",Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
• Survival of Renal Cell Carcinoma Patients 228  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.227obtain survival and the cause of death data available from the  Department of Medical Records in our hospital and the Korea  National Statistics Office.,OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
"• Survival of Renal Cell Carcinoma Patients http://jkms.org   229  http://dx.doi.org/10.3346/jkms.2013.28.2.227rized as underweight, 288 (27.8%) as normal weight, 555 (53.6%)  as overweight, and 170 (16.4%) as obese (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
• Survival of Renal Cell Carcinoma Patients 230  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.227cific survivals ( P= 0.475) among the three groups (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
• Survival of Renal Cell Carcinoma Patients http://jkms.org   231  http://dx.doi.org/10.3346/jkms.2013.28.2.227did not reveal any significant differences in overall ( P= 0.162)  and cancer-specific survivals ( P= 0.973) among the four groups  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
"• Survival of Renal Cell Carcinoma Patients 232  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.227DISCUSSION A number of recent studies have provided evidence indicating  that being overweight and/or obese, as indicated by body mass  index, are favorable prognostic factors in patients with RCC (4- 11).",Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
• Survival of Renal Cell Carcinoma Patients http://jkms.org   233  http://dx.doi.org/10.3346/jkms.2013.28.2.227creased survival.,Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
"• Survival of Renal Cell Carcinoma Patients 234  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.227factors for cancer-specific survival, but not for overall survival  (4, 6-11).",Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
"• Survival of Renal Cell Carcinoma Patients http://jkms.org   235  http://dx.doi.org/10.3346/jkms.2013.28.2.227ate analysis (13, 14).",Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
• Survival of Renal Cell Carcinoma Patients 236  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.227vival of patients with renal cell carcinoma after tumour nephrectomy.,Non-OADS,/arxiv_data1/oa_pdf/d9/02/jkms-28-227.PMC3565134.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Improved Therapeutic Effect against Leukemia by a Combination  of the Histone Methyltransferase Inhibitor Chaetocin and the  Histone Deacetylase Inhibitor Trichostatin A SUV39H1 is a histone 3 lysine 9 (H3K9)-specific methyltransferase that is important for  heterochromatin formation and the regulation of gene expression.",Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
http://dx.doi.org/10.3346/jkms.2013.28.2.237  • J Korean Med Sci 2013; 28: 237-246ORIGINAL ARTICLE  Oncology & Hematology INTRODUCTION Epigenetic deregulations that underlie the development of leu - kemia can be in one of two major categories: changes in the  DNA methylation state and alterations in the histone modifica - tion pattern (1).,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
"• Chaetocin and Trichostatin A against Leukemia 238  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.237concert with to DNA methylation via MeCP2, MBD1, and DNMT  binding (7).",Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
• Chaetocin and Trichostatin A against Leukemia http://jkms.org   239  http://dx.doi.org/10.3346/jkms.2013.28.2.237rpm for 15 min to remove the nuclear and cellular debris.,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
"• Chaetocin and Trichostatin A against Leukemia 240  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.237Kasumi, K562, and THP1 -on apoptosis by Annexin V staining.",Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
• Chaetocin and Trichostatin A against Leukemia http://jkms.org   241  http://dx.doi.org/10.3346/jkms.2013.28.2.237chaetocin for 24 hr.,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
• Chaetocin and Trichostatin A against Leukemia 242  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.237expression of these genes than that achieved through treatment  with chaetocin alone (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
• Chaetocin and Trichostatin A against Leukemia http://jkms.org   243  http://dx.doi.org/10.3346/jkms.2013.28.2.237than in cells treated with chaetocin alone.,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
• Chaetocin and Trichostatin A against Leukemia 244  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.237isolated from fresh BM from seven patients with AML.,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
"• Chaetocin and Trichostatin A against Leukemia http://jkms.org   245  http://dx.doi.org/10.3346/jkms.2013.28.2.237tocin and TSA cooperated in inducing TSG expression, which  may potentially have contributed to the superior antileukemic  activity of the combined treatment in HL60, Kasumi and K562  cells compared to KG1 and THP1 cells.",Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
• Chaetocin and Trichostatin A against Leukemia 246  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.237cer agent chaetocin is a competitive substrate and inhibitor of thioredox - in reductase.,Non-OADS,/arxiv_data1/oa_pdf/a8/79/jkms-28-237.PMC3565135.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Risk of Pancreatic Cancer in Relation to ABO Blood Group and  Hepatitis C Virus Infection in Korea: A Case-Control Study Several studies have reported that ABO blood group, hepatitis B virus (HBV) and hepatitis C  virus (HCV) infection contribute to the development of pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"Key Words:  ABO Blood-Group System; Hepatitis B Virus; Hepatitis C Virus; Pancreatic  Neoplasms; KoreaSang Myung Woo,1 Jungnam Joo,2  Woo Jin Lee,1 Sang-Jae Park,1  Sung-Sik Han,1 Tae Hyun Kim,1  Young Hwan Koh,1 Hyun Bum Kim,1  and Eun Kyung Hong1 1Center for Liver Cancer, 2Biometric Research  Branch, National Cancer Center, Goyang, Korea Received: 8 October 2012 Accepted: 26 December 2012 Address for Correspondence: Woo Jin Lee, MD Center for Liver Cancer, National Cancer Center,   1 1 1 Jungbalsan-ro, Ilsandong-gu, Goyang 410-769, Korea Tel: +82.31-920-1612, Fax: +82.31-920-2798 E-mail: lwj@ncc.re.kr The present study was partly supported by grants from the  National Cancer Center, Korea (Grant numbers 0910220).http://dx.doi.org/10.3346/jkms.2013.28.2.247  • J Korean Med Sci 2013; 28: 247-251ORIGINAL ARTICLE  Oncology & Hematology INTRODUCTION Pancreatic cancer is estimated as the ninth most frequent can - cer and fifth most common cause of cancer-related death in  Korea (1).",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"• ABO Blood Group, Hepatitis B/C Virus, and Pancreatic Cancer 248  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.247ies, these investigators showed that non-O blood types account - ed for 17% of all new pancreatic cancers.",OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"• ABO Blood Group, Hepatitis B/C Virus, and Pancreatic Cancer http://jkms.org   249  http://dx.doi.org/10.3346/jkms.2013.28.2.247or AB) groups after adjusting for age and gender (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"• ABO Blood Group, Hepatitis B/C Virus, and Pancreatic Cancer 250  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.247blood group type, indicating that Lewis antigen expression in  pancreatic cancer is independent of the blood group phenotype  and may be useful as a tumor marker (28).",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"Bethesda: National Cancer Institute, http://seer.cancer.gov/ csr/1975_2001.",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"• ABO Blood Group, Hepatitis B/C Virus, and Pancreatic Cancer http://jkms.org   251  http://dx.doi.org/10.3346/jkms.2013.28.2.247obesity and the risk of pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/cf/d1/jkms-28-247.PMC3565136.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Microalbuminuria is Independently Associated with Arterial  Stiffness and Vascular Inflammation but not with Carotid   Intima-Media Thickness in Patients with Newly Diagnosed   Type 2 Diabetes or Essential Hypertension   The association between microalbuminuria (MAU) and the indices of macrovascular  complication in patients with newly diagnosed type 2 diabetes (D) or essential hypertension  (H) was evaluated.",Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
"Key Words:  Albuminuria; Vascular Stiffness; Carotid Intima-Media Thickness;  InflammationDong Il Shin,1 Ki-Bae Seung,2  Hye Eun Yoon,3 Byung-Hee Hwang,2  Suk Min Seo,1 Seok Joon Shin,3  Pum-Joon Kim,2 Kiyuk Chang,2 and Sang Hong Baek2 1Division of Cardiology, Department of Internal  Medicine, Incheon St. Mary’s Hospital, The Catholic  University of Korea, Incheon; 2Division of Cardiology,  Department of Internal Medicine, Seoul St. Mary’s  Hospital, The Catholic University of Korea, Seoul;  3Division of Nephrology, Department of Internal  Medicine, Incheon St. Mary’s Hospital, The Catholic  University of Korea, Incheon, Korea Received: 30 July 2012 Accepted: 6 December 2012 Address for Correspondence: Ki-Bae Seung, MD Division of Cardiology, Department of Internal Medicine,   Seoul St. Mary’s Hospital, The Catholic University of Korea,   222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel: +82.2-2258-1 139, Fax: +82.2-591-1506      E-mail: kbseung@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.252  • J Korean Med Sci 2013; 28: 252-260ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Patients with type 2 diabetes or essential hypertension general - ly have a substantial burden of the macrovascular complication  including atherosclerotic cardiovascular disease (CVD) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
"• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension http://jkms.org   253  http://dx.doi.org/10.3346/jkms.2013.28.2.252er of microvascular dysfunction, and the indices of macrovas - cular complication such as PWV , IMT, and serum high-sensitiv - ity C-reactive protein (hsCRP) in patients with type 2 diabetes  or essential hypertension have been reported in several previ - ous studies (3, 5, 11-13).",Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension 254  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.252ankle arteries were stored.,OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension http://jkms.org   255  http://dx.doi.org/10.3346/jkms.2013.28.2.252performed on a total of 446 patients (79.9%).,Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
"• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension 256  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.252m/sec vs 14.1 ±1.1 m/sec, 0.8 ± 0.2 mm vs 0.5 ±0.1 mm, and 2.1  (0.6-9.9) mg/L vs 0.6 (0.2-2.4) mg/L, respectively; P< 0.001, Ta - ble 2).",Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension http://jkms.org   257  http://dx.doi.org/10.3346/jkms.2013.28.2.252the level of IMT was similar between both of the groups.,Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension 258  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.252MAU was independently associated with increased aortic stiff - ness in patients with essential hypertension (5).,Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
"• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension http://jkms.org   259  http://dx.doi.org/10.3346/jkms.2013.28.2.252 In conclusion, MAU is independently associated with arterial  stiffness and vascular inflammation but not with IMT in patients  with newly diagnosed type 2 diabetes or essential hypertension,  which emphasizes the importance of proactive clinical investi - gations for atherosclerotic complications in patients with MAU,  even in newly diagnosed diabetes or hypertension.",Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
"• Microalbuminuria in Newly Diagnosed Diabetes or Hypertension 260  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.252DA, Mazumdar M, Ballantyne CM, Paparello JJ, Klemmer PJ.",Non-OADS,/arxiv_data1/oa_pdf/92/33/jkms-28-252.PMC3565137.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Predictive Value of Conjointly Examined IL-1ra, TNF-R I, TNF-R  II, and RANTES in Patients with Primary Glomerulonephritis  Interleukin-1 receptor antagonist (IL-1ra), tumor necrosis factor soluble receptors (sTNF-R)  type I and II, and regulated upon activation, normal T-cell expressed and secreted (RANTES)  play an important role in the modulation of primary glomerulonephritis (GN) course.",Non-OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Key Words:  Immunosuppressive Treatment Outcomes; Interleukin-1 Receptor Antagonist;  Primary Glomerulonephritis; RANTES; Receptors, Tumor Necrosis Factor Rafał Zwiech Department of Kidney Transplantation,   Medical University of Łód ź, Łódź, Poland  Received: 24 April 2012 Accepted: 7 December 2012 Address for Correspondence: Rafał Zwiech, MD Department of Kidney Transplantation, Medical University of  Łódź, Kopcińskiego 22, 90-153 Łód ź, Poland Tel: +48 42 6776709, Fax: +48 42 6783632 E-mail: rafal.zwiech@umed.lodz.plhttp://dx.doi.org/10.3346/jkms.2013.28.2.261  • J Korean Med Sci 2013; 28: 261-267ORIGINAL ARTICLE Nephrology INTRODUCTION It has been well documented that both interleukin-1 and tumor  necrosis factor are major pro-inflammatory cytokines and their  continuous or uncontrolled release may lead to activation of lo - cal immunological response in the kidneys (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Zwiech R  • IL-1ra, TNF-R and RANTES in Predicting Glomerulonephritis 262  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.261MATERIAL AND METHODS The study was conducted on 84 primary glomerulonephritis  patients (45 males and 39 females) whose mean age was 41.44 ±   13.25 yr.",OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Zwiech R  • IL-1ra, TNF-R and RANTES in Predicting Glomerulonephritis http://jkms.org   263  http://dx.doi.org/10.3346/jkms.2013.28.2.261RESULTS No differences in distribution between the R and NR subgroups  were noticed–Fischer’s exact test and chi-square with Yates’s  modification.",OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Zwiech R  • IL-1ra, TNF-R and RANTES in Predicting Glomerulonephritis 264  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.2611ra, TNFR I and II, or RANTES ( P= 0.32, P= 0.38, and P= 0.29,  respectively).",OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Zwiech R  • IL-1ra, TNF-R and RANTES in Predicting Glomerulonephritis http://jkms.org   265  http://dx.doi.org/10.3346/jkms.2013.28.2.261urinary excretion of IL-1 and TNF- α activity inhibitors, and RAN - TES was tested in predicting the course of GN.",OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Zwiech R  • IL-1ra, TNF-R and RANTES in Predicting Glomerulonephritis 266  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.261TES urinary excretion indicates a worse course of GN.",Non-OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"Zwiech R  • IL-1ra, TNF-R and RANTES in Predicting Glomerulonephritis http://jkms.org   267  http://dx.doi.org/10.3346/jkms.2013.28.2.26121.",Non-OADS,/arxiv_data1/oa_pdf/07/91/jkms-28-261.PMC3565138.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Lysophosphatidylcholine, Oxidized Low-Density Lipoprotein  and Cardiovascular Disease in Korean Hemodialysis Patients:  Analysis at 5 Years of Follow-up Although oxidized low-density lipoprotein (LDL) and lysophosphatidylcholine (LPC) have  been proposed as important mediators of the atherosclerosis, the long-term contribution  to the risk of cardiovascular disease (CVD) in hemodialysis patients has not been evaluated.",Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
"Key Words:  Renal Dialysis; Cardiovascular Disease; Lipoproteins; Oxidized LDL;  LysophosphatidylcholinesYoung-Ki Lee,1 Dong Hun Lee,1  Jin Kyung Kim,1 Min-Jeong Park,2  Ji-Jing Yan,3 Dong-Keun Song,3  Nosratola D Vaziri,4 and Jung-Woo Noh1 1Department of Internal Medicine, Hallym Kidney  Research Institute, Hallym University College of  Medicine, Seoul; 2Department of Laboratory  Medicine, Hallym University College of Medicine,  Seoul; 3Department of Pharmacology, Hallym  University College of Medicine, Chuncheon, Korea;  4Division of Nephrology and Hypertension,  Department of Medicine, University of California,  Irvine, Irvine, California, USA Received: 24 June 2012 Accepted: 16 November 2012 Address for Correspondence: Jung-Woo Noh, MD Department of Internal Medicine, Kangnam Sacred Heart  Hospital, Hallym University College of Medicine, 1 Singil-ro,  Yeongdeungpo-gu, Seoul 150-950, Korea Tel: +82.2-829-5108, Fax: +82.2-848-9821 E-mail: jwn8671@unitel.co.kr This work was supported by a grant from Hallym University  Medical Center Research Fund (01-2006-08).http://dx.doi.org/10.3346/jkms.2013.28.2.268  • J Korean Med Sci 2013; 28: 268-273ORIGINAL ARTICLE  Nephrology INTRODUCTION Patients with end-stage renal disease have a high incidence of  cardiovascular disease (CVD).",Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
"• LPC and CVD in Hemodialysis Patients http://jkms.org   269  http://dx.doi.org/10.3346/jkms.2013.28.2.268en, mean age 56.2 ±12.1 yr) and 33 controls (16 men and 17  women, mean age 55.6 ±12.2 yr).",Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
• LPC and CVD in Hemodialysis Patients 270  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.2680.01) and albumin (r = 0.25; P= 0.03) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
"• LPC and CVD in Hemodialysis Patients http://jkms.org   271  http://dx.doi.org/10.3346/jkms.2013.28.2.26812 patients were transferred to other centers, and five patients  were transplanted.",Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
• LPC and CVD in Hemodialysis Patients 272  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.268taneous administration of LPC protected mice against sepsis  after cecal ligation and puncture or intraperitoneal injection of  Escherichia coli (12).,Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
• LPC and CVD in Hemodialysis Patients http://jkms.org   273  http://dx.doi.org/10.3346/jkms.2013.28.2.26810.,Non-OADS,/arxiv_data1/oa_pdf/a6/d8/jkms-28-268.PMC3565139.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Comparison of Immune Response by Virus Infection and  Vaccination to 2009 Pandemic Influenza A/H1N1 in Children We aimed to compare the immune response induced by natural infection with 2009  pandemic influenza A/H1N1 (pH1N1) virus and by monovalent pH1N1 vaccination in  children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.2.274  • J Korean Med Sci 2013; 28: 274-279ORIGINAL ARTICLE Pediatrics INTRODUCTION Novel swine-origin influenza A/H1N1 virus infection originat - ed in Mexico in April 2009 and was determined to be the cause  of febrile respiratory illness (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
• Comparison of Immune Response by pH1N1 Infection and Vaccination http://jkms.org   275  http://dx.doi.org/10.3346/jkms.2013.28.2.274fuged and stored at -70°C until analysis.,OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
• Comparison of Immune Response by pH1N1 Infection and Vaccination 276  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.274ly (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
• Comparison of Immune Response by pH1N1 Infection and Vaccination http://jkms.org   277  http://dx.doi.org/10.3346/jkms.2013.28.2.274of GMT between group A and B was more prominent (Table 3).,OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
• Comparison of Immune Response by pH1N1 Infection and Vaccination 278  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.274infected with influenza and not visit the hospital for laboratory  test confirmation.,Non-OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
"• Comparison of Immune Response by pH1N1 Infection and Vaccination http://jkms.org   279  http://dx.doi.org/10.3346/jkms.2013.28.2.274Stanton BF , editors.",Non-OADS,/arxiv_data1/oa_pdf/5b/f8/jkms-28-274.PMC3565140.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prevalence, Work-Loss Days and Quality of Life of Community  Dwelling Subjects with Depressive Symptoms  The nationwide prevalence of major depressive disorder in Korea is lower than most  countries, despite the high suicide rate.",Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
"Key Words:  Depression; Depressive Disorder, Major; Prevalence; Quality of Life; Mental  Health Jee Hoon Sohn,1,2,3 Seung Hee Ahn,3  Su Jeong Seong,2 Ji Min Ryu,2 and Maeng Je Cho2,4 1Division of Public Medicine Health Service, Seoul  National University Hospital, Seoul; 2Department of  Neuropsychiatry, Seoul National University Hospital,  Seoul; 3Jongno Community Mental Health Center,  Seoul; 4Department of Psychiatry and Behavioral  Science, Seoul National University College of  Medicine, Seoul, Korea Received: 25 October 2012 Accepted: 18 December 2012 Address for Correspondence: Maeng Je Cho, MD Department of Psychiatry & Behavioral Science, Seoul National  University College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 1 10-744, Korea Tel: +82.2-2072-3155, Fax: +82.2-747-5774 E-mail: mjcho@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.280  • J Korean Med Sci 2013; 28: 280-286ORIGINAL ARTICLE Psychiatry & Psychology INTRODUCTION So-called “common mental disorders” like depressive and anx - iety disorders are important concerns in communities.",Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
"• Functional Disability of Depressive Symptom  http://jkms.org   281  http://dx.doi.org/10.3346/jkms.2013.28.2.280old depression, which often has enough symptoms but cannot  achieve a formal diagnosis of depressive disorder according to  the Diagnostic and Statistical Manual of Mental Disorders, Fourth  edition (DSM-IV), or the International Classification of Diseases,  10th edition (ICD-10).",Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
"• Functional Disability of Depressive Symptom  282  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.280used by several previous studies dealing with the relationship  between work-loss days and common mental disorders (1, 23,  24).",Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
"• Functional Disability of Depressive Symptom  http://jkms.org   283  http://dx.doi.org/10.3346/jkms.2013.28.2.280 Among these, we found that about 2.24% of the study sample  had a major depressive disorder at the time of the diagnostic in - terview, and another 0.68% had dysthymic disorder.",Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
• Functional Disability of Depressive Symptom  284  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.280not function properly for around 1.4 days per month.,Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
• Functional Disability of Depressive Symptom  http://jkms.org   285  http://dx.doi.org/10.3346/jkms.2013.28.2.280categorical diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
• Functional Disability of Depressive Symptom  286  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.280subthreshold depressive symptoms?,Non-OADS,/arxiv_data1/oa_pdf/03/f7/jkms-28-280.PMC3565141.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Periarticular Osteoporosis Is a Prominent Feature in Early  Rheumatoid Arthritis: Estimation Using Shaft to Periarticular  Bone Mineral Density Ratio We aimed to quantify periarticular osteoporosis and investigate its significance in 45  patients with rheumatoid arthritis (RA) and 106 controls.",Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.2.287  • J Korean Med Sci 2013; 28: 287-294ORIGINAL ARTICLE  Musculoskeletal Disorders INTRODUCTION Rheumatoid arthritis (RA) is a paradigm of chronic and inflam - matory polyarthritis, particularly of the small joints of the hands  and feet.",Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
"• Osteoporosis in Early Rheumatoid Arthritis 288  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.287RA, the quantification of periarticular osteopenia, which is a  feature of early RA, could assist the identification of early RA.",Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
"• Osteoporosis in Early Rheumatoid Arthritis http://jkms.org   289  http://dx.doi.org/10.3346/jkms.2013.28.2.287of the peri and mid regions, we designed simple formulae as  follows.",Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
"• Osteoporosis in Early Rheumatoid Arthritis 290  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.287lar (peri) and nonperiarticular area, the peri BMD of one finger  was subtracted from the mid BMD of the same finger, and the  remainder was compared between two groups (= x - x´).",Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
• Osteoporosis in Early Rheumatoid Arthritis http://jkms.org   291  http://dx.doi.org/10.3346/jkms.2013.28.2.287also higher for the left and for both hands of early RA patients.,Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
• Osteoporosis in Early Rheumatoid Arthritis 292  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.287Risk factors for periarticular osteoporosis Clinical variables from the 45 patients with RA were collected to  determine clinical conditions related to the loss of juxta-articu - lar bone minerals.,OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
"• Osteoporosis in Early Rheumatoid Arthritis http://jkms.org   293  http://dx.doi.org/10.3346/jkms.2013.28.2.287 However, bone mineral wasting is silent, and the clinical def - inition of periarticular osteoporosis is very subtle.",Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
• Osteoporosis in Early Rheumatoid Arthritis 294  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.2873.,Non-OADS,/arxiv_data1/oa_pdf/d1/7e/jkms-28-287.PMC3565142.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Attenuation of Spinal Cord Injury-Induced Astroglial and  Microglial Activation by Repetitive Transcranial Magnetic  Stimulation in Rats Spinal cord injury (SCI) causes not only loss of sensory and motor function below the level  of injury but also chronic pain, which is difficult and challenging of the treatment.",Non-OADS,/arxiv_data1/oa_pdf/88/63/jkms-28-295.PMC3565143.pdf
"Key Words:  Spinal Cord Injury; Repetitive Transcranial Magnetic Stimulation; Microglia;  AstrocytesJi Young Kim,1 Gyu-Sik Choi,2  Yun-Woo Cho,2 HeeKyung Cho,2 Se-Jin Hwang,3 and Sang-Ho Ahn1,2 1Clinical Trial Center for Medical Devices of  Yeungnam University Hospital, Daegu; 2Department  of Rehabilitation Medicine, School of Medicine,  Yeungnam University, Daegu; 3Department of  Anatomy and Cell Biology, School of Medicine,  Hanyang University, Seoul, Korea Received: 18 September 2012 Accepted: 8 January 2013 Address for Correspondence: Sang-Ho Ahn, MD Department of Rehabilitation Medicine & Spine Center, School  of Medicine, and Chairman in Clinical Trial Center for Medical  Devices, Yeungnam University, 170 Hyeonchung-ro, Nam-gu,  Daegu 705-703, Korea Tel: +82.53-624-8353, Fax: +82.53-624-8356 E-mail: spineahn@ynu.ac.kr This research was supported by a grant from the Yeungnam  University Medical Center (2007).http://dx.doi.org/10.3346/jkms.2013.28.2.295  • J Korean Med Sci 2013; 28: 295-299ORIGINAL ARTICLE Rehabilitation & Sports Medicine INTRODUCTION Spinal cord injury (SCI) results in initial loss of motor, sensory,  and autonomic functions below the lesion (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/88/63/jkms-28-295.PMC3565143.pdf
"• Reduced Neuroglial Activation by rTMS in SCI Rats 296  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.295MATERIALS AND METHODS Animals and the induction of contusion injury All experiments with adult Sprague-Dawley rats (230-250 g, fe - male) were carried out in accordance with the guidelines issued  by the institutional animal care and use committee at the Yeung - nam University, Daegu, Korea.",Non-OADS,/arxiv_data1/oa_pdf/88/63/jkms-28-295.PMC3565143.pdf
• Reduced Neuroglial Activation by rTMS in SCI Rats http://jkms.org   297  http://dx.doi.org/10.3346/jkms.2013.28.2.295observed (Fig.,Non-OADS,/arxiv_data1/oa_pdf/88/63/jkms-28-295.PMC3565143.pdf
• Reduced Neuroglial Activation by rTMS in SCI Rats 298  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.295activations were found to be efficiently attenuated by rTMS.,OADS,/arxiv_data1/oa_pdf/88/63/jkms-28-295.PMC3565143.pdf
"• Reduced Neuroglial Activation by rTMS in SCI Rats http://jkms.org   299  http://dx.doi.org/10.3346/jkms.2013.28.2.295Tani N, Kato A, Yoshimine T. Reduction of intractable deafferentation  pain due to spinal cord or peripheral lesion by high-frequency repetitive  transcranial magnetic stimulation of the primary motor cortex.",Non-OADS,/arxiv_data1/oa_pdf/88/63/jkms-28-295.PMC3565143.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Intrathecal Lamotrigine Attenuates Antinociceptive Morphine  Tolerance and Suppresses Spinal Glial Cell Activation in  Morphine-Tolerant Rats Glial cells play a critical role in morphine tolerance, resulting from repeated administration  of morphine.",Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
"Key Words:  Astrocyte; Intrathecal; Lamotrigine; Microglia; Morphine; ToleranceIn-Gu Jun, Sung-Hoon Kim,   Yang-In Yoon, and Jong-Yeon Park Department of Anesthesiology and Pain Medicine,  Asan Medical Center, University of Ulsan College of  Medicine, Seoul, Korea Received: 4 March 2012 Accepted: 16 November 2012 Address for Correspondence: Jong-Yeon Park, MD Department of Anesthesiology and Pain Medicine, Asan Medical  Center, University of Ulsan College of Medicine, 88 Olympic-ro  43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-3868, Fax: +82.2-470-1363 E-mail: jongyeon_park@amc.seoul.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.300  • J Korean Med Sci 2013; 28: 300-307ORIGINAL ARTICLE  Anesthesiology & Pain INTRODUCTION Morphine is the most widely used narcotic analgesic for reliev - ing severe or chronic pain but its repeated administration leads  to a characteristic tolerance (1).",Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation http://jkms.org   301  http://dx.doi.org/10.3346/jkms.2013.28.2.300 Pre- and post-synaptic neuronal membranes as well as glial  cells express several different classes of glutamate receptors (16).,Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
"• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation 302  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.300acidic protein (GFAP), respectively.",Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation http://jkms.org   303  http://dx.doi.org/10.3346/jkms.2013.28.2.300sulted in significantly larger antinociceptive responses than  morphine alone ( P< 0.001) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation 304  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.300phine.,Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
"• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation http://jkms.org   305  http://dx.doi.org/10.3346/jkms.2013.28.2.300development and expression of morphine tolerance, as evi - denced by the suppression of spinal glial cell activation.",Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation 306  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.3003.,Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
• Intrathecal Lamotrigine Attenuates Morphine Tolerance and Suppresses Glial Activation http://jkms.org   307  http://dx.doi.org/10.3346/jkms.2013.28.2.300C-fibers innervating the plantar rat hindpaw one day after an incision.,Non-OADS,/arxiv_data1/oa_pdf/94/5b/jkms-28-300.PMC3565144.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Intrathecal Gabapentin Increases Interleukin-10 Expression   and Inhibits Pro-Inflammatory Cytokine in a Rat Model of  Neuropathic Pain We examined the possible anti-inflammatory mechanisms of gabapentin in the  attenuation of neuropathic pain and the interaction between the anti-allodynic effects of  gabapentin and interleukin-10 (IL-10) expression in a rat model of neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
"Key Words:  Allodynia; Gabapentin; Interleukin-10; Intrathecal; Pro-inflammatory  CytokinesByung-Sang Lee,1 In-Gu Jun,2  Sung-Hoon Kim,2 and Jong Yeon Park2 1Department of Anesthesiology and Pain Medicine,  CHA Medical Center, CHA University, Gumi;  2Department of Anesthesiology and Pain Medicine,  Asan Medical Center, University of Ulsan College of  Medicine, Seoul, Korea  Received: 6 September 2012 Accepted: 26 December 2012 Address for Correspondence: Jong-Yeon Park, MD  Department of Anesthesiology and Pain Medicine, Asan Medical  Center, University of Ulsan College of Medicine, 88 Olympic-ro  43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-3868, Fax: +82.2-470-1363 E-mail: jongyeon_park@amc.seoul.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.308  • J Korean Med Sci 2013; 28: 308-314ORIGINAL ARTICLE  Anesthesiology & Pain INTRODUCTION Peripheral nerve injury may lead to a chronic pain condition  called neuropathic pain, which is characterized by dysesthesia  (unpleasant, abnormal sensations), hyperalgesia (increased  sensitivity to a normally painful stimulus) and allodynia (pain  due to a normally painless stimulus) (1).",Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
"• Intrathecal Gabapentin Increases Interleukin-10 Expression http://jkms.org   309  http://dx.doi.org/10.3346/jkms.2013.28.2.308neuropathic pain (15), such as diabetic neuropathy (13) and  postherpetic neuralgia (14, 16).",Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
"• Intrathecal Gabapentin Increases Interleukin-10 Expression 310  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.308min intervals, and the mean value was used as the force required  to produce withdrawal responses.",OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
"• Intrathecal Gabapentin Increases Interleukin-10 Expression http://jkms.org   31 1  http://dx.doi.org/10.3346/jkms.2013.28.2.308577.4 ±97.1 pg/mL, P< 0.05; IL-6, 254.0 ±64.8 pg/mL vs 125.5 ±   44.1 pg/mL, P< 0.05).",Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
• Intrathecal Gabapentin Increases Interleukin-10 Expression 312  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.308The role of anti-IL-10 antibodies and gabapentin   in anti-allodynia in SNL rats Daily intrathecal injections of anti-IL-10 antibody (10 μg) had  an inhibitory effect on the anti-allodynic effects of gabapentin  while intrathecal injections of anti-IL-10 antibody (10 μg) alone  had neither allodynic nor anti-allodynic effects in the sham  group of rats (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
• Intrathecal Gabapentin Increases Interleukin-10 Expression http://jkms.org   313  http://dx.doi.org/10.3346/jkms.2013.28.2.308istered gabapentin inhibits pro-inflammatory cytokine produc - tion and attenuates the mechanical allodynia induced by SNL.,Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
• Intrathecal Gabapentin Increases Interleukin-10 Expression 314  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.3081042: 108-13.,Non-OADS,/arxiv_data1/oa_pdf/d2/10/jkms-28-308.PMC3565145.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Use of Backboard and Deflation Improve Quality of Chest  Compression When Cardiopulmonary Resuscitation Is Performed  on a Typical Air Inflated Mattress Configuration No study has examined the effectiveness of backboards and air deflation for achieving  adequate chest compression (CC) depth on air mattresses with the typical configurations  seen in intensive care units.",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/jkms-28-315.PMC3565146.pdf
"Key Words:  Backboard; Beds; Cardiopulmonary Resuscitation; Mattresses Jaehoon Oh,1 Hyunggoo Kang,1  Youngjoon Chee,2 Taeho Lim,1 Yeongtak Song,2 Youngsuk Cho,1 and Sangmo Je1  1Department of Emergency Medicine, Hanyang  University College of Medicine, Seoul; 2Department  of Biomedical Engineering, University of Ulsan,  Ulsan, Korea Received: 12 August 2012 Accepted: 24 December 2012 Address for Correspondence: Hyunggoo Kang, MD Department of Emergency Medicine, Hanyang University  College of Medicine, 222 Wangsimni-ro, Seongdong-gu,   Seoul 133-792, Korea  Tel: +82.2-2290-9291, Fax: +82.2-2290-9280 E-mail: emer0905@gmail.com This work was supported by a National Research Foundation  grant funded by the Korean Government (MEST) (2009-0064912).http://dx.doi.org/10.3346/jkms.2013.28.2.315  • J Korean Med Sci 2013; 28: 315-319ORIGINAL ARTICLE Emergency & Critical Care Medicine INTRODUCTION Chest compression depth (CCD) is an important factor in the  effective performance of chest compressions (CCs) during car - diopulmonary resuscitation (CPR) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/jkms-28-315.PMC3565146.pdf
• Backboard and Deflation Improve CPR Quality  316  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.315when performing CC according to ERC guidelines for Resusci - tation 2010.,Non-OADS,/arxiv_data1/oa_pdf/0f/f2/jkms-28-315.PMC3565146.pdf
• Backboard and Deflation Improve CPR Quality  http://jkms.org   317  http://dx.doi.org/10.3346/jkms.2013.28.2.315stool (15).,Non-OADS,/arxiv_data1/oa_pdf/0f/f2/jkms-28-315.PMC3565146.pdf
"• Backboard and Deflation Improve CPR Quality  318  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.315did when a patient was on a bed, and this without the use of  feedback monitoring.",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/jkms-28-315.PMC3565146.pdf
• Backboard and Deflation Improve CPR Quality  http://jkms.org   319  http://dx.doi.org/10.3346/jkms.2013.28.2.31514.,Non-OADS,/arxiv_data1/oa_pdf/0f/f2/jkms-28-315.PMC3565146.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Specific Activity Types at the Time of Event and Outcomes of   Out-of-Hospital Cardiac Arrest: A Nationwide Observational Study This study aimed to describe the characteristics of out-of-hospital cardiac arrest (OHCA)  according to specific activity types at the time of event and to determine the association  between activities and outcomes according to activity type at the time of event occurrence  of OHCA.",Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
"Key Words:  Heart Arrest; Resuscitation; Activity; OutcomeSang Hoon Na,1 Sang Do Shin,2 Young Sun Ro,3 Eui Jung Lee,4 Kyoung Jun Song,5 Chang Bae Park,2 and Joo Yeong Kim2 1Department of Emergency Medicine and  Cardiology, Seoul National University Hospital,  Seoul; 2Department of Emergency Medicine, Seoul  National University College of Medicine, Seoul;  3Department of Public Health, Seoul National  University Graduate School of Public Health, Seoul;  4Department of Emergency Medicine, Korea  University College of Medicine, Seoul; 5Department  of Emergency Medicine, Seoul City Municipal  Boramae Medical Center, Seoul National University,  Seoul, Korea Received: 8 December 2012 Accepted: 26 December 2012 Address for Correspondence: Sang Do Shin, MD Department of Emergency Medicine, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 1 10-744,  Korea Tel: +82.2-2072-0854, Fax: +82.2-741-7855 E-mail: shinsangdo@medimail.co.kr This study was financially supported by the Korean Center for  Disease Control and Prevention (2009-201 1) (No.0720090210  and No.0720100440).http://dx.doi.org/10.3346/jkms.2013.28.2.320  • J Korean Med Sci 2013; 28: 320-327ORIGINAL ARTICLE Emergency & Critical Care Medicine INTRODUCTION Out-of-hospital cardiac arrest (OHCA) is a global health concern  with poor outcomes (1).",Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest http://jkms.org   321  http://dx.doi.org/10.3346/jkms.2013.28.2.320pare more customized action plans for each specific activity.,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
"• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest 322  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.320RESULTS Demographic findings Of 72,256 patients with EMS-assessed OHCAs, 44,537 cases  were finally analyzed, excluding subjects with unavailable med - ical records (n = 5,201), subjects with unknown outcomes (n =   2,900), subjects who were younger than 20 yr old (n = 2,288),  and subjects with non-cardiac causes (n = 17,330).",Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest http://jkms.org   323  http://dx.doi.org/10.3346/jkms.2013.28.2.320Table 1.,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest 324  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.320cording to activity.,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest http://jkms.org   325  http://dx.doi.org/10.3346/jkms.2013.28.2.320healthy enough to perform those activities.,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest 326  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.320classified patients might be confounders.,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
Available at http://www.who.int/classifications/icd/ adaptations/iceci/en/.,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
• Activity Type and Outcomes of Out-of-Hospital Cardiac Arrest http://jkms.org   327  http://dx.doi.org/10.3346/jkms.2013.28.2.320Appendix 1 .,Non-OADS,/arxiv_data1/oa_pdf/68/6d/jkms-28-320.PMC3565147.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Extensive Thrombosis in a Patient with Familial Mediterranean  Fever, Despite Hyperimmunoglobulin D State in Serum - First  Adult Case in Korea Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by  recurrent episodes of fever accompanied by peritonitis, pleuritis, arthritis, or erysipelas-like  erythema.",Non-OADS,/arxiv_data1/oa_pdf/bc/b9/jkms-28-328.PMC3565148.pdf
"Key Words:  Familial Mediterranean Fever; Thrombosis; Immunoglobulin D; Hereditary  Autoinflammatory Diseases  Kowoon Joo,1 Won Park,1  Moon-Hyun Chung,2 Mie-Jin Lim,1 Kyong Hee Jung,1 Yoonseok Heo,3 and Seong-Ryul Kwon1 1Division of Rheumatology, 2Division of Infectious  Disease, Department of Internal Medicine,  3Department of General Surgery, Inha University  Hospital, Incheon, Korea Received: 20 July 2012 Accepted: 19 November 2012 Address for Correspondence: Seong-Ryul Kwon, MD Division of Rheumatology, Department of Internal Medicine,  Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon   400-71 1, Korea Tel: +82.32-890-3561, Fax: +82.32-890-2237 E-mail: rhksr@inha.ac.kr This work was supported by Inha University Research Grant.http://dx.doi.org/10.3346/jkms.2013.28.2.328  • J Korean Med Sci 2013; 28: 328-330CASE REPORT  Immunology, Allergic Disorders & Rheumatology INTRODUCTION Familial Mediterranean fever (FMF) is an autosomal recessive  disease characterized by recurrent episodes of fever accompa - nied by peritonitis, pleuritis, arthritis, or erysipelas-like erythe - ma (1).",Non-OADS,/arxiv_data1/oa_pdf/bc/b9/jkms-28-328.PMC3565148.pdf
• FMF with Thrombosis and Hyperimmunoglobulin D http://jkms.org   329  http://dx.doi.org/10.3346/jkms.2013.28.2.328sis of the MVK and MEFV gene was performed.,Non-OADS,/arxiv_data1/oa_pdf/bc/b9/jkms-28-328.PMC3565148.pdf
Over 200 sequence variants have  been recorded in the database of the Registry of Hereditary Au - to-Inflammatory Disorders Mutations ( http://fmf.igh.cnrs.fr/ infevers ) and the same complex mutation as our patient could  be found in an Armenian patient.,Non-OADS,/arxiv_data1/oa_pdf/bc/b9/jkms-28-328.PMC3565148.pdf
• FMF with Thrombosis and Hyperimmunoglobulin D 330  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.328serum IgD.,Non-OADS,/arxiv_data1/oa_pdf/bc/b9/jkms-28-328.PMC3565148.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Case of Alveolar Soft Part Sarcoma of the Pleura Alveolar soft part sarcoma (ASPS) is a rare malignant soft-tissue neoplasm of unknown  histogenesis.",Non-OADS,/arxiv_data1/oa_pdf/db/ee/jkms-28-331.PMC3565149.pdf
"Key Words:  Alveolar Soft Part Sarcoma; PleuraHyeong Uk Ju,1 Kwang Won Seo,1  Yangjin Jegal,1 Jong-Joon Ahn,1  Young Jik Lee,2 Young Min Kim,3  Chulho Oak,4 and Seung Won Ra1 Departments of 1Internal Medicine, 2Thoracic and  Cardiovascular Surgery, 3Pathology, Ulsan University  Hospital, University of Ulsan College of Medicine,  Ulsan; 4Department of Internal Medicine, Kosin  University Gospel Hospital, University of Kosin  College of Medicine, Busan, Korea Received: 25 August 2012 Accepted: 20 November 2012 Address for Correspondence: Seung Won Ra, MD Department of Internal Medicine, Ulsan University Hospital,  University of Ulsan College of Medicine, 877  Bangeojinsunhwan-doro, Dong-gu, Ulsan 682-714, Korea Tel: +82.52-250-7029, Fax: +8252-250-8858, 7048 E-mail: docra@docra.pe.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.331  • J Korean Med Sci 2013; 28: 331-335CASE REPORT Oncology & Hematology INTRODUCTION Alveolar soft part sarcoma (ASPS) is a rare malignant soft-tissue  neoplasm of unknown histogenesis, typically occurring in young  patients.",Non-OADS,/arxiv_data1/oa_pdf/db/ee/jkms-28-331.PMC3565149.pdf
"• Alveolar soft part sarcoma of the Pleura 332  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.331with pleural effusion in the left hemithorax, a 1.6 × 1.3 cm pul - monary nodule in the left upper lobe (LUL), and a right lower  pleural nodule (Fig.",Non-OADS,/arxiv_data1/oa_pdf/db/ee/jkms-28-331.PMC3565149.pdf
"• Alveolar soft part sarcoma of the Pleura http://jkms.org   333  http://dx.doi.org/10.3346/jkms.2013.28.2.331bilobulated, gray-white tumor with focal areas of necrosis and  hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/db/ee/jkms-28-331.PMC3565149.pdf
"• Alveolar soft part sarcoma of the Pleura 334  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.331ous mitochondria, prominent rough endoplasmic reticulum,  well-developed Golgi complexes, and many membrane-bound  electron-dense granules (Fig.",Non-OADS,/arxiv_data1/oa_pdf/db/ee/jkms-28-331.PMC3565149.pdf
• Alveolar soft part sarcoma of the Pleura http://jkms.org   335  http://dx.doi.org/10.3346/jkms.2013.28.2.331the relatively slow growth of the tumor.,Non-OADS,/arxiv_data1/oa_pdf/db/ee/jkms-28-331.PMC3565149.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Electrolyte Imbalances and Nephrocalcinosis in Acute Phosphate  Poisoning on Chronic Type 1 Renal Tubular Acidosis due to  Sjögren’s Syndrome Although renal calcium crystal deposits (nephrocalcinosis) may occur in acute phosphate  poisoning as well as type 1 renal tubular acidosis (RTA), hyperphosphatemic hypocalcemia  is common in the former while normocalcemic hypokalemia is typical in the latter.",Non-OADS,/arxiv_data1/oa_pdf/2d/38/jkms-28-336.PMC3565150.pdf
"Key Words:  Hypocalcemia; Nephrocalcinosis; Sodium Phosphate; Distal RTA; Sjögren’s  SyndromeSung-Gun Cho, Joo-Hark Yi,   Sang-Woong Han, and Ho-Jung Kim Renal Division, Department of Internal Medicine,  Hanyang University Guri Hospital, Guri, Korea Received: 5 September 2012 Accepted: 7 December 2012 Address for Correspondence: Joo-Hark Yi, MD Renal Division, Department of Internal Medicine,   Hanyang University Guri Hospital, 153 Gyeongchun-ro,   Guri 471-701, Korea Tel: +82.31-560-2186, Fax: +82.31-566-0801 E-mail: Joohark@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.2.336  • J Korean Med Sci 2013; 28: 336-339CASE REPORT Nephrology INTRODUCTION Despite the diverse etiologies of renal parenchymal calcification  (nephrocalcinosis), nephrocalcinosis combined with electro - lyte imbalance of hypokalemia can narrow down the differen - tial diagnosis into hereditary tubulopathy such as Bartter’s syn - drome, chronic laxative or diuretic abuse, type 1 renal tubular  acidosis (RTA), and recently recognized acute phosphate poi - soning such as oral sodium phosphate bowel preparation (OSP- BP) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/2d/38/jkms-28-336.PMC3565150.pdf
"• Unveiled Sjögren’s Syndrome in Acute Phosphate Poisoning http://jkms.org   337  http://dx.doi.org/10.3346/jkms.2013.28.2.336gesting renal potassium wasting despite dietary potassium sup - plementation, metabolic acidosis with normal blood anion gap  (9 to 11 mEq/L; reference, 10 ±2 mEq/L), and alkaline urine  pH (> 6.0) with positive urine anion gap (> 16 mEq/L) suggest - ed type 1 RTA, which was ascertained by other positive evidences  for the impaired urinary acidification of distal tubules by loop- diuretic (torsemide) test (urine pH > 6.5) and urine to blood  PCO 2 gradient (> 20 mmHg) upon intravenous alkali load with  sodium bicarbonate.",Non-OADS,/arxiv_data1/oa_pdf/2d/38/jkms-28-336.PMC3565150.pdf
"• Unveiled Sjögren’s Syndrome in Acute Phosphate Poisoning 338  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.336cium-phosphate crystals in distal renal tubules after OSP can  be only proven by renal biopsy since the intrarenal deposition  in acute hyperphosphatemia is usually not sufficient to be de - tectable in radiological imaging (1-3, 6).",Non-OADS,/arxiv_data1/oa_pdf/2d/38/jkms-28-336.PMC3565150.pdf
"• Unveiled Sjögren’s Syndrome in Acute Phosphate Poisoning http://jkms.org   339  http://dx.doi.org/10.3346/jkms.2013.28.2.336values under physiologic conditions, with comments on the effects of food  ingestion and hyperventilation.",Non-OADS,/arxiv_data1/oa_pdf/2d/38/jkms-28-336.PMC3565150.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Case of Odontogenic Orbital Cellulitis Causing Blindness by  Severe Tension Orbit  We report a very rare case of odontogenic orbital cellulitis causing blindness by severe  tension orbit.",Non-OADS,/arxiv_data1/oa_pdf/59/09/jkms-28-340.PMC3565151.pdf
"Key Words:  Central Retinal Artery Obstruction; Ischemic Optic Neuropathy; Odontogenic  Orbital Cellulitis; Tension OrbitChang Hyun Park, Dong Hyun Jee,   and Tae Yoon La  Department of Ophthalmology, St. Vincent’s  Hospital, College of Medicine, The Catholic  University of Korea, Suwon, Korea Received: 20 May 2012 Accepted: 15 November 2012 Address for Correspondence: Tae Yoon La, MD Department of Ophthalmology, St. Vincent’s Hospital, College of  Medicine, The Catholic University of Korea, 93 Jungbu-daero,  Paldal-gu, Suwon 442-723, Korea Tel: +82.31-249-7340, Fax: +82.31-251-6225  E-mail: laty@catholic.ac.kr  http://dx.doi.org/10.3346/jkms.2013.28.2.340  • J Korean Med Sci 2013; 28: 340-343CASE REPORT Ophthalmology INTRODUCTION Tension orbit is a clinical condition in which severe proptosis  occurs with the intraorbital space compression that subsequent - ly leads to severe stretching of the optic nerve and results in the  deterioration of vision.",Non-OADS,/arxiv_data1/oa_pdf/59/09/jkms-28-340.PMC3565151.pdf
• Odontogenic Orbital Cellulitis Causing Blindness  http://jkms.org   341  http://dx.doi.org/10.3346/jkms.2013.28.2.340in the left eye.,Non-OADS,/arxiv_data1/oa_pdf/59/09/jkms-28-340.PMC3565151.pdf
• Odontogenic Orbital Cellulitis Causing Blindness  342  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.2.340traocular pressure of the right eye had decreased to 34 mm Hg  on the following day of hospitalization.,Non-OADS,/arxiv_data1/oa_pdf/59/09/jkms-28-340.PMC3565151.pdf
"• Odontogenic Orbital Cellulitis Causing Blindness  http://jkms.org   343  http://dx.doi.org/10.3346/jkms.2013.28.2.340administration of steroid at an early stage may be helpful for  faster symptomatic improvement (12, 13).",Non-OADS,/arxiv_data1/oa_pdf/59/09/jkms-28-340.PMC3565151.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c9/75/srep01229.PMC3565164.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, W., Cochell, T. & Manthiram, A. Activation of Aluminum as an Effective Reducing Agent by Pitting Corrosion for Wet-chemical Synthesis.",Non-OADS,/arxiv_data1/oa_pdf/c9/75/srep01229.PMC3565164.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-ShareALike 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/b6/4a/srep01233.PMC3565165.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Wu, G.F. et al.",Non-OADS,/arxiv_data1/oa_pdf/b6/4a/srep01233.PMC3565165.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/d3/srep01226.PMC3565166.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Oncescu, V. & Erickson, D. High volumetric power density, non-enzymatic, glucose fuel cells.",Non-OADS,/arxiv_data1/oa_pdf/ad/d3/srep01226.PMC3565166.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a8/00/srep01230.PMC3565167.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Xu, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/00/srep01230.PMC3565167.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/52/srep01218.PMC3565168.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Corradini, D., Strekalova, E.G., Stanley, H.E.",Non-OADS,/arxiv_data1/oa_pdf/63/52/srep01218.PMC3565168.pdf
"Preprint at ,http://arxiv.org/ abs/quant-ph/0108033 .",Non-OADS,/arxiv_data1/oa_pdf/d7/aa/srep01235.PMC3565169.pdf
"Preprint at ,http://arxiv.org/abs/ quant-ph/0603163 .",Non-OADS,/arxiv_data1/oa_pdf/d7/aa/srep01235.PMC3565169.pdf
",http://arxiv.org/abs/1110.2574 .",Non-OADS,/arxiv_data1/oa_pdf/d7/aa/srep01235.PMC3565169.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Johnson, T.H., Biamonte, J.D., Clark, S.R.",Non-OADS,/arxiv_data1/oa_pdf/d7/aa/srep01235.PMC3565169.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Varo´n, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/7f/4a/srep01234.PMC3565170.pdf
"HUGO Gene Nomenclature for chemokines, cytokines, and defensins (http://www.genenames.org/) was used throughout the maunscript40.",Non-OADS,/arxiv_data1/oa_pdf/d0/19/srep01232.PMC3565171.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Harvey, L.E.",Non-OADS,/arxiv_data1/oa_pdf/d0/19/srep01232.PMC3565171.pdf
Data analysis was performed with the custom analysis programs Anavision and Ana (freely available at http://users.ge.ibf.cnr.it/pusch).,OADS,/arxiv_data1/oa_pdf/60/61/srep01231.PMC3565172.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/61/srep01231.PMC3565172.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zanardi, I., Zifarelli, G. & Pusch, M. An optical assay of the transport activity of ClC-7.",Non-OADS,/arxiv_data1/oa_pdf/60/61/srep01231.PMC3565172.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Novelli, F., Fausti, D., Giusti, F., Parmigiani, F. & Hoffmann, M. Mixed regime of light-matter interaction revealed by phase sensitive measurements of the dynamical Franz-Keldysh effect.",Non-OADS,/arxiv_data1/oa_pdf/7e/b1/srep01227.PMC3565173.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/05/ba/srep01228.PMC3565174.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sevinçli, H., Sevik, C., Çag ˘in, T. & Cuniberti, G. A bottom-up route to enhance thermoelectric figures of merit in graphene nanoribbons.",Non-OADS,/arxiv_data1/oa_pdf/05/ba/srep01228.PMC3565174.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)IL-6 mediates depressive behaviors in the CNS SJ Sukoff Rizzo et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/61/f6/tp2012120a.PMC3565187.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Cerebellar and hippocampal neurodegeneration in overweight and obesity K Mueller et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/39/9c/tp2012121a.PMC3565188.pdf
Two individual cases are detailed below and depicted in the movies joined to this article (http://vimeo.com/48520450; http://vimeo.com/48726291).,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/tp2012124a.PMC3565189.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Bumetanide and autism E Lemonnier et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/fe/ae/tp2012124a.PMC3565189.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)HERV-W in schizophrenia and bipolar disorder H Perron et al 10 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/44/8c/tp2012125a.PMC3565190.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/mPFC BDNF consolidates appetitive and aversive learning DC Choi et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/96/56/tp2012128a.PMC3565191.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Tight-junction between anorexia and hyperactivity A Jean et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/99/1d/tp2012131a.PMC3565192.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Fatty acid abnormalities in affective disorder FPC Y Tatebayashi et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/6d/21/tp2012132a.PMC3565193.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Glossary Motor and vocal tics : A simple motor tic is a sudden, brief, involuntary, repetitive, nonpurposeful movement of a single muscle group, such as an eye blink, face twitch, shoulder shrug, arm or leg jerk.",Non-OADS,/arxiv_data1/oa_pdf/d6/01/tp201275a.PMC3565204.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)GWAS of symptom dimensions in BD S Meier et al 5 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/e6/5f/tp201281a.PMC3565205.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Longitudinal MRS in bipolar disorder RO Brady Jr et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/a7/2f/tp201284a.PMC3565206.pdf
Case–control association analyses were con- ducted using PLINK (http://pngu.mgh.harvard.edu/ Bpurcell/ plink/) with an additive model for the single-SNP associations and the option hap-logistic for haplotype-based associations.Pp0.05 were considered as nominally signiﬁcant.,OADS,/arxiv_data1/oa_pdf/57/5c/tp201285a.PMC3565207.pdf
Fixed- effects meta-analysis and forest plots were assessedwith the R-library rmeta (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/57/5c/tp201285a.PMC3565207.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/TMEM132D gene variants in panic disorder A Erhardt et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/57/5c/tp201285a.PMC3565207.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)TET and APOBECs in the parietal cortex of psychotic patients E Dong et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/82/dc/tp201286a.PMC3565208.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Child predicts substance use A Lahat et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/0a/a6/tp201287a.PMC3565209.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Associative and limbic thalamus-related behavior JY Rotge et al 11 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/f6/13/tp201288a.PMC3565210.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Human fear extinction and cannabinoid receptor 1 I Heitland et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/f0/e5/tp201290a.PMC3565211.pdf
"34. http://www.cs.cmu.edu/ ,enron/ accessed: 12 december 2012.",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/srep01223.PMC3565226.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Czaplicka, A., Holyst, J.A.",Non-OADS,/arxiv_data1/oa_pdf/aa/ce/srep01223.PMC3565226.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/7b/TONIJ-7-1.PMC3565228.pdf
"Available at: http://www.casp-uk.net/wp- content/uploads/2011/11/CASP_Systematic_Review_Appraisal_Ch ecklist_14oct10.pdf [cited 2011 November 15]  [25] Zyga S, Malliarou M, Lavdaniti M, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/97/TONURSJ-7-14.PMC3565229.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/e7/TODENTJ-7-1.PMC3565230.pdf
"Available at: http://www.uptodate.com [Accessed : 20 th Sep  2010]  [47] Jensen WA, Fall MZ, Rooney J, Kordick DL, Breitschwerdt EB.",Non-OADS,/arxiv_data1/oa_pdf/64/97/TONEUJ-6-158.PMC3565243.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/ff/TOCHGENJ-6-93.PMC3565245.pdf
"C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any mediu m, provided the original work is properly cited.active leucocytes across the BNB in autoimmune disorders, including GBS.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"Cultures prepared in this manner 2 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"Optimized ampliﬁcation steps of 94 ◦C for 5 min; 94◦C for 15 s, annealing at 55–60◦Cf o r3 0 s , C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 3 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"Fixed PNMEC cultures were incubated overnight at 4◦C in the presence of either a 1:2000 dilution of rabbit anti-rat CCL2 polyclonal antibody 4 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"PNMEC culturespuriﬁed in this manner were found to (i) be >95+−7.5 % (n=3) free of Thy-1.1 expressing ﬁbroblasts, (ii) consis- tently establish contact-inhibited monolayers with a dis-tinctive cobblestone-like morphology (Figure 1A) and (iii) C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 5 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"The higher molecularmass isoform of this chemokine is in agreement with the pre-vious reports of N-terminal glycosylation of CCL2 in rodents 6 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 7 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"Consistent with this thesis, we observed a rapidand marked increase in CCL2 mRNA and protein expression in 8 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"Expression of CCL2 and ICAM-1 protein content by TNF α in PNMEC cultures may result from an increase in de novo synthesis, reduced proteasomal-, autophagosomal- or C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 9 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"10 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"Received 7 August 2012/21 November 2012; accepted 26 November 2012 Published as Immediate Publication 7 January 2013, doi 10.1042/AN20120048 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 11 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e2/an005e104.PMC3565377.pdf
"C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any mediu m, provided the original work is properly cited.Key words: axonopathies, CD4 T-cell, CD8 T-cell, multiple sclerosis, neurodegeneration, NK cells INTRODUCTION MS (multiple sclerosis) affects an estimated 400 000 people in the US and 2.5 million worldwide (Sospedra and Martin,2005).",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"After 4 days, non-adherent cells were transferred toa new ﬂask and the adherent (NK cells) and non-adherent 14 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"For Figures 2–7, brains and spinal cords on C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 15 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"Neuronal 16 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"Next, we reasoned that, due to C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 17 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"18 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"The ankyrin G +axon also still expressed MAP2 within the axonal initial segment, which isconsistent with early stages of axonogenesis (Boiko et al., C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 19 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"Consistent with our 20 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"However, a similar mechanism has C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 21 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"22 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"FUNDING This work was supported by the National Institutes of Health[grant number NS062235], the National Multiple Sclerosis C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 23 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"24 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) 25 which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"Received 10 December 2012/21 December 2012; accepted 4 January 2013 Published as Immediate Publication 4 January 2013, doi 10.1042/AN20120087 26 C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/54/an005e105.PMC3565378.pdf
"Raw data from the behavioral tests, the date on which each experiment was performed, and the age of the mice at the time of the experiment are shown in the mouse phenotype database (http://www.mouse-phenotype.org/).",Non-OADS,/arxiv_data1/oa_pdf/b8/82/srep01224.PMC3565454.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/82/srep01224.PMC3565454.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Toba, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/b8/82/srep01224.PMC3565454.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/13/srep01212.PMC3565467.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Tian, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/13/srep01212.PMC3565467.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/36/aa/361.PMC3565548.pdf
"Published by Oxford University Press on behalf of  the American Journal of Hypertension.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence: Arrigo F.G. Cicero (afgcicero@cardionet.it).",Non-OADS,/arxiv_data1/oa_pdf/67/5f/hps044.PMC3565599.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
"T rends in age-standardized cancer incidence and death rates  were analyzed using joinpoint regression, which involves fitting a series of joined straight lines on a logarithmic scale to the trends in the annual age-standardized rates (http://www.srab.cancer.gov/ joinpoint) (51) with at least three data points between changes in  joinpoints.",OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
"The average annual percentage change (AAPC)  was estimated as a geometric weighted average of the APCs, with the weights equal to the length of each line segment during the  prespecified fixed interval (eg, 2000–2009) (http://srab.cancer.",OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
Additional information available at http://www.census.gov/hhes/www/poverty.html.T able 6 (Continued).,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.naaccr.org/Certification/CertificationLevels.aspx.,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
ftp://ftp.cdc.,OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.cdc.gov/vaccines/programs/vfc/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.cdc.gov/brfss/technical_infodata/surveydata/2010.,OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.census.gov/ popest/data/historical/2000s/vintage_2009/index.html.,OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/ Datasets/NVSS/bridgepop/2009/DocumentationBridgedPostcenV2009.,OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.dh.gov.uk/en/publicationsandstatis- tics/publications/publicationspolicyandguidance/dh_123795.,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www2a.cdc.gov/nip/irar/grantee/granteeInfo.asp.,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.immunize.org/laws/.,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
http://www.ncsl.org/issues-research/health/hpv-vaccine-state- legislation-and-statutes.aspx#2011.,Non-OADS,/arxiv_data1/oa_pdf/df/43/djs491.PMC3565628.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ABCB1 polymorphism predicts antidepressant dose to remit AB Singh et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/53/f2/tp2012115a.PMC3565756.pdf
"ASL data analysis was performed using aslm 39(downloadable at http://aslm.sourceforge.net), a newly developed toolbox that allows multiple subjects to be analyzed at once and to perform region of interest analysis of ASL data.",OADS,/arxiv_data1/oa_pdf/43/77/tp2012114a.PMC3565757.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Response to transcranial magnetic stimulation P Homan et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/43/77/tp2012114a.PMC3565757.pdf
Films were scored using PlusMZ v1.0 software (available at http://blog.sbnec.org.br/2010/07/softwares-gratuitos-para-analise-do-labirinto-em-c ruz-elevado-e-campo-aberto/) by the same observer blind to the neonatal intervention.,Non-OADS,/arxiv_data1/oa_pdf/48/14/tp2012126a.PMC3565759.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/BDNF , anxiety and early adversity R Dalle Molle et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/48/14/tp2012126a.PMC3565759.pdf
NIA-LOAD Family Study (LOAD) p robands http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/e5/ba/tp2012119a.PMC3565761.pdf
the TARCC cohort and the publicly available NCRAD-LOAD (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000168.v1.p1) Caucasian probands ( N¼2166).,OADS,/arxiv_data1/oa_pdf/e5/ba/tp2012119a.PMC3565761.pdf
"(Table 1) The top hitARL17P1 corresponds to CNVR 7114.8 and CNVR 7114.10 (http://www.sanger.ac.uk/cgi-bin/humgen/cnv/42mio/down- loadBigDB.cgi), 24and the subsequent three probes coding CREB1 andFAM119A correspond to CNVR 1123.1.",OADS,/arxiv_data1/oa_pdf/e5/ba/tp2012119a.PMC3565761.pdf
"25,26 The associated deletion, CNVR 1123.1 has been reported and validated in endeavors to catalog CNVs genome-wide (http://www.sanger.ac.uk/cgi-bin/humgen/cnv/42mio/ Figure 2 The box plots depict the expression levels in Alzheimer’s disease (AD) and controls by copy number state (1 or deletion and 2 or diploid) for the three pr obes corresponding to the two adjacent genes ( CREB1 andFAM199A ) on chromosome 2.",Non-OADS,/arxiv_data1/oa_pdf/e5/ba/tp2012119a.PMC3565761.pdf
The BaylorCollege of Medicine and Department of Molecular and Human Genetics derive revenue from molecular genetics testing clinical services provided by the Medical GeneticsLaboratories; MGL https://www.bcm.edu/geneticlabs.,Non-OADS,/arxiv_data1/oa_pdf/e5/ba/tp2012119a.PMC3565761.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Association of CREB1 with Alzheimer’s disease YL i et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/e5/ba/tp2012119a.PMC3565761.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Adolescents’ brains and maternal afﬁliation S Schneider et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/26/c8/tp2012113a.PMC3565762.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/In vivo knockdown of GAD67 in the amygdala SA Heldt et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/6c/2c/tp2012101a.PMC3565763.pdf
"http://lcmodel.ca/pages/lcm-manual.shtml, 2011.",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/tp2012107a.PMC3565764.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Metabolic correlates of psychiatric symptoms RE Anglin et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/tp2012107a.PMC3565764.pdf
The AIBL investigatorsthank Richard Head of CSIRO for initiating and facilitating the AIBL collaboration(http://www.aibl.csiro.au/).,Non-OADS,/arxiv_data1/oa_pdf/58/ec/tp2012118a.PMC3565765.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Intense physical activity and cognitive performance BM Brown et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/58/ec/tp2012118a.PMC3565765.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Inﬂammatory mediators of neurogenesis HF green and YM Nolan 11 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/4d/08/tp2012117a.PMC3565766.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Mice expressing the Osaka intra-A bAPP mutation L Kulic et al 14 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/93/f1/tp2012109a.PMC3565767.pdf
"Genotype data from the Perlegen platform were obtained from dbGaP (http://www.ncbi.nlm.nih.gov/gap),which consisted of 435,291 SNPs.",OADS,/arxiv_data1/oa_pdf/db/a3/tp201295a.PMC3565768.pdf
We used each of the identiﬁed keywords as a search term to retrieve relevant candidate gene sets from the GO resource (http://www.geneontology.org).,OADS,/arxiv_data1/oa_pdf/db/a3/tp201295a.PMC3565768.pdf
"We are grateful to all the investigators, clinicians and study participants of the STAR*D, GAIN, QIMR and NESDA/NTR projects.Statistical analyses were carried out on the Broad Institute Cluster Computer (http://www.broadinstitute.org).",OADS,/arxiv_data1/oa_pdf/db/a3/tp201295a.PMC3565768.pdf
"NESDA/NTR: Genome-wide association study results for the NESDA/NTR MDD data set were obtained throughthe Genetic Association Information Network (GAIN), through dbGaP accessionnumber phs000020.v1.p1 (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000020.v2.p1).",OADS,/arxiv_data1/oa_pdf/db/a3/tp201295a.PMC3565768.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Genetic evidence for glutamatergic transmission in MDD PH Lee et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/db/a3/tp201295a.PMC3565768.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Long-term effects of cannabinoid treatment KA Gleason 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/41/f6/tp2012122a.PMC3565769.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Social function recovery by stem cell treatment T Shirasaka et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/tp2012111a.PMC3565770.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Low VEGF and IL-8 in CSF of suicide attempters J Isung et al 4 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/26/cb/tp2012123a.PMC3565771.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/GM progressive loss in patients with schizophrenia A Vita et al.",Non-OADS,/arxiv_data1/oa_pdf/33/15/tp2012116a.PMC3565772.pdf
"The microarraydata are available from the gene expression omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under the series accession number GSE38206.",OADS,/arxiv_data1/oa_pdf/68/7e/tp2012112a.PMC3565773.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)mRNA and miRNA signatures in major depression R Belzeaux et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/68/7e/tp2012112a.PMC3565773.pdf
Portions of our GWAS results for PD are publicly available in the Genome-Wide Association Database (GWAS DB; http://gwas.lifesciencedb.jp/).,OADS,/arxiv_data1/oa_pdf/ac/5e/tp201289a.PMC3565774.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Meta-analysis of GWAS for panic disorder T Otowa et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/ac/5e/tp201289a.PMC3565774.pdf
Australian Bureau of Statistics SEIFA: Socio-Economic Indexes for Areas 2008 Available fromhttp://www.abs.gov.au/websitedbs/D3310114.nsf/home/Seifa_entry_page.,OADS,/arxiv_data1/oa_pdf/93/51/tp2012100a.PMC3565809.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Sampling bias in internet treatment trials for depression L Donkin et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/93/51/tp2012100a.PMC3565809.pdf
7Raw intensities and genotypes were obtained from NHGRI-dbGaP (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/82/04/tp2012102a.PMC3565810.pdf
"They: (i) were located in chromosome X regions common to the two affected sibs (4331 SNPs and 299 indelsin 11 families); (ii) had with a minor allele frequency o1% in dbSNP135 (http://www.ncbi.nlm.nih.gov/projects/SNP/), Exome variant server (http://evs.gs.washington.edu/EVS/)and 29 other exomes; (iii) were found in genes expressed inbrain according to the Unigene (http://www.ncbi.nlm.nih.gov/ unigene) or Uniprot (http://www.uniprot.org/) databases; and (iv) were predicted to have an impact on the gene or theprotein (nonsense variants, missense variants, predicted at least once in silico to be deleterious, and synonymous, intronic or 5–3 0UTR variants with possible effects on splice sites or promoters using Alamutv2.1/AlamutHT).",Non-OADS,/arxiv_data1/oa_pdf/82/04/tp2012102a.PMC3565810.pdf
"Prediction of pathogenicity was assessedusing PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), SIFT (scale-invariant feature transform) (http://sift.bii.a- star.edu.sg/), Mutpred (http://mutpred.mutdb.org/) andSNPs&GO (http://snps-and-go.bioc omp.unibo.it/snps-and-go/).",OADS,/arxiv_data1/oa_pdf/82/04/tp2012102a.PMC3565810.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Analysis of chromosome X exome in autism C Nava et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/82/04/tp2012102a.PMC3565810.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Pattern of cocaine treatment and neuroadpatations S Puig et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/15/b7/tp2012103a.PMC3565811.pdf
"In all, 575 unipolar depressed patients (262 men and 313 women) aged 18 to 75 years who were admitted tothe hospital of the Max Planck Institute of Psychiatry, Munich, Germany, were enroled within the MARS project (http://www.mars-depression.de).",Non-OADS,/arxiv_data1/oa_pdf/e5/6e/tp2012104a.PMC3565812.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)The activin system is an antidepressant target K Ganea et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/e5/6e/tp2012104a.PMC3565812.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Schizophrenia genes and hippocampus development G Favre et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/1c/43/tp2012105a.PMC3565813.pdf
Each data set was imputed separately using phased haplotype data from HapMap I & II release 24 (http://hapmap.ncbi.nlm.nih.gov/) as the reference panel.,OADS,/arxiv_data1/oa_pdf/07/6c/tp2012106a.PMC3565814.pdf
A fulllist of the investigators who contributed to the generation of the data is available fromhttp://www.wtccc.org.uk.,OADS,/arxiv_data1/oa_pdf/07/6c/tp2012106a.PMC3565814.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Mood-incongruent psychotic bipolar disorder FS Goes et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/07/6c/tp2012106a.PMC3565814.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Atypical brain aging in autism during adulthood Y Aoki et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/01/d9/tp2012108a.PMC3565815.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Midbrain in sustaining motivation SJ Moeller et al 10 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/1c/df/tp2012110a.PMC3565817.pdf
"The SNPs, MOG rs2857766 and CNP rs2070106, were genotyped using KBiosciences (http://www.kbioscience.co.uk), with a competitive allele-speciﬁc PCRsystem.",Non-OADS,/arxiv_data1/oa_pdf/56/8b/tp201282a.PMC3565820.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/NRG1, MOG, CNP and white matter volume in psychotic disorders DM Cannon et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/56/8b/tp201282a.PMC3565820.pdf
"Furthermore, greater 1Centre of Excellence for Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia;2Sir James McCusker Alzheimer’s Disease Research Unit (Hollywood Private Hospital), Perth, Western Australia, Australia;3Taub Institute for Research of Alzheimer’s Disease and the Ageing Brain, Columbia University, New York, NY, USA;4Gertrude H. Sergievsky Centre, Columbia University, New York, NY, USA;5School of Pharmacy and Medical Sciences and Sansom Institute for Health Research, Division of Health Sciences, University of South Australia, Adelaide, Aust ralia;6Department of Medicine and Department of Biomedical Science, University of Adelaide, Adelaide, Australia;7Nutritional Interventions, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;8Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA;9CSIRO, Preventative Health Flagship, Adelaide, Australia;10Mental Health Research Institute, The University of Melbourne, Parkville, Victoria, Australia;11National Ageing Research Institute, Parkville, Victoria, Australia;12Department of Psychiatry, Academic Unit for Psychiatry of Old Age, The University of Melbourne, St Vincent’s Aged Psychiatry Service, St George’s Hospital, Victoria, Australia;13Centre for Neuroscience, The University of Melbourne, Parkville, Victoria, Australia;14CSIRO Preventative Health Flagship, CMSE Parkville, Parkville, Victoria, Australia and15Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Correspondence: Professor R Martins, Centre of Excellence for Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan Unive rsity, 270 Joondalup Drive, Joondalup, Western Australia 6027, Australia.E-mail: r.martins@ecu.edu.au 16http://www.aibl.csiro.au (for the AIBL Research Group) A full list of the AIBL investigators is available at http://www.aibl.csiro.au Received 14 June 2012; revised 16 August 2012; accepted 18 August 2012Keywords: AIBL; Alzheimer’s disease; Australia; Mediterranean diet; MCICitation: Transl Psychiatry (2012) 2, e164; doi:10.1038/tp.2012.91 &2012 Macmillan Publishers Limited All rights reserved 2158-3188/12 www.nature.com/tp",Non-OADS,/arxiv_data1/oa_pdf/0b/ff/tp201291a.PMC3565821.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Mediterranean diet and Alzheimer’s disease S Gardener et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/0b/ff/tp201291a.PMC3565821.pdf
Mol Psychiatry 2009 Available fromhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=19255581.,OADS,/arxiv_data1/oa_pdf/06/46/tp201292a.PMC3565822.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)cAMP signaling genes and bipolar disorder M-L McDonald et al 10 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/06/46/tp201292a.PMC3565822.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Adult neurogenesis in trait anxiety and comorbid depression-like behavior A Sah et al 13 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/40/dc/tp201294a.PMC3565824.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)The association of attempted suicide with genetic variants RC Clayden et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/cc/48/tp201296a.PMC3565826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Hsp90 aas a novel target for aripiprazole T Ishima et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/fc/78/tp201297a.PMC3565827.pdf
Available at: http://www.kantei.go.jp/saigai/ pdf/201205011700jisin.pdf (original in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/7a/b1/tp201298a.PMC3565828.pdf
Available at: http://www.bousai.metro.tokyo.jp/japanese/press/201108-03jyouhou.pdf (original in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/7a/b1/tp201298a.PMC3565828.pdf
Available at: http://www.jcc.co.jp/business/docuana_20110510.pdf (original inJapanese).,Non-OADS,/arxiv_data1/oa_pdf/7a/b1/tp201298a.PMC3565828.pdf
Available at: http://www.jcc.co.jp/business/ earthquake_2011_09_14.pdf (original in Japanese).25.,Non-OADS,/arxiv_data1/oa_pdf/7a/b1/tp201298a.PMC3565828.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Impact of the earthquake on schizophrenic patients in Tokyo A Aoki et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/7a/b1/tp201298a.PMC3565828.pdf
"Sim SCHome Page of the Human Cytochrome P450 (CYP) Allele Nomenclature Committee: Solna, SwedenKarolinska Institutet; 2011 [updated Last updated 9 September 2008; 15 December 2011]; Available from http://www.cypalleles.ki.se/, Access dateDecember 15, 2011.",OADS,/arxiv_data1/oa_pdf/16/e5/tp201299a.PMC3565829.pdf
NIMH Contract GMO-010111 2001: Available from http://www.edc.gsph.pitt.edu/stard/.,Non-OADS,/arxiv_data1/oa_pdf/16/e5/tp201299a.PMC3565829.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/A pharmacogenomic algorithm to guide treatment DK Hall-Flavin et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/16/e5/tp201299a.PMC3565829.pdf
http://dx.doi.org/10.1371/journal.ppat.0040026 .,Non-OADS,/arxiv_data1/oa_pdf/6b/9f/mBio.00019-13.PMC3565830.pdf
41:21. http://dx.doi .org/10.1051/vetres/2009069 .,Non-OADS,/arxiv_data1/oa_pdf/6b/9f/mBio.00019-13.PMC3565830.pdf
http://dx.doi.org /10.1371/journal.pone.0003764 .,Non-OADS,/arxiv_data1/oa_pdf/6b/9f/mBio.00019-13.PMC3565830.pdf
http://www.jbc.org/cgi/doi /10.1074/jbc.M112.430223 .,Non-OADS,/arxiv_data1/oa_pdf/6b/9f/mBio.00019-13.PMC3565830.pdf
6:12.http://dx.doi.org/10.1186/1472-6750-6-12 .,Non-OADS,/arxiv_data1/oa_pdf/6b/9f/mBio.00019-13.PMC3565830.pdf
Inspection of the crystal structure of the E. coli IlvE enzyme (1A3G [40; http://www.pdb.org/pdb/home/home.do .]),Non-OADS,/arxiv_data1/oa_pdf/dc/27/mBio.00033-13.PMC3565831.pdf
http://dx.doi.org/10 .1371/journal.pone.0043082 .,Non-OADS,/arxiv_data1/oa_pdf/dc/27/mBio.00033-13.PMC3565831.pdf
http://dx.doi.org/10.1371/journal.ppat.1000071 .,Non-OADS,/arxiv_data1/oa_pdf/dd/16/mBio.00558-12.PMC3565832.pdf
http://dx.doi.org/10.1371/journal.ppat.1002184 .,Non-OADS,/arxiv_data1/oa_pdf/dd/16/mBio.00558-12.PMC3565832.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e4003 | Page 1 of 6Video Article Generation of Mice Derived from Induced Pluripotent Stem Cells Michael J. Boland1, Jennifer L. Hazen1, Kristopher L. Nazor1, Alberto R. Rodriguez2, Greg Martin2, Sergey Kupriyanov2, Kristin K. Baldwin1 1Dorris Neuroscience Center & Department of Cell Biology, The Scripps Research Institute 2Mouse Genetics Core Facility, The Scripps Research Institute Correspondence to: Sergey Kupriyanov at sergey@scripps.edu , Kristin K. Baldwin at kbaldwin@scripps.edu URL: http://www.jove.com/video/4003 DOI: doi:10.3791/4003 Keywords: Stem Cell Biology, Issue 69, Molecular Biology, Developmental Biology, Medicine, Cellular Biology, Induced pluripotent stem cells, iPSC, stem cells, reprogramming, developmental potential, tetraploid embryo complementation, mouse Date Published: 11/29/2012 Citation: Boland, M.J., Hazen, J.L., Nazor, K.L., Rodriguez, A.R., Martin, G., Kupriyanov, S., Baldwin, K.K.",Non-OADS,/arxiv_data1/oa_pdf/13/75/jove-69-4003.PMC3565852.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4003/ Protocol This method was used in the research reported in Boland et al.,OADS,/arxiv_data1/oa_pdf/13/75/jove-69-4003.PMC3565852.pdf
"21, 546-549, http://www.nature.com/cr/journal/v21/n3/suppinfo/cr2010164s1.html (2011).",Non-OADS,/arxiv_data1/oa_pdf/13/75/jove-69-4003.PMC3565852.pdf
"463, 1096-1100, http://www.nature.com/ nature/journal/v463/n7284/suppinfo/nature08735_S1.html  (2010).",Non-OADS,/arxiv_data1/oa_pdf/13/75/jove-69-4003.PMC3565852.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e4457 | Page 1 of 5Video Article Micro 3D Printing Using a Digital Projector and its Application in the Study of Soft Materials Mechanics Howon Lee1, Nicholas X. Fang1 1Department of Mechanical Engineering, Massachusetts Institute of Technology Correspondence to: Nicholas X. Fang at nicfang@mit.edu URL: http://www.jove.com/video/4457 DOI: doi:10.3791/4457 Keywords: Mechanical Engineering, Issue 69, Materials Science, Physics, Chemical Engineering, 3D printing, stereo-lithography, photo- polymerization, gel, swelling, elastic instability, buckling, pattern formation Date Published: 11/27/2012 Citation: Lee, H., Fang, N.X.",Non-OADS,/arxiv_data1/oa_pdf/d3/a9/jove-69-4457.PMC3565856.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4457/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/a9/jove-69-4457.PMC3565856.pdf
"gM Cr ops & Food 2012;  3:258-64; http://www.landesbioscience.com/journals/ gmcrops/article/21231 in this review, the authors provide an overview  of therapeutic v accines and the principal tech- nologies used to generate them.",OADS,/arxiv_data1/oa_pdf/e5/65/bbug-4-1.PMC3566013.pdf
"Protein Expr Purif 2012; 83:75-83; PMID:22450161; http://dx.doi.org/10.1016/j.pep.2012.03.006Keywords:  sweet receptor, umami  receptor, sugar, sweetener, GPCR, taste,  recombinant protein, expression, bacteria, Escherichia coli Submitted: 07/11/12Revised: 08/17/12Accepted: 08/17/12http://dx.doi.org/10.4161/bioe.21877 *Correspondence to: Loïc Briand;   Email: loic.briand@dijon.inra.frSweet taste is mediated by a dimeric  receptor composed of two distinct  subunits, T1R2 and T1R3, whereas the T1R1/T1R3 receptor is involved in umami taste perception.",Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
EMBO  J 1999; 18:1723-9; PMID:10202136; http://dx.doi.org/10.1093/emboj/18.7.1723.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Pharmacol Ther 2003; 98:325-54; PMID:12782243; http://dx.doi.org/10.1016/S0163-7258(03)00038-X.3.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Mol Pharmacol 2009; 76:453-65; PMID:19487246; http://dx.doi.org/10.1124/mol.109.055244.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Pharmacol Ther 2010; 127:252-60; PMID:20451554; http://dx.doi.org/10.1016/j.pharmthera.2010.04.007.5.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Nature 2000; 407:971-7; PMID:11069170; http://dx.doi.org/10.1038/35039564.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Protein Sci 2011; 20:1720-34; PMID:21805523; http://dx.doi.org/10.1002/pro.707.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Chem Senses 2011; 36:527-37; PMID:21422378; http://dx.doi.org/10.1093/chemse/bjr014.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
J Biol Chem 2004; 279:45068-75; PMID:15299024; http://dx.doi.org/10.1074/jbc.M406779200.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Appl Microbiol Biotechnol 2012; In press;  PMID:22307499; http://dx.doi.org/10.1007/s00253-012-3897-3.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Trends Genet 2007; 23:212-5; PMID:17382427; http://dx.doi.org/10.1016/j.tig.2007.03.004.14.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Chem Senses 2006; 31:505-13; PMID:16621970; http://dx.doi.org/10.1093/chemse/bjj053.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Protein Expr Purif 2012; 83:75-83; PMID:22450161; http://dx.doi.org/10.1016/j.pep.2012.03.006.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
PLoS One 2012; 7:e35380; PMID:22536376; http://dx.doi.org/10.1371/journal.pone.0035380.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
J Biol Chem 2005; 280:15238-46; PMID:15668251; http://dx.doi.org/10.1074/jbc.M414287200.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
J Biol Chem 2005; 280:34296-305; PMID:16076846; http://dx.doi.org/10.1074/jbc.M505255200.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
BMC Neurosci 2005; 6:22; PMID:15817126; http://dx.doi.org/10.1186/1471-2202-6-22.7.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
J Biol Chem 1998; 273:13089-96; PMID:9582347; http://dx.doi.org/10.1074/jbc.273.21.13089.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
J Biol Chem 1999; 274:18382-6; PMID:10373443; http://dx.doi.org/10.1074/jbc.274.26.18382.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
In Vitro Cell Dev Biol Anim 2003; 39:80-8; PMID:12892531; http://dx.doi.org/10.1290/1543-706X(2003)039<0080:TRTIAE>2.0.CO;2.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Cell 2003; 115:255-66; PMID:14636554; http://dx.doi.org/10.1016/S0092-8674(03)00844-4.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Curr Biol 2005; 15:1948-52; PMID:16271873; http://dx.doi.org/10.1016/j.cub.2005.09.037.,OADS,/arxiv_data1/oa_pdf/1e/18/bbug-4-25.PMC3566016.pdf
Available from:  http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000555.jsp&mid=WC0b01ac0580607bfa2.,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/bbug-4-3.PMC3566017.pdf
PLoS Med 2012; 9:e1001202; http://dx.doi.org/10.1371/journal.pmed.10012023.,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/bbug-4-3.PMC3566017.pdf
2012  october 11; A vailable  from: http://www.gsk.com/media/press-releases/2012/GSK-announces-further-initiatives-to-tackle-global-health-challenges.html Philipp Morris and Medicago to produce influenca vaccines in China Medicago is a clinical-stage biopharmaceu- tical company developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases.,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/bbug-4-3.PMC3566017.pdf
"2012  october 29; A vailable from: http://www.nature.com/ news/politics-holds-back-animal-engineers-1.11596 First approval for gene therapy in Europe At the beginning of November, the European Commission approved “Glybera, ” a gene ther - apy developed by uniQure.",Non-OADS,/arxiv_data1/oa_pdf/0b/d1/bbug-4-3.PMC3566017.pdf
2012 November 2;  Available from: http://www.uniqure.com/news/167/182/uniQure-s-Glybera-First-Gene- ther apy-Approved-by- European-Commission.html Computing cures in the cloud the European   Commission has  recently committed €1.3 million of funds for the development of an ambitious cloud computing based clinical diagnostics platform.,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/bbug-4-3.PMC3566017.pdf
2012 November 7; Available from: http://sili-conrepublic.com/innovation/item/30104-medtech,Non-OADS,/arxiv_data1/oa_pdf/0b/d1/bbug-4-3.PMC3566017.pdf
"J Microbiol Biotechnol 2012; 22:292-300; PMID:22450783; http://dx.doi.org/10.4014/jmb.1107.07047Keywords:  ALL, asparaginase II,  immunogenic epitopes, immuno-Logo,  Rhizobium etli Submitted: 06/15/12Revised: 08/02/12Accepted: 08/02/12http://dx.doi.org/10.4161/bioe.21710 *Correspondence to: Alejandro Huerta-Saquero;  Email: saquero@ibt.unam.mxBacterial l-asparaginase has been a  universal component of therapies  for childhood acute lymphoblastic leu - kemia since the 1970s.",Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"32 Bioengineered  Volume 4 Issue 1cs.iastate.edu/bcpreds/)47,48 and Epitopia  (http://epitopia.tau.ac.il/).",Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"To this end, sequence comparison among asparaginases was performed by BLAST analysis (http://blast.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"A subsequent analysis of the amino acid sequences of the three enzymes was performed to investi - gate antigenic determinants (epitopes) by using the servers BCPREDS (B-cell epitope prediction server; http://ailab.of these enzymes 35,36 and also, primarily,  because both native and modified PEG-asparaginase versions of the enzyme are immunogenic, leading to adverse immune responses to both versions.",Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"First, we can identify the three-dimensional structure of AsnA was built by using the CPHmodels 3.2 server (http://www.cbs.dtu.dk/services/CPHmodels) with the structure of OXA10, a class d β -lactamase from Pseudomonas  aeruginosa  (PDB entry 1E3U.D), as a  template.",OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"In order to refine the model, it was minimized using the Gromacs server (http://lorentz.immstr.pasteur.fr/gro - macs).",OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"Finally, the RAMPAGE program (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) was used to validate the ste - reochemical quality of the resulting three-dimensional model.",OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
These structures were compared using the structural alignment Topmatch server (http://topmatch.services.came.sbg.ac.at).,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Science 1983; 219:632-7; PMID:6337396; http://dx.doi.org/10.1126/sci - ence.6337396.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Nat Biotechnol 2006; 24:769-76; PMID:16841057; http://dx.doi.org/10.1038/nbt0706-769.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Nat Rev Drug Discov 2008; 7:21-39; PMID:18097458; http://dx.doi.org/10.1038/nrd2399.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Nat Biotechnol 2004; 22:521-2; PMID:15122287; http://dx.doi.org/10.1038/nbt0504-521.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Curr Pharm Biotechnol  2011; 12:268-74; PMID:21050165; http://dx.doi.org/10.2174/138920111794295693.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Cytotechnology 2007; 53:121-5; PMID:19003198; http://dx.doi.org/10.1007/s10616-007-9075-2.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Biomed Mater Res A 2009; 91:719-29; PMID:19048635; http://dx.doi.org/10.1002/jbm.a.32254.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Clin Immunol 2009; 131:189-201; PMID:19269256; http://dx.doi.org/10.1016/j.clim.2009.01.009.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Exp Cell Res 2011; 317:1261-9; PMID:21371474; http://dx.doi.org/10.1016/j.yexcr.2011.02.013.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Natl Cancer Inst 1989; 81:531-5; PMID:2466128; http://dx.doi.org/10.1093/jnci/81.7.531.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Allergy Clin Immunol 2001; 108(Suppl):S111-6; PMID:11586277; http://dx.doi.org/10.1067/mai.2001.117824.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Allergy  Clin Immunol 2000; 105:S637-44; PMID:10856171; http://dx.doi.org/10.1067/mai.2000.106156.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Nephrol Dial Transplant 2005; 20(Suppl 6):vi3-9; PMID:15958824; http://dx.doi.org/10.1093/ndt/gfh1092.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Drug Discov Today 2004; 9:82-90; PMID:15012932; http://dx.doi.org/10.1016/S1359-6446(03)02953-2.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Biotechnol Adv 2007; 25:318-24; PMID:17337336; http://dx.doi.org/10.1016/j.biotechadv.2007.01.006.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Annu Rev Pharmacol 1970; 10:421-40; PMID:4911021; http://dx.doi.org/10.1146/annurev.pa.10.040170.002225.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Methods Enzymol 2012; 502:291-319; PMID:22208990; http://dx.doi.org/10.1016/B978-0-12-416039-2.00015-X.29.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Exp Med 1967; 125:17-31; PMID:5334543; http://dx.doi.org/10.1084/jem.125.1.17.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Biochemistry 1967; 6:721-30; PMID:5337885; http://dx.doi.org/10.1021/bi00855a011.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Arch Biochem  Biophys 1964; 105:450-2; PMID:14186753; http://dx.doi.org/10.1016/0003-9861(64)90032-3.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Oncologist 2007; 12:991-8; PMID:17766659; http://dx.doi.org/10.1634/theoncologist.12-8-991.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Expert Opin Biol Ther 2009; 9:111-9; PMID:19063697; http://dx.doi.org/10.1517/14712590802586058.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Clin Cancer Res 2004; 10:5335-41; PMID:15328169; http://dx.doi.org/10.1158/1078-0432.CCR-04-0222.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Bioresour Technol 2011; 102:2077-82; PMID:20832300; http://dx.doi.org/10.1016/j.biortech.2010.07.114.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Mol  Recognit 2008; 21:243-55; PMID:18496882; http://dx.doi.org/10.1002/jmr.893.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Bioinformatics 2001; 17:282-3; PMID:11294794; http://dx.doi.org/10.1093/bioin - formatics/17.3.282.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
BMC Bioinformatics 2008; 9:514; PMID:19055730; http://dx.doi.org/10.1186/1471-2105-9-514.45.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Biotechnol 2007; 127:657-69; PMID:16984804; http://dx.doi.org/10.1016/j.jbio - tec.2006.07.037.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Process Biochem 2002; 38:115-22; http://dx.doi.org/10.1016/S0032-9592(02)00067-5.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Appl Sci 2006; 6:1389-95; http://dx.doi.org/10.3923/jas.2006.1389.1395.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
J Bacteriol 2002; 184:2148-54; PMID:11914346; http://dx.doi.org/10.1128/JB.184.8.2148-2154.2002.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
Appl Microbiol Biotechnol 2000; 53:180-4; PMID:10709980; http://dx.doi.org/10.1007/s002530050006.,OADS,/arxiv_data1/oa_pdf/b7/2c/bbug-4-30.PMC3566018.pdf
"Nat Commun 2012;  3:686; PMID:22353717; http://dx.doi.org/10.1038/ncomms1688Keywords:  Nannochloropsis, algae, bio - fuels, genomics, lipids Submitted: 07/12/12Accepted: 08/18/12http://dx.doi.org/10.4161/bioe.21880 *Correspondence to: Matthew C. Posewitz;   Email: mposewit@mines.eduNannochloropsis species have  emerged as leading phototrophic  microorganisms for the production of bio - fuels.",Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
BioEnergy Research  2010; 3:204-13; http://dx.doi.org/10.1007/s12155-009-9046-x.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Curr Opin Biotechnol 2012; 23:290-7; PMID:22172528; http://dx.doi.org/10.1016/j.copbio.2011.11.022.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Bioproducts and Biorefining 2009; 3:431-40; http://dx.doi.org/10.1002/bbb.159.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Eukaryot Cell 2010; 9:486-501; PMID:20139239; http://dx.doi.org/10.1128/EC.00364-09.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant  Cell 2009; 21:3436-49; PMID:19948792; http://dx.doi.org/10.1105/tpc.109.068825.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
J Phycol 2006; 42:1059-65; http://dx.doi.org/10.1111/j.1529-8817.2006.00269.x.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Nat Commun 2012;  3:686; PMID:22353717; http://dx.doi.org/10.1038/ncomms1688.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Eukaryot Cell 2009; 8:1856-68; PMID:19880756; http://dx.doi.org/10.1128/EC.00272-09.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Eukaryot Cell 2010; 9:1251-61; PMID:20562225; http://dx.doi.org/10.1128/EC.00075-10.12.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Nature 2005; 438:90-3; PMID:16267554; http://dx.doi.org/10.1038/nature04056.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Biochemistry 1992; 31:6045-56; PMID:1339288; http://dx.doi.org/10.1021/bi00141a013.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
J Biol Chem 2006; 281:5604-11; PMID:16368684; http://dx.doi.org/10.1074/jbc.M512962200.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant Cell 2012; 24:692-707; PMID:22353371; http://dx.doi.org/10.1105/tpc.111.093146.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant Physiol  2000; 123:497-508; PMID:10859180; http://dx.doi.org/10.1104/pp.123.2.497.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant Sci 2009; 176:597-601; http://dx.doi.org/10.1016/j.plantsci.2009.02.005.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Eur J Biochem 2003; 270:1043-9; PMID:12631264; http://dx.doi.org/10.1046/j.1432-1033.2003.03469.x.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant Cell  2005; 17:182-203; PMID:15608338; http://dx.doi.org/10.1105/tpc.104.026211.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Crit Rev Biotechnol 2012; In press; PMID:22524446; http://dx.doi.org/10.3109/07388551.2012.668671.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Prog Lipid Res 2002; 41:182-96; PMID:11755683; http://dx.doi.org/10.1016/S0163-7827(01)00023-6.22.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant Physiol 2000; 122:1057-71; PMID:10759501; http://dx.doi.org/10.1104/pp.122.4.1057.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Plant Physiol 1997; 113:75-81; PMID:9008389; http://dx.doi.org/10.1104/pp.113.1.75.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Genome Res 2008; 18:188-96; PMID:18025269; http://dx.doi.org/10.1101/gr.6743907.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
J Biol Chem 2004; 279:25711-20; PMID:15082711; http://dx.doi.org/10.1074/jbc.M403206200.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Curr  Opin Plant Biol 2007; 10:190-8; PMID:17291820; http://dx.doi.org/10.1016/j.pbi.2007.01.012.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Nucleic Acids Res 1987; 15:1281-95; PMID:3547335; http://dx.doi.org/10.1093/nar/15.3.1281.,OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
Biofuels 2011; 2:125-44; http://dx.doi.org/10.4155/bfs.11.7.,Non-OADS,/arxiv_data1/oa_pdf/43/e5/bbug-4-37.PMC3566019.pdf
"The elucidation of  *Correspondence to: Mingtao Zeng; Email address: mt.zeng@ttuhsc.edu Submitted: 07/16/12; Revised: 08/22/12; Accepted: 08/23/12http://dx.doi.org/10.4161/bioe.21950The influenza virus is a respiratory pathogen with a negative- sense, segmented RNA genome.",Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2012; 86:1433-48; PMID:22114331; http://dx.doi.org/10.1128/JVI.05820-11.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Nat Med 2001; 7:1306-12; PMID:11726970; http://dx.doi.org/10.1038/nm1201-1306.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2003; 77:7214-24; PMID:12805420; http://dx.doi.org/10.1128/JVI.77.13.7214-7224.2003.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2009; 83:8021-31; PMID:19494001; http://dx.doi.org/10.1128/JVI.00826-09.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Nucleic Acids Res 1978; 5:1207-19; PMID:652519; http://dx.doi.org/10.1093/nar/5.4.1207.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2003; 77:10575-83; PMID:12970442; http://dx.doi.org/10.1128/JVI.77.19.10575-10583.2003.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2006; 80:2318-25; PMID:16474138; http://dx.doi.org/10.1128/JVI.80.5.2318-2325.2006.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Arch Virol 2009; 154:821-32; PMID:19370391; http://dx.doi.org/10.1007/s00705-009-0380-2.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Cell 1989; 59:1107-13; PMID:2598262; http://dx.doi.org/10.1016/0092-8674(89)90766-6.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Virology 1994; 202:477-9; PMID:8009859; http://dx.doi.org/10.1006/viro.1994.1365.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2009; 83:9296-303; PMID:19587040; http://dx.doi.org/10.1128/JVI.00781-09.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2005; 79:10672-7; PMID:16051859; http://dx.doi.org/10.1128/JVI.79.16.10672-10677.2005.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Cell 2010; 140:397-408; PMID:20144762; http://dx.doi.org/10.1016/j.cell.2010.01.020.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Rev Med Virol 1999; 9:237-44; PMID:10578119; http://dx.doi.org/10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G. 29.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Curr Top Microbiol Immunol 2009; 333:165-76; PMID:19768405; http://dx.doi.org/10.1007/978-3-540-92165-3_8.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Curr Top Microbiol Immunol 2009; 333:83-108; PMID:19768401; http://dx.doi.org/10.1007/978-3-540-92165-3_4.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Vaccine 2007; 25:3062-5; PMID:17276554; http://dx.doi.org/10.1016/j.vaccine.2007.01.030.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Vet Microbiol 2000; 74:117-31; PMID:10799784; http://dx.doi.org/10.1016/S0378-1135(00)00172-3.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2011; 85:2469-73; PMID:21177819; http://dx.doi.org/10.1128/JVI.01650-10.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2010; 84:7204-13; PMID:20463066; http://dx.doi.org/10.1128/JVI.00203-10.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Vaccine 2002; 20:1579-85; PMID:11858865; http://dx.doi.org/10.1016/S0264-410X(01)00491-1.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
T uberculosis (Edinb) 2006; 86:236-46; PMID:16677861; http://dx.doi.org/10.1016/j.tube.2006.01.010.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Clin Vaccine Immunol 2006; 13:898-904; PMID:16893990; http://dx.doi.org/10.1128/CVI.00056-06.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2010; 84:8062-71; PMID:20519387; http://dx.doi.org/10.1128/JVI.00722-10.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2010; 84:2157-63; PMID:19939917; http://dx.doi.org/10.1128/JVI.01433-09.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Nat Biotechnol 2009; 27:572-6; PMID:19483680; http://dx.doi.org/10.1038/nbt.1542.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Virology 2004; 324:67-73; PMID:15183054; http://dx.doi.org/10.1016/j.virol.2004.03.035.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Gen Virol 2009; 90:1398-407; PMID:19264657; http://dx.doi.org/10.1099/vir.0.009639-0.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Nat Biotechnol 2004; 22:589-94; PMID:15064769; http://dx.doi.org/10.1038/nbt957.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
BMC Biol 2008; 6:40; PMID:18793381; http://dx.doi.org/10.1186/1741-7007-6-40.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2001; 75:8899-908; PMID:11533153; http://dx.doi.org/10.1128/JVI.75.19.8899-8908.2001.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2006; 80:11621-7; PMID:16971432; http://dx.doi.org/10.1128/JVI.01645-06.36.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Hum Gene Ther 1999; 10:1533-44; PMID:10395378; http://dx.doi.org/10.1089/10430349950017860.,OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2010; 84:8300-7; PMID:20504926; http://dx.doi.org/10.1128/JVI.00183-10.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2011; 85:6832-43; PMID:21543486; http://dx.doi.org/10.1128/JVI.00609-11.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
Vaccine 2005; 23:2922-7; PMID:15780741; http://dx.doi.org/10.1016/j.vac-cine.2004.11.058.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2003; 77:7411-24; PMID:12805440; http://dx.doi.org/10.1128/JVI.77.13.7411-7424.2003.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2004; 78:1020-5; PMID:14694134; http://dx.doi.org/10.1128/JVI.78.2.1020-1025.2004.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
J Virol 2010; 84:12075-81; PMID:20826692; http://dx.doi.org/10.1128/JVI.00046-10.,Non-OADS,/arxiv_data1/oa_pdf/c4/1a/bbug-4-9.PMC3566024.pdf
"www.landesbioscience.com Cancer Biology & Therapy 13Cancer Biology & Therapy 14:1, 13–19; January 2013; © 2013 Landes BioscienceCLiniC aL STudy  CLiniC aL STudy *Correspondence to: Yoshito Terai; Email: y-terai@poh.osaka-med.ac.jp Submitted: 06/04/12; Revised: 08/21/12; Accepted: 10/22/12http://dx.doi.org/10.4161/cbt.22625Introduction Endometrial cancer is the most common gynecologic malig - nancy in Japan and the western world, where the incidence has  dramatically increased over the past decade.",Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Supplemental Materials Supplemental materials may be found here:http://www.landesbioscience.com/journals/cbt/article/22625/Immunohistochemistry.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Best  Pract Res Clin Obstet Gynaecol 2006; 20:207-25;  PMID:16359925; http://dx.doi.org/10.1016/j.bpob- gyn.2005.10.007.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Gynecol Oncol  1991; 40:55-65; PMID:1989916; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Nat Rev Cancer 2002; 2:563-72;  PMID:12154349; http://dx.doi.org/10.1038/nrc865.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Cancer 1997; 80(Suppl):1529- 37; PMID:9362419; http://dx.doi.org/10.1002/ (SICI)1097-0142(19971015)80:8+<1529::AID- CNCR2>3.0.CO;2-F .,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Int J Gynecol Cancer 2002; 12:286-9; PMID:12060450;  http://dx.doi.org/10.1046/j.1525-1438.2002.t01-1- 01103.x.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Nat Rev Mol Cell  Biol 2006; 7:131-42; PMID:16493418; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
J Cell Physiol  2007; 213:374-83; PMID:17680632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Dev Cell 2008; 14:818-29; PMID:18539112; http://dx.doi.org/10.1016/j.devcel.2008.05.009.14.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Semin Cell Dev Biol 2008; 19:294- 308; PMID:18343170; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Nat Rev Mol Cell Biol 2003; 4:657- 65; PMID:12923528; http://dx.doi.org/10.1038/ nrm1175.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Curr Opin Cell Biol 2005; 17:548-58; PMID:16098727; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Nat Rev Mol Cell Biol 2002; 3:155-66; PMID:11994736; http://dx.doi.org/10.1038/ nrm757.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Gene 2000; 257:1-12;  PMID:11054563; http://dx.doi.org/10.1016/S0378- 1119(00)00371-1.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Hum Pathol 1998; 29:455-62;  PMID:9596268; http://dx.doi.org/10.1016/S0046- 8177(98)90060-0.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Nat Cell  Biol 2000; 2:76-83; PMID:10655586; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Front Biosci  2009; 14:3035-50; PMID:19273255; http://dx.doi.org/10.2741/3433.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Clin Cancer Res 2005; 11:8070- 8; PMID:16299238; http://dx.doi.org/10.1158/1078- 0432.CCR-05-0687.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Br J Cancer 2006; 94:1816- 22; PMID:16773075; http://dx.doi.org/10.1038/ sj.bjc.6603193.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
J Cell Sci 2003; 116:499- 511; PMID:12508111; http://dx.doi.org/10.1242/jcs.00224.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Stem Cells  2009; 27:2059-68; PMID:19544473; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
BMC Cancer 2010; 10:411;  PMID:20691079; http://dx.doi.org/10.1186/1471- 2407-10-411.32.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Oncogene 2002; 21:3241- 6; PMID:12082640; http://dx.doi.org/10.1038/ sj.onc.1205416.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Nat Cell Biol 2000; 2:84-9; PMID:10655587; http://dx.doi.org/10.1038/35000034.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Br J Cancer 2008; 98:489- 95; PMID:18026186; http://dx.doi.org/10.1038/ sj.bjc.6604115.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
BMC  Cancer 2009; 9:289; PMID:19695091; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Gynecol Oncol 2005; 97:155- 65; PMID:15790452; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Cancer 2005; 103:1631-43; PMID:15742334; http://dx.doi.org/10.1002/cncr.20946.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
T rends Mol  Med 2007; 13:535-41; PMID:17981506; http://dx.doi.org/10.1016/j.molmed.2007.10.004.21.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Oncogene 2003; 22:4205-11; PMID:12833143;  http://dx.doi.org/10.1038/sj.onc.1206467.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Genes Dev 2004; 18:1131- 43; PMID:15155580; http://dx.doi.org/10.1101/ gad.294104.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Curr Opin Cell Biol 1993; 5:806- 11; PMID:8240824; http://dx.doi.org/10.1016/0955- 0674(93)90029-P .,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Br J Surg 2000; 87:992-1005; PMID:10931041;  http://dx.doi.org/10.1046/j.1365-2168.2000.01513.x.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Gynecol Oncol 1994; 53:183-9; PMID:8188077; http://dx.doi.org/10.1006/gyno.1994.1113.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
J Clin Oncol 2002; 20:2417- 28; PMID:12011119; http://dx.doi.org/10.1200/ JCO.2002.08.159.,Non-OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Proc Natl Acad Sci USA 1995; 92:7416- 9; PMID:7543680; http://dx.doi.org/10.1073/ pnas.92.16.7416.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Mol Cell 2001; 7:1267-78; PMID:11430829; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/1b/cbt-14-13.PMC3566047.pdf
Wood; Email: woodl@ohsu.edu Submitted: 07/03/12; Revised: 08/31/12; Accepted: 10/22/12http://dx.doi.org/10.4161/cbt.22628of doxorubicin and perhaps other cytotoxic chemotherapeutic  agents.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Cancer Cell 2009; 16:401-12; PMID:19878872;  http://dx.doi.org/10.1016/j.ccr.2009.09.028.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Cancer Chemother Pharmacol 1981;  5:267-70; PMID:7261254; http://dx.doi.org/10.1007/ BF00434396.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Am J Pathol 2005; 166:323-39; PMID:15632024; http://dx.doi.org/10.1016/S0002- 9440(10)62256-0.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Eur J Cancer Clin Oncol 1985; 21:1307- 13; PMID:3865777; http://dx.doi.org/10.1016/0277- 5379(85)90309-8.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Mol Cancer Res 2005; 3:373-9;  PMID:16046548; http://dx.doi.org/10.1158/1541- 7786.MCR-05-0046.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Cancer  Res 2009; 69:695-9; PMID:19147586; http://dx.doi.org/10.1158/0008-5472.CAN-08-3076.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Eur J Heart Fail 2008; 10:233- 43; PMID:18321777; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Mol Immunol  2007; 44:2761-71; PMID:17257680; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Cell Microbiol 2008; 10:1468-77; PMID:18331592;  http://dx.doi.org/10.1111/j.1462-5822.2008.01139.x.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
J Biol Chem 2005; 280:19298- 305; PMID:15737997; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
J Biol Chem 2002; 277:40687-96; PMID:12186863;  http://dx.doi.org/10.1074/jbc.M204455200.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
BMC  Pharmacol 2006; 6:5; PMID:16504051; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Cancer Biol Ther 2010; 10:258-66; PMID:20559024; http://dx.doi.org/10.4161/cbt.10.3.12367.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
J Mol Cell Cardiol 2001; 33:1739- 50; PMID:11549352; http://dx.doi.org/10.1006/ jmcc.2001.1437.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
J Biol Chem 2001; 276:4276-86;  PMID:11042189; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
J Biol Chem 2002; 277:13873- 82; PMID:11836244; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Biochem Biophys Res  Commun 2000; 274:811-6; PMID:10924358; http://dx.doi.org/10.1006/bbrc.2000.3236.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Nat Biotechnol 2008; 26:127-32; PMID:18183025; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Biochim Biophys Acta 2010; 1804:445-53;  PMID:19922818; http://dx.doi.org/10.1016/j.bba- pap.2009.11.008.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Nat Biotechnol 2011; 29:1046- 51; PMID:22037378; http://dx.doi.org/10.1038/ nbt.1990.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Br J Cancer  2006; 94:1765-9; PMID:16721371; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Semin Oncol 2011;  38(Suppl 1):S3-9; PMID:21419934; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Curr Med Chem  2012; 19:938-44; PMID:22214462; http://dx.doi.org/10.2174/092986712799320736.References 1.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Br  J Cancer 2007; 96:937-43; PMID:17325706; http://dx.doi.org/10.1038/sj.bjc.6603640.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Chest 1994; 105:897-904; PMID:8131560; http://dx.doi.org/10.1378/chest.105.3.897.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Br Heart J 1994; 72:561-6; PMID:7857740; http://dx.doi.org/10.1136/ hrt.72.6.561.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Biomed Pharmacother  2011; 65:481-5; PMID:22000485; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Cancer Biol Ther  2011; 11:1008-16; PMID:21464611; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Eur J Pharmacol 2010; 643:247-53;  PMID:20599921; http://dx.doi.org/10.1016/j.ejphar.2010.06.024.,OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Brain Behav Immun 2007; 21:413-27;  PMID:17178209; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
J Pharmacol Exp Ther  2009; 328:458-68; PMID:19004925; http://dx.doi.org/10.1124/jpet.108.142950.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Crit  Care Med 2000; 28(Suppl):N67-77; PMID:10807318; http://dx.doi.org/10.1097/00003246-200004001- 00008.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
"Gastroenterology 2011; 141:e19-20, author reply e20- 1; PMID:21794834; http://dx.doi.org/10.1053/j.gas- tro.2011.04.063.41.",Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
PLoS One 2012; 7:e37735;  PMID:22662203; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/92/c5/cbt-14-56.PMC3566053.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/39/3e/srep01204.PMC3566116.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, Z., Guo, R., Ding, L., Tong, Y.",Non-OADS,/arxiv_data1/oa_pdf/39/3e/srep01204.PMC3566116.pdf
http://www.enerex.ca/articles/nutrition_ digest.pdf .,Non-OADS,/arxiv_data1/oa_pdf/42/0b/12011_2012_Article_9578.PMC3566392.pdf
"6: 223-229, December, 2012 223REVIEW ARTICLEhttp://dx.doi.org/10.4110/in.2012.12.6.223 pISSN 1598-2629    eISSN 2092-6685 Received on October 17, 2012.",Non-OADS,/arxiv_data1/oa_pdf/ee/e0/in-12-223.PMC3566416.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/e0/in-12-223.PMC3566416.pdf
"6: 230-239, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.230 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 230Received on October 29, 2012.",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/in-12-230.PMC3566417.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/in-12-230.PMC3566417.pdf
"6: 240-246, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.240 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 240Received on November 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/80/06/in-12-240.PMC3566418.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/06/in-12-240.PMC3566418.pdf
"6: 247-252, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.247 pISSN 1598-2629    eISSN 2092-6685 247ORIGINAL ARTICLE Received on October 16, 2012.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/in-12-247.PMC3566419.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/aa/in-12-247.PMC3566419.pdf
"6: 253-260, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.253 pISSN 1598-2629    eISSN 2092-6685 253ORIGINAL ARTICLE Received on October 23, 2012.",Non-OADS,/arxiv_data1/oa_pdf/55/3e/in-12-253.PMC3566420.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/3e/in-12-253.PMC3566420.pdf
"6: 261-268, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.261 pISSN 1598-2629    eISSN 2092-6685 261ORIGINAL ARTICLE Received on October 29, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2f/05/in-12-261.PMC3566421.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/05/in-12-261.PMC3566421.pdf
"6: 269-276, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.269 pISSN 1598-2629    eISSN 2092-6685 269ORIGINAL ARTICLE Received on November 6, 2012.",Non-OADS,/arxiv_data1/oa_pdf/ff/93/in-12-269.PMC3566422.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/93/in-12-269.PMC3566422.pdf
"6: 277-283, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.277 pISSN 1598-2629    eISSN 2092-6685 277ORIGINAL ARTICLE Received on November 27, 2012.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/in-12-277.PMC3566423.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/in-12-277.PMC3566423.pdf
"6: 284-290, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.284 pISSN 1598-2629    eISSN 2092-6685BRIEF COMMUNICATION 284Received on November 8, 2012.",Non-OADS,/arxiv_data1/oa_pdf/0c/38/in-12-284.PMC3566424.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/38/in-12-284.PMC3566424.pdf
"6: 291-295, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.291 pISSN 1598-2629    eISSN 2092-6685 291BRIEF COMMUNICATION Received on November 21, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2c/a7/in-12-291.PMC3566425.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/a7/in-12-291.PMC3566425.pdf
"6: 296-300, December, 2012http://dx.doi.org/10.4110/in.2012.12.6.296 pISSN 1598-2629    eISSN 2092-6685BRIEF COMMUNICATION 296Received on December 3, 2012.",Non-OADS,/arxiv_data1/oa_pdf/8b/ed/in-12-296.PMC3566426.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/ed/in-12-296.PMC3566426.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:101-106 http://dx.doi.org/10.4174/jkss.2013.84.2.101 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 14, 2012, Revised November 13, 2012, Accepted December 14, 2012 Correspondence to: Hyung-Il Seo Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 602-739,  Korea Tel: ＋82-51-240-7238, Fax: ＋82-51-247-1365, E-mail: seohi71@hanmail.net cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/13/c9/jkss-84-101.PMC3566467.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:107-113 http://dx.doi.org/10.4174/jkss.2013.84.2.107 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 20, 2012, Revised November 12, 2012, Accepted November 17, 2012 Correspondence to: Jin Hyun Joh Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727, KoreaTel: ＋82-2-440-6261, Fax: ＋82-2-440-6296, E-mail: jhjoh@khu.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/6d/70/jkss-84-107.PMC3566468.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:114-117 http://dx.doi.org/10.4174/jkss.2013.84.2.114 CASE REPORTJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 14, 2012, Revised October 16, 2012, Accepted October 26, 2012 Correspondence to: Hyung-Jin Kim Department of Surgery, St. Vincent's Hospital, The Catholic Univ ersity of Korea College of Medi cine, 93 Jungbu-daero, Paldal-gu , Suwon  442-723, KoreaTel: ＋82-31-249-8303, Fax: ＋82-31-247-5347, E-mail: hj@catholic.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/73/09/jkss-84-114.PMC3566469.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:118-122 http://dx.doi.org/10.4174/jkss.2013.84.2.118 CASE REPORTJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received July 9, 2012, Revised November 13, 2012, Accepted November 17, 2012 Correspondence to: Woon-Kee Lee Department of Surgery, Gachon University Gil Medical Center, Ga chon University, 21 Namdong-daero 774beon-gil, Namdong-gu, Inche on  405-760, KoreaTel: ＋82-32-460-3244, Fax: ＋82-32-460-3247, E-mail: lwk@gilhospital.com cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/e0/aa/jkss-84-118.PMC3566470.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:123-130 http://dx.doi.org/10.4174/jkss.2013.84.2.123 CLINICAL TRIAL NOTEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received June 21, 2012, Revised October 30, 2012, Accepted November 11, 2012 Correspondence to: Hyung-Ho Kim Department of Surgery, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, KoreaTel: ＋82-31-787-7095, Fax: ＋82-31-787-4055, E-mail: hhkim@snubh.org cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/f5/8e/jkss-84-123.PMC3566471.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:73-79 http://dx.doi.org/10.4174/jkss.2013.84.2.73 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received May 9, 2012, Revised November 12, 2012, Accepted December 4, 2012 Correspondence to: Keum Seok Bae Department of Surgery, Yonsei University Wonju Colleg e of Medicine, 20 Ilsan-ro, Wonju 220-701, Korea Tel: ＋82-33-741-0573, Fax: ＋82-33-742-1815, E-mail: bksgs@yonsei.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/52/e5/jkss-84-73.PMC3566472.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:80-87 http://dx.doi.org/10.4174/jkss.2013.84.2.80 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received August 2, 2012, Revised October 29, 2012, Accepted November 11, 2012 Correspondence to: Young-Joon Lee Department of Surgery, Gyeongsang National University Hospital, 79 Gangnam-ro, Jinju 660-702, KoreaTel: ＋82-55-750-8446, Fax: ＋82-55-757-5442, E-mail: yjleegnu@gmail.com cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/ef/89/jkss-84-80.PMC3566473.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:88-93 http://dx.doi.org/10.4174/jkss.2013.84.2.88 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 15, 2012, Revised November 14, 2012, Accepted December 4, 2012 Correspondence to: Seung Ho Choi Department of Surgery, Gangnam Severance Hospital, Yonsei Univ ersity College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-7 20,  KoreaTel: ＋82-2-2019-3374, Fax: ＋82-2-3462-5994, E-mail: choish@yuhs.ac cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/2f/58/jkss-84-88.PMC3566474.pdf
The study was also registered on the ClinicalTrials.gov website (http://www.clinicaltrials.gov/) (NCT01373346).,Non-OADS,/arxiv_data1/oa_pdf/2f/58/jkss-84-88.PMC3566474.pdf
"diabetes-smc.jp/MIndex.htm l, https://sasl.unibas.ch/  11calculators-QUICKI.php).",Non-OADS,/arxiv_data1/oa_pdf/2f/58/jkss-84-88.PMC3566474.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:94-100 http://dx.doi.org/10.4174/jkss.2013.84.2.94 ORIGINAL ARTICLEJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 9, 2012, Revised November 22, 2012, Accepted December 9, 2012 Correspondence to: Jin Cheon Kim Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138 -736,  KoreaTel: ＋82-2-3010-3489, Fax: ＋82-2-474-9027, E-mail: jckim@amc.seoul.kr  cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/bf/3d/jkss-84-94.PMC3566475.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journa l, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/06/83/ehs239.PMC3566528.pdf
"NREL/TP-510-32438 (2002); available at (http://www.nrel.gov/docs/fy02osti/32438.pdf, accessed 22/03/2012).",OADS,/arxiv_data1/oa_pdf/8b/30/srep01244.PMC3566532.pdf
"NREL/TP-510-34929 (2003); available at (http://www.nrel.gov/docs/fy04osti/34929.pdf, accessed 22/03/2012).",OADS,/arxiv_data1/oa_pdf/8b/30/srep01244.PMC3566532.pdf
"‘‘The Production of Methanol and Gasoline’’ Report of the New Zealand Institute of Chemistry ; available at (http://nzic.org.nz/ChemProcesses/energy/7D.pdf, accessed 22/03/2012).",OADS,/arxiv_data1/oa_pdf/8b/30/srep01244.PMC3566532.pdf
"Cook, G., Epstein, K. & Brown, H. The Biomass Economy (Technical Report No.NREL/JA-810-31967 2002); available at (http://www.nrel.gov/docs/fy02osti/31967.pdf, accessed 22/03/2012).",OADS,/arxiv_data1/oa_pdf/8b/30/srep01244.PMC3566532.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The University of Science and Technology of China has filed a WO provisional patent on the technology described in this manuscript.,Non-OADS,/arxiv_data1/oa_pdf/8b/30/srep01244.PMC3566532.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Deng, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/30/srep01244.PMC3566532.pdf
"Molecular modelling For modelling the catalytic domain of CaMKII γC-1 iso- form, we have used the Swiss Model server (http://swissmodel.expasy.org/) [ 25–27].",Non-OADS,/arxiv_data1/oa_pdf/6f/88/bsr033e024.PMC3566533.pdf
"CSF and WML volumes (ml)  were measured using MCMXXXVI  [12] , a validated image pro- cessing algorithm for semiautomatic brain tissue segmentation (http://sourceforge.net/projects/bric1936/).",OADS,/arxiv_data1/oa_pdf/f9/52/ced-0034-0336.PMC3566554.pdf
The scans and associated data collection were funded by the  Chief Scientist Office of the Scottish Executive and the Center for Cognitive Ageing and Cognitive Epidemiology (http://www.ccace.ed.ac.uk/).,OADS,/arxiv_data1/oa_pdf/f9/52/ced-0034-0336.PMC3566554.pdf
"The imaging was conducted at the Brain Re-search Imaging Centre, University of Edinburgh (http://www.bric.ed.ac.uk/).",OADS,/arxiv_data1/oa_pdf/f9/52/ced-0034-0336.PMC3566554.pdf
"The domestic pig ( Sus scrofa ) is a eutherian mammal and a member of the Cetartiodactyla order, a clade distinct from rodent and primates, that last shared a common ancestor with humans between 79 and 97 million years (Myr) ago1,2(http://www.timetree.net).",Non-OADS,/arxiv_data1/oa_pdf/7f/04/41586_2012_Article_BFnature11622.PMC3566564.pdf
Results of an independent annotation by the NCBI can be obtained from http://www.ncbi.nlm.nih.gov/mapview/stats/ BuildStats.cgi?taxid 59823&build 54&ver51.,OADS,/arxiv_data1/oa_pdf/7f/04/41586_2012_Article_BFnature11622.PMC3566564.pdf
"{An improved ncRNA annotation with 3,601 ncRNAs and structured elements is available as a separate track in Ensembl version 70 and for download from http://rth.dk/resources/rnannotator/susscr102.",OADS,/arxiv_data1/oa_pdf/7f/04/41586_2012_Article_BFnature11622.PMC3566564.pdf
"The high-quality annotated reference genome sequence has already proven to be a critical framework for comparing individual genomes39,43,44and its value is further illustrated in associated papers published elsewhere (http://www.biomedcentral.com/series/swine).",OADS,/arxiv_data1/oa_pdf/7f/04/41586_2012_Article_BFnature11622.PMC3566564.pdf
The primary source of the Sscrofa10.2 assembly is the NCBI ftp site (ftp://ftp.ncbi.nih.gov/genbank/genomes/Eukaryotes/vertebrates_mammals/ Sus_scrofa/Sscrofa10.2/).,OADS,/arxiv_data1/oa_pdf/7f/04/41586_2012_Article_BFnature11622.PMC3566564.pdf
"To view a copy of this licence, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Martien A. M. Groenen1*, Alan L. Archibald2*, Hirohide Uenishi3, Christopher K. Tuggle4, Yasuhiro Takeuchi5, Max F. Rothschild4, Claire Rogel-Gaillard6,C h a n k y u Park7, Denis Milan8, Hendrik-Jan Megens1, Shengting Li9,10, Denis M. Larkin11, Heebal Kim12, Laurent A. F. Frantz1, Mario Caccamo13, Hyeonju Ahn12, Bronwen L. Aken14, Anna Anselmo15, Christian Anthon16, Loretta Auvil17, Bouabid Badaoui15, Craig W. Beattie18, Christian Bendixen19, Daniel Berman20, Frank Blecha21, Jonas Blomberg22, Lars Bolund9,10, Mirte Bosse1, Sara Botti15, Zhan Bujie19, Megan Bystrom4, Boris Capitanu17, Denise Carvalho-Silva23, Patrick Chardon6, Celine Chen24, Ryan Cheng4, Sang-Haeng Choi25, William Chow14, Richard C. Clark14, Christopher Clee14, Richard P. M. A. Crooijmans1, Harry D. Dawson24, Patrice Dehais8, Fioravante De Sapio2, Bert Dibbits1, Nizar Drou13, Zhi-Qiang Du4, Kellye Eversole26, Joa˜o Fadista19{, Susan Fairley14, Thomas Faraut8, Geoffrey J. Faulkner2{, Katie E. Fowler27, Merete Fredholm16, Eric Fritz4, James G. R. Gilbert14, Elisabetta Giuffra6,15, Jan Gorodkin16, Darren K. Griffin27, Jennifer L. Harrow14, Alexander Hayward28, Kerstin Howe14, Zhi-Liang Hu4, Sean J. Humphray14{, Toby Hunt14, Henrik Hornshøj19, Jin-Tae Jeon29{, Patric Jern28, Matthew Jones14, Jerzy Jurka30, Hiroyuki Kanamori3,31, Ronan Kapetanovic2, Jaebum Kim7,32, Jae-Hwan Kim33, Kyu-Won Kim34, Tae-Hun Kim35, Greger Larson36, Kyooyeol Lee7, Kyung-Tai Lee35, Richard Leggett13, Harris A. Lewin37, Yingrui Li9, Wansheng Liu38, Jane E. Loveland14, Yao Lu9, Joan K. Lunney20, Jian Ma39, Ole Madsen1, Katherine Mann20{, Lucy Matthews14, Stuart McLaren14, Takeya Morozumi31, Michael P. Murtaugh40, Jitendra Narayan11, Dinh Truong Nguyen7, Peixiang Ni9, Song-Jung Oh41, Suneel Onteru4, Frank Panitz19, Eung-Woo Park35, Hong-Seog Park25, Geraldine Pascal42, Yogesh Paudel1, Miguel Perez-Enciso43, Ricardo Ramirez-Gonzalez13, James M. Reecy4, Sandra Rodriguez-Zas44, Gary A. Rohrer45, Lauretta Rund44, Yongming Sang21, Kyle Schachtschneider44, Joshua G. Schraiber46, John Schwartz40, Linda Scobie47, Carol Scott14, Stephen Searle14, Bertrand Servin8, Bruce R. Southey44, Goran Sperber48, Peter Stadler49, Jonathan V. Sweedler50, Hakim Tafer49, Bo Thomsen19, Rashmi Wali47, Jian Wang9, Jun Wang9,51, Simon White14, Xun Xu9, Martine Yerle8, Guojie Zhang9,52, Jianguo Zhang9, Jie Zhang53, Shuhong Zhao53, Jane Rogers13, Carol Churcher14& Lawrence B. Schook54 1Animal Breeding and Genomics Centre, Wageningen University, De Elst 1, 6708 WD, Wageningen, The Netherlands.2The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, UK.3National Institute of Agrobiological Sciences, 2-1-2 Kannondai, Tsukuba, Ibaraki 305-8602, Japan.4Department of Animal Science and Center for Integrated Animal Genomics, Iowa State University, 2255 Kildee Hall, Ames 50011, USA.5MRC/UCL Centre for Medical Molecular Virology and Wohl Virion Centre, Division of Infection & Immunity, University College London, CruciformBuilding, Gower Street, London WC1E 6BT, UK.6INRA, Laboratory of Animal Genetics and Integrative Biology/AgroParisTech, Laboratory of Animal Genetics and Integrative Biology/CEA, DSV, IRCM, Laboratoire de Radiobiologie et Etude du Ge ´nome, Domaine de Vilvert, F-78350 Jouy-en-Josas, France.7Department of Animal Biotechnology, Konkuk University, 1 Hwayang-dong, Kwangjin-gu, Seoul 143-701, South Korea.8INRA, Laboratoire de Ge ´ne´tique Cellulaire, Chemin de Borde-Rouge, Auzeville, 31320 Castanet Tolosan, France.9BGI-Shenzhen, Shenzhen 518083, China.10Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.11Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, Ceredigion SY23 3DA, UK.12Department of Agricultural Biotechnology and C&K Genomics, Seoul National University, Gwanakgu, Seoul 151-742, South Korea.13The Genome Analysis Centre, Norwich Research Park, Norwich NR4 7UH, UK.14Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.15Parco Tecnologico Padano, Via Einstein, Loc.",Non-OADS,/arxiv_data1/oa_pdf/7f/04/41586_2012_Article_BFnature11622.PMC3566564.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the CreativeCommons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/ by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/df/bc/S0021932012000569a.PMC3566591.pdf
Access to safe water and The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/06/d6/S0950268812000829a.PMC3566592.pdf
"(http://www.who.int/ immunization/sage/1_Bac kground_Paper_Cholera_ Vaccines_FINALdraft_13_oct_v2.pdf), 2009.",Non-OADS,/arxiv_data1/oa_pdf/06/d6/S0950268812000829a.PMC3566592.pdf
Full details on the aims and protocol of EARS-Net are available online (http://ecdc.europa.eu).,Non-OADS,/arxiv_data1/oa_pdf/80/bd/S0950268812001057a.PMC3566593.pdf
"These are deﬁned by several national and international organizations, among which some of the most widely used are the Clinical and Labora- tory Standards Institute (CLSI) and the European The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.",Non-OADS,/arxiv_data1/oa_pdf/80/bd/S0950268812001057a.PMC3566593.pdf
"To date, 13 serogroups of Nmhave been identiﬁed, with serogroups A, B, C, W135, Y, The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10 .1017/S0950268812001689.,Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
Annual morbidity- textbook 1984–2010 (http://www.dgepi.salud.gob.mx/ anuario/html/anuarios.html).,Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
"Tenth International Pathogenic Neisseria Conference, Baltimore, Maryland, 8–13 September 1996, Abstract 150 (http://neisseria.org/ipnc/1996/Neis1996-chap7.pdf).Accessed 3 March 2011.",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
2011 (http://portal.saude.gov.br/portal/saude/proﬁssional/visualiz ar_texto.cfm?idtxt =37810).,Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
"Meningococcal disease (MD) epidemiology in Chile, 2011 (http://epi.minsal.cl/epi/ html/bolets/reportes/meningitis/meningitis.pdf).",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
"Meningococcal disease (MD) epidemiology in Chile, 2010 (http://epi.minsal.cl/ epi/html/bolets/reportes/Me ningitis/meningitisold1.",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
"National vaccine con- sensus, 2011 (http://www.sap.org.ar/docs/publicaciones/ ConsensoVacunas2011.pdf).",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
"Outbreak of serogroup C meningococcal disease in Porto Seguro/Bahia, 2009(http://www2.saude.ba.gov.br/divep/arquivos/Boletins%20Epidemiologicos/Meningite/2009/Nota%20Meningite %20em%20Porto%20Seguro%20(04-11-2009).pdf).",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
"Meningococcal Disease situation, 1990–2008, 2009 (http://www.minsa.gob.pa/minsa/tl_ﬁles/documents/informacion_salud/meningo cocica/meningoccica.pdf).",Non-OADS,/arxiv_data1/oa_pdf/af/f5/S0950268812001689a.PMC3566594.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d1/75/srep01238.PMC3566595.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/75/srep01238.PMC3566595.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Luxmoore, I.J.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/srep01239.PMC3566596.pdf
MD simulations were performed on a 320 processor SUN Microsystems cluster at the Supercomputing Facility (http://www.scfbio-iitd.res.in) of Indian Institute of Technology Delhi.MD simulation protocol has been validated based on the crystal structure of WT-ANG.,OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
"The Active Site Prediction server (http://www.scfbio-iitd.res.in/dock/ActiveSite.jsp) was used for the prediction of active sites, which computes cavities (potential binding sites) in the protein.",OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
"SASA calculation of nuclear localization signal residues 31RRR33.SASA of nuclear localization signal residues31RRR33, was calculated using MolSpace (previously called SurfVol) (http://www.compbiochem.org/Software/molspace/Home.html), a Plug-in for Visual Molecular Dynamics (VMD) software (version 1.9.1)12.S A S Aw a s calculated for all the ANG mutants using a probe radius of 1.4 A ˚.",OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
Graphics .All figures were generated using the PyMOL (http://www.pymol.org)30.,Non-OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
Hydrogen bond interaction network figures were generated using Cytoscape (http://www.cytoscape.org/)14.,OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
http://www.pymol.org/ Accessed 2013 Jan 14.,Non-OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
"Acknowledgements Programme support for the Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology Delhi from the Department of Biotechnology(http://dbtindia.nic.in/index.asp), Government of India is gratefully acknowledged.",Non-OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Padhi, A.K., Jayaram, B.",Non-OADS,/arxiv_data1/oa_pdf/86/e5/srep01225.PMC3566597.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6d/17/srep01240.PMC3566598.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Filippov, A.",Non-OADS,/arxiv_data1/oa_pdf/6d/17/srep01240.PMC3566598.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/09/00/srep01242.PMC3566599.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, J., Wang, L., Li, X.",Non-OADS,/arxiv_data1/oa_pdf/09/00/srep01242.PMC3566599.pdf
"Pardus (http://www.pardus.at) is a browser-based MMOG in a science-fiction setting, played since September 2004.",Non-OADS,/arxiv_data1/oa_pdf/8d/6a/srep01214.PMC3566601.pdf
"A character owns a spacecraft with a certain cargo capa- city, and can roam the virtual universe, trade commodities, socialize,and do much more, usually with the motivation to gain wealth, socialstanding, respect, and fame in the virtual world (http://www.pardus.at/index.php?section 5about).",Non-OADS,/arxiv_data1/oa_pdf/8d/6a/srep01214.PMC3566601.pdf
( b ) Each player of the MMOG Pardus chooses a male (circles) or female (squares) gender when joining the game (adapted from http://www.pardus.at).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 1214 | DOI: 10.1038/srep01214 2,Non-OADS,/arxiv_data1/oa_pdf/8d/6a/srep01214.PMC3566601.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Michael Szell owns stock in Bayer and Szell OG ,t h e company that owns and maintains Pardus.",Non-OADS,/arxiv_data1/oa_pdf/8d/6a/srep01214.PMC3566601.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Szell, M. & Thurner, S. How women organize social networks different from men.",Non-OADS,/arxiv_data1/oa_pdf/8d/6a/srep01214.PMC3566601.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors have submitted two patents relating to this work.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/srep01095.PMC3566603.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Park, D.M.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/srep01095.PMC3566603.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f1/01/srep01241.PMC3566612.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Meng, X.G.",Non-OADS,/arxiv_data1/oa_pdf/f1/01/srep01241.PMC3566612.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Huang, Y.-W. et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/03/srep01237.PMC3566619.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: PYL, GS, GC, MA, AL and TI are employees or own stocks of Ayasdi Inc.",Non-OADS,/arxiv_data1/oa_pdf/23/75/srep01236.PMC3566620.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Lum, P.Y.",Non-OADS,/arxiv_data1/oa_pdf/23/75/srep01236.PMC3566620.pdf
Website page: http://www.bernardvanleer.org/partners/africa/tanzania_- _kiwakkuki (last accessed 20 August 2009).,Non-OADS,/arxiv_data1/oa_pdf/b1/50/dar092.PMC3566659.pdf
"University of Bergen, http://hdl.handle.net/ 1956/4453 .",Non-OADS,/arxiv_data1/oa_pdf/b1/50/dar092.PMC3566659.pdf
University of Bergen: https://bora.uib.no/handle/1956/4450 .,Non-OADS,/arxiv_data1/oa_pdf/b1/50/dar092.PMC3566659.pdf
University ofBergen: https://bora.uib.no/handle/1956/4466 .Mapping synergy and antagony in North–South partnerships for health 59,Non-OADS,/arxiv_data1/oa_pdf/b1/50/dar092.PMC3566659.pdf
University of Bergen:https://bora.uib.no/handle/1956/4276 .,Non-OADS,/arxiv_data1/oa_pdf/b1/50/dar092.PMC3566659.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/22/dks418.PMC3566665.pdf
The study was sponsored bythe University of Oxford and conducted by the South East Asian Infec- tious Diseases Clinical Research Network [SEAICRN (http://www.seaicrn.,Non-OADS,/arxiv_data1/oa_pdf/e3/22/dks418.PMC3566665.pdf
"http://us.gsk.com/ products/assets/us_relenza.pdf (1 September 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/e3/22/dks418.PMC3566665.pdf
"42Division of AIDS table for grading the severity of adult and pediatric adverse events 2004. http://www.niaid.nih.gov/LabsAndResources/ resources/DAIDSClinRsrch/Documents/daidsaegradingtable.pdf (1 January 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/e3/22/dks418.PMC3566665.pdf
"http://www.who.int/csr/resources/publications/swineﬂu/realtimeptpcr/en/index.html (1 January 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e3/22/dks418.PMC3566665.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/4c/65/kws256.PMC3566707.pdf
( http://www.chinaids.org.cn/n16/n1193/ n4073/n745902.,Non-OADS,/arxiv_data1/oa_pdf/4c/65/kws256.PMC3566707.pdf
The following link hasbeen created to allow review of record GSE35815: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=rbwjncouicamlc&acc=GSE35856 1.,OADS,/arxiv_data1/oa_pdf/57/55/tp2012130a.PMC3566713.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Maternal effect on CpG methylation J-e Oh et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/57/55/tp2012130a.PMC3566713.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Concordance of psychiatric symptom ratings PM Thompson et al 6 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/0d/54/tp2012133a.PMC3566714.pdf
"Our slot-machine game implemented a return-to-player of 80%, which is representative of at least some commercial EGMs widely available in the United Kingdom (http://www.gamblingcommission.gov.uk/shared_content_areas/ gaming_machines_technical_stan.aspx).",Non-OADS,/arxiv_data1/oa_pdf/6e/69/tp2012134a.PMC3566715.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Slot-machine, reinforcement learning and personality R Shao et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/6e/69/tp2012134a.PMC3566715.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)SERT-siRNA hastens antidepressant effects A Ferre ´s-Coy et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/c7/83/tp2012135a.PMC3566716.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Antidepressant effects of astrocyte-derived adenosine DJ Hines et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/b2/9d/tp2012136a.PMC3566717.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Role of amygdala in the acute effects of SSRIs S Ravinder et al 11 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/7c/c4/tp2012137a.PMC3566718.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Antipsychotics’ pathways to insulin resistance V Mondelli et al 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/8c/a9/tp2012138a.PMC3566719.pdf
"We identiﬁed by UCSC (University of Califor- nia, Santa Cruz) genome browser (http://genome.ucsc.edu/index.html?org=Human&db=hg19&hgsid=242691861) a CpG island region located at chr11:27743473–27744564 (CpG count: 81, % GC ¼60.5 and Obs/Exp ¼0.83) in the BDNF promoter region, upstream of the ATG start in exon I. PCR design includes 9 CpGs and is located from –1096 to – 900 (numbers relate to the translation start site considered as þ1 in exon I).",Non-OADS,/arxiv_data1/oa_pdf/40/84/tp2012140a.PMC3566720.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Methylation of BDNF and borderline personality disorder N Perroud et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/40/84/tp2012140a.PMC3566720.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Neurogenesis in the remission from depressive-like behavior A Mateus-Pinheiro et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/18/ca/tp2012141a.PMC3566721.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Early biochemical changes induced by sertraline and placebo R Kaddurah-Daouk et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/a5/88/tp2012142a.PMC3566722.pdf
"3Indeed, some have suggested that the systemic abnormalities in ASD such asmitochondrial dysfunction may arise from environmental triggers 7in genetically sensitive subpopulations.8,9Enteric short-chain fatty-acids, such as propionic acid (PPA),10–17 which are fermentation by-products of ASD-associated enteric bacteria (that is, Clostridia, Desulfovibrio, Sutterella and Bacteroidetes ), have been suggested as a possible environmental triggers in ASD.18,19Interestingly, humans with impairments in PPA metabolism20–22exhibit neurodevelop- mental conditions with ASD features.23 Recently, a rodent model has been development in which reversible (30 min) bouts of ASD-type (that is, stereotyped, perseverative and impaired social) behaviors are produced by brief intracerebroventricular infusions of PPA (http://www.psy-chology.uwo.ca/autism/autism6.htm for behavioral video).",Non-OADS,/arxiv_data1/oa_pdf/2f/81/tp2012143a.PMC3566723.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Acyl-carnitine proﬁles in autism RE Frye et al 10 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/2f/81/tp2012143a.PMC3566723.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Peripuberty stress leads to abnormal aggression CM a´rquez et al 12 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/b9/ec/tp2012144a.PMC3566724.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Hippocampal perineuronal nets and schizophrenia A Shah and DJ Lodge 7 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/b4/19/tp2012145a.PMC3566725.pdf
"Haplotype frequencies of DAT variants (rs6347, intron8 rs38366790, rs27072, 9/10 repeatrs2836317) were estimated using the EM algorithm sepa- rately by race, and case status, with both STATA’s haplologit command and R’s haplo.em (haplo.stats package from Rsoftware; http://cran.r-project.org/).",OADS,/arxiv_data1/oa_pdf/f3/17/tp2012146a.PMC3566726.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)DAT DRD2 cocaine interaction D Sullivan et al 8 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/f3/17/tp2012146a.PMC3566726.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Ab1–42 and its putative role on neuronal death L Manterola et al 11 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/2b/a6/tp2012147a.PMC3566727.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Munc18-1a and schizophrenic-like phenotype L Urigu ¨enet al 10 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/f4/ac/tp2012149a.PMC3566728.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Dp44mT targets NDRG1 BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.582 419,Non-OADS,/arxiv_data1/oa_pdf/0a/df/bjc2012582a.PMC3566801.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)REG I aas a biomarker in chemotherapy for gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.572 401,Non-OADS,/arxiv_data1/oa_pdf/88/ff/bjc2012572a.PMC3566803.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Circulating microRNA in plasma of pancreatic cancer patients BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.546 369,Non-OADS,/arxiv_data1/oa_pdf/6d/5a/bjc2012546a.PMC3566805.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER HDAC6 inhibitor with antitumour activity 350 www.bjcancer.com | DOI:10.1038/bjc.2012.576,Non-OADS,/arxiv_data1/oa_pdf/20/1b/bjc2012576a.PMC3566806.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Neoadjuvant therapy of ILC and IDC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.557 291,Non-OADS,/arxiv_data1/oa_pdf/79/1f/bjc2012557a.PMC3566807.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Protein biomarkers in breast cancer tissue 360 www.bjcancer.com | DOI:10.1038/bjc.2012.552,Non-OADS,/arxiv_data1/oa_pdf/4f/a9/bjc2012552a.PMC3566809.pdf
http://seer.cancer.gov/csr/1975_2007/index.html (Accessed 18 Aug. 2011).,Non-OADS,/arxiv_data1/oa_pdf/6c/62/bjc2012543a.PMC3566810.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Sorafenib in elderly patients with RCC: a pooled analysis 318 www.bjcancer.com | DOI:10.1038/bjc.2012.543,Non-OADS,/arxiv_data1/oa_pdf/6c/62/bjc2012543a.PMC3566810.pdf
"10th revision, 4th edition (2010) ISBN 978 92 4 154834 2 http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf.",Non-OADS,/arxiv_data1/oa_pdf/6a/45/bjc2012598a.PMC3566811.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Prognostic value of Ki-67 for prostate cancer death BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.598 277,Non-OADS,/arxiv_data1/oa_pdf/6a/45/bjc2012598a.PMC3566811.pdf
"org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc) APPENDIX A Michael Donnelly, Reader in Health and Social Care Research, Centre for Public Health, Queen’s University Belfast, MulhouseBuilding, Grosvenor Road, Belfast, BT12 6BJ, UK David Donnelly, Northern Ireland Cancer Registry, Centre for Public Health, Queen’s University Belfast, Mulhouse Building, Grosvenor Road, Belfast BT12 6BJ, UK Anette Fischer Pedersen, Post Doctoral Researcher, Research Centre for Cancer Diagnosis in Primary Care, Research Unit for General Practice, Aarhus University, Bartholins Alle ´2, DK-8000 Aarhus, Denmark Deb Keen, Director, Primary Prevention, Canadian Partnership Against Cancer, 1 University Avenue, Suite 300, Toronto, Ontario M5J 2P1, Canada Chris Roberts, Welsh Cancer National Specialist Advisory Group, 14 Cathedral Road, Cardiff CF11 9LH, UK James Kite, Research & Evaluation Co-ordinator, Cancer Prevention Division, Cancer Institute New South Wales, 8 Central Avenue, Eveleigh, New South Wales, Australia 2015Blythe O’Hara, Manager Cancer Prevention Division, Cancer Institute New South Wales, 8 Central Avenue, Eveleigh, New South Wales 2015, Australia Donna Perez, Research & Evaluation Co-ordinator, Cancer Prevention Division, Cancer Institute New South Wales, 8 Central Avenue, Eveleigh, New South Wales 2015, Australia Lisa Petermann, Programme Manager, Canadian Partnership against Cancer, 1 University Avenue, Suite 300,Toronto, Ontario M5J 2P1, Canada Chris Roberts, Welsh Cancer National Specialist Advisory Group, 14 Cathedral Road, Cardiff CF11 9LH, UK Melanie Wakefield, Director, Centre for Behavioural Research in Cancer, Cancer Council Victoria, 100 Drummond St, Carlton, Victoria 3053, Australia Christian Wulff, Research Fellow, Danish Research Centre for Cancer Diagnosis in Primary Care, Department of Public Health, Aarhus University, Bartholins Alle 2, DK-8000 Aarhus, DenmarkBRITISH JOURNAL OF CANCER Differences in cancer awareness and beliefs 300 www.bjcancer.com | DOI:10.1038/bjc.2012.542",Non-OADS,/arxiv_data1/oa_pdf/bd/0c/bjc2012542a.PMC3566814.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic value of APN in prostate cancer 428 www.bjcancer.com | DOI:10.1038/bjc.2012.549,Non-OADS,/arxiv_data1/oa_pdf/90/0c/bjc2012549a.PMC3566819.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER E-cadherin in hypoxic cervical cancer 408 www.bjcancer.com | DOI:10.1038/bjc.2012.570,Non-OADS,/arxiv_data1/oa_pdf/94/84/bjc2012570a.PMC3566820.pdf
Only one study called IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls; http://www.impact-study.co.uk) investigated prostate cancer screening targeted at men with a known genetic predis- position to the disease.,Non-OADS,/arxiv_data1/oa_pdf/11/1f/bjc2012486a.PMC3566821.pdf
"The study required that all patients completed two QLQs – the EORTC core questionnaire (the QLQ-C30, version 3.0; available at http://groups.eortc.be/qol/questionnaires_qlqc30.htm) and the QLQ-GINET21 (see Appendix Table A1) – at all assessment time points (baseline, and 3 and 6 months post-baseline).",Non-OADS,/arxiv_data1/oa_pdf/af/22/bjc2012560a.PMC3566824.pdf
"Such SCRs were identified by searching a database of 30UTRs obtained from Sylarray (Bartonicek and Enright, 2010), on the basis of Ensembl v57 (http://www.ensembl.org/index.html).",OADS,/arxiv_data1/oa_pdf/a3/5b/bjc2012564a.PMC3566827.pdf
The overlap between genes differentially expressed in NCx and HaCaT cells was plotted using the Bioconductor venndiagram package (http://faculty.ucr.edu/ Btgirke/Documents/ R_BioCond/My_R_Scripts/vennDia.R).,OADS,/arxiv_data1/oa_pdf/a3/5b/bjc2012564a.PMC3566827.pdf
"The gene sets used (http://baderlab.org/GeneSetDB_02?action=AttachFile& do=view&target=GO_K_NCI_BIOC_PF_Hs_eg.GMT) were derived from: GO (Biological Process, Molecular Function and Cellular Component), NCI pathways, KEGG pathways, Reactome and PFAM protein domain families.",OADS,/arxiv_data1/oa_pdf/a3/5b/bjc2012564a.PMC3566827.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Predicted vsactual siRNA off-target effects 460 www.bjcancer.com | DOI:10.1038/bjc.2012.564,Non-OADS,/arxiv_data1/oa_pdf/a3/5b/bjc2012564a.PMC3566827.pdf
http://home.jesus.ox.ac.uk/ Bclifford/CIS/AngeloCanty.boot.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/69/bjc2012568a.PMC3566828.pdf
http://www.cancerresearchuk.org/cancer-info/news/archive/pressrelease/2012-03-16-hpv-push-oral-cancer-cases-past-6000-a-year.,Non-OADS,/arxiv_data1/oa_pdf/ae/69/bjc2012568a.PMC3566828.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)The epigenetic landscape of oral cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.568 379,Non-OADS,/arxiv_data1/oa_pdf/ae/69/bjc2012568a.PMC3566828.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER EGFR pathway in advanced pancreatic cancer 476 www.bjcancer.com | DOI:10.1038/bjc.2012.495,Non-OADS,/arxiv_data1/oa_pdf/3f/ac/bjc2012495a.PMC3566829.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2012 |  70  | e3739 | Page 1 of 5Video Article Methods for Intravenous Self Administration in a Mouse Model Elizabeth K. Kmiotek1, Corey Baimel1, Kathryn J. Gill1 1Addictions Unit, McGill University Health Centre Correspondence to: Kathryn J. Gill at kathryn.gill@mcgill.ca URL: http://www.jove.com/video/3739 DOI: doi:10.3791/3739 Keywords: Medicine, Issue 70, Neuroscience, Pharmacology, Behavior, Anatomy, Physiology, Surgery, Intravenous self-administration, IVSA, catheterization, indwelling catheters, drug abuse, addiction, operant training, mouse, animal model Date Published: 12/8/2012 Citation: Kmiotek, E.K., Baimel, C., Gill, K.J.",Non-OADS,/arxiv_data1/oa_pdf/cf/de/jove-70-3739.PMC3567158.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3739/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/de/jove-70-3739.PMC3567158.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2012 |  60  | e3288 | Page 1 of 5Video Article Culturing and Electrophysiology of Cells on NRCC Patch-clamp Chips Christophe Py1, Marzia Martina2, Robert Monette2, Tanya Comas2, Mike W. Denhoff1, Collin Luk3, Naweed I. Syed3, Geoff Mealing2 1Institute for Microstructural Sciences, National Research Council of Canada 2Institute for Biological Sciences, National Research Council of Canada 3Hotchkiss Brain Institute, University of Calgary Correspondence to: Christophe Py at christophe.py@nrc.ca URL: http://www.jove.com/video/3288 DOI: doi:10.3791/3288 Keywords: Neuroscience, Issue 60, disease models, pharmaceutical screens, electrophysiological recordings, patch-clamp, silicon planar patch- clamp chip, cultured neurons Date Published: 2/7/2012 Citation: Py, C., Martina, M., Monette, R., Comas, T., Denhoff, M.W., Luk, C., Syed, N.I., Mealing, G. Culturing and Electrophysiology of Cells on NRCC Patch-clamp Chips.",Non-OADS,/arxiv_data1/oa_pdf/13/cd/jove-60-3288.PMC3567197.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3288/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/13/cd/jove-60-3288.PMC3567197.pdf
Available from: http://www.nrc-cnrc.gc.ca/eng/solutions/facilities/prototyping_index.html (2012).,OADS,/arxiv_data1/oa_pdf/13/cd/jove-60-3288.PMC3567197.pdf
"Lydall at d.a.lydall@ncl.ac.uk URL: http://www.jove.com/video/4018 DOI: doi:10.3791/4018 Keywords: Physiology, Issue 66, Medicine, Robotic, microbial, culture, yeast, array, library, high-throughput, analysis, fitness, growth rate, quantitative, solid agar Date Published: 8/13/2012 Citation: Banks, A., Lawless, C., Lydall, D. A Quantitative Fitness Analysis Workflow.",OADS,/arxiv_data1/oa_pdf/dd/4c/jove-66-4018.PMC3567198.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4018/ Protocol Manual QFA Protocol (for S. cerevisiae strains ) 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/jove-66-4018.PMC3567198.pdf
"Adapted from Supplementary Figure 1B  1, raw data from which this plot was generated can be downloaded from here: http://research.ncl.ac.uk/colonyzer/AddinallQFA/.",OADS,/arxiv_data1/oa_pdf/dd/4c/jove-66-4018.PMC3567198.pdf
Available from http://qfa.r-forge.r-project.org/  (2012).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/jove-66-4018.PMC3567198.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/A dopamine ontogeny model of schizophrenia B Calcagno et al 10 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/cb/5f/tp2012139a.PMC3567203.pdf
"Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4trial and the predictive value of the test at trial entry Leukemia (2013) 27,507–510; doi:10.1038/leu.2012.209 The choice of treatment according to in vitro drug response testing was developed for chronic lymphocytic leukemia (CLL) as the Differential Staining Cytotoxicity assay.1This demonstrated that ﬂudarabine-test-resistant patients treated with ﬂudarabine had a poorer response rate and worse median survival than ﬂudarabine-test-sensitive patients.2A simpliﬁed method, the tumor response to anti-neoplastic compo unds (TRAC) assay, was developed and its value documented in CLL patients.3 We report the largest study in patients entered into a randomized trial, in three contexts: (1) As a randomized variable in nonresponders and relapsed patients to assess its value in the choice of second-line therapy.",Non-OADS,/arxiv_data1/oa_pdf/83/25/leu2012209a.PMC3567236.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) Whole-genome-ampliﬁed DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acutemyeloid leukemia Leukemia (2013) 27,510–512; doi:10.1038/leu.2012.250 Acute myeloid leukemia (AML) is the most common acute leukemia in adults, whereas it constitutes only B15–20% of childhood leukemias.",Non-OADS,/arxiv_data1/oa_pdf/83/25/leu2012209a.PMC3567236.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Targeted vascular therapy with HSV-1 requires MEK CL Skelly et al 224 Gene Therapy (2013) 215 - - 224 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/79/6e/gt201226a.PMC3567261.pdf
"Journal of  Preventive Medicine  & Public Health S1  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S1-S2   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S1 Physical Activity for Health: Evidence, Theory, and   Practice Jin-Jong Chen1, Yunhwan Lee2 1Department of Physical Therapy and Assistive Technology, National Yang-Ming University, Taipei, Taiwan; 2Department of Preventive Medicine  and Public Health, Ajou University Shool of Medicine, Suwon, KoreaEditorial Corresponding author:  Yunhwan Lee, MD, DrPH 164 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5085, Fax: +82-31-219-5084 E-mail : yhlee@ajou.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Physical activity, including exercise, is widely recognized as  one of the key health behaviors for maintaining health and en - hancing quality of life for all age groups.",Non-OADS,/arxiv_data1/oa_pdf/0a/e5/jpmph-46-S1.PMC3567312.pdf
Available from:  http://www.who.int/dietphysicalactivity/factsheet_recom - mendations/en/.,Non-OADS,/arxiv_data1/oa_pdf/0a/e5/jpmph-46-S1.PMC3567312.pdf
Available from: http://www.cdc.gov/nccdphp/sgr/pdf/ sgrfull.pdf.,OADS,/arxiv_data1/oa_pdf/0a/e5/jpmph-46-S1.PMC3567312.pdf
"Journal of  Preventive Medicine  & Public Health S12 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S12-S21   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S12 Exercise and Physical Activity in Mental Disorders:   Clinical and Experimental Evidence Elisabeth Zschucke, Katharina Gaudlitz, Andreas Ströhle Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, GermanySpecial Article Several epidemiological studies have shown that exercise (EX) and physical activity (PA) can prevent or delay the onset of different  mental disorders, and have therapeutic benefits when used as sole or adjunct treatment in mental disorders.",Non-OADS,/arxiv_data1/oa_pdf/9b/62/jpmph-46-S12.PMC3567313.pdf
"Key words:  Exercise, Mental disorders, Motor activity Received:  March 21, 2012 Accepted:  December 7, 2012 Corresponding author:  Andreas Ströhle, MD Charitéplatz 1, 10117 Berlin, Germany Tel: +49-30-450-517034, Fax: +49-30-450-517934 E-mail : andreas.stroehle@charite.de This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Mental disorders constitute a huge social and economic  burden for health care systems worldwide [1], raising the  question of effective and lasting treatments.",Non-OADS,/arxiv_data1/oa_pdf/9b/62/jpmph-46-S12.PMC3567313.pdf
"Journal of  Preventive Medicine  & Public Health S22 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S22-S27   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S22 Mental Exercises for Cognitive Function: Clinical Evidence Ryuta Kawashima Smart Ageing International Research Center, Institute for Development, Aging and Cancer, Tohoku University, Sendai, JapanSpecial Article The purpose of this study was to examine the beneficial effects of a new cognitive intervention program designed for the care and  prevention of dementia, namely Learning Therapy.",Non-OADS,/arxiv_data1/oa_pdf/43/de/jpmph-46-S22.PMC3567314.pdf
"Key words:  Arithmetic, Prefrontal cortex, Reading aloud, Transfer effect, Working memory training Received:  November 30, 2011 Accepted:  March 8, 2012 Corresponding author:  Ryuta Kawashima, MD 4-1 Seiryocho, Aobaku, Sendai 980-8575, Japan Tel: +81-11-717-7988, Fax: +81-11-717-7988 E-mail : ryuta@idac.tohoku.ac.jp This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION In Japan, the percent of the population of elderly people  age 65 and over was 23.1% in 2010, an unprecedentedly high  percentage, making Japan the world’s first super-aging soci - ety.",Non-OADS,/arxiv_data1/oa_pdf/43/de/jpmph-46-S22.PMC3567314.pdf
"Journal of  Preventive Medicine  & Public Health S28 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S28-S34   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S28 Physical Activity and Quality of Life Diane L. Gill, Cara C. Hammond, Erin J. Reifsteck, Christine M. Jehu, Rennae A. Williams, Melanie M. Adams,   Elizabeth H. Lange, Katie Becofsky, Enid Rodriguez, Ya-Ting Shang Department of Kinesiology, University of North Carolina at Greensboro, Greensboro, NC, USA Special Article Physical activity (PA) professionals and participants recognize enhanced quality of life (QoL) as a benefit of and motivator for PA. How - ever, QoL measures are often problematic and rarely consider the participants’ perspective.",Non-OADS,/arxiv_data1/oa_pdf/b0/64/jpmph-46-S28.PMC3567315.pdf
"Key words:  Motor activity, Quality of life, Participant views Received:  January 23, 2012 Accepted:  April 30, 2012 Corresponding author:  Diane L. Gill, PhD PO Box 26170, Greensboro, NC 27402-6170, USA Tel: +1-336-334-4683, Fax: +1-336-334-3070 E-mail : dlgill@uncg.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION This paper focuses on physical activity (PA) and quality of  life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/b0/64/jpmph-46-S28.PMC3567315.pdf
Available from: http://www.who.int/governance/eb/ constitution/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/b0/64/jpmph-46-S28.PMC3567315.pdf
"Journal of  Preventive Medicine  & Public Health S3  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S3-S11   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S3 An Update on Accumulating Exercise and Postprandial  Lipaemia: Translating Theory Into Practice Masashi Miyashita1, Stephen F Burns2, David J Stensel3 1Faculty of Education, Tokyo Gakugei University, Tokyo, Japan; 2Physical Education and Sports Science Academic Group, Nanyang Technological  University, Singapore; 3School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, United KingdomSpecial Article Over the last two decades, significant research attention has been given to the acute effect of a single bout of exercise on postprandi - al lipaemia.",Non-OADS,/arxiv_data1/oa_pdf/bd/fd/jpmph-46-S3.PMC3567316.pdf
"Key words:  Physcal activity, Postprandial period, Lipid metabolism, Cardiovascular disease Received:  January 25, 2012 Accepted:  November 12, 2012 Corresponding author:  Masashi Miyashita, PhD 4-1-1 Nukuikitamachi, Koganei, Tokyo 184-8501, Japan Tel: +82-4-329-7622, Fax: +82-4-329-7622 E-mail : masashi@u-gakugei.ac.jp This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION In 1995 the Centers for Disease Control and Prevention and  the American College of Sports Medicine published physical  activity guidelines which stated that adults should accumulate  30 minutes of moderate intensity activity on most, preferably  all, days of the week [1].",Non-OADS,/arxiv_data1/oa_pdf/bd/fd/jpmph-46-S3.PMC3567316.pdf
"Journal of  Preventive Medicine  & Public Health S35  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S35-S42   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S35 Commitment to Sport and Exercise: Re-examining the  Literature for a Practical and Parsimonious Model Lavon Williams Sports Studies Department, Guilford College, Greensboro, NC, USASpecial Article A commitment to physical activity is necessary for personal health, and is a primary goal of physical activity practitioners.",Non-OADS,/arxiv_data1/oa_pdf/f2/16/jpmph-46-S35.PMC3567317.pdf
"Key words:  Motivation, Personal satisfaction, Behavior, Motor activity, Physical fitness, Health Received:  February 8, 2012 Accepted:  September 6, 2012 Corresponding author:  Lavon Williams, PhD 5600 West Friendly Avenue, Guilford College, Greensboro, NC 27410,  USA Tel: +1-336-315-2953, Fax: +1-336-316-2495 E-mail : lwilliam@guilford.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Physical inactivity is a leading cause of most non-infectious  diseases [1-3], including heart disease, some cancers, and type  2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f2/16/jpmph-46-S35.PMC3567317.pdf
"Journal of  Preventive Medicine  & Public Health S43  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S43-S49   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S43 Experiences in Sport, Physical Activity, and Physical   Education Among Christian, Buddhist, and Hindu Asian  Adolescent Girls Kaori Araki1, Iku Kodani1, Nidhi Gupta2, Diane L. Gill3 1School of Human Science and Environment, University of Hyogo, Hyogo, Japan; 2Physical Education and Sports Science, National Institute of  Education, Nanyang Technological University, Singapore; 3Department of Kinesiology, University of North Carolina at Greensboro, NC, USASpecial Article Multicultural scholarship in sport and exercise psychology should help us understand and apply cultural competencies for all to be  physically active.",Non-OADS,/arxiv_data1/oa_pdf/21/b3/jpmph-46-S43.PMC3567318.pdf
"Key words:  Adolescent, Cultural competency, Diversity, Motor activity  Received:  January 30, 2012 Accepted:  November 13, 2012 Corresponding author:  Kaori Araki, PhD 1-1-12 Shinzaikechonho Himeji, Hyogo 670-0092, Japan Tel: +81-79-292-9357, Fax: +81-79-292-9357 E-mail : kaoriaraki@shse.u-hyogo.ac.jp This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.and high schools in Japan and Singapore offer PE classes.",Non-OADS,/arxiv_data1/oa_pdf/21/b3/jpmph-46-S43.PMC3567318.pdf
Available from: http://www18.ocn.ne.jp/  ~njpa/sub/h22bukatsu.htm (Japanese).,Non-OADS,/arxiv_data1/oa_pdf/21/b3/jpmph-46-S43.PMC3567318.pdf
Available from: http://www.ssc.gov.,Non-OADS,/arxiv_data1/oa_pdf/21/b3/jpmph-46-S43.PMC3567318.pdf
Available from: http://www.sing - stat.gov.sg/pubn/popn/cop2000admin.pdf.,OADS,/arxiv_data1/oa_pdf/21/b3/jpmph-46-S43.PMC3567318.pdf
Available from: http://www.moe.gov.sg/media/press/2012/  07/racial-harmony-day-celebrations-2012.php.,Non-OADS,/arxiv_data1/oa_pdf/21/b3/jpmph-46-S43.PMC3567318.pdf
"Journal of  Preventive Medicine  & Public Health S50 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:S50-S54   •  http://dx.doi.org/10.3961/jpmph.2013.46.S.S50 Promoting Mobility in Older People  Taina Rantanen Department of Health Sciences and Gerontology Research Center, University of Jyväskylä, Jyväskylä, FinlandSpecial Article Out-of-home mobility is necessary for accessing commodities, making use of neighborhood facilities, and participation in meaningful  social, cultural, and physical activities.",Non-OADS,/arxiv_data1/oa_pdf/dc/54/jpmph-46-S50.PMC3567319.pdf
"Key words:  Aging, Walking, Motor activity, Muscle strength, Environmental barriers, Health promotion  Received:  January 29, 2012 Accepted:  March 29, 2012 Corresponding author:  Taina Rantanen, PhD PO Box 35, FI-40014, University of Jyväskylä, Jyväskylä, Finland Tel: +358-40-805-3590, Fax: +358-14-260-4600 E-mail : taina.rantanen@jyu.fi This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION “Sarah, an older lady with a walker, was waiting for me with  her outdoor clothes on in her studio apartment.",Non-OADS,/arxiv_data1/oa_pdf/dc/54/jpmph-46-S50.PMC3567319.pdf
"Journal of  Preventive Medicine  & Public Health 1  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:1-9   •  http://dx.doi.org/10.3961/jpmph.2013.46.1.1 Association Between Local Government Social   Expenditures and Mortality Levels in Korea Hansoo Ko, Jinseob Kim, Donggil Kim, Saerom Kim, Yukyung Park, Chang-yup Kim Preventive Medicine Program, Graduate School of Public Health, Seoul National University, Seoul, KoreaOriginal Article Objectives: We examined the association between social expenditures of the local government and the mortality level in Korea, 2004  to 2010.",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/jpmph-46-1.PMC3567320.pdf
"Key words:  Social expenditure, Local government, Mortality,  Received:  June 28, 2012 Accepted:  October 12, 2012 Corresponding author:  Chang-yup Kim, MD, PhD 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Tel: +82-2-880-2722, Fax: +82-2-762-9105 E-mail : cykim@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Health status is affected by social determinants.",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/jpmph-46-1.PMC3567320.pdf
"Journal of  Preventive Medicine  & Public Health 10 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:10-18   •  http://dx.doi.org/10.3961/jpmph.2013.46.1.10 PM 10 Exposure and Non-accidental Mortality in Asian  Populations: A Meta-analysis of Time-series and   Case-crossover Studies Hye Yin Park1, Sanghyuk Bae1, Yun-Chul Hong1,2 1Department of Preventive Medicine, Seoul National University College of Medicine; 2Institute of Environmental Medicine, Seoul National University  Medical Research Center, Seoul, Korea Original Article Objectives: We investigated the association between particulate matter less than 10 μm in aerodynamic diameter (PM 10) exposure  and non-accidental mortality in Asian populations by meta-analysis, using both time-series and case-crossover analysis.",Non-OADS,/arxiv_data1/oa_pdf/6a/84/jpmph-46-10.PMC3567321.pdf
"Key words:  PM 10, Non-accidental mortality, Asia, Meta-analysis Received:  September  21, 2012 Accepted:  November 22, 2012 Corresponding author:  Yun-Chul Hong, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea  Tel: +82-2-740-8394, Fax: +82-2-747-4830 E-mail : ychong1@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Associations between air pollution and daily mortality out - comes have been well-documented by numerous studies [1-pISSN 1975-8375  eISSN 2233-4521  4], and it has been reported that, among the ambient air pol - lutants, particulate matter (PM) has shown the most consis - tent associations with mortality [5-7].",Non-OADS,/arxiv_data1/oa_pdf/6a/84/jpmph-46-10.PMC3567321.pdf
"Journal of  Preventive Medicine  & Public Health 19  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:19-27   •  http://dx.doi.org/10.3961/jpmph.2013.46.1.19 The Effects of Temperature on Heat-related Illness   According to the Characteristics of Patients During the  Summer of 2012 in the Republic of Korea Wonwoong Na1, Jae-Yeon Jang1, Kyung Eun Lee1, Hyunyoung Kim1, Byungyool Jun2, Jun-Wook Kwon2, Soo-Nam Jo2 1Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon; 2Korea Centers for Disease Control and  Prevention, Cheongwon, KoreaOriginal Article Objectives: This study was conducted to investigate the relationship between heat-related illnesses developed in the summer of 2012  and temperature.",Non-OADS,/arxiv_data1/oa_pdf/91/b2/jpmph-46-19.PMC3567322.pdf
"Key words:  Extreme heat, Heat waves, Heat stress disorders, Heat stroke, Republic of Korea, Threshold Received:  October 10, 2012 Accepted:  November 24, 2012 Corresponding author:  Soo-Nam Jo, MPH Osong Health Technology Administration Complex, 187 Osongsaeng - myeong 2-ro, Osong-eup, Cheongwon 363-700, Korea Tel: +82-43-719-7263, Fax: +82-31-219-5084 E-mail : joria517@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Due to global climate change, heat waves are increasing in  frequency, intensity, and duration [1].",Non-OADS,/arxiv_data1/oa_pdf/91/b2/jpmph-46-19.PMC3567322.pdf
"For statistical analysis, SPSS version 19.0 (IBM, Armonk, NY,  USA) and R version 2.15 (The Comprehensive R Archive Net - work, http://cran.r-project.org) were used.",OADS,/arxiv_data1/oa_pdf/91/b2/jpmph-46-19.PMC3567322.pdf
Available from: http://www.kma.go.kr/ weather/observation/past_cal.jsp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/91/b2/jpmph-46-19.PMC3567322.pdf
"Journal of  Preventive Medicine  & Public Health 28 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:28-38   •  http://dx.doi.org/10.3961/jpmph.2013.46.1.28 The Relationship Between the Social Network of   Community-living Elders and Their Health-related Quality  of Life in Korean Province Jun Tae Lim1, Jong-Heon Park2, Jin-Seok Lee1,2, Juhwan Oh2*, Yoon Kim1,2   1Department of Health Policy and Management, Seoul National University College of Medicine; 2Institute of Health Policy and Management,  Medical Research Center, Seoul National University, Seoul, KoreaOriginal Article Objectives: This study aimed to collect information that will help enhance the social networks and improve the quality of life among  elderly people by observing the relationship between their social network and health-related quality of life (HRQoL) and by analyzing  social network factors affecting HRQoL.",Non-OADS,/arxiv_data1/oa_pdf/bd/96/jpmph-46-28.PMC3567323.pdf
"Key words:  Social network, Health, Quality of life, Aged  Received:  July 19, 2012 Accepted:  December 6, 2012 Corresponding author:  Yoon Kim, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-2072-3124, Fax: +82-2-2072-3124 E-mail : yoonkim@snu.ac.kr *Current affiliation: JW Lee Center for Global Medicine, Seoul National University  College of Medicine, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The elderly population in Korea is rapidly increasing and so  is the importance of their health problems.",Non-OADS,/arxiv_data1/oa_pdf/bd/96/jpmph-46-28.PMC3567323.pdf
Available from: http://www2.korea.kr/exp - doc/viewDocument.req?id =30319 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/bd/96/jpmph-46-28.PMC3567323.pdf
"Journal of  Preventive Medicine  & Public Health 39  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:39-49   •  http://dx.doi.org/10.3961/jpmph.2013.46.1.39 Prevalence of Musculoskeletal Symptoms Related With  Activities of Daily Living and Contributing Factors in   Korean Adults Kyusik Choi, Jae-Hyun Park, Hae-Kwan Cheong Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon, KoreaOriginal Article Objectives: This study aims to investigate the prevalence of musculoskeletal symptoms and factors related to daily activities in a rep - resentative Korean population.",Non-OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
"Key words:  Musculoskeletal diseases, Korean General Social Survey, 12-Item Short Form Health Survey, Quality of life, Activities of dai - ly living Received:  September 28, 2012 Accepted:  December 26, 2012 Corresponding author:  Jae-Hyun Park, MD, PhD 2066 Seobu-ro, Jangan-gu, Suwon 440-746, Korea Tel: +82-31-299-6301, Fax: +82-31-299-6299 E-mail : pjaehyun@skku.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION According to a study on the prevalence rate of musculoskel - etal symptoms in South Korea, 19.7% of Korean adults aged pISSN 1975-8375  eISSN 2233-4521  19 and over have musculoskeletal disease (osteoarthritis) in at  least one part of the body [1].",Non-OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
Available from: https://kgss.skku.edu/index_ssl.htm  (Korean).,OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
Available from: http://www.kosha.,Non-OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
Available from: http://www.cdc.gov/ niosh/hhe/reports/pdfs/1993-0920-2548.pdf.,OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
Available from: http://www.psychsupport.com.au/ bundles/gppsui/assets/SF12-Questionnaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
Available from: http://gim.med.ucla.edu/FacultyPages/Hays/ UTILS/sf12v2-1.sas.,Non-OADS,/arxiv_data1/oa_pdf/14/ba/jpmph-46-39.PMC3567324.pdf
"Journal of  Preventive Medicine  & Public Health 50 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:50-60   •  http://dx.doi.org/10.3961/jpmph.2013.46.1.50 Socioeconomic Status and Number of Children Among  Korean Women: The Healthy Twin Study Jinseob Kim, Joohon Sung Preventive Medicine Program, Graduate School of Public Health, Seoul National University, Seoul, KoreaOriginal Article Objectives: This study aimed to evaluate whether the birth rate is associated with socioeconomic status in the women of the Republic  of Korea, where the birth rate is rapidly decreasing.",Non-OADS,/arxiv_data1/oa_pdf/66/37/jpmph-46-50.PMC3567325.pdf
"Key words:  Fertility, Family, Social class  Received:  July 2, 2012 Accepted:  December 28, 2012 Corresponding author:  Joohon Sung, MD, PhD 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Tel: +82-2-880-2828, Fax: +82-2-762-9105 E-mail : jsung@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The low birthrate in the Republic of Korea (hereafter, Korea)  has come to the fore as one of the most important social prob - lems, yet effective measures for dealing with this problem  have not been developed.",Non-OADS,/arxiv_data1/oa_pdf/66/37/jpmph-46-50.PMC3567325.pdf
Available from: http://kosis.kr/abroad/abroad_  01List.jsp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/66/37/jpmph-46-50.PMC3567325.pdf
Database URL: http://cabindb.iasri.res.in/pigeonpea/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction Pigeonpea or ‘tur’ is one of the most important pulse crops belonging to family Fabaceae and scientifically known asCajanus cajan .,Non-OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
"Our database is unique and user friendly as itdesigns primer on loci of choice with amplicon range up to500 bp, further facilitating the low-cost rapid revalidationin simple agrose gel.Database development Database flow The chromosome-wise pigeonpea genome, available in public domain (http://www.icrisat.org/gt-bt/iipg/genome- data.zip), was downloaded in FASTA format.",OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
Availability PIPEMicroDB can be accessed freely at http://cabindb.iasri.,OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
"References 1. http://faostat.fao.org (15 June 2012, date last accessed).2.",Non-OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
"4. http://www.crnindia.com/commodity/tur.html (15 June 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
"10. http://pgrc.ipk-gatersleben.de/misa/ (15 June 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e0/b4/bas054.PMC3567484.pdf
pseudoMap is freely accessible at http://pseudomap.mbc.nctu.edu.tw/.,OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
Database URL: http://pseudomap.mbc.nctu.edu.tw/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction Pseudogenes are genomic DNA sequences homologous to functional genes yet are not translated into proteins ( 1).,OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
"Construction and content In pseudoMap, various databases are integrated and main- tained with MySQL (http://www.mysql.com/) relationaldatabase management system.",OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
"While operating on anApache HTTP server (http://www.apache.org/) and PHP(http://www.php.net/) on a Linux operation system (http://www.linux.com), pseudoMap was constructed using theSmarty template engine (http://www.smarty.net).",OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
"Basedon PHP, JavaScript (http://www.javascriptsource.com/), CSS(http://www.w3schools.com/css/) and HTML (http://www.w3schools.com/html/) languages, the web interface enablesdynamic MySQL queries with user-friendly graphics.",OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
"Comparisons of pseudoMap with currently public databases of pseudogenes Supported features pseudoMap (our database) PseudoGene database UI pseudogene Hoppsigen Web interface http://pseudomap.mbc.nctu.edu.tw/ http://www.pseudogene.org/ https://genome.uiowa.edu/pseudogenes/ http://pbil.univ-ly on1.fr/databases/hopp sigen.html Description pseudoMap provides a comprehensive re- source for genome-wide identifying the functions and regulators of human pseudogenes.This site contains a comprehensive database of identified pseudogenes, utilities used to find pseudogenes, various publication data sets and apseudogene knowledgebase.This site serves as a repository for all pseudogenes in the human genome and provides a ranked list of human pseudogenes that have been identifiedas candidates for gene conversion.Hoppsigen is a nucleic database of homologous processed pseudogenes.",OADS,/arxiv_data1/oa_pdf/c9/c3/bat001.PMC3567485.pdf
Database URL: http://www.crosstope.com.br ............................................................................................................................................................................................................................................................................................. Introduction A great challenge in immunology is the discovery of new targets to the development of vaccines against even common infectious diseases.,OADS,/arxiv_data1/oa_pdf/76/25/bat002.PMC3567486.pdf
"UntilSeptember 2012, there were /C24430 pMHC-I structures avail- able at PDB (http://www.rcsb.org), including redundantcomplexes, and /C246252 human MHC-I alleles described at the HLA (Human leucocyte antigens) Nomenclature web-site (http://hla.alleles.org/nomenclature/stats.html), encod-ing/C244578 different proteins (allotypes).",OADS,/arxiv_data1/oa_pdf/76/25/bat002.PMC3567486.pdf
"By clicking the plus icon in a spe-cific epitope from the list, an output containing a completedescription (manually curated) of that target is generated(Figure 4 ): complex code, source protein and source organ- ism, epitope position, immunological background (cross-reactivity data and immunogenicity degree presented bythe epitopes) and original reference of the epitopes, aswell as links to the major databases in the area (NCBI: http://www.ncbi.nlm.nih.gov/; Uniprot: http://www.uni prot.org/; and IEDB: http://www.iedb.org/).",OADS,/arxiv_data1/oa_pdf/76/25/bat002.PMC3567486.pdf
"HLA-A*02:01 is one of the most frequenthuman MHC alleles (http://www.allelefrequencies.net/),and HLA-B*27:05 has important roles in autoimmunity(23,24) and also in viral control of HCV and HIV ( 25–27 ).",Non-OADS,/arxiv_data1/oa_pdf/76/25/bat002.PMC3567486.pdf
Theapp is available from iTunes (http://itunes.com/apps/yeastgenome).,Non-OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
"............................................................................................................................................................................................................................................................................................. Introduction The Saccharomyces Genome Database [SGD, ( 1)] gathers, organizes and provides biological information about the budding yeast Saccharomyces cerevisiae in an integrated format via the internet (http://www.yeastgenome.org).",OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
The de-velopment of YeastMine [http://yeastmine.yeastgenome.,Non-OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
"org ( 6)], a Saccharomyces -specific installation of InterMine [http://intermine.org ( 7)] that was developed and ismaintained at SGD in collaboration with the Intermine pro- ject, has allowed us to keep the YeastGenome app com-pact, with the ability to quickly access curated data fromSGD’s database.",OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
"When internet access is available, the raw sequence, Locus Summary page provid- ing full information at SGD, feature-specific data atYeastMine and expression data [http://spell.yeastgenome.",OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
Source code and support online The source code is freely available at https://github.com/edwong57/YeastGenome-app.,OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
"A web page is provided that provides basic app information and how to obtainhelp, ‘http://www.yeastgenome.org/yeastgenome-app- information’.",OADS,/arxiv_data1/oa_pdf/a7/f6/bat004.PMC3567487.pdf
"(2012 ),  http://onlinelibrary.wiley.com/doi/10.1111/j.1755 - 3768.2012.02406.x/abstract;jsessionid=709547A0B32B5AF6026818404FFA2F39.d03t01 .",Non-OADS,/arxiv_data1/oa_pdf/6d/be/220.PMC3567709.pdf
"National Cancer Institute , “Breast Cancer Risk in American Women,”  http://www.cancer.gov/cancertopics/factsheet/detection/probability -breast -cancer .",Non-OADS,/arxiv_data1/oa_pdf/e6/df/287.PMC3567715.pdf
"GRINTECH GmbH, “GRIN  lens systems for medical applic ations,” http://www.grintech.de/grin -lens-systems- for-medical -applications.html .",Non-OADS,/arxiv_data1/oa_pdf/e6/df/287.PMC3567715.pdf
"ISO, “Photography —electronic still-picture cameras —resolution measurements,” ISO 12233:2000,   http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.htm?csnumber=33715 .",Non-OADS,/arxiv_data1/oa_pdf/e6/df/287.PMC3567715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Soc iety and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/8f/f2/cvs350.PMC3567785.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Soc iety and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/21/5a/cvs352.PMC3567786.pdf
"The relativeintensity of the bands was quantiﬁed by scanning densitometry, usingthe Image J software (available at http://rsb.info.nih.gov/).",OADS,/arxiv_data1/oa_pdf/21/5a/cvs352.PMC3567786.pdf
Available at http://www.aiha.org/insideaiha/volunteergroups/EASC/Documents/EASC-IHSTAT -V225.xls.,Non-OADS,/arxiv_data1/oa_pdf/c4/db/mes066.PMC3567810.pdf
Available at: http://www.tsi.com/ en-1033/products/14000/dusttrak%E2%84%A2_aerosol_monitors/14004/8533.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c4/db/mes066.PMC3567810.pdf
Available at: http://monographs.iarc.fr/ENG/Monographs/vol93/mono93.pdf Woo EJ.,Non-OADS,/arxiv_data1/oa_pdf/c4/db/mes066.PMC3567810.pdf
Available at http://www.fao.org/docrep/003/X6939E/X6939e00.htm.,Non-OADS,/arxiv_data1/oa_pdf/3a/37/mes064.PMC3567811.pdf
Available at http://www.arbeidstilsynet.no/artikkel.html?tid=78880#15.,Non-OADS,/arxiv_data1/oa_pdf/3a/37/mes064.PMC3567811.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Journal of Cardio-Thoracic Surgery 43 (2013) 534 –540 ORIGINAL ARTICLE doi:10.1093/ejcts/ezs332 Advance Access publication 3 July 2012",Non-OADS,/arxiv_data1/oa_pdf/f5/6d/ezs332.PMC3567831.pdf
This paper is available on line at http://www.mcponline.org Molecular & Cellular Proteomics 12.2 369,Non-OADS,/arxiv_data1/oa_pdf/3a/a6/zjw369.PMC3567860.pdf
AllpPSMs and corresponding MS/MS spectra can be found inPRIDE ( http://www.ebi.ac.uk/pride/ ) and the ProMEX data- base ( http://promex.pph.univie.ac.at/promex/ ).,OADS,/arxiv_data1/oa_pdf/3a/a6/zjw369.PMC3567860.pdf
This paper is available on line at http://www.mcponline.org 426 Molecular & Cellular Proteomics 12.2,Non-OADS,/arxiv_data1/oa_pdf/fc/16/zjw426.PMC3567864.pdf
": Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System www.karger.com/nne  © 2012 S. Karger AG, Basel   5 Novartis Media Releases December 20, 2011. http://www.novartis.com/newsroom/media-releases/ en/2011/1572562.shtml.",Non-OADS,/arxiv_data1/oa_pdf/9e/1c/nne-0002-0278.PMC3567880.pdf
http://www.clinicaltrials.gov/show/NCT01351675.,Non-OADS,/arxiv_data1/oa_pdf/9e/1c/nne-0002-0278.PMC3567880.pdf
http://www.unfpa.org/swp/2007/english/introduction.html.,Non-OADS,/arxiv_data1/oa_pdf/3f/67/ger-0059-0003.PMC3567881.pdf
"They*Correspondence to: Viviane Gomide; Email: vsgomide@gmail.com Submitted: 05/15/12; Revised: 08/13/12; Accepted: 09/11/12 http://dx.doi.org/10.4161/biom.22170REVIEW Biomatter 2:4, 1 –9; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 1",Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Bone 2011; 48:171-81; PMID:20932947; http://dx.doi.org/10.1016/j.bone.2010.09.138 2.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Aust N Z J Surg 1999; 69: 726-8; PMID:10527350; http://dx.doi.org/10.1046/j.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Foot Ankle Surg 1996; 35:413-7; PMID:8915864; http://dx.doi.org/10.1016/S1067- 2516(96)80061-5 6.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res 2002; 62:136- 48; PMID:12124795; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
ANZ J Surg 2001; 71:354-61; PMID: 11409021; http://dx.doi.org/10.1046/j.1440-1622.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Mater Chem 2010; 20:8747-59; http://dx.doi.org/10.1039/ c0jm00795a 10.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Injury 2011; 42(Suppl 2):S56-63; PMID:21752369; http://dx.doi.org/10.1016/j.injury.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biotechnol Bioeng 2003; 84:205-14; PMID:12966577; http://dx.doi.org/10.1002/bit.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Science 2002; 295:1009-14; PMID:11834815; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Mol Ther 2000; 1:12-5; PMID:10933907; http://dx.doi.org/10.1006/mthe.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Chem Technol Biotechnol 2008; 83:408-20; http://dx.doi.org/10.1002/jctb.1918 15.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Trends Biotechnol 2004; 22:80- 6; PMID:14757042; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Ann Biomed Eng 2004; 32:112-22; PMID:14964727; http://dx.doi.org/ 10.1023/B:ABME.0000007796.48329.b4 18.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2003; 67A:357-67; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Biotechnol 2009; 2009:873816; PMID:20037739; http://dx.doi.org/10.1155/2009/873816 21.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Int J Artif Organs 2011; 34: 259-70; PMID:21374561; http://dx.doi.org/10.5301/ IJAO.2011.6333 22.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Macromol Biosci 2007; 7:643-55; PMID:17477447; http://dx.doi.org/ 10.1002/mabi.200700030 23.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2001; 22: 2581-93; PMID:11519777; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Tissue Eng Part A 2009; 15:205-19; PMID:18694293; http://dx.doi.org/10.1089/ten.tea.2008.0131 26.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2007; 88A: 935-46; http://dx.doi.org/10.1002/jbm.a.31914 27.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2001; 22:1279-88; PMID: 11336300; http://dx.doi.org/10.1016/S0142-9612(00) 00280-5 28.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Ann Biomed Eng 2007; 35:429-42; PMID:17216348; http://dx.doi.org/10.1007/s10439-006-9244-z 29.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Tissue Eng 2003; 9:549-54; PMID:12857422; http://dx.doi.org/10.1089/ 107632703322066723 30.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2006; 27:315-23; PMID:16125223; http://dx.doi.org/10.1016/j.biomaterials.2005.07.04431.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2008; 29:2616-27; PMID:18374976; http://dx.doi.org/10.1016/j.biomaterials.2008.03.003 32.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Tissue Eng Part A 2008; 14: 1809-20; PMID:18620487; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
AIChE J 1996; 42:850- 60; http://dx.doi.org/10.1002/aic.690420323 35.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Proc Natl Acad Sci U S A 2006; 103:2488-93; PMID:16477044; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2011; 97:251-63; PMID:21442726; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2007; 28:1036-47; PMID:17081601; http://dx.doi.org/10.1016/j.biomaterials.2006.10.003 38.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Med Biol Eng Comput 1998; 36:513- 9; PMID:10198539; http://dx.doi.org/10.1007/ BF02523224 39.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 1999; 20:989-1001; PMID:10378799; http://dx.doi.org/10.1016/S0142-9612(98)00183-5 40.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2004; 69:205-15; PMID:15057993; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res 2001; 55:242-53; PMID:11255176; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomech 1994; 27:339-60; PMID:8051194; http://dx.doi.org/10.1016/0021- 9290(94)90010-8 8 Biomatter Volume 2 Issue 4,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2006; 27:6138-49; PMID:16895736; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
"In Vitro Cell Dev Biol Anim 2001; 37: 157-65; PMID:11370806; http://dx.doi.org/10.1290/ 1071-2690(2001)037 ,0157:BTEWBM .2.0.CO;2 46.",Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Mater Sci Eng C 2002; 20:3-8; http://dx.doi.org/10.1016/S0928-4931 (02)00006-1 47.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2003; 24:2077-82; PMID:12628828; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2008; 86:323-32; PMID: 17969035; http://dx.doi.org/10.1002/jbm.a.31624 49.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biotechnol Lett 2006; 28:1215-9; PMID:16799759; http://dx.doi.org/10.1007/s10529-006-9111-x 51.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2005; 74:171-80; PMID:15965910; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2003; 67:87-95; PMID:14517865; http://dx.doi.org/10.1002/jbm.a.10075 54.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Tissue Eng 2003; 9:1205-14; PMID: 14670108; http://dx.doi.org/10.1089/107632703607 2811655.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Ann Biomed Eng 2005; 33:1238-48; PMID: 16133930; http://dx.doi.org/10.1007/s10439-005- 5536-y 56.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biomaterials 2007; 28:2525-33; PMID:17258311; http://dx.doi.org/10.1016/j.biomaterials.2007.01.013 57.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Macromol Biosci 2007; 7:579-88; PMID:17457938; http://dx.doi.org/ 10.1002/mabi.200600280 61.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2006; 79:338-48; PMID:16878315; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Tissue Eng 2003; 9:1197-203; PMID:14670107; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biotechnol 2008; 133:490-6; PMID:18221813; http://dx.doi.org/10.1016/j.jbiotec.2007.11.010 64.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biotechnol Bioeng 2006; 93:500-10; PMID:16224789; http://dx.doi.org/10.1002/bit.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biotechnol Bioeng 2011; 108:1159-70; PMID:21449028; http://dx.doi.org/10.1002/bit.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biotechnol Bioeng 2012; 109:1095-9; PMID:22068720; http://dx.doi.org/10.1002/bit.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomed Mater Res A 2003; 64:235-41; PMID: 12522809; http://dx.doi.org/10.1002/jbm.a.10365 69.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Biotechnol Bioeng 2009; 102:1670-8; PMID:19160373; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomech 2008; 41:1885-91; PMID:18495131; http://dx.doi.org/10.1016/j.jbiomech.2008.04.001 72.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
J Biomech Eng 2011; 133:091005; PMID:22010740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Ann Biomed Eng 2009; 37:445-53; PMID:19130228; http://dx.doi.org/ 10.1007/s10439-008-9632-7 74.,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
Tissue Eng Part A 2008; 14:1213-23; PMID:18433309; http://dx.doi.org/10.1089/ten.tea.2007.0321 www.landesbioscience.com Biomatter 9,Non-OADS,/arxiv_data1/oa_pdf/bb/a6/biom-2-167.PMC3568103.pdf
"PMMA is used for fixation of joint replacement implants.4The most important application of bioactive ceramics such as hydroxyapatite has been the coating of orthopedic metal implants, at locations where a strong interface with bone is required (i.e., femoral stems and acetabular metal- backs for the hip joints and tibial and femoral components for the knee joints).5Alumina and zirconia are primarily used in the fabrication of femoral heads.6On the other hand, the introduction of an implant in the body is always associated with the risk of microbial infection, particularly for the fixation of*Correspondence to: Marta Ribeiro; Email: ribeiro_marta88@hotmail.com Submitted: 02/13/12; Revised: 10/19/12; Accepted: 11/14/12 http://dx.doi.org/10.4161/biom.22905Biomatter 2:4, 176 –194; October/November/December 2012; G2012 Landes Bioscience 176 Biomatter Volume 2 Issue 4",Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J R Soc Interface 2008; 5:1137-58; PMID:18667387; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Mater Sci Eng Rep 2009; 66:1-70; http://dx.doi.org/10.1016/j.mser.2009.05.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Toxicol Pathol 2008; 36:85-91; PMID:18337225; http://dx.doi.org/10.1177/0192623307310951 5.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Eur Ceram Soc 2009; 29:1245-55; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
C R Chim 2010; 13:174-85; http://dx.doi.org/10.1016/j.crci.2009.03.004 7.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Mater Chem 2006; 16:2309-21; http://dx.doi.org/10.1039/b517634d 8.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Acta Biomater 2011; 7:3003-12; PMID:21515421; http://dx.doi.org/10.1016/j.actbio.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Control Release 2008; 130:202-15; PMID:18687500; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Clin Orthop Relat Res 2003; 414:69-88; PMID:12966280; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Nat Rev Drug Discov 2003; 2:114- 22; PMID:12563302; http://dx.doi.org/10.1038/ nrd1008 13.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2006; 27:2331-9; PMID:16364434; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Mater Sci Eng C 2010; 30:295-303; http://dx.doi.org/10.1016/j.msec.2009.11.007 18.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Care Injured 2006; 37: 3-14; http://dx.doi.org/10.1016/j.injury.2006.04.003 19.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Infect Dis 2010; 14:e913-8; PMID:20729115; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Med Microbiol 2010; 300:193-204; PMID:19889575; http://dx.doi.org/10.1016/j.ijmm.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Med Microbiol 2011; 301:347-53; PMID:21193348; http://dx.doi.org/10.1016/j.ijmm.2010.10.004 22.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2008; 29:4108- 16; PMID:18676012; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Proteomics 2010; 73:701-8; PMID: 19879388; http://dx.doi.org/10.1016/j.jprot.2009.10.007 24.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
FEMS Microbiol Lett 1999; 173:279-84; PMID:10227156; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2004; 25: 4825-9; PMID:15120529; http://dx.doi.org/10.1016/ j.biomaterials.2003.11.056 26.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Res Microbiol 2005; 156:650-5; PMID:15950124; http://dx.doi.org/10.1016/j.resmic.2005.02.004 27.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Microbes Infect 2002; 4:481-9; PMID:11932199; http://dx.doi.org/10.1016/S1286-4579(02)01563-0 28.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2007; 28:5155-68; PMID:17764738; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2005; 26:6530-5; PMID:15949842; http://dx.doi.org/10.1016/j.biomaterials.2005.04.031 30.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Clin Microbiol Newsl 2006; 28: 65-72; http://dx.doi.org/10.1016/j.clinmicnews.2006.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Oral Maxillofac Surg 2010; 68:731-8; PMID:19954877; http://dx.doi.org/10.1016/j.joms.2009.07.060 32.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Best Pract Res Clin Rheumatol 2003; 17:209-18; PMID:12787522; http://dx.doi.org/10.1016/S1521-6942(03)00002-0 34.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Lancet 2004; 364:369-79; PMID:15276398; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Bone Joint Surg Br 2001; 83:99-102; PMID:11245548; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Ann Rheum Dis 2002; 61:267-9; PMID: 11830437; http://dx.doi.org/10.1136/ard.61.3.267 41.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Lancet 2010; 375:846-55; PMID:20206778; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Lancet 1998; 351: 197-202; PMID:9449882; http://dx.doi.org/10.1016/ S0140-6736(97)09522-6 43.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Best Pract Res Clin Rheumatol 2003; 17:183-200; PMID:12787520; http://dx.doi.org/10.1016/S1521-6942(02)00106-7 44.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Ann Rheum Dis 2008; 67:638-43; PMID:17901088; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Rheumatology (Oxford) 2006; 45:1039-41; PMID: 16829534; http://dx.doi.org/10.1093/rheumatology/ kel163a 48.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2008; 32:287-93; PMID: 18617373; http://dx.doi.org/10.1016/j.ijantimicag.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2007; 28:1711-20; PMID: 17187854; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Clin Infect Dis 2001; 32:419-30; PMID:11170950; http://dx.doi.org/10.1086/318502 55.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Clin Infect Dis 2003; 36:1157-61; PMID:12715311; http://dx.doi.org/10.1086/374554 56.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
N Engl J Med 2004; 351:1645-54; PMID:15483283; http://dx.doi.org/10.1056/ NEJMra040181 57.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Best Pract Res Clin Rheumatol 2006; 20:1045-63; PMID: 17127196; http://dx.doi.org/10.1016/j.berh.2006.08.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
"J Biomed Mater Res 1998; 42:425-32; PMID:9788506; http://dx.doi.org/ 10.1002/(SICI)1097-4636(19981205)42:3 ,425::AID- JBM12.3.0.CO;2-F 61.",Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 1995; 24:29-40; http://dx.doi.org/10.1016/ 0167-7012(95)00051-8 63.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2007; 29:S143-S144; http://dx.doi.org/10.1016/ S0924-8579(07)70458-2 65.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Mater Sci Mater Med 2001; 12:543-8; PMID: 15348271; http://dx.doi.org/10.1023/A: 1011227915575 66.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Effect of subinhibitory concentration of piperacillin/ tazobactam on Pseudomonas aeruginosa .JM e d Microbiol 2004; 53:903-10; PMID:15314198; http://dx.doi.org/10.1099/jmm.0.45637-0 67.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res 2002; 60:578-84; PMID: 11948516; http://dx.doi.org/10.1002/jbm.1011368.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2007; 28:4880-8; PMID: 17697708; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Lancet 2001; 358:135-8; PMID: 11463434; http://dx.doi.org/10.1016/S0140-6736 (01)05321-1 71.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Clin Microbiol Rev 2002; 15:167-93; PMID: 11932229; http://dx.doi.org/10.1128/CMR.15.2.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2004; 25:4135-48; PMID: 15046904; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Mater Sci Mater Med 2006; 17:679-89; PMID:16897160; http://dx.doi.org/10.1007/s10856-006-9678-8 75.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Chem Soc Rev 2006; 35:780-9; PMID:16936926; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomater Sci Polym Ed 2003; 14:439-55; PMID:12807146; http://dx.doi.org/10.1163/156856203766652057 77.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res A 2012; 100:1823-30; PMID:22489063; http://dx.doi.org/10.1002/jbm.a.34139 78.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2010; 35:164-8; PMID: 19942411; http://dx.doi.org/10.1016/j.ijantimicag.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res A 2011; 99:344-53; PMID: 22021182; http://dx.doi.org/10.1002/jbm.a.33178 80.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Cell 2002; 110:1-4; PMID:12150990; http://dx.doi.org/10.1016/S0092- 8674(02)00821-8 190 Biomatter Volume 2 Issue 4,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biotechnol Bioeng 2002; 80:289- 96; PMID:12226861; http://dx.doi.org/10.1002/bit.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Acta Biomater 2010; 6:1107-18; PMID: 19671455; http://dx.doi.org/10.1016/j.actbio.2009.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Water Res 2002; 36:1653-65; PMID: 12044065; http://dx.doi.org/10.1016/S0043-1354 (01)00379-7 84.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
"Biotechnol Bioeng 2000; 68:628-36; PMID: 10799987; http://dx.doi.org/10.1002/(SICI)1097- 0290(20000620)68:6 ,628::AID-BIT5 .3.0.CO;2-D 85.",OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Prog Nat Sci 2008; 18:1049- 56; http://dx.doi.org/10.1016/j.pnsc.2008.04.001 87.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Bacteriol 2001; 183:6875-84; PMID:11698377; http://dx.doi.org/10.1128/JB.183.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Med Microbiol 2009; 58: 132-7; PMID:19074665; http://dx.doi.org/10.1099/ jmm.0.002758-0 91.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Bone Miner Res 2001; 16:1780-6; PMID:11585341; http://dx.doi.org/10.1359/jbmr.2001.16.10.1780 92.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2003; 24:4865-9; PMID:14530084; http://dx.doi.org/10.1016/S0142-9612(03)00379-X 94.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2002; 23:4143-53; PMID: 12182316; http://dx.doi.org/10.1016/S0142-9612 (02)00157-6 95.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Emerg Infect Dis 2002; 8:881-90; PMID:12194761; http://dx.doi.org/10.3201/eid0809.020063 97.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Annu Rev Microbiol 2002; 56:187-209; PMID:12142477; http://dx.doi.org/10.1146/annurev.micro.56.012302.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Lancet 2001; 358:135-8; PMID: 11463434; http://dx.doi.org/10.1016/S0140-6736 (01)05321-1 99.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Sci Am 2001; 285:74-81; PMID:11432197; http://dx.doi.org/ 10.1038/scientificamerican0701-74 100.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2003; 22:164-7; PMID:12927958; http://dx.doi.org/10.1016/S0924- 8579(03)00149-3 101.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Infect Dis 2000; 182:351-5; PMID:10882623; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Diagn Microbiol Infect Dis 2010; 67:311-8; PMID: 20638597; http://dx.doi.org/10.1016/j.diagmicrobio.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res 2002; 60:206-15; PMID: 11835177; http://dx.doi.org/10.1002/jbm.10069 105.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2004; 23:226-34; PMID: 15164962; http://dx.doi.org/10.1016/j.ijantimicag.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Colloid Interface Sci 1998; 208:23-33; PMID: 9820746; http://dx.doi.org/10.1006/jcis.1998.5717 107.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Clin Oral Implants Res 2006; 17(Suppl 2):68-81; PMID:16968383; http://dx.doi.org/10.1111/j.1600-0501.2006.01353.x 109.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Colloid Interface Sci 2006; 304: 524-9; PMID:17010358; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biotechnol J 2008; 3:536-44; PMID:18246568; http://dx.doi.org/10.1002/biot.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2010; 31:3674-83; PMID: 20163851; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Colloids Surf B Biointerfaces 2005; 41:129-38; PMID:15737538; http://dx.doi.org/10.1016/j.colsurfb.2004.11.010 113.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Nanotechnology 2005; 16:S449-57; PMID: 21727466; http://dx.doi.org/10.1088/0957-4484/16/ 7/021 114.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res A 2006; 78:595-604; PMID:16752397; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res 1979; 13:101-8; PMID:429378; http://dx.doi.org/10.1002/jbm.820130111 116.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Ann Surg 1987; 206:612-20; PMID:2960278; http://dx.doi.org/ 10.1097/00000658-198711000-00010 117.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Microbes Infect 2000; 2:391-400; PMID:10817641; http://dx.doi.org/10.1016/S1286- 4579(00)00328-2 118.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
APMIS 1994; 102:538-44; PMID:7917223; http://dx.doi.org/10.1111/j.1699-0463.1994.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2008; 29:4039-44; PMID:18657857; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Appl Environ Microbiol 2005; 71:3093-9; PMID:15933006; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Hosp Infect 1992; 20:173-84; PMID:1348772; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2007; 28:3273-83; PMID:17466368; http://dx.doi.org/10.1016/j.biomaterials.2007.03.032 www.landesbioscience.com Biomatter 191,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2010; 31:9285-92; PMID:20863561; http://dx.doi.org/10.1016/j.biomaterials.2010.08.031 126.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Colloids Surf B Biointerfaces 2006; 51:16-24; PMID: 16806854; http://dx.doi.org/10.1016/j.colsurfb.2006.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2003; 24:3013-9; PMID:12895573; http://dx.doi.org/10.1016/S0142-9612(03)00133-9 128.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 1997; 28:77-84; http://dx.doi.org/10.1016/S0167-7012(96)00967-0 129.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
FEMS Microbiol Rev 2011; 35:147-200; PMID:20695902; http://dx.doi.org/10.1111/j.1574-6976.2010.00243.x 130.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Calcif Tissue Int 2002; 70:416-21; PMID:12055657; http://dx.doi.org/ 10.1007/s00223-001-2073-z 131.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Infect Immun 2002; 70: 6805-10; PMID:12438356; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Langmuir 2010; 26:10764-70; PMID:20218549; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Eur J Cell Biol 2000; 79:672-9; PMID: 11089915; http://dx.doi.org/10.1078/0171-9335-00104 134.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Infect 2000; 41:23-31; PMID: 10942636; http://dx.doi.org/10.1053/jinf.2000.0657 135.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Eur J Cell Biol 2010; 89:103-11; PMID:19913940; http://dx.doi.org/10.1016/j.ejcb.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Mol Microbiol 2010; 75:187-207; PMID: 19943904; http://dx.doi.org/10.1111/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomater Appl 1991; 5: 204-26; PMID:2013835; http://dx.doi.org/10.1177/ 088532829100500305 140.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Bone Joint Surg Br 1997; 79:816-9; PMID:9331043; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Diagn Microbiol Infect Dis 2010; 67:311-8; PMID: 20638597; http://dx.doi.org/10.1016/j.diagmicrobio.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Hosp Infect 2010; 76:165-70; PMID: 20615578; http://dx.doi.org/10.1016/j.jhin.2010.05.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Col Surf B: Biointerf 2002; 24:217-28; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Infect Dis 1988; 158:693-701; PMID:3171224; http://dx.doi.org/10.1093/infdis/158.4.693 146.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2004; 25: 4825-9; PMID:15120529; http://dx.doi.org/10.1016/ j.biomaterials.2003.11.056 147.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
"J Biomed Mater Res 1998; 40:660-70; PMID:9599043; http://dx.doi.org/10.1002/ (SICI)1097-4636(19980615)40:4 ,660::AID-JBM18 .",Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Infect Dis 2001; 184:52-5; PMID:11398109; http://dx.doi.org/ 10.1086/321003 149.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Annu Rev Microbiol 1994; 48:585- 617; PMID:7826020; http://dx.doi.org/10.1146/ annurev.mi.48.100194.003101 150.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Appl Microbiol 2003; 94:413-20; PMID: 12588550; http://dx.doi.org/10.1046/j.1365-2672.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2003; 86:319-25; http://dx.doi.org/10.1016/ S1570-0232(02)00744-4 152.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Crit Care Med 2000; 28(Suppl):S12-9; PMID: 11007191; http://dx.doi.org/10.1097/00003246- 200009001-00004 153.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res A 2007; 82:479-91; PMID:17295255; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Science 1985; 229:275-7; PMID:3160113; http://dx.doi.org/ 10.1126/science.3160113 155.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Infect Dis 1993; 167:329-36; PMID:8421167; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Trans Am Soc Artif Intern Organs 1996; 42:M655-60; http://dx.doi.org/10.1097/00002480- 199609000-00069 157.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Biomed Mater Res A 2003; 66:21-8; PMID: 12833427; http://dx.doi.org/10.1002/jbm.a.10493 158.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Micron 2005; 36:293-320; PMID: 15857770; http://dx.doi.org/10.1016/j.micron.2004.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Mol Microbiol 1996; 20:1083-91; PMID: 8809760; http://dx.doi.org/10.1111/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Mol Microbiol 2002; 43:1367-78; PMID:11952892; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Appl Environ Microbiol 2009; 75:1723-33; PMID:19168650; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
APMIS 2000; 108:589-600; PMID:11110047; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Col Surf B: Biointerf 2002; 23:231-47; http://dx.doi.org/ 10.1016/S0927-7765(01)00233-8 167.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Res Microbiol 2008; 159:415-22; PMID:18550342; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Funct Biomater 2012; 3:418-31; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2011; 84:167-73; PMID: 21081140; http://dx.doi.org/10.1016/j.mimet.2010.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
APMIS 2007; 115:891- 9; PMID:17696944; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Bacteriol 2007; 189: 8233-40; PMID:17827282; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Antimicrob Agents Chemother 2009; 53:3166-9; PMID:19451302; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Folia Microbiol (Praha) 2005; 50:487-93; PMID:16681145; http://dx.doi.org/10.1007/ BF02931435 175.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2008; 32:233-40; PMID: 18640013; http://dx.doi.org/10.1016/j.ijantimicag.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 1997; 30: 141-52; http://dx.doi.org/10.1016/S0167-7012(97) 00058-4 177.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Food Microbiol 2010; 141(Suppl 1):S125-33; PMID:20153071; http://dx.doi.org/10.1016/j.ijfoodmicro.2010.01.012179.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Analyst (Lond) 2008; 133:835-45; http://dx.doi.org/10.1039/b715532h 180.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Colloids Surf B Biointerfaces 2001; 20:37-50; PMID:11084307; http://dx.doi.org/10.1016/S0927-7765(00)00173-9 181.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Micron 2007; 38:390-401; PMID:16990007; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Invest Ophthalmol Vis Sci 2003; 44:4382-7; PMID:14507883; http://dx.doi.org/ 10.1167/iovs.03-0185 183.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Hosp Infect 2004; 58:224-9; PMID:15501338; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Gynaecol Obstet 2005; 90:148-9; PMID:15964000; http://dx.doi.org/10.1016/j.ijgo.2005.04.006 185.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Hosp Infect 2006; 64:313-25; PMID: 17046102; http://dx.doi.org/10.1016/j.jhin.2006.06.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Antimicrob Agents 2000; 13:169-73; PMID: 10724020; http://dx.doi.org/10.1016/S0924-8579 (99)00120-X 187.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Food Microbiol 2005; 22: 253-9; http://dx.doi.org/10.1016/j.fm.2004.03.004 190.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Appl Environ Microbiol 2000; 66: 4679-87; PMID:11055910; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Appl Microbiol 2002; 92:352-61; PMID:11849365; http://dx.doi.org/10.1046/j.1365- 2672.2002.01538.x 192.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Colloid Interface Sci 2000; 226:185-8; PMID:11401364; http://dx.doi.org/ 10.1006/jcis.2000.6801 195.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2000; 40:89-97; PMID: 10739347; http://dx.doi.org/10.1016/S0167-7012 (99)00137-2 196.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Coll Surf B: Biointerf 2002; 23:231-47; http://dx.doi.org/ 10.1016/S0927-7765(01)00233-8 197.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Langmuir 2002; 18:2343-6; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Life Sci 2003; 72: 2553-60; PMID:12672501; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Curr Opin Microbiol 2003; 6: 317-23; PMID:12831910; http://dx.doi.org/10.1016/ S1369-5274(03)00058-4 200.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Langmuir 2004; 20:4172-7; PMID:15969413; http://dx.doi.org/10.1021/la035847y 201.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Biomaterials 2005; 26:7115-23; PMID:16009416; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Opt Express 2010; 18:23924-32; PMID: 21164738; http://dx.doi.org/10.1364/OE.18.023924 203.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Pharm Biomed Anal 2005; 37:1105-8; PMID: 15862692; http://dx.doi.org/10.1016/j.jpba.2004.08.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int Biodeterior Biodegradation 1998; 41:1-11; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2006; 67:273-80; PMID: 16737754; http://dx.doi.org/10.1016/j.mimet.2006.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2007; 68:236-42; PMID:17049398; http://dx.doi.org/10.1016/j.mimet.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2007; 69:146-53; PMID:17316849; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Food Microbiol 2005; 105:369-76; PMID:16126293; http://dx.doi.org/10.1016/j.ijfoodmicro.2005.04.018 209.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Anal Chem 2000; 72: 119-27; PMID:10655643; http://dx.doi.org/10.1021/ ac990661i 210.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Gen Microbiol 1991; 137:69-79; PMID:1710644; http://dx.doi.org/ 10.1099/00221287-137-1-69 211.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Clin Microbiol 2003; 41:324-9; PMID:12517868; http://dx.doi.org/ 10.1128/JCM.41.1.324-329.2003 212.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Influence of electrical properties on the evaluation of the surface hydrophobicity of Bacillus subtilis .J Microbiol Methods 2001; 45:119-26; PMID: 11311397; http://dx.doi.org/10.1016/S0167-7012 (01)00240-8 215.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Res Microbiol 2006; 157:471-8; PMID:16376056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Microbiology 2003; 149:353-62; PMID: 12624197; http://dx.doi.org/10.1099/mic.0.25932-0 217.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2003; 54:269- 76; PMID:12782382; http://dx.doi.org/10.1016/ S0167-7012(03)00034-4 218.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 1999; 37:77-86; PMID:10395466; http://dx.doi.org/ 10.1016/S0167-7012(99)00048-2 219.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Science 2002; 295:1487; PMID: 11859186; http://dx.doi.org/10.1126/science.295.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Application of fluorescently labelled lectins for the visualization and biochemical characterization of poly- saccharides in biofilms of Pseudomonas aeruginosa .J Microbiol Methods 2002; 50:237-48; PMID: 12031574; http://dx.doi.org/10.1016/S0167-7012 (02)00032-5221.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2005; 63:287-95; PMID: 15936097; http://dx.doi.org/10.1016/j.mimet.2005.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
J Microbiol Methods 2006; 64:217-24; PMID: 15979176; http://dx.doi.org/10.1016/j.mimet.2005.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Antimicrob Agents Chemother 2005; 49:2612-7; PMID:15980327; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Int J Dent 2012; 2012:529495; PMID: 22505901; http://dx.doi.org/10.1155/2012/529495 227.,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
Sci Total Environ 2004; 333:1-7; PMID:15364515; http://dx.doi.org/10.1016/j.scitotenv.2004.05.003 194 Biomatter Volume 2 Issue 4,OADS,/arxiv_data1/oa_pdf/78/62/biom-2-176.PMC3568104.pdf
"Submitted: 04/03/12; Revised: 08/24/12; Accepted: 10/09/12 http://dx.doi.org/10.4161/biom.22494REPORT Biomatter 2:4, 1 –7; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 1",Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Int J Pharm 2007; 336:367-75; PMID:17207944; http://dx.doi.org/10.1016/j.ijpharm.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Curr Opin Solid State Mater Sci 2002; 6:319-27; http://dx.doi.org/10.1016/ S1359-0286(02)00117-1 5.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Int J Pharm 2008; 364:298-327; PMID:18621492; http://dx.doi.org/10.1016/j.ijpharm.2008.04.042 6.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Adv Drug Deliv Rev 2011; 63:170-83; PMID: 20965219; http://dx.doi.org/10.1016/j.addr.2010.10.008 7.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Bioconjug Chem 2010; 21:93-101; PMID:19958018; http://dx.doi.org/10.1021/bc900311h 9.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
J Control Release 2007; 120:18-26; PMID:17509712; http://dx.doi.org/ 10.1016/j.jconrel.2007.03.012 10.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Eur J Pharm Biopharm 2009; 72:428-37; PMID:19462479; http://dx.doi.org/10.1016/j.ejpb.2009.02.002 12.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Nat Rev Drug Discov 2010; 9:615-27; PMID:20616808; http://dx.doi.org/10.1038/nrd2591 13.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Colloids Surf 1986; 20:247-56; http://dx.doi.org/10.1016/0166-6622(86)80274-8 14.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Colloid Polym Sci 2009; 287:627-43; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Adv Mater 2006; 18:80- 3; http://dx.doi.org/10.1002/adma.200501043 16.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Colloid Polym Sci 2008; 286: 571-7; http://dx.doi.org/10.1007/s00396-007-1817-3 17.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
J Macromol Sci -Chem 1968; 2: 1441-55; http://dx.doi.org/10.1080/10601326808051910 18.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
J Membr Sci 1987; 33: 191-200; http://dx.doi.org/10.1016/S0376-7388(00) 80377-4 19.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Colloids and Surfaces a-Physicochemical and Engineering Aspects 2000; 170:137-49; http://dx.doi.org/10.1016/S0927- 7757(00)00490-8 20.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Macromolecules 1993; 26:2496-500; http://dx.doi.org/10.1021/ma00062a016 22.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Semin Arthritis Rheum 1996; 25:254-72; PMID:8834014; http://dx.doi.org/10.1016/S0049-0172(96)80036-9 23.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
N Engl J Med 2001; 344:907-16; PMID:11259725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Nat Mater 2008; 7: 248-54; PMID:18246072; http://dx.doi.org/10.1038/ nmat2116 25.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Mol Pharm 2009; 6:190-201; PMID:19035785; http://dx.doi.org/ 10.1021/mp800137z 27.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Macromolecules 2000; 33:8301-6; http://dx.doi.org/10.1021/ma001398m 28.,OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Langmuir 2003; 19:4544-7; http://dx.doi.org/10.1021/la034392+ 29.,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
Macromolecules 2003; 36:8780-5; http://dx.doi.org/10.1021/ma034771+ www.landesbioscience.com Biomatter 7,Non-OADS,/arxiv_data1/oa_pdf/db/60/biom-2-195.PMC3568105.pdf
"1A and B ).33-35a-CD bears hydroxyl groups that can be modified to create a variety of functionalities that also allow *Correspondence to: Jennifer H. Elisseeff; Email: jhe@jhu.edu Submitted: 08/20/12; Revised: 09/24/12; Accepted: 10/30/12 http://dx.doi.org/10.4161/biom.22723Biomatter 2:4, 202 –212; October/November/December 2012; G2012 Landes Bioscience 202 Biomatter Volume 2 Issue 4",Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Interface Focus 2012; 2:366-77; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2003; 24:4337-51; PMID:12922147; http://dx.doi.org/10.1016/S0142-9612(03)00340-5 3.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Nat Mater 2005; 4:518-24; PMID:16003400; http://dx.doi.org/10.1038/nmat1421 4.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Science 2002; 295:1009-14; PMID:11834815; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Biomed Mater Res 2002; 60:613- 21; PMID:11948520; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2003; 24:2077-82; PMID:12628828; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Tissue Eng 2005; 11:101-9; PMID:15738665; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Adv Drug Deliv Rev 2007; 59:1413-33; PMID:17916396; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2008; 29:1989-2006; PMID:18281090; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomed Mater 2007; 2:R24-37; PMID:18458475; http://dx.doi.org/ 10.1088/1748-6041/2/4/R02 12.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Adv Drug Deliv Rev 2009; 61:1084-96; PMID:19647024; http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Adv Drug Deliv Rev 2007; 59:1392-412; PMID: 17884240; http://dx.doi.org/10.1016/j.addr.2007.04.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Tissue Eng 2006; 12:1197-211; PMID: 16771634; http://dx.doi.org/10.1089/ten.2006.12.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2005; 26:5158-66; PMID:15792543; http://dx.doi.org/10.1016/j.biomaterials.2005.01.002 16.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2005; 26:599-609; PMID:15282138; http://dx.doi.org/10.1016/j.bioma- terials.2004.03.005 17.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Prog Polym Sci 2010; 35:1217-56; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Nanotechnology 2008; 19: 455102; PMID:21832761; http://dx.doi.org/10.1088/ 0957-4484/19/45/455102 19.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Tissue Eng 2005; 11:1149- 58; PMID:16144451; http://dx.doi.org/10.1089/ten.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Biomed Biotechnol 2012; 2012:428503; PMID:22319242; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomacromolecules 2005; 6: 2583-9; PMID:16153095; http://dx.doi.org/10.1021/ bm050314k 24.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2008; 29:2907-14; PMID:18403012; http://dx.doi.org/10.1016/j.biomaterials.2008.03.034 25.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2008; 29:4532-9; PMID:18757094; http://dx.doi.org/10.1016/j.bioma- terials.2008.08.007 26.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Biomed Mater Res B Appl Biomater 2009; 91:213-20; PMID:19422050; http://dx.doi.org/10.1002/jbm.b.3139227.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Acta Biomater 2007; 3: 321-30; PMID:17321811; http://dx.doi.org/10.1016/ j.actbio.2007.01.002 28.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Biomed Mater Res A 2009; 90:906-19; PMID: 18646204; http://dx.doi.org/10.1002/jbm.a.32052 29.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Colloids Surf B Biointerfaces 2007; 60: 137-57; PMID:17683921; http://dx.doi.org/10.1016/ j.colsurfb.2007.06.019 30.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Chem Soc Rev 2009; 38:1139-51; PMID:19421585; http://dx.doi.org/10.1039/b811392k 31.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Mater Chem 2011; 21:9419-53; http://dx.doi.org/10.1039/ c0jm04502k 32.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Macromolecules 2002; 33: 4472-7; http://dx.doi.org/10.1021/ma992103b 34.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
"Macromol Biosci 2004; 4:1075-83; PMID:15586392; http://dx.doi.org/10.1002/mabi.200400118 35. van de Manakker F, Vermonden T, van Nostrum CF, Hennink WE.",OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomacromolecules 2009; 10:3157-75; PMID: 19921854; http://dx.doi.org/10.1021/bm901065f 36.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Chem Rev 1998; 98:1977-96; PMID:11848955; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Adv Drug Deliv Rev 2008; 60:1000-17; PMID:18413280; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Chem Soc Rev 2009; 38:875-82; PMID:19421567; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Inclusion Polymers 2009; 222:55-77; http://dx.doi.org/10.1007/12_2008_8 41.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Am Chem Soc 1996; 118:5039-46; http://dx.doi.org/10.1021/ ja953981243.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Angew Chem Int Ed Engl 1994; 33:803-22; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Macromol Rapid Commun 2007; 28:2095-9; http://dx.doi.org/ 10.1002/marc.200700502 45.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomacromolecules 2002; 3:201-7; PMID:11866574; http://dx.doi.org/10.1021/bm015609m 46.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Polymer (Guildf) 1998; 39: 4857-65; http://dx.doi.org/10.1016/S0032-3861(97) 00568-5 47.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Macromolecules 1996; 29:5611-4; http://dx.doi.org/10.1021/ ma960428b 48.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2010; 31:5875-85; PMID: 20452016; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
J Biomed Mater Res A 2007; 81:900- 10; PMID:17236222; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2008; 29: 4792-9; PMID:18823660; http://dx.doi.org/10.1016/ j.biomaterials.2008.08.039 52.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Tissue Eng 2001; 7:729-41; PMID:11749730; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Circ Res 2007; 100:1249-60; PMID:17495232; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Stem Cells 2007; 25:818-27; PMID:17420225; http://dx.doi.org/10.1634/stemcells.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Acta Biomater 2010; 6:2386- 93; PMID:20080214; http://dx.doi.org/10.1016/j.actbio.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomed Mater 2009; 4:035002; PMID:19390143; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Tissue Eng 2006; 12:927-37; PMID: 16674304; http://dx.doi.org/10.1089/ten.2006.12.927 58.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Adv Drug Deliv Rev 2009; 61:1065-83; PMID:19646493; http://dx.doi.org/10.1016/j.addr.2009.07.00859.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Biomaterials 2006; 27:2042-50; PMID:16305806; http://dx.doi.org/10.1016/j.biomaterials.2005.10.028 60.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Stem Cells 2006; 24:376-85; PMID:16322640; http://dx.doi.org/ 10.1634/stemcells.2005-023461.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
Nucleic Acids Res 2001; 29:e45; PMID:11328886; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/40/9a/biom-2-202.PMC3568106.pdf
"The use of rifampicin together with other antibiotics in the treatment of Staphylococcus aureus infections has been reviewed by Perlroth et al.7In general, in in vivo and human studies, the combination of ciprofloxacin with rifampicin was *Correspondence to: Niina Ahola; Email: niina.ahola@tut.fi Submitted: 08/08/12; Revised: 10/13/12; Accepted: 11/06/12 http://dx.doi.org/10.4161/biom.22793REPORT Biomatter 2:4, 213 –225; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 213",Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Control Release 2006; 113:102-10; PMID: 16740332; http://dx.doi.org/10.1016/j.jconrel.2006.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Dis Mon 2010; 56: 6-31; http://dx.doi.org/10.1016/j.disamonth.2009.07.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Am J Surg 2004; 188(Suppl):57-66; PMID:15223504; http://dx.doi.org/10.1016/S0002- 9610(03)00292-7 5.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Control Release 2008; 130:202-15; PMID:18687500; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Expert Opin Drug Deliv 2010; 7:589-603; PMID:20230306; http://dx.doi.org/10.1517/17425241003671544 7.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Arch Intern Med 2008; 168:805-19; PMID:18443255; http://dx.doi.org/10.1001/archinte.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Antimicrob Chemother 2010; 65:1799-806; PMID:20542908; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Eur J Clin Microbiol Infect Dis 2007; 26: 849-56; PMID:17712583; http://dx.doi.org/10.1007/ s10096-007-0378-1 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Antimicrob Chemother 2005; 56:1063-8; PMID: 16234335; http://dx.doi.org/10.1093/jac/dki366 12.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Biomed Mater Res B Appl Biomater 2008; 85:93-104; PMID: 17696153; http://dx.doi.org/10.1002/jbm.b.30921 13.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Bone 2005; 36:292-9; PMID:15780955; http://dx.doi.org/ 10.1016/j.bone.2004.11.009 14.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Biomaterials 2008; 29:350-8; PMID: 17977596; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Craniofac Surg 2009; 20:58-61; PMID: 19164990; http://dx.doi.org/10.1097/SCS.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Drug Deliv 2011; 18:236-45; PMID:21189060; http://dx.doi.org/ 10.3109/10717544.2010.52807018.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Eur J Pharm Biopharm 2005; 60:401- 6; PMID:15996581; http://dx.doi.org/10.1016/j.ejpb.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Antimicrob Agents Chemother 2005; 49:1502-8; PMID:15793132; http://dx.doi.org/ 10.1128/AAC.49.4.1502-1508.2005 21.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Biomed Mater Res A 2006; 78:532-40; PMID:16736479; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Biomaterials 2011; 32:3166-77; PMID: 21315446; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Polym Degrad Stabil 2009; 94:438-42; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Eur J Pharm Sci 1998; 7:57-65; PMID:9845778; http://dx.doi.org/10.1016/ S0928-0987(98)00005-0 26.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Ther Drug Monit 1997; 19:669-74; PMID:9421109; http://dx.doi.org/10.1097/00007691-199712000-00011 28.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Control Release 1987; 5:23-36; http://dx.doi.org/10.1016/0168-3659(87)90034-4 30.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Chem Eng J 2011; 172:1088-95; http://dx.doi.org/10.1016/j.cej.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
Biomacromolecules 2004; 5:1303-9; PMID:15244444; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Org Chem 1982; 47:2652-61; http://dx.doi.org/10.1021/ jo00134a028 35.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Appl Polym Sci 2011; 120:2872-80; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Mater Sci Mater Med 1990; 1:198-206; http://dx.doi.org/10.1007/ BF00701077 37.,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Appl Polym Sci 1981; 26:3779-87; http://dx.doi.org/10.1002/app.,OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
J Biomater Appl 2012; In press; PMID:23048066; http://dx.doi.org/10.1177/0885328212462258 www.landesbioscience.com Biomatter 225,Non-OADS,/arxiv_data1/oa_pdf/f2/d5/biom-2-213.PMC3568107.pdf
"*Correspondence to: Sandra Franz; Email: sandra.franz@medizin.uni-leipzig.de Submitted: 09/17/12; Revised: 11/07/12; Accepted: 11/11/12 http://dx.doi.org/10.4161/biom.22855Biomatter 2:4, 226 –236; October/November/December 2012; G2012 Landes Bioscience 226 Biomatter Volume 2 Issue 4",Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Semin Immunol 2008; 20:86- 100; PMID:18162407; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Biomaterials 2011; 32:6692-709; PMID: 21715002; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Tissue Eng Part A 2010; 16:3309-17; PMID:20528669; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Orthop Res 2007; 25:1052-61; PMID:17457829; http://dx.doi.org/10.1002/jor.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Orthop Res 2009; 27:15-21; PMID:18634066; http://dx.doi.org/10.1002/jor.20719 6.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Curr Opin Cell Biol 1999; 11:634-40; PMID:10508658; http://dx.doi.org/10.1016/S0955- 0674(99)00026-5 7.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Biomacromolecules 2009; 10:3290-7; PMID:19894734; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Acta Biomater 2012; 8:2144-52; PMID:22426137; http://dx.doi.org/10.1016/j.actbio.2012.03.0219.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Carbohydr Res 2012; 356:196-203; PMID: 22444322; http://dx.doi.org/10.1016/j.carres.2012.02.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Biomaterials 2011; 32:8938-46; PMID:21875749; http://dx.doi.org/10.1016/j.biomaterials.2011.08.025 11.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Nat Rev Immunol 2008; 8: 958-69; PMID:19029990; http://dx.doi.org/10.1038/ nri2448 12.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Semin Liver Dis 2010; 30:245-57; PMID:20665377; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Nat Rev Immunol 2010; 10:826- 37; PMID:21088683; http://dx.doi.org/10.1038/ nri2873 15.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Leukoc Biol 2007; 81:1- 5; PMID:17032697; http://dx.doi.org/10.1189/jlb.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Am J Pathol 1998; 153:1849-60; PMID:9846975; http://dx.doi.org/10.1016/S0002-9440(10)65699-4 18.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Invest Dermatol 2007; 127:514-25; PMID:17299434; http://dx.doi.org/10.1038/sj.jid.570070119.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Forensic Sci Int 2000; 113:251-64; PMID:10978634; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
"Ann N Y Acad Sci 1989; 557:454-64, discussion 464-5; PMID:2472095; http://dx.doi.org/10.1111/j.",OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Arterioscler Thromb Vasc Biol 2012; 32:1696-706; PMID:22596222; http://dx.doi.org/10.1161/ ATVBAHA.112.251181 23.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Cytokine 1996; 8:548-56; PMID:8891436; http://dx.doi.org/10.1006/cyto.1996.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
FASEB J 2002; 16:963-74; PMID: 12087057; http://dx.doi.org/10.1096/fj.01-0776com www.landesbioscience.com Biomatter 235,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Leukoc Biol 2006; 79:285- 93; PMID:16330536; http://dx.doi.org/10.1189/jlb.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Front Biosci 2008; 13:453-61; PMID:17981560; http://dx.doi.org/ 10.2741/2692 28.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Nat Rev Immunol 2008; 8:837-48; PMID:18927578; http://dx.doi.org/10.1038/nri2423 29.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Acta Biomater 2012; 8:659-66; PMID: 22061106; http://dx.doi.org/10.1016/j.actbio.2011.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Cancer Metastasis Rev 2005; 24:425-39; PMID:16258730; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Biol Chem 2007; 282: 21924-33; PMID:17540774; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Biomaterials 2012; 33:4136-46; PMID: 22417617; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Soft Matter 2011; 7: 3599-606; PMID:21479122; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
J Immunol 2010; 184: 3964-77; PMID:20176743; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
Thromb Res 1996; 81:383-95; PMID:8928095; http://dx.doi.org/10.1016/0049- 3848(96)00009-6 236 Biomatter Volume 2 Issue 4,Non-OADS,/arxiv_data1/oa_pdf/49/8c/biom-2-226.PMC3568108.pdf
"santos Division of Pharmaceutical t echnology; University of Helsinki; Helsinki, Finland Correspondence to: Hélder A. Santos; Email: helder.santos@helsinki.fi Submitted: 11/27/12; Accepted: 11/27/12http://dx.doi.org/10.4161/biom.23024for periodontal treatment and their impacts on the experimen - tal/clinical management of periodontal defect.",Non-OADS,/arxiv_data1/oa_pdf/cc/8e/biom-2-237.PMC3568109.pdf
"*Correspondence to: Meital Zilberman; Email: meitalz@eng.tau.ac.il Submitted: 09/14/12; Revised: 11/07/12; Accepted: 11/09/12 http://dx.doi.org/10.4161/biom.22838SPECIAL FOCUS REVIEW Biomatter 2:4, 239 –270; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 239",Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Tissue Eng 2005; 11:1876-86; PMID: 16411834; http://dx.doi.org/10.1089/ten.2005.11.1876 2.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res B Appl Biomater 2006; 77:357-68; PMID: 16362956; http://dx.doi.org/10.1002/jbm.b.30444 3.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2005; 26:7241-50; PMID:16011846; http://dx.doi.org/10.1016/j.bioma- terials.2005.05.043 4.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2008; 84:1078-86; PMID:17685398; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2008; 29: 3625-35; PMID:18556060; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Tissue Eng 2005; 11:1297- 311; PMID:16259586; http://dx.doi.org/10.1089/ten.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2004; 25: 4149-61; PMID:15046905; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Acta Biomater 2009; 5:2872-83; PMID:19416766; http://dx.doi.org/10.1016/j.actbio.2009.04.007 11.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Science 2005; 310:1135-8; PMID:16293749; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Cell Sci 2010; 123: 4201-13; PMID:21123618; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomech 2010; 43:55-62; PMID:19800626; http://dx.doi.org/ 10.1016/j.jbiomech.2009.09.009 14.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Adv Drug Deliv Rev 2007; 59:1306-18; PMID:17920155; http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Clin Mater 1992; 9: 179-87; PMID:10149968; http://dx.doi.org/10.1016/ 0267-6605(92)90098-E 17.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2005; 26: 5474-91; PMID:15860204; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
"J Pharm Sci 2008; 97:1135-54; PMID:17688274; http://dx.doi.org/10.1002/jps.21059 20. de Groot JH, Nijenhuis AJ, Bruin P, Pennings AJ, Veth RPH, Klompmaker J.",OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Colloid Polym Sci 1990; 268:1073-81; http://dx.doi.org/10.1007/ BF01410672 21.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Polymer (Guildf) 2006; 47:4703-17; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2006; 78:306-15; PMID:16637043; http://dx.doi.org/10.1002/jbm.a.30704 www.landesbioscience.com Biomatter 267,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2008; 87:1010-6; PMID:18257081; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res B Appl Biomater 2008; 86:9-17; PMID:18098188; http://dx.doi.org/10.1002/jbm.b.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Polymer (Guildf) 1994; 35:1068-77; http://dx.doi.org/10.1016/0032- 3861(94)90953-9 26.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 1996; l17:1417-22; PMID: 8830969; http://dx.doi.org/10.1016/0142-9612(96) 87284-X 28.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
"J Biomed Mater Res 2000; 53:1-7; PMID:10634946; http://dx.doi.org/10.1002/ (SICI)1097-4636(2000)53:1 ,1::AID-JBM1 .3.0.CO;2-R 29.",Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Tissue Eng 1995; 1:15-28; PMID: 19877912; http://dx.doi.org/10.1089/ten.1995.1.15 30.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Polymer (Guildf) 1995; 36:837-42; http://dx.doi.org/10.1016/0032- 3861(95)93115-3 31.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Control Release 2007; 120:70-8; PMID: 17509717; http://dx.doi.org/10.1016/j.jconrel.2007.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Colloids Surf B Biointerfaces 2011; 88:587-92; PMID:21856134; http://dx.doi.org/ 10.1016/j.colsurfb.2011.07.045 33.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Acta Biomater 2009; 5:2872-83; PMID: 19416766; http://dx.doi.org/10.1016/j.actbio.2009.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2010; 31:2193-200; PMID: 20034665; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Bone Joint Surg Am 2009; 91: 1159-71; PMID:19411465; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Vasc Surg 2011; 54:1439-50; PMID:21802240; http://dx.doi.org/10.1016/j.jvs.2011.05.023 38.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Tissue Eng 2006; 12:481-7; PMID:16579681; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Pediatr Surg Int 2010; 26:575-80; PMID: 20425118; http://dx.doi.org/10.1007/s00383-010- 2609-2 40.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Orthop Res 2009; 27:495-503; PMID: 18924141; http://dx.doi.org/10.1002/jor.20752 41.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Sports Med Arthrosc 2006; 14:177-84; PMID:17135965; http://dx.doi.org/10.1097/00132585-200609000- 00010 42.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2004; 68:286-95; PMID:14704970; http://dx.doi.org/10.1002/jbm.a.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Annu Rev Mater Res 2006; 36: 333-68; http://dx.doi.org/10.1146/annurev.matsci.36.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2005; 26:5330-8; PMID:15814131; http://dx.doi.org/10.1016/j.bioma- terials.2005.01.052 45.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Scr Mater 2003; 49: 1197-202; http://dx.doi.org/10.1016/j.scriptamat.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomol Eng 2007; 24:564-7; PMID:17869173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2005; 73:223- 33; PMID:15761810; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomed Mater 2011; 6:045010; PMID: 21747152; http://dx.doi.org/10.1088/1748-6041/6/ 4/045010 50.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Prog Mater Sci 2001; 46:559-632; http://dx.doi.org/10.1016/S0079- 6425(00)00002-551.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Acta Biomater 2009; 5:3616-24; PMID:19505597; http://dx.doi.org/10.1016/j.actbio.2009.06.002 52.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2006; 27:974-85; PMID: 16055183; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2006; 27:955-63; PMID:16115681; http://dx.doi.org/10.1016/j.biomaterials.2005.07.041 54.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2002; 23:4739-51; PMID: 12361612; http://dx.doi.org/10.1016/S0142-9612 (02)00223-5 55.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Mater Sci Mater Med 2002; 13:23-8; PMID:15348200; http://dx.doi.org/ 10.1023/A:1013622216071 56.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Anat Rec A Discov Mol Cell Evol Biol 2003; 272:497-502; PMID:12740943; http://dx.doi.org/10.1002/ar.a.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2000; 21:2545-51; PMID:11071604; http://dx.doi.org/10.1016/S0142-9612(00)00122-8 61.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Adv Colloid Interface Sci 2006; 123- 126:259-93; PMID:16854363; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Curr Drug Deliv 2005; 2:297-310; PMID: 16305433; http://dx.doi.org/10.2174/ 156720105774370267 63.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2001; 22:231-41; PMID:11197498; http://dx.doi.org/10.1016/S0142- 9612(00)00178-2 268 Biomatter Volume 2 Issue 4,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Control Release 2002; 83: 147-55; PMID:12220846; http://dx.doi.org/10.1016/ S0168-3659(02)00176-1 65.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Pharm Pharmacol 2005; 57:1261-9; PMID:16259754; http://dx.doi.org/10.1211/jpp.57.10.0004 66.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Eur J Pharm Biopharm 2000; 50:227-36; PMID:10962232; http://dx.doi.org/10.1016/S0939- 6411(00)00109-0 67.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Acta Biomater 2010; 6:1278-87; PMID:19887123; http://dx.doi.org/10.1016/j.actbio.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2006; 79:779-87; PMID:16883584; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Acta Biomater 2011; 7: 325-36; PMID:20643231; http://dx.doi.org/10.1016/ j.actbio.2010.07.013 70.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res B Appl Biomater 2010; 93:425-35; PMID:20127990; http://dx.doi.org/10.1002/jbm.b.31599 71.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Control Release 2008; 126:139-48; PMID:18201789; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Eur J Pharm Sci 2009; 37:351-62; PMID:19491026; http://dx.doi.org/10.1016/j.ejps.2009.03.004 73.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Wound Repair Regen 2004; 12:288-94; PMID:15225207; http://dx.doi.org/ 10.1111/j.1067-1927.2004.012304.x 74.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Am J Surg 1994; 167(1A):2S- 6S; PMID:8109679; http://dx.doi.org/10.1016/0002- 9610(94)90002-7 75.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Burns 1977; 3:159-65; http://dx.doi.org/10.1016/0305-4179(77)90004-3 76.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Pharm Sci 2008; 97:2892-923; PMID:17963217; http://dx.doi.org/10.1002/jps.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Burns 1998; 24:347-9; PMID:9688200; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Dermatol Surg 2003; 29:631-5; PMID:12786708; http://dx.doi.org/10.1046/j.1524- 4725.2003.29146.x 81.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Arch Surg 1984; 119:312-22; PMID:6365034; http://dx.doi.org/ 10.1001/archsurg.1984.01390150050013 82.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res 1994; 28:463-9; PMID:8006051; http://dx.doi.org/10.1002/jbm.820280409 83.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Adv Drug Deliv Rev 2003; 55:1679-98; PMID:14623407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Surg Res 1996; 66:174-8; PMID: 9024831; http://dx.doi.org/10.1006/jsre.1996.0391 85.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2006; 27:2450-67; PMID:16337266; http://dx.doi.org/10.1016/j.biomaterials.2005.11.031 86.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
N Engl J Med 1996; 335:1445-53; PMID: 8875923; http://dx.doi.org/10.1056/ NEJM199611073351907 87.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Acta Biomater 2007; 3:51-7; PMID:16956799; http://dx.doi.org/10.1016/j.actbio.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2009; 89:654-66; PMID:18442118; http://dx.doi.org/ 10.1002/jbm.a.32013 90.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res 2002; 59: 438-49; PMID:11774301; http://dx.doi.org/10.1002/ jbm.1260 91.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res B Appl Biomater 2004; 70:389-96; PMID:15264324; http://dx.doi.org/10.1002/jbm.b.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res B Appl Biomater 2005; 74:686-98; PMID:15988752; http://dx.doi.org/ 10.1002/jbm.b.3023693.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 1987; 8:367-71; PMID:3676423; http://dx.doi.org/10.1016/0142-9612(87)90007-X 94.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Pharm Sci 2008; 97:2892-923; PMID:17963217; http://dx.doi.org/10.1002/jps.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2006; 27:1452-61; PMID: 16143390; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2005; 26:1961-8; PMID:15576170; http://dx.doi.org/10.1016/j.biomaterials.2004.06.032 98.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Antimicrob Agents Chemother 1990; 34:1865-8; PMID:2291653; http://dx.doi.org/10.1128/AAC.34.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
"Plast Reconstr Surg 2006; 117 (Suppl):110S-8S, discussion 119S-20S; PMID: 16799377; http://dx.doi.org/10.1097/01.prs.",OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Toxicol In Vitro 2004; 18:703- 10; PMID:15251189; http://dx.doi.org/10.1016/j.tiv.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Wound Repair Regen 2007; 15: 94-104; PMID:17244325; http://dx.doi.org/10.1111/ j.1524-475X.2006.00190.x 104.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Science 1982; 215:174-6; PMID:7031899; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Trauma 1984; 24:106-15; PMID:6420578; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Burns 1990; 16:13-6; PMID:2322389; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
FEMS Immunol Med Microbiol 1997; 19: 307-14; PMID:9537756; http://dx.doi.org/10.1016/ S0928-8244(97)00097-7 108.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Antimicrob Chemother 1985; 16:519-26; PMID:3934130; http://dx.doi.org/10.1093/jac/16.4.519 109.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
"J Biomed Mater Res 2001; 57:346-56; PMID: 11523029; http://dx.doi.org/10.1002/1097-4636 (20011205)57:3 ,346::AID-JBM1177 .3.0.CO;2-8 111.",Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Burns 2007; 33:52-8; PMID:17079089; http://dx.doi.org/10.1016/j.burns.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Burns 2011; 37: 896-904; PMID:21466923; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Burns 2004; 30: 140-7; PMID:15019121; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Ann Biomed Eng 2003; 31:667-77; PMID:12797616; http://dx.doi.org/10.1114/1.1575756 116.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Control Release 1987; 6:225-37; http://dx.doi.org/10.1016/0168-3659(87)90079-4 121.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Polym Int 2002; 51:1464-72; http://dx.doi.org/10.1002/pi.1086 123.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Circulation 2001; 103: 2289-95; PMID:11342479; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Int J Pharm 1999; 183:85-100; PMID: 10361159; http://dx.doi.org/10.1016/S0378-5173 (99)00087-3 125.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Control Release 2001; 71:53-69; PMID:11245908; http://dx.doi.org/ 10.1016/S0168-3659(00)00364-3 127.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Circulation 2001; 104:473-9; PMID:11468212; http://dx.doi.org/ 10.1161/hc3001.092037 128.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biol Chem 1995; 270:22263-70; PMID:7673206; http://dx.doi.org/10.1074/jbc.270.38.22263 129.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Arterioscler Thromb Vasc Biol 2004; 24: 363-8; PMID:14670932; http://dx.doi.org/10.1161/ 01.ATV.0000112021.98971.f0 130.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Semin Cancer Biol 2004; 14:253-61; PMID:15219618; http://dx.doi.org/10.1016/j.semcancer.2004.04.004 131.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Macromol Biosci 2006; 6:977-90; PMID:17128422; http://dx.doi.org/10.1002/mabi.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2004; 69:47-54; PMID: 14999750; http://dx.doi.org/10.1002/jbm.a.20101 133.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Pharm Sci 2011; 100:133-49; PMID: 20623695; http://dx.doi.org/10.1002/jps.22238 134.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Biomed Mater Res A 2012; Accepted; PMID:23065767; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biochemistry 1998; 37:1306-14; PMID: 9477957; http://dx.doi.org/10.1021/bi972032d 137.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Mol Cancer Ther 2007; 6:1765- 73; PMID:17541036; http://dx.doi.org/10.1158/ 1535-7163.MCT-06-0706 138.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Cancer Res 2006; 66:11709-17; PMID:17178866; http://dx.doi.org/10.1158/0008-5472.CAN-06-1878 140.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Science 1993; 260:920-6; PMID:8493529; http://dx.doi.org/ 10.1126/science.8493529 141.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Pharm Res 2000; 17: 497-504; PMID:10888299; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Pharm Res 2003; 20:1103-12; PMID:12948005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Biomaterials 2008; 29:4195-204; PMID:18691753; http://dx.doi.org/10.1016/j.bioma- terials.2008.07.017 145.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Tissue Eng 2006; 12:959-68; PMID: 16674307; http://dx.doi.org/10.1089/ten.2006.12.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
J Control Release 2006; 112:103-10; PMID:16516328; http://dx.doi.org/10.1016/j.jconrel.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
Curr Opin Colloid Interface Sci 2004; 8:515-22; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/35/9e/biom-2-239.PMC3568110.pdf
").9Xenografts*Correspondence to: Zhang Yufeng; Email: zyf@whu.edu.cn Submitted: 09/10/12; Revised: 10/31/12; Accepted: 11/17/12 http://dx.doi.org/10.4161/biom.22948SPECIAL FOCUS REVIEW Biomatter 2:4, 271 –277; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 271",Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
"J Clin Periodontol 2002; 29(Suppl 3):117-35, discussion 160-2; PMID:12787213; http://dx.doi.org/10.1034/j.",Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Clin Periodontol 2010; 37:374-81; PMID:20447261; http://dx.doi.org/ 10.1111/j.1600-051X.2010.01539.x 4.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2008; 79:25- 32; PMID:18166089; http://dx.doi.org/10.1902/jop.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Periodontol 2000 2012; 59:185-202; PMID:22507066; http://dx.doi.org/10.1111/j.1600- 0757.2011.00432.x 6.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Aust Dent J 2011; 56 (Suppl 1):107-18; PMID:21564121; http://dx.doi.org/ 10.1111/j.1834-7819.2010.01301.x 7.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Dentomaxillofac Radiol 2001; 30: 157-61; PMID:11420628; http://dx.doi.org/10.1038/ sj.dmfr.4600601 8.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Clin Oral Implants Res 2001; 12:95-103; PMID: 11251657; http://dx.doi.org/10.1034/j.1600-0501.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontal Implant Sci 2012; 42:127-35; PMID: 22977742; http://dx.doi.org/10.5051/jpis.2012.42.4.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Periodontol 2000 2000; 22: 104-32; PMID:11276509; http://dx.doi.org/10.1034/ j.1600-0757.2000.2220108.x12.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Clin Implant Dent Relat Res 2008; 10:99-105; PMID:18462206; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Clin Periodontol 2008; 35(Suppl):106-16; PMID: 18724845; http://dx.doi.org/10.1111/j.1600-051X.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Periodontol 2000 2009; 51: 208-19; PMID:19878476; http://dx.doi.org/10.1111/ j.1600-0757.2009.00317.x 15.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2007; 28:3338-48; PMID:17481726; http://dx.doi.org/10.1016/j.bioma- terials.2007.04.014 16.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res 1993; 27:1047-55; PMID:8408117; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res 1995; 29:89-99; PMID: 7713963; http://dx.doi.org/10.1002/jbm.820290113 18.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontal Res 1987; 22:270-83; PMID: 3040957; http://dx.doi.org/10.1111/j.1600-0765.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2001; 22:87-96; PMID:11085388; http://dx.doi.org/ 10.1016/S0142-9612(00)00174-522.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2004; 25:4749-57; PMID:15120521; http://dx.doi.org/10.1016/j.bioma- terials.2003.12.005 23.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontal Implant Sci 2012; 42:50-8; PMID:22586523; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2004; 25:4817-24; PMID: 15120528; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2010; 81:325-34; PMID: 20151813; http://dx.doi.org/10.1902/jop.2009.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res 2002; 63:601-4; PMID:12209906; http://dx.doi.org/10.1002/jbm.10380 30.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Arch Oral Biol 2009; 54:1083-90; PMID: 19828137; http://dx.doi.org/10.1016/j.archoralbio.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Clin Oral Investig 2011; 15:983-91; PMID:20697757; http://dx.doi.org/10.1007/s00784- 010-0454-2 37.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
ANZ J Surg 2001; 71:354-61; PMID: 11409021; http://dx.doi.org/10.1046/j.1440-1622.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84:424-9; PMID:9347509; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2008; 79:1886-93; PMID: 18834243; http://dx.doi.org/10.1902/jop.2008.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2002; 73:1352-9; PMID:12479641; http://dx.doi.org/10.1902/jop.2002.73.11.1352 43.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2006; 77:780- 9; PMID:16671869; http://dx.doi.org/10.1902/jop.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2008; 79:1630-7; PMID:18771362; http://dx.doi.org/10.1902/jop.2008.070282 45.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2001; 72:296-302; PMID:11327056; http://dx.doi.org/10.1902/jop.2001.72.3.296 46.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2004; 75:340-7; PMID:15088870; http://dx.doi.org/ 10.1902/jop.2004.75.3.340 47.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Science 2002; 295:1014-7; PMID: 11834817; http://dx.doi.org/10.1126/science.1067404 50.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 1991; 12:155-63; PMID:1878450; http://dx.doi.org/10.1016/0142-9612(91)90194-F 51.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Oral Rehabil 1997; 24:70-5; PMID:9049923; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
"J Biomed Mater Res 2001; 55:151-7; PMID: 11255166; http://dx.doi.org/10.1002/1097-4636 (200105)55:2 ,151::AID-JBM1001 .3.0.CO;2-D 55.",Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Oral Rehabil 1997; 24: 171-81; PMID:9131472; http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Arch Orthop Trauma Surg 2001; 121:583-90; PMID: 11768641; http://dx.doi.org/10.1007/s004020100291 58.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Oral Sci 2011; 53:481-8; PMID:22167034; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Med Oral Patol Oral Cir Bucal 2011; 16: e239-44; PMID:21196894; http://dx.doi.org/10.4317/ medoral.16.e239 60.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2003; 74: 899-908; PMID:12887004; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2006; 77:1781-7; PMID:17032123; http://dx.doi.org/10.1902/jop.2006.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2012; 83:453-64; PMID:21861641; http://dx.doi.org/ 10.1902/jop.2011.110347 63.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2003; 24: 1595-601; PMID:12559819; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res B Appl Biomater 2012; 100:1435-43; PMID:22287502; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res B Appl Biomater 2007; 80:290-6; PMID: 16767723; http://dx.doi.org/10.1002/jbm.b.30596 68.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2007; 28:1515-22; PMID:17169421; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biochem Biophys Res Commun 2006; 344:362-9; PMID:16600180; http://dx.doi.org/ 10.1016/j.bbrc.2006.03.106 276 Biomatter Volume 2 Issue 4,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomaterials 2004; 25:3829-35; PMID: 15020158; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomater Appl 2007; 21:333-49; PMID:16543282; http://dx.doi.org/10.1177/ 0885328206063853 73.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Clin Periodontol 2003; 30: 443-53; PMID:12716338; http://dx.doi.org/10.1034/ j.1600-051X.2003.10283.x 74.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res B Appl Biomater 2005; 72:86-93; PMID:15389496; http://dx.doi.org/10.1002/jbm.b.30121 75.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Periodontol 2000; 71:1306-14; PMID:10972646; http://dx.doi.org/10.1902/jop.2000.,OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Clin Periodontol 2008; 35:37-43; PMID:18173400; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
"J Biomed Mater Res 1998; 42:303-11; PMID:9773827; http://dx.doi.org/10.1002/(SICI)1097-4636(199811) 42:2,303::AID-JBM16 .3.0.CO;2-J82.",Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Biomed Mater 2009; 4: 055001; PMID:19776491; http://dx.doi.org/10.1088/ 1748-6041/4/5/055001 83.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res A 2003; 67:54-60; PMID:14517861; http://dx.doi.org/ 10.1002/jbm.a.10058 84.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
J Biomed Mater Res A 2010; 95:857- 69; PMID:20824651; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
Clin Oral Investig 2012; In press; PMID:22552596; http://dx.doi.org/10.1007/ s00784-012-0743-z 86.,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
"Dent Clin North Am 2006; 50:245-63, ix; PMID:16530061; http://dx.doi.org/10.1016/j.cden.",OADS,/arxiv_data1/oa_pdf/4d/f1/biom-2-271.PMC3568111.pdf
"Interesting findings have been observed, as the enhanced binding of growth factors to sulfate hyaluronic acid when comparing with chondroitin sulfate with the same sulfation degree, which has been attributed to differences in the sulfation pattern.28This is in agreement with the findings of Gama and coworkers, where the*Correspondence to: Tiago H. Silva; Email: tiago.silva@dep.uminho.pt Submitted: 08/30/12; Revised: 11/15/12; Accepted: 11/17/12 http://dx.doi.org/10.4161/biom.22947Biomatter 2:4, 278 –289; October/November/December 2012; G2012 Landes Bioscience 278 Biomatter Volume 2 Issue 4",Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 2009; 30:701-2; PMID:19058401; http://dx.doi.org/ 10.1016/j.biomaterials.2009.01.049 4.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biomater Sci Polym Ed 2001; 12:107-24; PMID:11334185; http://dx.doi.org/ 10.1163/156856201744489 5.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 2001; 22:883-9; PMID:11311006; http://dx.doi.org/10.1016/S0142-9612(00)00211-8 6.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 1996; 17:1417-22; PMID: 8830969; http://dx.doi.org/10.1016/0142-9612(96) 87284-X 7.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Acta Biomater 2012; 8: 289-301; PMID:22019518; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Tissue Eng 2006; 12:801-9; PMID:16674293; http://dx.doi.org/10.1089/ten.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biomed Mater Res 1993; 27:183-9; PMID:8382203; http://dx.doi.org/10.1002/jbm.820270207 12.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 2000; 21:2529-43; PMID: 11071603; http://dx.doi.org/10.1016/S0142-9612 (00)00121-6 13.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biomed Mater Res A 2009; 91:489-504; PMID:18985771; http://dx.doi.org/10.1002/jbm.a.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 1993; 14: 323-30; PMID:8507774; http://dx.doi.org/10.1016/ 0142-9612(93)90049-8 16.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Polymer (Guildf) 1994; 35:1068-77; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Acta Biomater 2008; 4:1637-45; PMID: 18635412; http://dx.doi.org/10.1016/j.actbio.2008.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 2002; 23:551-9; PMID:11761175; http://dx.doi.org/10.1016/S0142- 9612(01)00137-5 19.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Mater Sci Mater Med 2005; 16:1077-85; PMID:16362204; http://dx.doi.org/10.1007/s10856- 005-4709-4 20.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Tissue Eng Part A 2011; 17:2663-74; PMID: 21790302; http://dx.doi.org/10.1089/ten.tea.2010.0635 21.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Tissue Eng Regen Med 2009; 3:37-42; PMID: 19021239; http://dx.doi.org/10.1002/term.132 22.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Tissue Eng Regen Med 2011; 5: 253-63; PMID:20661867; http://dx.doi.org/10.1002/ term.310 23.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Bioact Compat Polym 2009; 24:385-400; http://dx.doi.org/10.1177/ 0883911509105796 25.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 2011; 32:8938-46; PMID:21875749; http://dx.doi.org/10.1016/j.biomaterials.2011.08.025 27.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Acta Biomater 2012; 8:2144-52; PMID:22426137; http://dx.doi.org/10.1016/j.actbio.2012.03.021 29.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Glycoconj J 2010; 27:151-8; PMID:19941065; http://dx.doi.org/10.1007/s10719- 009-9270-9 31.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Tissue Eng Regen Med 2012; In press; PMID:22718572; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Mater Chem 2012; 22: 7172-8; http://dx.doi.org/10.1039/c2jm15762d 33.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Mar Drugs 2011; 9:1664-81; PMID: 22131964; http://dx.doi.org/10.3390/md9091664 34.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int Mater Rev 2012; 57:276-306; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2009; 23:1903-9; http://dx.doi.org/10.1016/j.foodhyd.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Hydrobiologia 1990; 204-205:533-8; http://dx.doi.org/10.1007/ BF00040282 38.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2001; 15:441-52; http://dx.doi.org/10.1016/S0268-005X (01)00066-2 39.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Food Sci 2010; 75:E153-6; PMID:20492288; http://dx.doi.org/10.1111/j.1750-3841.2010.01519.x 40.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Hydrobiologia 1987; 151-152:31- 47; http://dx.doi.org/10.1007/BF00046103 41.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 1997; 32:81-7; http://dx.doi.org/10.1016/S0144- 8617(96)00167-1 www.landesbioscience.com Biomatter 285,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2008; 22:727-34; http://dx.doi.org/10.1016/j.foodhyd.2007.05.013 43.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Appl Phycol 2008; 20:527-35; http://dx.doi.org/10.1007/ s10811-007-9229-9 46.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2002; 16:515-22; http://dx.doi.org/10.1016/S0268- 005X(01)00131-X 47.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 1997; 32:81-7; http://dx.doi.org/10.1016/S0144- 8617(96)00167-1 48.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Compos Interfaces 2007; 14:1-19; http://dx.doi.org/10.1163/156855407779230344 49.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Innov Food Sci Emerg Technol 2005; 6:465-72; http://dx.doi.org/10.1016/j.ifset.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Bioact Compat Polym 2007; 22:42-61; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Mol Biol 1980; 138:349-62; PMID:7411612; http://dx.doi.org/10.1016/0022- 2836(80)90291-0 52.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomacromolecules 2011; 12:3952-61; PMID: 21970513; http://dx.doi.org/10.1021/bm200965x 53.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Materials 2011; 4:1805-17; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biomater Sci Polym Ed 2008; 19:47-59; PMID:18177553; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Bioact Compat Polym 2007; 22:342-56; http://dx.doi.org/10.1177/0883911507078519 56.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Mater Chem 2010; 20:7953- 6; http://dx.doi.org/10.1039/c0jm00985g 57.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2012; 89:282-9; http://dx.doi.org/10.1016/j.carbpol.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomacromolecules 2007; 8:2350-7; PMID: 17625907; http://dx.doi.org/10.1021/bm070096q 59.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Colloid Interface Sci 2008; 324:205-11; PMID:18495143; http://dx.doi.org/10.1016/j.jcis.2008.04.051 60.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Chem Mater 2007; 19:1362-8; PMID:18802491; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 2005; 340:1113-29; PMID:15797127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Trends Food Sci Technol 2002; 13:73- 92; http://dx.doi.org/10.1016/S0924-2244(02)00066- 3 63.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2004; 18:71-9; http://dx.doi.org/10.1016/ S0268-005X(03)00043-2 65.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Toxicol Environ Chem 1995; 47:65-70; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Bot Mar 1994; 37:467-70; http://dx.doi.org/10.1515/botm.1994.37.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Biol Macromol 1987; 9:146- 52; http://dx.doi.org/10.1016/0141-8130(87)90042-0 68.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
"Br Food J 1994; 96:12-7; http://dx.doi.org/10.1108/ 00070709410060763 69. van de Velde F, Lourenco ND, Pinheiro HM, Bakker M. Carrageenan: A food-grade and biocompatible support for immobilisation techniques.",Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
"Adv Synth Catal 2002; 344:815-35; http://dx.doi.org/10.1002/ 1615-4169(200209)344:8 ,815::AID-ADSC815 .3.",Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2005; 19:541-7; http://dx.doi.org/10.1016/j.foodhyd.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2000; 14:273-80; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2005; 19:187-95; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 1989; 10:259-80; http://dx.doi.org/ 10.1016/0144-8617(89)90066-0 75.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Hydrocoll 2005; 19:83-91; http://dx.doi.org/10.1016/j.foodhyd.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Cosmet Toxicol 1976; 14:85-93; PMID:817996; http://dx.doi.org/10.1016/S0015-6264(76)80249-0 79.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2006; 65:134-8; http://dx.doi.org/10.1016/j.carbpol.2005.12.033 80.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Bioorg Med Chem Lett 2006; 16:1329-34; PMID:16337378; http://dx.doi.org/10.1016/j.bmcl.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Mar Drugs 2011; 9:2514-25; PMID: 22363237; http://dx.doi.org/10.3390/md9122514 82.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
PLoS One 2010; 5:e14320; PMID: 21179403; http://dx.doi.org/10.1371/journal.pone.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Antiviral Res 1991; 15:139-48; PMID:1713439; http://dx.doi.org/10.1016/0166-3542(91)90031-L 85.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
PLoS Pathog 2006; 2:e69; PMID:16839203; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
PLoS One 2008; 3:e3162; PMID:18776937; http://dx.doi.org/10.1371/journal.pone.0003162 286 Biomatter Volume 2 Issue 4,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Pharmacol Res 2004; 50:47-53; PMID:15082028; http://dx.doi.org/10.1016/j.phrs.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biol Chem 2000; 275:29299- 307; PMID:10882718; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Am J Physiol Gastrointest Liver Physiol 2007; 292:G829-38; PMID:17095757; http://dx.doi.org/10.1152/ajpgi.00380.2006 95.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Eur J Pharmacol 2007; 577:156-61; PMID:17850787; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Life Sci 2006; 79:442-7; PMID:16481007; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Agents Actions 1991; 32:46-51; PMID:2058470; http://dx.doi.org/10.1007/BF01983307 98.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomacromolecules 2009; 10:1392-401; PMID:19385660; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Bioact Compat Polym 2011; 26:493-507; http://dx.doi.org/ 10.1177/0883911511420700 101.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
"J Mol Catal, B Enzym 2004; 31: 143-50; http://dx.doi.org/10.1016/j.molcatb.2004.08.",OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biotechnol Appl Biochem 2012; 59:132-41; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Br Phycol J 1979; 14:103-17; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Glycobiology 2008; 18:1016-27; PMID: 18796647; http://dx.doi.org/10.1093/glycob/cwn085 106.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biotechnol Adv 2011; 29:483-501; PMID: 21672617; http://dx.doi.org/10.1016/j.biotechadv.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 2007; 342:586-96; PMID:17134684; http://dx.doi.org/10.1016/j.carres.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2010; 81:572-7; http://dx.doi.org/10.1016/j.carbpol.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biol Pharm Bull 2009; 32:892-8; PMID: 19420760; http://dx.doi.org/10.1248/bpb.32.892 112.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Biol Macromol 1999; 26:151-4; PMID: 10517522; http://dx.doi.org/10.1016/S0141-8130 (99)00079-3 114.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biosci Biotechnol Biochem 1998; 62:1647- 52; PMID:9805364; http://dx.doi.org/10.1271/bbb.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2011; 85:394-400; http://dx.doi.org/10.1016/j.carbpol.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Biol Macromol 2009; 44:70-4; PMID:19007806; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2008; 71:428-34; http://dx.doi.org/10.1016/j.carbpol.2007.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Appl Phycol 1993; V5:195-200; http://dx.doi.org/10.1007/ BF00004017 119.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 1994; 262:115-25; http://dx.doi.org/10.1016/ 0008-6215(94)84008-3 120.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Appl Phycol 2009; 21:451-6; http://dx.doi.org/10.1007/ s10811-008-9390-9 121.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2009; 77:206-16; http://dx.doi.org/10.1016/j.carbpol.2008.12.023 122.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2006; 66:408-16; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 1995; 274:313-8; http://dx.doi.org/ 10.1016/0008-6215(95)00059-3 124.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 1995; 274:251-61; http://dx.doi.org/10.1016/0008- 6215(95)00138-J 125.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Chem 2007; 104:928-35; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Am J Bot 2004; 91:1535-56; PMID: 21652308; http://dx.doi.org/10.3732/ajb.91.10.1535 127.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Mol Evol 1980; 15:1-12; PMID:7365805; http://dx.doi.org/10.1007/ BF01732578 128.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Plant Physiol 2010; 153:373-83; PMID: 20421458; http://dx.doi.org/10.1104/pp.110.158055 129.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Chem 2009; 112:575-81; http://dx.doi.org/10.1016/j.foodchem.2008.06.008 133.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Biol Macromol 2005; 37:195-9; PMID:16310843; http://dx.doi.org/ 10.1016/j.ijbiomac.2005.10.008 135.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Aquaculture 2006; 254:9-20; http://dx.doi.org/10.1016/j.aquaculture.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Aquaculture 2004; 229:67-78; http://dx.doi.org/10.1016/S0044-8486(03)00401-0 139.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Biol Macromol 2011; 49:1051-8; PMID: 21907732; http://dx.doi.org/10.1016/j.ijbiomac.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 2010; 345:1452-4; PMID:20362278; http://dx.doi.org/10.1016/j.carres.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int Immunopharmacol 2007; 7:879-88; PMID:17499190; http://dx.doi.org/10.1016/j.intimp.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Med Food 2009; 12:236-58; PMID:19459725; http://dx.doi.org/ 10.1089/jmf.2008.0151 143.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Pharmacol Res 2003; 48:543- 9; PMID:14527817; http://dx.doi.org/10.1016/ S1043-6618(03)00215-9 144.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Appl Phycol 2003; 15:21-7; http://dx.doi.org/10.1023/A:1022997622334145.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Chem Toxicol 2008; 46:3262-7; PMID:18706469; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 2008; 343:3085-95; PMID: 18845298; http://dx.doi.org/10.1016/j.carres.2008.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Planta Med 1999; 65:527-31; PMID:10483372; http://dx.doi.org/10.1055/s-1999-14009 149.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2009; 76:349-61; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biochim Biophys Acta 2000; 1543:86-94; PMID: 11087944; http://dx.doi.org/10.1016/S0167-4838 (00)00193-X 153.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2011; 84:1093-102; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Pharm 2012; 426:76-81; PMID: 22281048; http://dx.doi.org/10.1016/j.ijpharm.2012.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Supercrit Fluids 2012; 65:32-8; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Macromol Chem Phys 2010; 211:821-32; http://dx.doi.org/10.1002/macp.200900562 157.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biomed Mater Res A 2012; In press; PMID: 22965453; http://dx.doi.org/10.1002/jbm.a.34403 158.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Mar Drugs 2011; 9:2514-25; PMID: 22363237; http://dx.doi.org/10.3390/md9122514 160.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Hoppe Seylers Z Physiol Chem 1913; 83:171-97; http://dx.doi.org/ 10.1515/bchm2.1913.83.3.171 161.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Glycobiology 2003; 13:29R-40R; PMID:12626402; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Molecules 2008; 13:1671-95; PMID: 18794778; http://dx.doi.org/10.3390/mole- cules13081671 166.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Mar Drugs 2011; 9:196-223; PMID: 21566795; http://dx.doi.org/10.3390/md9020196 168.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2007; 69:530-7; http://dx.doi.org/ 10.1016/j.carbpol.2007.01.009 169.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Sci Food Agric 2007; 87:1630-8; http://dx.doi.org/10.1002/jsfa.2829 171.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Res 1989; 194:315-20; PMID: 2620305; http://dx.doi.org/10.1016/0008-6215(89) 85032-3 173.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Biol Chem 2000; 275:29299- 307; PMID:10882718; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 1989; 10:363-8; PMID:2804225; http://dx.doi.org/10.1016/0142-9612(89)90127-0 175.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Russ J Plant Physiol 2006; 53:246-51; http://dx.doi.org/10.1134/S1021443706020154 178.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Planta Med 2004; 70:813-7; PMID: 15386190; http://dx.doi.org/10.1055/s-2004-827228 179.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Gen Pharmacol 1997; 29:497-511; PMID:9352294; http://dx.doi.org/10.1016/S0306-3623(96)00563-0 180.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2012; 88:13-20; http://dx.doi.org/10.1016/j.carbpol.2011.12.029 181.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Food Chem 2003; 81: 327-32; http://dx.doi.org/10.1016/S0308-8146(02) 00426-0 182.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Meat Sci 2009; 83:492-8; PMID:20416671; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biotechnology and Bioprocess Engineering 2008; 13:511-23; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Microencapsul 2006; 23:513-22; PMID:16980273; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
AAPS PharmSciTech 2007; 8:E94-101; PMID:18181554; http://dx.doi.org/10.1208/pt0802039 188.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biomaterials 2010; 31:83- 90; PMID:19775748; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
J Mater Chem 2011; 21:17710-8; http://dx.doi.org/ 10.1039/c1jm12915e 190.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Carbohydr Polym 2012; 90:181-8; http://dx.doi.org/ 10.1016/j.carbpol.2012.05.012191.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biol Pharm Bull 2008; 31:2326-33; PMID: 19043221; http://dx.doi.org/10.1248/bpb.31.2326 192.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Tissue Eng Part B Rev 2012; 18:155-66; PMID:22220809; http://dx.doi.org/ 10.1089/ten.teb.2011.0553 194.,Non-OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Int J Biol Macromol 2003; 31:177-85; PMID:12568926; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
Biophys Chem 2003; 104:95- 105; PMID:12834830; http://dx.doi.org/10.1016/ S0301-4622(02)00341-1 196.,OADS,/arxiv_data1/oa_pdf/be/53/biom-2-278.PMC3568112.pdf
"Enhancing cell-cell contact and providing nonimmunogenic matrices before transplantation has been shown to improve cell engraftment in animal models.14Furthermore, tissue-engineered products, such as skin substitutes and cartilage replacement, have already helped thousands of patients15,16and*Correspondence to: Junichi Kasuya; Email: kasuya@sudo.sd.keio.ac.jp and jkasuya@mit.edu Submitted: 08/31/12; Revised: 10/03/12; Accepted: 10/05/12 http://dx.doi.org/10.4161/biom.22481SPECIAL FOCUS REVIEW Biomatter 2:4, 1 –6; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 1",Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Hepatology 2002; 36:227-42; PMID: 12085369; http://dx.doi.org/10.1053/jhep.2002.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Annu Rev Pathol 2006; 1:23- 61; PMID:18039107; http://dx.doi.org/10.1146/ annurev.pathol.1.110304.100230 6.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Nat Rev Mol Cell Biol 2004; 5:836-47; PMID: 15459664; http://dx.doi.org/10.1038/nrm1489 7.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
"Ann Surg 2004; 239:660-7, discussion 667-70; PMID:15082970; http://dx.doi.org/10.1097/01.sla.0000124298.74199.",OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Gut 2009; 58:1690-702; PMID:19923348; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Transplantation 2006; 82:441- 9; PMID:16926585; http://dx.doi.org/10.1097/01.tp.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Transplantation 2012; 93: 342-7; PMID:22082820; http://dx.doi.org/10.1097/ TP.0b013e31823b72d6 13.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Science 1993; 260:920-6; PMID:8493529; http://dx.doi.org/ 10.1126/science.8493529 15.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Trends in the sciences 2009; 14:36-43; http://dx.doi.org/10.5363/ tits.14.8_36 16.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Hepatology 1999; 29:90- 100; PMID:9862855; http://dx.doi.org/10.1002/hep.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng Part A 2008; 14:995-1006; PMID:19230124; http://dx.doi.org/10.1089/ten.tea.2007.0087 19.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Am J Transplant 2006; 6:50-9; PMID:16433756; http://dx.doi.org/10.1111/j.1600- 6143.2005.01155.x 20.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
FASEB J 2007; 21:790-801; PMID:17197384; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
J Hepatol 2003; 39:716-23; PMID:14568252; http://dx.doi.org/10.1016/S0168- 8278(03)00412-4 23.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng 2003; 9:1227-32; PMID: 14670110; http://dx.doi.org/10.1089/ 10763270360728134 24.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Biomaterials 2005; 26: 6415-22; PMID:16011847; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Nat Med 2007; 13:880-5; PMID: 17572687; http://dx.doi.org/10.1038/nm1576 27.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Biomacromolecules 2000; 1:377-81; PMID: 11710126; http://dx.doi.org/10.1021/bm0002961 28.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Biomaterials 2003; 24:1223-32; PMID:12527263; http://dx.doi.org/10.1016/S0142-9612(02)00469-6 29.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng 2004; 10:873-80; PMID:15265305; http://dx.doi.org/10.1089/ 1076327041348446 30.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
J Biosci Bioeng 2007; 104:371-8; PMID: 18086436; http://dx.doi.org/10.1263/jbb.104.371 www.landesbioscience.com Biomatter 5,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Hepatology 1999; 29:111-25; PMID:9862857; http://dx.doi.org/10.1002/hep.510290103 32.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng 1999; 5:421-34; PMID: 10586098; http://dx.doi.org/10.1089/ten.1999.5.421 34.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Biomaterials 2010; 31:4113-20; PMID: 20149432; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng 2001; 7:385-94; PMID:11506728; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Biomaterials 2012; 33:2693-700; PMID:22236830; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Biomaterials 2009; 30:3573-9; PMID:19362363; http://dx.doi.org/ 10.1016/j.biomaterials.2009.03.045 38.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng Part A 2010; 16:2441-55; PMID:20214453; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Tissue Eng Part A 2012; 18:1045-56; PMID: 22220631; http://dx.doi.org/10.1089/ten.tea.2011.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Proc Jpn Acad Ser B 2006; 82:155-64; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Keio J Med 2001; 50:66-71; PMID:11450594; http://dx.doi.org/10.2302/kjm.50.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Differentiation 2008; 76:784-94; PMID: 18177423; http://dx.doi.org/10.1111/j.1432-0436.,OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Gastroenterology 2008; 135:671-9; PMID:18570897; http://dx.doi.org/10.1053/j.gastro.2008.04.010 47.,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
Science 2002; 295:1005-9; PMID:11834813; http://dx.doi.org/10.1126/science.1068660 6 Biomatter Volume 2 Issue 4,Non-OADS,/arxiv_data1/oa_pdf/df/88/biom-2-290.PMC3568113.pdf
"Cancer deaths in the European Unioncountries are estimated to be near 1.3 million in 2012, 2anddeaths from cancer worldwide are projected to continue rising,with an estimated 13.1 million deaths in 2030 (http://globocan.iarc.fr).",Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
"3,5Thus, the drug delivery system along with the therapeutic agent would be*Correspondence to: Hélder A. Santos; Email: helder.santos@helsinki.fi Submitted: 08/12/12; Revised: 09/15/12; Accepted: 09/20/12 http://dx.doi.org/10.4161/biom.22347SPECIAL FOCUS REVIEW Biomatter 2:4, 1 –17; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 1 ©2012 Landes Bioscience.",Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/ 10.3322/caac.20107 2.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Ann Oncol 2012; 23:1044-52; PMID: 22373539; http://dx.doi.org/10.1093/annonc/mds024 3.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Rev Cancer 2002; 2:750-63; PMID: 12360278; http://dx.doi.org/10.1038/nrc903 4.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
DrugDiscov Today 2010; 15:842-50; PMID:20727417; http://dx.doi.org/10.1016/j.drudis.2010.08.006 6.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
CA Cancer J Clin 2008; 58:97-110; PMID:18227410; http://dx.doi.org/10.3322/CA.2007.0003 7.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanotech 2008; 19:415101; http://dx.doi.org/10.1088/0957-4484/19/ 41/415101 8.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Rev Cancer 2005; 5:161-71; PMID: 15738981; http://dx.doi.org/10.1038/nrc1566 9.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
"Chem Soc Rev2011; 40:233-45; PMID:20886124; http://dx.doi.org/10.1039/c0cs00003e 11. von Maltzahn G, Park JH, Lin KY, Singh N, Schwöppe C, Mesters R, et al.",OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Biotechnol 2007; 25:1159-64; PMID: 17873867; http://dx.doi.org/10.1038/nbt1332 14.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Intern Med 2010; 267: 22-43; PMID:20059642; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2010; 6:1952-67; PMID: 20690133; http://dx.doi.org/10.1002/smll.200901789 17.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Curr Drug Discov Technol 2011; 8:228-49; PMID:21291407; http://dx.doi.org/10.2174/15701631179679905318.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Acc Chem Res 2011;44:979-89; PMID:21902173; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Chem Soc Rev 2012; 41:2590-605; PMID: 22216418; http://dx.doi.org/10.1039/c1cs15246g 21.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2008; 29:4045-55; PMID:18675454; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biochim Biophys Acta 2011; 1810:361-73; PMID:20435096; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanoscale 2010; 2:1870-83; PMID:20730166;http://dx.doi.org/10.1039/c0nr00156b 25.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Curr Drug Targets 2011; 12:1166-86; PMID:21443474; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanomedicine (Lond) 2012; 7:111-20; PMID: 22191780; http://dx.doi.org/10.2217/nnm.11.166 27.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Drug Deliv Rev 2012; In press; PMID:22634160; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Colloid Interface Sci 2011; 361:16-24; PMID:21689824; http://dx.doi.org/ 10.1016/j.jcis.2011.05.038 30.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Recent Pat Nanotechnol 2008; 2:128-36; PMID:19076047; http://dx.doi.org/10.2174/ 187221008784534514 32.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Drug Deliv Rev 2008; 60:1266-77; PMID:18508154; http://dx.doi.org/10.1016/j.addr.2008.03.017 33.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Mol Ther 2011; 19:1538-46; PMID:21629222; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Int J Pharm 2011; 414:148- 56; PMID:21601623; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2011; 32:2625-33; PMID: 21194747; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2011; 32:9089-99; PMID: 21864895; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2010; 4: 3023-32; PMID:20509673; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Mol Pharm 2011; 8:1799-806; PMID: 21875120; http://dx.doi.org/10.1021/mp2001654 40.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2012; 33:3353-62; PMID: 22285465; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanoscale 2012; 4:3184-92; PMID:22508528; http://dx.doi.org/10.1039/c2nr30397c 42.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Pharm Sci 2011; 100:3294-306; PMID:21520084; http://dx.doi.org/ 10.1002/jps.22577 43.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Int J Pharm 2011; 421:388-96; PMID:22001840; http://dx.doi.org/10.1016/j.ijpharm.2011.10.013 45.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Am Chem Soc 2006; 128:14792-3; PMID: 17105274; http://dx.doi.org/10.1021/ja0645943 46.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanobiotechnology 2007; 3:89-95; PMID:19936038; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2010; 6:1794-805; PMID: 20623530; http://dx.doi.org/10.1002/smll.201000538 48.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2010; 6:2546-52; PMID:20814923; http://dx.doi.org/ 10.1002/smll.201000841 49.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Funct Mater 2009; 19:733-41;http://dx.doi.org/10.1002/adfm.200800921 50.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Mater 2012; 24:2890-5; PMID:22539076; http://dx.doi.org/10.1002/adma.201104797 51.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2010; 4:4371-9; PMID:20731423; http://dx.doi.org/10.1021/nn901376h 52.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano2008; 2:2401-9; PMID:19206408; http://dx.doi.org/ 10.1021/nn800592q 53.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2009; 3:197-206; PMID:19206267; http://dx.doi.org/ 10.1021/nn800781r 54.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Drug Deliv Rev 2008; 60:1278-88; PMID:18514969; http://dx.doi.org/10.1016/j.addr.2008.03.012 55.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Angew Chem Int Ed Engl 2007; 46:1455-7; PMID:17221893; http://dx.doi.org/10.1002/anie.200603404 56.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Angew Chem Int Ed Engl 2011; 50:640-3; PMID:21226142; http://dx.doi.org/10.1002/ anie.201005061 57.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Angew Chem Int Ed Engl 2009; 48:3092-5; PMID:19309022; http://dx.doi.org/10.1002/anie.200805818 58.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Colloid Interface Sci 2011; 354:771-6; PMID:21056426; http://dx.doi.org/10.1016/j.jcis.2010.10.040 59.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Am Chem Soc 2010; 132: 1450-1; PMID:20078044; http://dx.doi.org/10.1021/ja907560y 60.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Langmuir 2008; 24:239-44; PMID:18052081; http://dx.doi.org/10.1021/la701570z 61.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Dalton Trans 2011; 40:10203-8; PMID:21901222; http://dx.doi.org/10.1039/c1dt11114k62.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Funct Mater 2010; 20:4168-74; PMID:21274422; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomed Microdevices 2009; 11: 49-63; PMID:18663578; http://dx.doi.org/10.1007/s10544-008-9209-0 64.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Pharm Res2011; 28:273-8; PMID:20814720; http://dx.doi.org/ 10.1007/s11095-010-0214-7 66.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.Methods Mol Biol 2010; 624:25-37; PMID: 20217587; http://dx.doi.org/10.1007/978-1-60761-609-2_3 67.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Am Chem Soc 2010; 132:4834-42; PMID:20230032; http://dx.doi.org/10.1021/ ja910846q 6 8 .,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2009; 5:2722-9; PMID: 19780070; http://dx.doi.org/10.1002/smll.200900923 69.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Mater 2009; 8:331-6; PMID:19234444; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Chembiochem 2008; 9:53- 7; PMID:17999392; http://dx.doi.org/10.1002/cbic.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2009; 5:57-62; PMID:19051185; http://dx.doi.org/ 10.1002/smll.200800926 72.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Am Chem Soc 2009; 131:1354-5;PMID:19173660; http://dx.doi.org/10.1021/ja808018y 73.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Mater 2011; 10: 389-97; PMID:21499315; http://dx.doi.org/10.1038/nmat2992 74.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2010; 31:1085-92; PMID: 19880176; http://dx.doi.org/10.1016/j.biomaterials.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Liposome Res 2008; 18: 195-209; PMID:18720195; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2010; 31:3335-46; PMID:20106517; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2010; 31:438-48; PMID:19800115; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2011; 5:5717-28; PMID: 21630682; http://dx.doi.org/10.1021/nn2013904 79.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2010; 4:789-94; PMID: 20131868; http://dx.doi.org/10.1021/nn9015345 80.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
FASEB J 2005; 19:2014-6; PMID:16230334; http://dx.doi.org/10.1096/fj.05-4288fje 81.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2009; 5:1408-13; PMID: 19296554; http://dx.doi.org/10.1002/smll.200900005 82.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Chem Res Toxicol 2009; 22:1869-80; PMID:19817448; http://dx.doi.org/10.1021/tx900276u 83.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanoscale 2012; 4: 970-5; PMID:22200056; http://dx.doi.org/10.1039/c2nr11691j 84.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Pharm Sci 2012; 101:1136-44; PMID:22190350;http://dx.doi.org/10.1002/jps.23016 86.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomed Microdevices 2012; 14:259-70; PMID:22124885; http://dx.doi.org/10.1007/s10544- 011-9604-9 87.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells.Biomaterials 2007; 28:2959-66; PMID:17397919; http://dx.doi.org/10.1016/j.biomaterials.2007.03.006 88.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Rev Mol Cell Biol 2004; 5:121-32; PMID:15040445;http://dx.doi.org/10.1038/nrm1315 89.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Anal Chem 2008; 80:9597-603; PMID:19007246; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Biomed Mater Res A 2012; In press; PMID:22767395; http://dx.doi.org/10.1002/jbm.a.34294 94.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanoscale 2010; 2:2230-6; PMID:20835434; http://dx.doi.org/ 10.1039/c0nr00161a 95.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Angew Chem Int Ed Engl 2008; 47:8438-41; PMID:18726979; http://dx.doi.org/10.1002/anie.200802469 96.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Am Chem Soc 2010; 132:552-7; PMID:20017538; http://dx.doi.org/10.1021/ja905793q 97.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanomedicine 2012; 8:212-20; PMID:21703996; http://dx.doi.org/10.1016/j.nano.2011.06.002 98.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2010; 6:2678-82; PMID: 21069757; http://dx.doi.org/10.1002/smll.201001447 100.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2011; 5:5390-9; PMID:21634407;http://dx.doi.org/10.1021/nn200365a 101.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Funct Mater 2009; 19:215-22; http://dx.doi.org/10.1002/adfm.200800753 102.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2010; 31:5564-74; PMID:20417962;http://dx.doi.org/10.1016/j.biomaterials.2010.03.048 103.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2011; 7:271-80; PMID:21213393; http://dx.doi.org/10.1002/smll.201001459 104.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
"Angew Chem Int Ed Engl 2008; 47:7284-8; PMID: 18696519; http://dx.doi.org/10.1002/anie.200801810 105. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, et al.",OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2009; 3:16-20; PMID: 19206243; http://dx.doi.org/10.1021/nn900002m 107.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Annu Rev Biomed Eng 2007; 9:257-88; PMID:17439359; http://dx.doi.org/10.1146/annurev.bioeng.9.060906.152025 109.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Drug Deliv Rev 2010; 62:378-93; PMID: 19922750; http://dx.doi.org/10.1016/j.addr.2009.11.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Drug Deliv Rev 2000; 41:147-62; PMID:10699311; http://dx.doi.org/10.1016/S0169- 409X(99)00062-9 113.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Int J Pharm 2012; 423:509-15; PMID:22178618; http://dx.doi.org/10.1016/j.ijpharm.2011.11.045 114.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Drug Deliv Rev 2011; 63:943-55; PMID:21679733; http://dx.doi.org/ 10.1016/j.addr.2011.05.021 115.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Adv Mater 2012; 24:3981-7; PMID:22689074;http://dx.doi.org/10.1002/adma.201200776 117.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Int J Biol Macromol 2012; 50:1048-54; PMID:22421216; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Bioconjug Chem 2012; 23:698-704; PMID: 22375899; http://dx.doi.org/10.1021/bc200301a 119.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanotechnology 2012; 23:085101; PMID:22293239; http://dx.doi.org/10.1088/0957-4484/23/8/085101120.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Appl Mater Interfaces 2010; 2: 2489-95; PMID:20707315; http://dx.doi.org/10.1021/am100530t 121.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
J Am Chem Soc 2010; 132:6906-7; PMID: 20433206; http://dx.doi.org/10.1021/ja102414t 122.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2011; 5:4131-44; PMID: 21524062; http://dx.doi.org/10.1021/nn200809t 123.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nat Nanotechnol 2007; 2:469-78; PMID:18654343; http://dx.doi.org/10.1038/nnano.2007.223 124.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanomedicine (Lond) 2007; 2:99- 111; PMID:17716196; http://dx.doi.org/10.2217/17435889.2.1.99 125.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Small 2009; 5:2673-7; PMID:19780069; http://dx.doi.org/10.1002/smll.200900621 126.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Chem Eng J 2009; 156:184-92; http://dx.doi.org/10.1016/j.cej.2009.10.018 128.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
ACS Nano 2011; 5:1366-75; PMID:21294526; http://dx.doi.org/10.1021/nn103077k 129.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Biomaterials 2010; 31:6142-53; PMID:20510446; http://dx.doi.org/10.1016/j.biomaterials.2010.04.055 130.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
"Santos HA, Bimbo LM, Herranz B, Shahbazi MA, Hirvonen J, Salonen J. Nanostructured porous siliconin preclinical imaging: Moving from bench to bedside.J Mater Res 2012; In Press; http://dx.doi.org/10.1557/ jmr.2012.271 131.",OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
Nanomedicine 2012; 7:1281-84; PMID: 22994953; http://dx.doi.org/10.2217/nnm.12.106 www.landesbioscience.com Biomatter 17 ©2012 Landes Bioscience.,OADS,/arxiv_data1/oa_pdf/7d/40/biom-2-296.PMC3568114.pdf
"The first type of FePt magnetic capsule was an inorganic-organic hybrid capsule that was fabricated by growing ordered alloy FePt nanoparticles on silica template particles with an anionic surface that had been modified with a cationic *Correspondence to: Yoshitaka Kitamoto; Email: kitamoto.t.aa@m.titech.ac.jp Submitted: 07/25/12; Revised: 10/17/12; Accepted: 10/21/12 http://dx.doi.org/10.4161/biom.22617SPECIAL FOCUS REPORT Biomatter 2:4, 313 –320; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 313",Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Colloid Interface Sci 2012; 368:97-106; PMID:22112979; http://dx.doi.org/10.1016/j.jcis.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Thin Solid Films 2006; 515:2555-61; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Colloid Interface Sci 2011; 354:94-9; PMID:21044785; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Magn Magn Mater 2010; 322:2172-6; http://dx.doi.org/10.1016/j.jmmm.2010.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Nanotech 2008; 19:055602; http://dx.doi.org/10.1088/0957-4484/19/05/055602 6.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Colloid Interface Sci 2010; 341:64-8; PMID:19819464; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Magn Magn Mater 2009; 321:645-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Colloid Interface Sci 2009; 333:329-34; PMID:19251272; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Chem Mater 2009; 21:2442-51; http://dx.doi.org/10.1021/cm900268z 11.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Colloid Interface Sci 2009; 338:584-90; PMID:19640548; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
React Funct Polym 2011; 71:227-34; http://dx.doi.org/10.1016/j.reactfunctpo- lym.2010.10.009 15.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Control Release 1998; 55:219-29; PMID:9795065; http://dx.doi.org/ 10.1016/S0168-3659(98)00054-6 16.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Drug Discov Today 2005; 2:21-6; http://dx.doi.org/ 10.1016/j.ddtec.2005.05.007 17.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Biochim Biophys Acta 1994; 1190:99-107; PMID:8110825; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Langmuir 2011; 27:2923-8; PMID:21291255; http://dx.doi.org/10.1021/ la1041019 19.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Biomaterials 2012; 33:1682-7; PMID:22123601; http://dx.doi.org/10.1016/j.biomaterials.2011.11.016 www.landesbioscience.com Biomatter 319,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Acc Chem Res 2011; 44:1080-93; PMID: 21786832; http://dx.doi.org/10.1021/ar200011r 21.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Nat Nanotechnol 2009; 4:598-606; PMID: 19734934; http://dx.doi.org/10.1038/nnano.2009.202 22.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Phys D Appl Phys 2003; 26:167-80; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Magn Magn Mater 2006; 300:284-92; http://dx.doi.org/10.1016/j.jmmm.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
Electrochim Acta 2009; 54:5969-72; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Colloid Interface Sci 2007; 308:564-7; PMID:17289069; http://dx.doi.org/10.1016/j.jcis.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
J Magn Magn Mater 2005; 293:483-96; http://dx.doi.org/10.1016/j.jmmm.2005.,OADS,/arxiv_data1/oa_pdf/28/d9/biom-2-313.PMC3568115.pdf
"The properties *Correspondence to: Hsin-Yi Lin; Email: hbrunken@ntut.edu.tw Submitted: 07/27/12; Revised: 11/05/12; Accepted: 11/06/12 http://dx.doi.org/10.4161/biom.22817SPECIAL FOCUS REPORT Biomatter 2:4, 321 –328; October/November/December 2012; G2012 Landes Bioscience www.landesbioscience.com Biomatter 321",Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Biomaterials 2005; 26:6335-42; PMID:15919113; http://dx.doi.org/10.1016/j.biomaterials.2005.04.012 2.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Biomaterials 2000; 21: 1797-802; PMID:10905462; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
J Biomed Mater Res 2002; 63:610-8; PMID:12209908; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Burns 2000; 26:265-70; PMID: 10741593; http://dx.doi.org/10.1016/S0305-4179(99) 00133-3 14.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
J Biomed Mater Res A 2008; 87:933- 43; PMID:18228269; http://dx.doi.org/10.1002/jbm.,Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Carbohydr Polym 2003; 53:225-31; http://dx.doi.org/10.1016/S0144- 8617(03)00108-5 17.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Macromol Biosci 2004; 4:811-9; PMID:15468275; http://dx.doi.org/10.1002/mabi.200300100 18.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Polym Adv Technol 2008; 19:6-14; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
J Mater Sci Mater Med 2012; 23:137-48; PMID: 22105221; http://dx.doi.org/10.1007/s10856-011-4471-8 22.,Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
"Cell Mol Bioeng 2008; 1:93-102; PMID: 19890444; http://dx.doi.org/10.1007/s12195-008-0014-x 2 4 .C h i uC T ,L e eJ S ,C h uC S ,C h a n gY P ,W a n gY J .",OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
J Mater Sci Mater Med 2008; 19:2503-13; PMID: 18266085; http://dx.doi.org/10.1007/s10856-008-3389-2 25.,Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Biomaterials 1996; 17:1639-43; PMID:8842370; http://dx.doi.org/10.1016/0142-9612(95)00324-X 26.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
Mat Sci Eng C-Bio S 2007; 27:469-78; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
J Mater Sci Mater Med 2007; 18:1369-75; PMID: 17277984; http://dx.doi.org/10.1007/s10856-007-0121-6 28.,Non-OADS,/arxiv_data1/oa_pdf/00/cf/biom-2-321.PMC3568116.pdf
"www.landesbioscience.com Biomatter 329Biomatter 2:4, 329–339; October/November/December 2012; © 2012 Landes Bioscience SpeciaL  FOcuS  RepOR t SpeciaL  FOcuS  RepOR t *Correspondence to: Pedro Fonte; Email: pedrofonte86@gmail.com Submitted: 12/05/12; Revised: 12/12/12; Accepted: 12/13/12http://dx.doi.org/10.4161/biom.23246Introduction Therapeutic protein delivery may occur under unfavorable stress  conditions, leading to aggregation or denaturation with unpre - dictable side effects, such as toxicity or immunogenicity.1 To  mitigate these problems, proteins are often encapsulated into nanoparticles (NP).",Non-OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int J Pharm 1998; 164:103-11;  http://dx.doi.org/10.1016/S0378-5173(97)00404-3.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Fluoresc 1993; 3:215-7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Chem Eng Sci 2000; 55:2223-36; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Eur J Pharm Biopharm  2011; 78:248-63; PMID:21426937; http://dx.doi.org/10.1016/j.ejpb.2011.03.010.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Pharm Pharmacol  2005; 57:699-707; PMID:15969924; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int J Pharm 2002; 233:239-52;  PMID:11897428; http://dx.doi.org/10.1016/S0378- 5173(01)00944-9.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Biophys J 1996; 71:2087- 93; PMID:8889183; http://dx.doi.org/10.1016/ S0006-3495(96)79407-9.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Biophys J 1996; 71:2022-32;  PMID:8889176; http://dx.doi.org/10.1016/S0006- 3495(96)79400-6.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Colloids Surf B Biointerfaces  2003; 27:159-68; http://dx.doi.org/10.1016/S0927-7765(02)00053-X.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int J Pharm 2006; 327:153-9; PMID:16935443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Biomed Chromatogr  2006; 20:898-903; PMID:16389645; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Microencapsul 2005;  22:593-601; PMID:16401576; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Adv Drug Deliv Rev  2006; 58:1688-713; PMID:17118485; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int  J Pharm 2008; 350:14-26; PMID:18162341; http://dx.doi.org/10.1016/j.ijpharm.2007.11.012.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Eur J Pharm Biopharm 2012; 81:57-63; PMID:22306701;  http://dx.doi.org/10.1016/j.ejpb.2012.01.009.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Biomed Nanotechnol 2009;  5:45-53; PMID:20055105; http://dx.doi.org/10.1166/ jbn.2009.022.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Drug Delivery and  T ranslational Research 2011; 1:299-308; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Crit  Rev Ther Drug Carrier Syst 2004; 21:387-422;  PMID:15719481; http://dx.doi.org/10.1615/ CritRevTherDrugCarrierSyst.v21.i5.20.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Control Release 1998; 50:31-40; PMID:9685870; http://dx.doi.org/10.1016/S0168-3659(97)00106-5.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Control Release  2002; 82:105-14; PMID:12106981; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Expert Opin Drug Deliv  2005; 2:1029-37; PMID:16296807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Control Release 2012; 161:505- 22; PMID:22353619; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Colloids Surf B Biointerfaces 2010; 75:1-18;  PMID:19782542; http://dx.doi.org/10.1016/j.col- surfb.2009.09.001.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Eur J Pharm Biopharm 2000; 50:379-87; PMID:11072195; http://dx.doi.org/10.1016/S0939- 6411(00)00125-9.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
J Microencapsul  1997; 14:777-87; PMID:9394259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Biomaterials  1996; 17:2191-7; PMID:8922605; http://dx.doi.org/10.1016/0142-9612(96)00049-X.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int J Pharm 2000; 203:1-60;  PMID:10967427; http://dx.doi.org/10.1016/S0378-5173(00)00423-3.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int J Pharm 2003; 266:51-60;  PMID:14559393; http://dx.doi.org/10.1016/S0378- 5173(03)00380-6.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Eur J  Pharm Biopharm 2009; 72:428-37; PMID:19462479;  http://dx.doi.org/10.1016/j.ejpb.2009.02.002.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Eur J Pharm Biopharm 1998;  45:221-9; PMID:9653626; http://dx.doi.org/10.1016/S0939-6411(98)00004-6.,Non-OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
Int J Pharm  2005; 301:161-9; PMID:16026945; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/f6/biom-2-329.PMC3568117.pdf
"The work presented here is part of the OntoGene project (http://www.ontogene.org/), which aims at improving bio- medical text mining through the usage of advanced natural ............................................................................................................................... ............................................................................................................................... ............................... /C223The Author(s) 2013.",Non-OADS,/arxiv_data1/oa_pdf/a5/93/bas053.PMC3568389.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/93/bas053.PMC3568389.pdf
"In the OntoGene textmining pipeline, sentence and token boundaries of theenriched abstracts are identified using the LingPipe frame- work (more information can be found at http://alias-i.com/lingpipe).",OADS,/arxiv_data1/oa_pdf/a5/93/bas053.PMC3568389.pdf
"Informationderived from the OntoGene pipeline, and from the ranking process described in the previous section, is then added as additional features in order to improve the baselineranking generated by the IR system [the integration ofthe various components is performed using mainly JRuby(http://jruby.org/), through which the Lucene API isaccessed].",OADS,/arxiv_data1/oa_pdf/a5/93/bas053.PMC3568389.pdf
http://www.umiacs.umd.edu/~hal/docs/daume04cg-bfgs.,Non-OADS,/arxiv_data1/oa_pdf/a5/93/bas053.PMC3568389.pdf
pdf and http://hal3.name/megam/.,OADS,/arxiv_data1/oa_pdf/a5/93/bas053.PMC3568389.pdf
"Database URL: http://www.ebi.ac.uk/patentdata/nr/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction The patent data are a valuable resource, not only for the intellectual property world but also for the scientific com- munity ( 1,2).",OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
"Proprietary data also exist from the commercial sector providing alternative annotations of patent sequence data, such as GENESEQTM(Thomson Reu- ters, http://thomsonreuters.com/products_services/science/ science_products/a-z/geneseq/), GQ-PAT (GenomeQuest,http://wiki.genomequest.com/index.php/GQ_Pat), USGENE (SequenceBase, http://www.sequencebase.com/usgene- sequences-database), but these require commercial li- censes, which impose usage restrictions on the data.",OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
"Sequence submissions by the inventors can be made as part of the patent application process using tools, such as BISSAP (http://www.epo.org/bissap/), an application developed to facilitate the creation of sequence listings (WIPO ST.25 and proposed XML format) for patent applica- tions containing biological sequences by the EPO in collab- oration with national patent offices and the EMBL-EBI.",OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
"The patent equivalents database is also developed to provide patent family information extracted from the OPS service for the sequences collected in this study ( Figure 2 b).In patents, a right of priority is a time-limited right trig- gered by the first filing of a patent application; a patent family refers to several patent applications or publications for an individual invention, claiming exactly the same pri- ority or priorities; all of these family equivalents are related to each other by common priority numbers and associated priority dates (http://www.epo.org/searching/essentials/ patent-families/about.html).",OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
The database format is detailed in the user manual (http://www.ebi.ac.uk/patent- data/doc/Family_equivalents_database_v3.pdf).,OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
The annotation format is detailed in the user manual (http://www.ebi.ac.uk/patentdata/doc/Non- redundant_databases-user_manual_v3.pdf).,OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
"The data coverage is slightly larger than the commercial patent sequence database GENESEQ, which included >27 million sequences from >150 000 patents in Oct 2012 (http://thomsonreuters.com/products_services/sci ence/science_products/a-z/geneseq/).",OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
The NR patent sequence databases can be accessed through four major routes ( Figure 2 c) at EMBL-EBI: (1) The flat files can be downloaded through the data- bases website (http://www.ebi.ac.uk/patentdata/nr/) and through the FTP site (ftp://ftp.ebi.ac.uk/pub/data bases/patentdata/).,OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
(2) The EMBL-like formatted annotation data can be retrieved on a per-accession through the Dbfetch/ WSDbfetch service (http://www.ebi.ac.uk/Tools/ dbfetch/dbfetch/) and also through the SRS server (http://srs.ebi.ac.uk/).,OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
"(3) Sequence similarity/homology searches including FASTA ( 11), BLAST ( 12,13) and PSI-Search ( 14) against the databases are available through the web form submissions (http://www.ebi.ac.uk/Tools/sss/) and also through the corresponding EMBL-EBI SOAP/REST web services ( 15).",OADS,/arxiv_data1/oa_pdf/f3/0e/bat005.PMC3568390.pdf
"TCC% cutoffs have been validated individ- ually for diagnostic gene expression applications: 75 % forthe classifier PAM50 ( http://www.aruplab.com/guides/ug/ tests/2004700.jsp ), 50 % for Oncotype DX ( http://www.on- cotypedx.com/en-US/Breast.aspx ), or 30 % for EndoPredict [18].",Non-OADS,/arxiv_data1/oa_pdf/5d/d6/428_2012_Article_1357.PMC3568476.pdf
"The Korean Academy of Conservative Dentistry.187This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A case report as an inductive approach As disciplines of clinical dentistry, operative dentistry, restorative dentistry, and endodontics which belong to the scope  of Restorative Dentistry and Endodontics (RDE) deal with anatomic structures, hard and soft tissue diseases and their  pathologies, clinical protocols, restorative materials and endodontic medicaments, and tissue reactions against biomaterials  or pathogens.",Non-OADS,/arxiv_data1/oa_pdf/a9/2d/rde-37-187.PMC3568636.pdf
"4, 2012ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.4.187 Editorial",Non-OADS,/arxiv_data1/oa_pdf/a9/2d/rde-37-187.PMC3568636.pdf
"The Korean Academy of Conservative Dentistry.188This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Chemical characteristics of mineral trioxide aggregate and its hydration reaction Mineral trioxide aggregate (MTA) was developed in early 1990s and has been successfully used for root perforation repair, root end filling, and one-visit apexification.",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
"Chang SW, Center for Health  Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea  *Correspondence to  Seok-Woo Chang, DDS, MSD, PhD.Assistant Professor, Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, Korea 135-710TEL, +82-2-3410-2420; FAX, +82-2-3410-0038; E-mail, swc2007smc@gmail.comReview article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.188 ※ This study was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education,  Science and Technology (MEST) (2011-0014231) and also supported by Samsung Biomedical Research Institute grant (SBRI C-B1-310-1), and Samsung  Medical Center Clinical Research Development Program grant (CRS-111-14-1).",Non-OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
And  it was postulated that the formation of calcium hydroxide Hydration reaction of mineral trioxide aggregate http://dx.doi.org/10.5395/rde.2012.37.4.188,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
(b) (a)Chang SW http://dx.doi.org/10.5395/rde.2012.37.4.188,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
Aust Endod Hydration reaction of mineral trioxide aggregate http://dx.doi.org/10.5395/rde.2012.37.4.188,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
"Bird DC, Komabayashi T, Guo L, Opperman LA, Spears Chang SW http://dx.doi.org/10.5395/rde.2012.37.4.188",OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
Hydration reaction of mineral trioxide aggregate http://dx.doi.org/10.5395/rde.2012.37.4.188,Non-OADS,/arxiv_data1/oa_pdf/2c/d8/rde-37-188.PMC3568637.pdf
"The Korean Academy of Conservative Dentistry.194This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Evaluation of the rat tissue reaction to experimental new resin cement and mineral trioxide aggregate cement Objectives:  New resin cement (NRC) has been developed as a root repairing material  and the material is composed of organic resin matrix and inorganic powders.",Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
"seoul.kr  ※This study was supported by a grant (2010-359) from the Asan Institute for Life Sciences, Seoul, Korea.Research article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.194",Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.194toluidine catalyst,Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.194,Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
(a) (b) (c) (d) (e) (f)Tissue toxicity of new resin cement http://dx.doi.org/10.5395/rde.2012.37.4.194,Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.194,Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
A comparative study of the biocompatibility of three root-Tissue toxicity of new resin cement http://dx.doi.org/10.5395/rde.2012.37.4.194,Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.194,Non-OADS,/arxiv_data1/oa_pdf/68/1b/rde-37-194.PMC3568638.pdf
"The Korean Academy of Conservative Dentistry.201This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A survey of experience-based preference of Nickel-Titanium rotary files and incidence of fracture among general dentists Objectives:  The purpose was to investigate the preference and usage technique of NiTi  rotary instruments and to retrieve data on the frequency of re-use and the estimated incidence of file separation in the clinical practice among general dentists.",Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
"Associate Professor, Department  of Conservative Dentistry, Pusan  National University School of Dentistry, 49, Busandaehak-ro, Mulgeum-eup, Yangsan, Korea 626-870TEL, +82-55-360-5222; FAX, +82-55-360-5214; E-mail, golddent@ pusan.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.4.201 ※This work was supported by a 2-Year Research Grant of Pusan National University.",Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.201,Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
Preference of NiTi rotary file instrumentation  technique according to experience CareerInstrumentation technique (%) Crown-down Sequential Hybrid Less than 6 mon 54.2 27.0 18.8 6 mon to 2 yr 33.3 30.0 36.7 More than 2 yr 40.9 23.2 35.9 Total 44.6 29.3 26.0 http://dx.doi.org/10.5395/rde.2012.37.4.201,Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.201,Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
J Endod 2004;30:432-435.Preference and fracture incidence http://dx.doi.org/10.5395/rde.2012.37.4.201,Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.201,Non-OADS,/arxiv_data1/oa_pdf/fc/4b/rde-37-201.PMC3568639.pdf
"The Korean Academy of Conservative Dentistry.207This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of chlorhexidine application on the bond strength of resin core to axial dentin in endodontic cavity Objectives:  This study evaluated the influence of chlorhexidine (CHX) on the  microtensile bonds strength (μTBS) of resin core with two adhesive systems to dentin in endodontic cavities.",Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
"Kim YH; Shin DH, Department of  Conservative Dentistry, Dankook University College of Dentistry and Institute of Dental Science, Cheonan, Korea*Correspondence to Dong-Hoon Shin, DDS, PhD.Professor, Department of Conservative Dentistry, Dankook University College of Dentistry and Institute of Dental Science, San 7-1, Shinbu-dong, Dongnam-gu, Cheonan, Korea 330-716TEL, +82-41-550-1965; FAX, +82-41-553-1258; E-mail, donyshin@dankook.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.207",Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
"Restorative procedure All the endodontic cavities were submitted to the bonding  protocols using two-step total-etch adhesive system (Adper  Single Bond 2, 3M ESPE, St. Paul, MN, USA), two-step self-Kim YH and Shin DH http://dx.doi.org/10.5395/rde.2012.37.4.207",Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.207,Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
"CHX, Chlorhexidine digluconate; μTBS, Microtensile bond strength.pink yellow pink yellowsky bluesky blueKim YH and Shin DH http://dx.doi.org/10.5395/rde.2012.37.4.207",Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.207,Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
"Conclusions Within the limitations of this in vitro study, 2% CHX  application for 15 seconds proved to alleviate the decrease Kim YH and Shin DH http://dx.doi.org/10.5395/rde.2012.37.4.207",Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
Effect of resin primer solvents and surface  http://dx.doi.org/10.5395/rde.2012.37.4.207,Non-OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
Kim YH and Shin DH http://dx.doi.org/10.5395/rde.2012.37.4.207,OADS,/arxiv_data1/oa_pdf/33/db/rde-37-207.PMC3568640.pdf
"The Korean Academy of Conservative Dentistry.215This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Influence of glide path on the screw-in effect and torque of nickel-titanium rotary files in simulated resin root canals Objectives:  The purpose of this study was to investigate the screw-in effect and  torque generation depending on the size of glide path during root canal preparation.",Non-OADS,/arxiv_data1/oa_pdf/6f/dd/rde-37-215.PMC3568641.pdf
"Professor, School of Mechanical Engineering, Yeungnam University 214-1, Dae-dong, Gyeongsan, Korea 712-749TEL, +82-53-810-3538; FAX, +82-53-810-4627; E-mail, pss@ynu.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.215 ※This research was supported by Kyungpook National University Research Fund, 2011.",Non-OADS,/arxiv_data1/oa_pdf/6f/dd/rde-37-215.PMC3568641.pdf
(b) (a)(c) (b) (a)Ha JH and Park SS http://dx.doi.org/10.5395/rde.2012.37.4.215,OADS,/arxiv_data1/oa_pdf/6f/dd/rde-37-215.PMC3568641.pdf
4 2 0Screw-in effect (N) 0      20      40     60     80    100   120    140   160    180   200  Sec18 16 14 12 10 86420-2 Torque (Nmm)4 2 0Screw-in effect (N) 0      20      40     60     80    100   120    140   160   180   200  Sec18 16 14 12 10 8 6 42 0 -2 Torque (Nmm) 4 2 0Screw-in effect (N) 0      20      40     60     80    100   120    140   160    180   200  Sec18 16 14 12108 6 420-2 Torque (Nmm)4 2 0Screw-in effect (N) 0      20     40     60     80    100   120    140   160    180   200  Sec18 16 14121086420-2 Torque (Nmm)(c)(a) (d)(b) http://dx.doi.org/10.5395/rde.2012.37.4.215,Non-OADS,/arxiv_data1/oa_pdf/6f/dd/rde-37-215.PMC3568641.pdf
"Maximum screw-in effect and torque Size of glide path #13 #15 #18 #20 Screw-in effect (N) 3.50 (0.43)a3.48 (0.55)a3.25 (0.61)a2.80 (0.13)b Torque (Ncm) 1.86 (0.34)a1.65 (0.32)a,b1.43 (0.46)b,c1.29 (0.12)c Different superscript letters indicate significant difference between groups in horizontal row (p < 0.05).The numbers in the parentheses are standard deviations.Ha JH and Park SS http://dx.doi.org/10.5395/rde.2012.37.4.215",Non-OADS,/arxiv_data1/oa_pdf/6f/dd/rde-37-215.PMC3568641.pdf
J Endod 2005;31:120-123.Influence of glide path on screw-in effect http://dx.doi.org/10.5395/rde.2012.37.4.215,OADS,/arxiv_data1/oa_pdf/6f/dd/rde-37-215.PMC3568641.pdf
"The Korean Academy of Conservative Dentistry.220This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A comparison of the shaping ability of reciprocating NiTi instruments in simulated curved canals Objectives:  The study was to compare the shaping ability of Reciproc (VDW) and  WaveOne (Dentsply Maillefer) instruments compared with ProTaper, Profile and hand instrument during the preparation of simulated root canals.",Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
"Yoo YS; Cho YB, Department of  Conservative Dentistry, Dankook  University College of Dentistry,  Cheonan, Korea *Correspondence to  Yong-Bum Cho, DDS, PhD.Professor, Department of  Conservative Dentistry, Dankook  University, College of Dentistry, San  7-1, Shinbu-dong, Dongnam-gu,  Cheonan, Korea 330-716TEL, +82-41-550-1966; FAX, +82- 41-553-1258; E-mail, raindrop@ dku.eduResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.220",Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
(a)  (b)Shaping ability of reciprocating instruments http://dx.doi.org/10.5395/rde.2012.37.4.220,Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
The loss of working length was determined Yoo YS and Cho YB http://dx.doi.org/10.5395/rde.2012.37.4.220,OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
Shaping ability of reciprocating instruments http://dx.doi.org/10.5395/rde.2012.37.4.220,Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
500 450 400 350300250 200 150100 50 0Amount of removed resin (μm ) 1        2       3        4      5        6        7       8        9       10 Level (mm) Inner side of the curveReciproc  Waveone  Protaper  Profile  K-file 400 350300250 200 150100 50 0Amount of removed resin (μm ) 1        2       3        4      5        6        7       8        9       10 Level (mm) Outer side of the curveReciproc  Waveone  Protaper  Profile  K-fileYoo YS and Cho YB http://dx.doi.org/10.5395/rde.2012.37.4.220,Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
Loss of working length (mm) after canal preparation Instrument Reciproc Waveone ProTaper ProFile K file Loss of working length 0.36 (0.08) 0.43 (0.26) 0.58 (0.26) 0.41 (0.16) 0.30 (0.18) The numbers in the parentheses are standard deviations.Shaping ability of reciprocating instruments http://dx.doi.org/10.5395/rde.2012.37.4.220,Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79:492-496.Yoo YS and Cho YB http://dx.doi.org/10.5395/rde.2012.37.4.220,Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
Shaping ability of reciprocating instruments http://dx.doi.org/10.5395/rde.2012.37.4.220,Non-OADS,/arxiv_data1/oa_pdf/c5/24/rde-37-220.PMC3568642.pdf
"The Korean Academy of Conservative Dentistry.228This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Invasive cervical resorption: treatment challenges Invasive cervical resorption is a relatively uncommon form of external root resorption.",Non-OADS,/arxiv_data1/oa_pdf/21/6a/rde-37-228.PMC3568643.pdf
"Kim Y; Lee CY; Kim ES; Roh BD,  Department of Conservative  Dentistry, Yonsei University College  of Dentistry, Seoul, Korea *Correspondence to  Byoung-Duck Roh, DDS, MSD, PhD.Professor, Department of  Conservative Dentistry, Yonsei  University College of Dentistry, 50  Yonsei-Ro, Seodaemun-gu, Seoul,  Korea 120-752TEL, +82-2-2228-8701; FAX, +82- 2-313-7575; E-mail, operatys16@ yuhs.acCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.228",Non-OADS,/arxiv_data1/oa_pdf/21/6a/rde-37-228.PMC3568643.pdf
(a) (b) http://dx.doi.org/10.5395/rde.2012.37.4.228,Non-OADS,/arxiv_data1/oa_pdf/21/6a/rde-37-228.PMC3568643.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.228,Non-OADS,/arxiv_data1/oa_pdf/21/6a/rde-37-228.PMC3568643.pdf
J Endod 2008;34:394-407. http://dx.doi.org/10.5395/rde.2012.37.4.228,OADS,/arxiv_data1/oa_pdf/21/6a/rde-37-228.PMC3568643.pdf
"The Korean Academy of Conservative Dentistry.232This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Hypoesthesia after IAN block anesthesia with lidocaine: management of mild to moderate nerve injury Hypoesthesia after an inferior alveolar nerve (IAN) block does not commonly occur, but some cases are reported.",Non-OADS,/arxiv_data1/oa_pdf/a3/1e/rde-37-232.PMC3568644.pdf
"Moon S; Lee SJ; Kim E; Lee CY,  Department of Conservative  Dentistry, Yonsei University  College of Dentistry, Seoul, Korea *Correspondence to  Chan-Young Lee, DDS, MSD, PhD.Professor, Department of  Conservative Dentistry, Yonsei  University College of Dentistry,  50 Yonsei-ro, Seodaemun-gu,  Seoul, Korea 120-752TEL, +82-2-2228-8701; FAX,  +82-2-313-7575; E-mail,  CHANYOUNGL@yuhs.acCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.232",Non-OADS,/arxiv_data1/oa_pdf/a3/1e/rde-37-232.PMC3568644.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.232,Non-OADS,/arxiv_data1/oa_pdf/a3/1e/rde-37-232.PMC3568644.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.232,Non-OADS,/arxiv_data1/oa_pdf/a3/1e/rde-37-232.PMC3568644.pdf
Int J Prosthodont 2010;23:342-346. http://dx.doi.org/10.5395/rde.2012.37.4.232,OADS,/arxiv_data1/oa_pdf/a3/1e/rde-37-232.PMC3568644.pdf
"The Korean Academy of Conservative Dentistry.236This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Non-destructive management of white spot lesions by using tooth jewelry Although several methods including composite resin restoration and microabrasion have been used for management of white spot lesion, tooth jewelry can be considered as another noninvasive option.",Non-OADS,/arxiv_data1/oa_pdf/2c/dc/rde-37-236.PMC3568645.pdf
"Kim HJ; Karanxha L; Park SJ,  Department of Conservative Dentistry, Wonkwang University School of Dentistry, Iksan, Korea*Correspondence to Su-Jung Park, DDS, MSDAssistant Professor, Department of Conservative Dentistry, Wonkwang University School of Dentistry, 895, Moowang-ro, Iksan, Korea 570-749TEL, +82-63-850-6930; FAX, 82-63-859-2932; E-mail, conspsj@wonkwang.ac.krCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.236 ※This study was supported by Wonkwang University in 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/dc/rde-37-236.PMC3568645.pdf
Petroleum jelly Tooth jewelry http://dx.doi.org/10.5395/rde.2012.37.4.236,Non-OADS,/arxiv_data1/oa_pdf/2c/dc/rde-37-236.PMC3568645.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.236,Non-OADS,/arxiv_data1/oa_pdf/2c/dc/rde-37-236.PMC3568645.pdf
J Am Dent Assoc 1994;125: 1219-1226. http://dx.doi.org/10.5395/rde.2012.37.4.236,Non-OADS,/arxiv_data1/oa_pdf/2c/dc/rde-37-236.PMC3568645.pdf
"The Korean Academy of Conservative Dentistry.240This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Considerations during crown reattachment procedure over the pulpal exposure: case report Crown reattachment is the most conservative treatment which can be used to restore fractured tooth, presumably with sufficient strength, while maintaining original contour, incisal translucency, and reducing chair time and cost.",Non-OADS,/arxiv_data1/oa_pdf/d3/81/rde-37-240.PMC3568646.pdf
"1Kim B; Song MJ; Shin SJ; Park  JW, Department of Conservative Dentistry, Gangnam Severance Dental Hospital, Yonsei University College of Dentistry, Seoul, Korea 2Lee Y, Department of Conservative  Dentistry, Yonsei University Wonju College of Medicine, Wonju, Korea*Correspondence to Jeong-Won Park, DDS, PhD.Associate professor, Department of Conservative Dentistry, Yonsei University College of Dentistry, 712 Unju-ro, Gangnam-gu, Seoul, Korea 135-720TEL, +82-2-2019-1350; FAX, +82-2-3463-4052; E-mail, pjw@yuhs.acCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.240",Non-OADS,/arxiv_data1/oa_pdf/d3/81/rde-37-240.PMC3568646.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.240,Non-OADS,/arxiv_data1/oa_pdf/d3/81/rde-37-240.PMC3568646.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.240,Non-OADS,/arxiv_data1/oa_pdf/d3/81/rde-37-240.PMC3568646.pdf
(a) (b) (c) http://dx.doi.org/10.5395/rde.2012.37.4.240,Non-OADS,/arxiv_data1/oa_pdf/d3/81/rde-37-240.PMC3568646.pdf
http://dx.doi.org/10.5395/rde.2012.37.4.240,Non-OADS,/arxiv_data1/oa_pdf/d3/81/rde-37-240.PMC3568646.pdf
"The Korean Academy of Conservative Dentistry.245This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1) Features of samples from normal populations Various parametric tests make assumptions of the normal distribution, including t -test,  analysis of variance (ANOVA), correlation, and regression.",Non-OADS,/arxiv_data1/oa_pdf/69/68/rde-37-245.PMC3568647.pdf
Open lecture on statistics ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.245 Statistical notes for clinical researchers: assessing normal distribution (1) Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/69/68/rde-37-245.PMC3568647.pdf
– 21.7292  N = 100Histogram Normal Q-Q plot of YFrequency Expected normal20 15 10 5 0 4 20 -2 -4 60.00     80.00    100.00    120.00    40.00 40          60           80         100         120         140        160   Y Observed valueKim HY http://dx.doi.org/10.5395/rde.2012.37.4.245,OADS,/arxiv_data1/oa_pdf/69/68/rde-37-245.PMC3568647.pdf
Dev = 19.72003  N = 500Histogram Normal Q-Q plot of YFrequency Expected normal60 5040302010 0 3 2 1 0 -1-2-3 40.00   60.00   80.00  100.00  120.00   140.00 20        40         60        80       100       120       140      160 Y Observed value http://dx.doi.org/10.5395/rde.2012.37.4.245,OADS,/arxiv_data1/oa_pdf/69/68/rde-37-245.PMC3568647.pdf
"Y 0.044 500 0.020 0.993 500 0.029 a, Lilliefors significance correct.Kim HY http://dx.doi.org/10.5395/rde.2012.37.4.245",OADS,/arxiv_data1/oa_pdf/69/68/rde-37-245.PMC3568647.pdf
"The Korean Academy of Conservative Dentistry.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.‘Wet or Dry tooth surface?’ - for self-adhesive resin cementReaders' forum ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.4.249 Does the dryness of tooth surface influence the bonding efficacy of self-adhesive resin cement?",Non-OADS,/arxiv_data1/oa_pdf/c2/7f/rde-37-249.PMC3568648.pdf
J Am Dent Assoc 1980; 100:34-38. http://dx.doi.org/10.5395/rde.2012.37.4.249,Non-OADS,/arxiv_data1/oa_pdf/c2/7f/rde-37-249.PMC3568648.pdf
Available  from: http://www.schizophreniaguidelines.co.uk/.,Non-OADS,/arxiv_data1/oa_pdf/c9/9d/cpn-9-17.PMC3568650.pdf
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.,Non-OADS,/arxiv_data1/oa_pdf/54/07/TONEUJ-7-4.PMC3568883.pdf
"[15] N. Yoder, “PeakFinder”, Internet: http://www.mathworks.com- /matlabcentral/fileexchange/25500, Jun.14, 2011 [Oct. 20 2012].",Non-OADS,/arxiv_data1/oa_pdf/06/ad/TOBEJ-7-1.PMC3568887.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/ad/TOBEJ-7-1.PMC3568887.pdf
Available  from http://kostat.go.kr/po rtal/korea/index.action.,Non-OADS,/arxiv_data1/oa_pdf/f6/70/cpn-9-91.PMC3569078.pdf
AlzGene website (http://www.alzgene.org) 33)  is a database with continuous ly updated list of genes asso- ciating with AD.,OADS,/arxiv_data1/oa_pdf/8c/ec/cpn-9-54.PMC3569084.pdf
"Thanks to a collaboration with the Brain NetEurope  (http://www.brainnet-europe.org) and to the kind compre-hension of the donors and their families, the above de-",Non-OADS,/arxiv_data1/oa_pdf/2c/43/cpn-9-95.PMC3569116.pdf
"The black boxes show the differenti ally expressed enzymes and metab olites revealed by proteomics  in the glycolysis found in SCZ brain tissue (Illustration by KE GG - http://www.genome.jp/kegg).37) HK, hexokinase; ALDOC, fructose-  bisphosphate aldolase C; TPI1, triosephosphate isomerase; GAPDH , glyceraldehyde-3-phosphate dehydrogenase; PGK1, phosphoglycer ate  kinase 1; PGAM1, phosphoglycerate mutase 1; ENO2, gamma-enolase ; PKM1, pyruvate kinase isozymes M1/M2; DLD, dihydrolipoyl  dehydrogenase, mitochondrial.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/cpn-9-95.PMC3569116.pdf
Available from: http://www.child-developmentinfo.com/learning/ learning_disabilities.shtml 4.,Non-OADS,/arxiv_data1/oa_pdf/1a/67/cpn-10-105.PMC3569149.pdf
Statistical Analysis SNPStats (http://bioinfo.iconcologia.net/index.,OADS,/arxiv_data1/oa_pdf/3a/b9/cpn-10-88.PMC3569151.pdf
Sample Power  The power of the sample size was estimated using a ge- netic power calculator (http://pngu.mgh.harvard.edu/~purcell/  gpc).,OADS,/arxiv_data1/oa_pdf/3a/b9/cpn-10-88.PMC3569151.pdf
*Control subjects in this study (http://www.ncbi.nlm.nih.gov/pr ojects/SNP).,Non-OADS,/arxiv_data1/oa_pdf/3a/b9/cpn-10-88.PMC3569151.pdf
"125Review http://dx.doi.org/10.9758/cpn.2012.10.3.125 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):125-135 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/1d/cpn-10-125.PMC3569160.pdf
" Original Article http://dx.doi.org/10.9758/cpn.2012.10.3.163 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):163-167 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology 163 This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/14/cpn-10-163.PMC3569161.pdf
"180 This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Original Article http://dx.doi.org/10.9758/cpn.2012.10.3.180 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):180-184 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology                       Received:  May 2, 2012/ Revised:  July 4, 2012 Accepted:  July 27, 2012 Address for correspondence: Kyoung-Uk Lee, MD, PhD Department of Psychiatry, Uijeongbu St. Mary's Hospital, The  Catholic University of Korea College of Medicine, 271, Cheonbo- ro,  Uijeongbu 480-717, KoreaTel: +82-31-820-3609, Fax: +82-31-847-3630E-mail: mindcure@catholic.ac.krCharacteristics of Drug Overdose  in Young Suicide Attempters Yong-Sil Kweon1, Sunyoung Hwang1, Bora Yeon1, Kyoung Ho Choi2, Youngmin Oh2, Hae-Kook Lee1, Chung Tai  Lee1, Kyoung-Uk Lee1 Departments of 1Psychiatry and 2Emergency Medicine, Uijeongbu St. Mary's Hospital, The Catholic  University of Korea College of Medicine,  Uijeongbu, Korea Objective: Few studies have focused on the characteristic features of drug  overdose in children and adolescents who have  attempted suicide in Korea.",Non-OADS,/arxiv_data1/oa_pdf/ac/e2/cpn-10-180.PMC3569162.pdf
"168 This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Original Article http://dx.doi.org/10.9758/cpn.2012.10.3.168 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):168-179 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology                       Received:  April 16, 2012/ Revised:  May 15, 2012 Accepted:  May 17, 2012 Address for correspondence: Ming Li, PhD Department of Psychology, University of Nebraska-Lincoln, 238  Burnett Hall, Lincoln, NE 68588-0308, USATel: +1-402-472-3144, Fax: +1-402-472-4637E-mail: mli2@unl.eduIptakalim Preferentially Decreases Nicotine-induced Hyperlocomotion in Phen- cyclidine-sensitized Rats: A Potential Dual Action against Nicotine Addiction and Psychosis Nick Volf1, Gang Hu2, Ming Li1 1Department of Psychology, University of Nebraska-Lincoln, Linco ln, NE, USA, 2Jiangsu Key Laboratory of Neurodegeneration, Department  of Pharmacology, Nanjing Medic al University, Nanjing, China Objective:  Iptakalim is a putative ATP-sensitive potassium (K ATP) channel opener.",Non-OADS,/arxiv_data1/oa_pdf/d1/17/cpn-10-168.PMC3569163.pdf
"144 This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Review http://dx.doi.org/10.9758/cpn.2012.10.3.144 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):144-154 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology                       Received:  July 20, 2012/ Revised:  August 27, 2012 Accepted:  August 28, 2012 Address for correspondence: Preethi Premkumar, PhD Division of Psychology, Nottingham Trent University, Burton Str eet,  Nottingham NG1 4BU, United KingdomTel: +44-(0)115-848-4511, Fax: +44-(0)115-848-2390E-mail: Preethi.premkumar@ntu.ac.ukAre You Being Rejected or Excluded?",Non-OADS,/arxiv_data1/oa_pdf/3e/4b/cpn-10-144.PMC3569164.pdf
"155Original Article http://dx.doi.org/10.9758/cpn.2012.10.3.155 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):155-162 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/4f/cpn-10-155.PMC3569165.pdf
"136Review http://dx.doi.org/10.9758/cpn.2012.10.3.136 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):136-143 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/6f/cpn-10-136.PMC3569166.pdf
"185 This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Original Article http://dx.doi.org/10.9758/cpn.2012.10.3.185 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2012;10(3):185-189 Copyrightⓒ 2012, Korean College of Neuropsychopharmacology                       Received:  June 7, 2012/ Revised:  August 9, 2012 Accepted:  August 10, 2012 Address for correspondence: Shin-ya Watanabe, MD Department of Psychiatry, Course of Integrated Brain Sciences,  University of Tokushima School of Medicine, Kuramoto-cho 2-50-1 ,  Tokushima 770-8503, JapanTel: +81-86-633-7130, Fax: +81-86-633-7131E-mail: shinya550314@yahoo.co.jpAssociation Study of Fat-mass and Obesity-associated Gene and Body Mass  Index in Japanese Patients with Schizophrenia and Healthy Subjects Shin-ya Watanabe1, Jun-ichi Iga1, Shusuke Numata1, Masahito Nakataki1, Toshihito Tanahashi2, Mitsuo Itakura3,  Tetsuro Ohmori1 1Department of Psychiatry, Course of Integrated Brain Sciences, University of Tokushima School of Medicine, Tokushima, 2Division of  Gastroenterology, Department of Internal Medicine, Graduate Sch ool of Medicine, Kobe University, Kobe, 3Division of Genetic Information,  Institute of Genome Research, University of Tokushima, Tokushim a, Japan Objective: Fat-mass and obesity-associated (FTO) gene is known to be invol ved in the pathophysiology of obesity and a sin- gle-nucleotide polymorphism (SNP) rs9939609 of FTO gene is repe atedly confirmed to be associated with body mass index  (BMI) and obesity.",Non-OADS,/arxiv_data1/oa_pdf/33/cf/cpn-10-185.PMC3569167.pdf
"The Korean Academy of Conservative Dentistry.129This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Restorative Dentistry and Endodontics in Korea On a very hot summer day in 2012, Restorative Dentistry & Endodontics (RDE, www.rde.ac) changes its official language  from Korean to English in order to join and to contribute to the international society of specific dental professions.",Non-OADS,/arxiv_data1/oa_pdf/28/99/rde-37-129.PMC3569395.pdf
"When the related articles have been published in RDE, if you type in two keywords at the search window of the Google Scholar (English version, http://scholar.google.com), you can find the RDE articles, move to the KoreaMed Synapse (http://synapse.koreamed.org), and download the full text pdf files from the journal's homepage.",OADS,/arxiv_data1/oa_pdf/28/99/rde-37-129.PMC3569395.pdf
"3, 2012ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.129 Editorial",Non-OADS,/arxiv_data1/oa_pdf/28/99/rde-37-129.PMC3569395.pdf
"The Korean Academy of Conservative Dentistry.130This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Power density of various light curing units through resin inlays with modified layer thickness Objectives:  The purpose of this study was to enhance curing light penetration through  resin inlays by modifying the thicknesses of the dentin, enamel, and translucent layers.",Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
The authors are grateful to 3M ESPE Korea for supplying indirect lab composite materials in order to carry out this study.Research article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.130,Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.130,Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.130,Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
Elipar S10.Power density through layer thickness modified resin inlays http://dx.doi.org/10.5395/rde.2012.37.3.130,Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.130,Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
J Prosthet Power density through layer thickness modified resin inlays http://dx.doi.org/10.5395/rde.2012.37.3.130,Non-OADS,/arxiv_data1/oa_pdf/11/72/rde-37-130.PMC3569396.pdf
"The Korean Academy of Conservative Dentistry.136This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Minimizing the extra-oral time in autogeneous tooth transplantation: use of computer-aided rapid prototyping (CARP) as a duplicate model tooth Objectives:  The maintenance of the healthy periodontal ligament cells of the root  surface of donor tooth and intimate surface contact between the donor tooth and the recipient bone are the key factors for successful tooth transplantation.",Non-OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
"Lee SJ; Kim E, Microscope Center,  Department of Conservative Dentistry and Oral Science Research Center, Yonsei University College of Dentistry, Seoul, Korea*Correspondence to Euiseong Kim, DDS, MSD, PhD.Professor, Microscope Center, Department of Conservative Dentisty, Yonsei University College of Dentistry50 Yonsei-ro, Seodaemun-gu, Seoul,  Korea 120-752TEL, +82-2-2228-8701; FAX, +82-2-313-7575; E-mail, andyendo@yuhs.acResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.3.136 ※ This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of  Education, Science and Technology (2010-0021281).",Non-OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
(a) (b) (c) http://dx.doi.org/10.5395/rde.2012.37.3.136,Non-OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
DC 0.5 mm DA1.5 mmMC0.5 mm MA1.0 mmLee SJ & Kim E http://dx.doi.org/10.5395/rde.2012.37.3.136,OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
"Absolute difference (average ± SD) between real tooth, 3D CT image model, and CARP model (Unit; micrometer; n = 12) Between Crown Cervical Wet Dry Maxilla Mandible Total  RT and CTIM 199 ± 112 193 ± 122 181 ± 104 217 ± 125 181 ± 107 216 ± 122 199 ± 116 CTIM and CARP 153 ± 138 185 ± 166 174 ± 162 163 ± 145 176 ± 153 162 ± 154 169 ± 153 RT and CARP 263 ± 263 318 ± 309 298 ± 295 283 ± 282 327 ± 355 255 ± 194 291 ± 287 RT, real tooth; CTIM, computed tomography  image model; CARP, computer-aided rapid prototyping.Tooth transplantation using CARP model http://dx.doi.org/10.5395/rde.2012.37.3.136",Non-OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
Interrelation between alveolar bone and Lee SJ & Kim E http://dx.doi.org/10.5395/rde.2012.37.3.136,Non-OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
J Periodontal Res 1994;29:250-258.Tooth transplantation using CARP model http://dx.doi.org/10.5395/rde.2012.37.3.136,Non-OADS,/arxiv_data1/oa_pdf/45/8f/rde-37-136.PMC3569397.pdf
"The Korean Academy of Conservative Dentistry.142This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Analysis of gene expression during odontogenic differentiation of cultured human dental pulp cells Objectives:  We analyzed gene-expression profiles after 14 day odontogenic induction  of human dental pulp cells (DPCs) using a DNA microarray and sought candidate genes possibly associated with mineralization.",Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
"1Seo MS; Hwang KG, Department  of Dentistry, Hanyang University College of Medicine, Seoul, Korea 2Seo MS; Baek SH, Department  of Conservative Dentistry, Seoul National University School of  Dentistry, Seoul, Korea 3Kim H, Graduate School  of Biomedical Science and  Engineering, Hanyang University College of Medicine,, Seoul, Korea*Correspondence to Seung-Ho Baek, DDS, PhD.Professor, Department of Conservative Dentistry, Seoul National University School of Dentistry, 101, Daehag-ro, Jongro-gu, Seoul, Korea 110-768 TEL, +82-2-2072-3820; FAX, +82-2-747-0958; E-mail, shbaek@snu.ac.kr ※ This study was supported by Biostart Program from graduate school of biomedical science and engineering, Hanyang University.Research article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.142",Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
"Array signals were detected  using Amershamfluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) and scanned with an Il- http://dx.doi.org/10.5395/rde.2012.37.3.142",OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.142,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
Genes up-regulated on day 14 in odontogenic medium (over a five-fold change) RefSeq transcript Gene symbol Gene title Fold NM_000240.2 MAOA monoamine oxidase A 34.04 NM_139314.1 ANGPTL4 angiopoietin-like 4 17.63 NM_001647.2 APOD apolipoprotein D 15.34 NM_000584.2 IL8 interleukin 8 10.70 NM_001463.2 FRZB frizzled-related protein 10.51 NM_005841.1 SPRY1 sprouty homolog 1 9.81 NM_004117.2 FKBP5 FK506 binding protein 5 9.01 NM_001008539.2 SLC7A2 solute carrier family 7 8.90 NM_199161.1 SAA1 serum amyloid A1 7.84 NM_001039667.1 ANGPTL4 angiopoietin-like 4 7.15 NM_001007139.3 IGF2 insulin-like growth factor 2 6.64 NM_000956.2 PTGER2 prostaglandin E receptor 2 6.52 NM_005950.1 MT1G metallothionein 1G 6.44 NM_001003679.1 LEPR leptin receptor 6.42 NM_199327.1 SPRY1 sprouty homolog 1 6.33 NM_176870.2 MT1M metallothionein 1M 6.08 NM_001013642.2 TRNP1 TMF1-regulated nuclear protein 1 6.01 NM_000667.2 ADH1A alcohol dehydrogenase 1A 5.24Gene expression of human DPCs http://dx.doi.org/10.5395/rde.2012.37.3.142,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.142,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
Gene expression of human DPCs http://dx.doi.org/10.5395/rde.2012.37.3.142,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.142,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/rde-37-142.PMC3569398.pdf
"The Korean Academy of Conservative Dentistry.149This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Accuracy of Root ZX in teeth with simulated root perforation in the presence of gel or liquid type endodontic irrigant Objectives:  To evaluate the accuracy of the Root ZX in teeth with simulated root  perforation in the presence of gel or liquid type endodontic irrigants, such as saline, 5.25% sodium hypochlorite (NaOCl), 2% chlorhexidine liquid, 2% chlorhexidine gel, and RC-Prep, and also to determine the electrical conductivities of these endodontic irrigants.",Non-OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
"1Shin HS; Yang WK; Kim MR; Ko  HJ, Department of Conservative Dentistry, Ulsan University Asan Medical Center, Seoul, Korea 2Cho KM; Park SH; Kim JW,  Department of Conservative Dentistry, Gangneung-Wonju National University College of Dentistry, Gangneung, Korea*Correspondence to Jin-Woo Kim, DDS, PhDProfessor, Department of Conservative Dentistry, Gangneung-Wonju National University College of Dentistry,    7 Jukheon-gil, Gangneung, Korea 210-702TEL, +82-33-640-3189; FAX, +82-33-640-3102; E-mail, mendo7@gwnu.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.3.149",Non-OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.149,Non-OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.149,Non-OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.149,Non-OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
"Angwaravong O, Panitvisai P. Accuracy of an electronic Accuracy of Root ZX http://dx.doi.org/10.5395/rde.2012.37.3.149",OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.149,Non-OADS,/arxiv_data1/oa_pdf/f3/ae/rde-37-149.PMC3569399.pdf
"The Korean Academy of Conservative Dentistry.155This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of moisture and drying time on the bond strength of the one-step self-etching adhesive system Objectives:  To investigate the effect of dentin moisture degree and air-drying time  on dentin-bond strength of two different one-step self-etching adhesive systems.",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/rde-37-155.PMC3569400.pdf
"1Lee Y, Department of Conservative  Dentistry, Yonsei University Wonju College of Medicine, Wonju, Korea 2Park JW, Department of  Conservative Dentistry, Yonsei University College of Dentistry, Seoul, Korea*Correspondence to Jeong-Won Park, DDS, PhD.Associate Professor, Department of Conservative Dentistry, Yonsei University College of Dentistry, 146-92 Dogok-Gong, Gangnam-gu, Seoul, Korea 135-720TEL, +82-2-2019-1350; FAX, +82-2-3463-4052; E-mail, pjw@yuhs.acResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.3.155 ※ This research was supported by the grant of 2007 Yonsei university school of dentistry research funds (7-2007-0070).",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/rde-37-155.PMC3569400.pdf
"4-MET, 4-methacryloyloxyethyl trimellitate; UDMA, urethane dimethacrylate; DMA, dimethacrylate; 10-MDP, 10-methacryloxydecyl di-hydrogen phosphate; HEMA, 2-hydroxyethyl methacrylate; bis-GMA, 2,2 bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl] propane.Lee Y & Park JW http://dx.doi.org/10.5395/rde.2012.37.3.155",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/rde-37-155.PMC3569400.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.155,Non-OADS,/arxiv_data1/oa_pdf/fa/b9/rde-37-155.PMC3569400.pdf
ModelEstimated  coefficientStandard errorStandardized  Coefficientt value p value (constant) 3.594 1.864 1.947 0.054 Materials 5.055 0.806 0.249 6.273 0.000 Dentin wetness 2.381 0.806 0.117 2.954 0.004 Drying time(1*5) 12.564 0.987 0.593 12.729 0.000 Drying time(1*10) 21.325 0.987 0.990 21.606 0.000Lee Y & Park JW http://dx.doi.org/10.5395/rde.2012.37.3.155,Non-OADS,/arxiv_data1/oa_pdf/fa/b9/rde-37-155.PMC3569400.pdf
Dent Mater J 2006;25:120-124.Effect of moisture on one-step self-etching adhesive system http://dx.doi.org/10.5395/rde.2012.37.3.155,Non-OADS,/arxiv_data1/oa_pdf/fa/b9/rde-37-155.PMC3569400.pdf
"The Korean Academy of Conservative Dentistry.160This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The reduction methods of operator’s radiation dose for portable dental X-ray machines Objectives:  This study was aimed to investigate the methods to reduce operator’s  radiation dose when taking intraoral radiographs with portable dental X-ray machines.",Non-OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
"Cho JY; Han WJ, Department of  Oral and Maxillofacial Radiology,  Dankook University Colledge of  Dentistry, Cheonan, Korea *Correspondence to  Won-Jeong Han, DDS, MSD, PhD.Associate Professor, Department  of Oral & Maxillofacial Radiology,  Dankook University College  of Dentistry, 119 Dandae-ro,  Dongnam-gu, Cheonan, Korea 330-714 TEL, +82-41-550-1922; FAX, +82- 41-556-7127; E-mail, wjhan@ dankook.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.160 ※ This research was supported by a grant (11172KFDA528) from Korea Food and Drug Administration in 2011.",Non-OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.160,Non-OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
Operator’s radiation dose at hand level of operator was measured using short and long cones.Cho JY & Han WJ http://dx.doi.org/10.5395/rde.2012.37.3.160,OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
"*dose in µR means the average leakage and scattered radiation dose and standard deviation measured by 1,800 cc ionizing chamber.Operator’s radiation dose for portable dental X-ray machine  http://dx.doi.org/10.5395/rde.2012.37.3.160",Non-OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
"Available from: http://www.michigan.gov/lara/0,4601,7-154-35299_28142_3579-46448--,00.html (updated 2012 July 30).",Non-OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
Available from: http://www.odh.ohio.gov/~/media/ODH/ASSETS/Files/rules/final/37011-66/37011-66-06.ashx (updated 2012 July 30).,OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
Available from: http://apps.leg.wa.gov/wac/default.aspx?cite=246-225A&full=true#246-225A-085 (updated 2012 July 30).,OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
Available from: http://www.nifds.go.kr/nifds/01_about/about08.jsp?mode=view&article_no=4813&pager.offset=0&board_no=2 (updated 2012 July 30).,OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
Available from: http://aribex.com/portable-x-ray-machine/dental-x-ray-machine/nomad-x-ray/nomad-safety (update 2012 Jan 30).,Non-OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
Forensic Sci Int 2010;201:112-117.Cho JY & Han WJ http://dx.doi.org/10.5395/rde.2012.37.3.160,OADS,/arxiv_data1/oa_pdf/ae/ce/rde-37-160.PMC3569401.pdf
"The Korean Academy of Conservative Dentistry.165This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/7f/rde-37-165.PMC3569402.pdf
"Associate Professor, Department of  Conservative Dentistry, Kyungpook  National University School of  Dentistry, 2-188-1 Samduk-dong, Jung-gu, Daegu, Korea 700-412 TEL, +82-53-600-7601; FAX, +82- 53-426-8958; E-mail, wisekim@ knu.ac.krCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.165",Non-OADS,/arxiv_data1/oa_pdf/88/7f/rde-37-165.PMC3569402.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.165,Non-OADS,/arxiv_data1/oa_pdf/88/7f/rde-37-165.PMC3569402.pdf
(b)(a) http://dx.doi.org/10.5395/rde.2012.37.3.165,Non-OADS,/arxiv_data1/oa_pdf/88/7f/rde-37-165.PMC3569402.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.165,Non-OADS,/arxiv_data1/oa_pdf/88/7f/rde-37-165.PMC3569402.pdf
World J Orthod 2007;8:13-18. http://dx.doi.org/10.5395/rde.2012.37.3.165,OADS,/arxiv_data1/oa_pdf/88/7f/rde-37-165.PMC3569402.pdf
"The Korean Academy of Conservative Dentistry.170This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnostic challenges of nonodontogenic toothache The objective of this article was to present two nonodontogenic conditions that may mimic odontogenic toothache: trigeminal neuralgia and burning mouth syndrome.",Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
ac.krCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.170,Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
(b) (a)Diagnostic challenge of nonodontogenic toothache http://dx.doi.org/10.5395/rde.2012.37.3.170,Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.170,Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
"20 The patient can misunderstand the pain  which is actually nonodontogenic pain, occurs because of  http://dx.doi.org/10.5395/rde.2012.37.3.170",Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
Available from: http://www.ihs-headache.org/frame_non_members.asp (updated 2005 May).,Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.170,Non-OADS,/arxiv_data1/oa_pdf/4b/ae/rde-37-170.PMC3569403.pdf
"175This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Endodontic management of a C-shaped maxillary first molar with three independent buccal root canals by using cone-beam computed tomography The aim of this study was to present a method for endodontic management of a maxillary first molar with unusual C-shaped morphology of the buccal root verified by cone-beam computed tomography (CBCT) images.",Non-OADS,/arxiv_data1/oa_pdf/24/86/rde-37-175.PMC3569404.pdf
"1Karanxa L; Kim HJ; Hong SO; Min  KS, Department of Conservative Dentistry, Wonkwang University School of Dentistry, Iksan, Korea 2Lee W, Department of Oral and  Maxillofacial Radiology, Wonkwang University School of Dentistry, Iksan, Korea 3Kim PS, Choice Dental Clinic,  Suwon, Korea*Correspondence to Kyung-San Min, DDS, PhD.Associate Professor, Department of Conservative Dentistry, Wonkwang University School of Dentistry, 460, Iksandae-ro, Iksan, 570-749, KoreaTEL, +82-63-850-6930; FAX, +82-63-859-2932; E-mail, endomin@gmail.com ※ This paper was supported by Wonkwang University in 2012.Case report ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2012.37.3.175 ©Copyrights 2012.",Non-OADS,/arxiv_data1/oa_pdf/24/86/rde-37-175.PMC3569404.pdf
(b) (a) http://dx.doi.org/10.5395/rde.2012.37.3.175Karanxha L et al.,OADS,/arxiv_data1/oa_pdf/24/86/rde-37-175.PMC3569404.pdf
"177 www.rde.acC-shaped maxillary molar with 3 buccal canals http://dx.doi.org/10.5395/rde.2012.37.3.175Discussion The C-shaped configuration refers to a continuous  slit between all the canals so that a horizontal section  through the root yields a space in the shape of the letter C. 13 This variation is a result of the lack of division of  the roots, which leads to a communication between the root canals, which may extend up to the apical third of the canals.",Non-OADS,/arxiv_data1/oa_pdf/24/86/rde-37-175.PMC3569404.pdf
http://dx.doi.org/10.5395/rde.2012.37.3.175,Non-OADS,/arxiv_data1/oa_pdf/24/86/rde-37-175.PMC3569404.pdf
179 www.rde.acC-shaped maxillary molar with 3 buccal canals http://dx.doi.org/10.5395/rde.2012.37.3.175mandibular molars.,Non-OADS,/arxiv_data1/oa_pdf/24/86/rde-37-175.PMC3569404.pdf
"The Korean Academy of Conservative Dentistry.180This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Management of horizontal root fractures by fabrication of canine protected occlusion using composite resin Traumatic injuries of the face often involve root fractures especially in anterior teeth.",Non-OADS,/arxiv_data1/oa_pdf/7d/c4/rde-37-180.PMC3569405.pdf
"1Shin JH, Department of  Conservative Dentistry, Korea University Guro Hospital, Seoul, Korea 2Kim RJY, Department of  Conservative Dentistry, Seoul National University Dental Hospital, Seoul, Korea*Correspondence to Joo-Hee Shin DDS, MDS, PhD.Clinical Professor, Department of Conservative Dentistry, Korea University Guro Hospital, 97 Gurodong-gil, Guro-gu, Seoul, KoreaTEL, +82-2-2626-1922; FAX, +82-2-837-6245; E-mail, endoshin11@gmail.comCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.3.180",Non-OADS,/arxiv_data1/oa_pdf/7d/c4/rde-37-180.PMC3569405.pdf
(b) (a) http://dx.doi.org/10.5395/rde.2012.37.3.180,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/rde-37-180.PMC3569405.pdf
(b) (a)Shin JH & Kim RJY http://dx.doi.org/10.5395/rde.2012.37.3.180,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/rde-37-180.PMC3569405.pdf
"183 www.rde.acManagement of hoizontal root fracture http://dx.doi.org/10.5395/rde.2012.37.3.180Discussion Root fractures are usually a result of impact that  creates compression zones labially or lingually resulting  in chipping, dislocation of the fragment or mobility.6  The prognosis of a root fracture depends on the extent of the fracture line, pulp tissue situation, stage of root formation, dislocation of fragments and the general health of the patient.",Non-OADS,/arxiv_data1/oa_pdf/7d/c4/rde-37-180.PMC3569405.pdf
Dent Clin North Am 2001;45:7-29.Shin JH & Kim RJY http://dx.doi.org/10.5395/rde.2012.37.3.180,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/rde-37-180.PMC3569405.pdf
"The Korean Academy of Conservative Dentistry.185This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Precipitate from a combination of sodium hypochlorite and chlorhexidine Reader's forum ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2012.37.3.185 Recently I heard that Chlorhexidine can form a precipitate when used in combination with NaOCl during intra-canal  irrigation.",Non-OADS,/arxiv_data1/oa_pdf/69/cc/rde-37-185.PMC3569406.pdf
186 www.rde.ac 186http://dx.doi.org/10.5395/rde.2012.37.3.185Kim JW References 1.,Non-OADS,/arxiv_data1/oa_pdf/69/cc/rde-37-185.PMC3569406.pdf
"National Institute for Minamata Disease website; http://www.nimd.go.jp/english/kenkyu/ docs/2004_march_mercury_analysis_manual(e).pdf Date of access: October 3, 2012.",OADS,/arxiv_data1/oa_pdf/eb/23/srep01175.PMC3569543.pdf
12.RSOFT Design Group website; http://www.rsoftdesign.com/ products.php?sub 5Component 1Design&itm 5DiffractMOD.,Non-OADS,/arxiv_data1/oa_pdf/eb/23/srep01175.PMC3569543.pdf
"Theiss Hard and Software website; http://www.wtheiss.com/ ?c51&content 5scout, or http://www.techno-synergy.co.jp/.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/srep01175.PMC3569543.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Hoang, C.V., Oyama, M., Saito, O., Aono, M. & Nagao, T. Monitoring the Presence of Ionic Mercury in Environmental Water by Plasmon-Enhanced Infrared Spectroscopy.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/srep01175.PMC3569543.pdf
"6) Specific cardiac magnetic resonance (CMR) imaging sequences as Review http://dx.doi.org/10.4070/kcj.2013.43.1.1 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Advanced Cardiac MR Imaging for Myocardial Characterization and Quantification: T1 Mapping Sung Ho Hwang, MD and Byoung Wook Choi, MD Department of Radiology, Yonsei University College of Medicine, Seoul, Korea Magnetic resonance as an imaging modality provides an excellent soft tissue differentiation, which is an ideal choice for cardiac imaging.",Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.T1-weighted image with an administration of the gadolinium, an ex - tracellular contrast agent, can be performed to characterize specific  molecular environments within the target tissue.",Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
2 Myocardial Characterization by Using T1 Mapped CMR http://dx.doi.org/10.4070/kcj.2013.43.1.1 www.e-kcj.org will present a variety of technical and clinical points to be considered  for practical interpretation of pre- and post-contrast T1 mapping.,Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.1 www.e-kcj.org is arbitrary and unsuitable for quantification in inter-individual com- parison or longitudinal comparison in an individual.,Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
4 Myocardial Characterization by Using T1 Mapped CMR http://dx.doi.org/10.4070/kcj.2013.43.1.1 www.e-kcj.org diffuse fibrosis.,Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.1 www.e-kcj.org normal myocardium by T1 mapping with MOLLI sequence at 1.5T.,Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
6 Myocardial Characterization by Using T1 Mapped CMR http://dx.doi.org/10.4070/kcj.2013.43.1.1 www.e-kcj.org 15.,Non-OADS,/arxiv_data1/oa_pdf/02/3d/kcj-43-1.PMC3569561.pdf
"A recent genome-wide association study Original Article http://dx.doi.org/10.4070/kcj.2013.43.1.13 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Association between Serine/Threonine Kinase 39  Gene Polymorphism,  Hypertension, and Other Cardiovascular Risk Factors in Koreans Dong-Jik Shin, PhD1, Sang-Hak Lee, MD2, Sungha Park, MD2, and Yangsoo Jang, MD2 1Cardiovascular Genome Center, Yonsei University Health System, Seoul,  2Cardiology Division, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Background and Objectives:  Although the association between single nucleotide polymorphisms (SNPs) of Serine/Threonine Kinase 39  (STK39)  and hypertension has been reported, the prior studies have been inconsistent.",Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.examined single nucleotide polymorphisms (SNPs) in American Old  Order Amish and identified SNPs in the Serine/Threonine Kinase 39  (STK39)  that were associated with hypertension.1) STK39  encodes a  serine/threonine kinase known as a Ste20-related proline-rich ki - nase (SPAK), one of STE20 family.",Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
14 STK39  Polymorphisms and Hypertension http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org pose was to evaluate the association between the two SNPs and the  risk of hypertension in females and males.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org owed a tendency to have hypertension in the female subgroup.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
16 STK39  Polymorphisms and Hypertension http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org fied findings are listed in the same table.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org Table 4.,OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
18 STK39  Polymorphisms and Hypertension http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org was clearer in women.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org Hypertens  201 1;25:278-80.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
20 STK39  Polymorphisms and Hypertension http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org Supplementary Table 3.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
22 STK39  Polymorphisms and Hypertension http://dx.doi.org/10.4070/kcj.2013.43.1.13 www.e-kcj.org Supplementary Table 3.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/kcj-43-13.PMC3569562.pdf
"23 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Atherosclerosis is one of leading causes of death in developed Original Article http://dx.doi.org/10.4070/kcj.2013.43.1.23 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Hypercholesterolemia and In-Vivo  Coronary Plaque Composition  in Patients with Coronary Artery Disease: A Virtual Histology -   Intravascular Ultrasound Study Young Hoon Seo, MD, Chung Seop Lee, MD, Hyung Bin Yuk, MD, Dong Ju Yang, MD, Hyun Woong Park, MD,   Ki Hong Kim, MD, Wan Ho Kim, MD, Taek-Geun Kwon, MD, and Jang-Ho Bae, MD Division of Cardiology, Heart Center, Konyang University Hospital, Daejeon, Korea Background and Objectives:  Hypercholesterolemia is a key factor in the development of atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.countries.",Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
24 Hypercholesterolemia and Plaque Composition with Virtual Histology Study http://dx.doi.org/10.4070/kcj.2013.43.1.23 www.e-kcj.org sition.1 1-13) We sought to evaluate the relation between hyperchole- sterolemia and in vivo  plaque composition in patients with coronary  artery disease using VH-IVUS analysis.,Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.23 www.e-kcj.org group was younger than the normocholesterolemic group (59.7 ±  13.3 years vs. 62.6 ±1 1.5 years, p=0.036).",Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
"26 Hypercholesterolemia and Plaque Composition with Virtual Histology Study http://dx.doi.org/10.4070/kcj.2013.43.1.23 www.e-kcj.org and percent necrotic core volume (r=0.132, p=0.018) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.23 www.e-kcj.org tic core volume in the culprit lesion.,Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
28 Hypercholesterolemia and Plaque Composition with Virtual Histology Study http://dx.doi.org/10.4070/kcj.2013.43.1.23 www.e-kcj.org but the difference of the LDL-C level between the two groups was  greater than those of the HDL-C level.,Non-OADS,/arxiv_data1/oa_pdf/ad/30/kcj-43-23.PMC3569563.pdf
"As such, ablation of these subsequent organized arrhythmias is Original Article http://dx.doi.org/10.4070/kcj.2013.43.1.29 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Characteristics and Outcomes of Atrial Tachycardia Originating   from the Sinus Venosus during Catheter Ablation   of Atrial Fibrillation Yae Min Park, MD, Hyungdon Kook, MD, Woohyeon Kim, MD, Son Ki Lee, MD, Jong-Il Choi, MD,   Hong Euy Lim, MD, Sang Weon Park, MD, and Young-Hoon Kim, MD Division of Cardiology, Korea University College of Medicine, Seoul, Korea Background and Objectives:  The sinus venosus (SV) is not a well known source of atrial tachycardia (AT), but it can harbor AT during cathe - ter ablation of atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.an integral part of the procedure to achieve sinus rhythm.1-3) Alth- ough catheter ablation can successfully eliminate AT with the use  of electroanatomical and/or entrainment mapping with precision, these ATs are sometimes difficult to identify and eliminate.",Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
30 Atrial Tachycardia from the Sinus Venosus during Atrial Fibrillation Ablation http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org lation for drug-refractory AF from June 1998 to October 201 1 at our  institution were screened.,Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org months thereafter.,Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
"32 Atrial Tachycardia from the Sinus Venosus during Atrial Fibrillation Ablation http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org tivation sequence of CS was proximal to distal in all, except three  patients who received linear peri-mitral ablation with a bidirectional block before developing AT from SV.",Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org Other than this one patient, all patients were free from any ar - rhythmia recurrences thereafter.",Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
34 Atrial Tachycardia from the Sinus Venosus during Atrial Fibrillation Ablation http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org oped during AF ablation is as rare as 0.82% among patients under - going AF ablation.,Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org cycle length.,OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
"36 Atrial Tachycardia from the Sinus Venosus during Atrial Fibrillation Ablation http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org owed spontaneous resolution.2) Lastly, the patients were followed for  a relatively short duration, constituting a limitation with respect to  AT developing over the long-term.",Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.29 www.e-kcj.org regular atrial tachycardia according to electrophysiological mecha- nisms and anatomical bases; a Statement from a Joint Expert Group from The Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electro - physiology.,Non-OADS,/arxiv_data1/oa_pdf/04/97/kcj-43-29.PMC3569564.pdf
"Most of the susceptible genes are related to inflammation and Original Article http://dx.doi.org/10.4070/kcj.2013.43.1.38 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Interleukin-21 Receptor Gene Polymorphisms in Kawasaki Disease Mi Hyun Kim, MD1, Yon Jung Bae, MD1, Hyun Keun Lee, MD1, Yeong Ro Lee, BS2, Dong Hoon Lee, BS2, Kiho Bae, PhD2,  Sang Baek Koh, MD3, Mee Kyung Namgoong, MD1, Byung Ho Cha, MD1, and Hae Yong Lee, MD1 1Departments of Pediatrics and 3Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, 2Division of Biological Science and Technology & Yonsei-Frauhofer Medical Device Lab, College of Science and Technology, Yonsei University, Wonju, Korea Background and Objectives:  Interleukin-21 receptor (IL-21R) gene polymorphism is related with the development of systemic vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.aberrant immune reactions.4) Whatever the initiating agent of in - flammatory reaction is, the individual differences of a series of im - munologic inflammatory cascades due to a given genetic polymor - phism are the primary focus of etiologic research on KD.5) Inter- leukin-6 (IL-6) gene polymorphisms,6)7) tumor necrosis factor- α  (TNF- α) gene polymorphisms,8) CD40 ligand gene polymorphisms,9)  genetic polymorphisms of encoding chemokine receptors,10) pro- grammed death-1 (PD-1) gene polymorphisms,1 1) and other genome  wide association studies have been researched.2)  In addition, the paucity of regulatory T cells (Treg cells)12)13) and the  plasticity of T cell populations14) have been investigated in the devel - opment of KD.",Non-OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.38 www.e-kcj.org mune insufficiency generates autoimmunity.,Non-OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
"40 IL-21R Gene Polymorphisms in Kawasaki Disease http://dx.doi.org/10.4070/kcj.2013.43.1.38 www.e-kcj.org Statistical analysis Sample size was determined by the PASS program 2008 (NCSS  Statistical Software, Kaysville, UT, USA).",OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.38 www.e-kcj.org there was no significant difference between two groups (p=0.18).,OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
42 IL-21R Gene Polymorphisms in Kawasaki Disease http://dx.doi.org/10.4070/kcj.2013.43.1.38 www.e-kcj.org quency of combination of SNPs was higher in patients group than  in controls.,OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.38 www.e-kcj.org 26.,Non-OADS,/arxiv_data1/oa_pdf/25/d1/kcj-43-38.PMC3569565.pdf
"IVUS is very useful to measure the vessel wall and to evaluate plaque burden, whereas the OCT (with almost microsco-Case Report http://dx.doi.org/10.4070/kcj.2013.43.1.44 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Utility of Optical Coherence Tomography to Assess a Hazy   Intracoronary Image after Percutaneous Coronary Intervention Sebastian Carrizo, MD, Pablo Salinas, MD, Santiago Jimenez-Valero, MD, and Raul Moreno, MD University Hospital La Paz, Interventional Cardiology Department, Madrid, Spain Although its use in daily practice is not common, optical coherence tomography (OCT) is a powerful research tool in invasive cardiology.",Non-OADS,/arxiv_data1/oa_pdf/2f/62/kcj-43-44.PMC3569566.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pic resolution) is an excellent method for characterizing luminal and  intimal lesions.2-4)  Herein, we present a case that illustrates the ability of OCT for ac- curate diagnosis of an intracoronary post-angioplasty that had an uncertain hazy image, and its usefulness as a guide for therapeutic strategy.",Non-OADS,/arxiv_data1/oa_pdf/2f/62/kcj-43-44.PMC3569566.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.44 www.e-kcj.org tion 3 flow.,OADS,/arxiv_data1/oa_pdf/2f/62/kcj-43-44.PMC3569566.pdf
"46 Utility of OCT to Assess a Hazy Intracoronary Image http://dx.doi.org/10.4070/kcj.2013.43.1.44 www.e-kcj.org Discussion  Acute stent thrombosis may occur in patients, with or without acu- te coronary syndrome.4)6-12) Rinaldi et al.6) identified 4 independent  predictors of stent thrombosis during PCI: higher baseline platelet  count, acute myocardial infarction indication, use of a coil or self-expanding stent, and preprocedural thrombus.",Non-OADS,/arxiv_data1/oa_pdf/2f/62/kcj-43-44.PMC3569566.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.44 www.e-kcj.org phology in acute myocardial infarction: ability of optical coherence to - mography compared with intravascular ultrasound and coronary an - gioscopy.,Non-OADS,/arxiv_data1/oa_pdf/2f/62/kcj-43-44.PMC3569566.pdf
"2) While there are several reports re - garding the severe multi-vessel coronary spasm after the placement of first generation DES, 3-6) no reports have been published regarding  the spasm in relation to second generation DES which were design-Case Report http://dx.doi.org/10.4070/kcj.2013.43.1.48 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Patient with Repeated Catastrophic Multi-Vessel Coronary Spasm   after Zotarolimus-Eluting Stent Implantation Shi Hyun Rhew, MD, Youngkeun Ahn, MD, Eun Ae Cho, MD, Min Sok Kim, MD,   Su Young Jang, MD, Ki Hong Lee, MD, Min Goo Lee, MD, Keun Ho Park, MD,   Doo Sun Sim, MD, Young Joon Hong, MD, Ju Han Kim, MD, and Myung Ho Jeong, MD Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Korea Drug-eluting stents (DES) have gained great popularity because of extraordinarily low rates of restenosis.",Non-OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ed for a decrease in neointimal response and more rapid re-endoth- elialization.7)  Herein, we report a case of severe, multi-vessel coronary spasm  that occurred on two occasions, two months and two years after the placement of zotarolimus-eluting stents; first one was relieved by intracoronary nitroglycerin alone and the second was treated with intracoronary nitroglycerin and everolimus-eluting stents.",Non-OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.48 www.e-kcj.org cardia, which was successfully resuscitated with electric counter - shock.",Non-OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
"50 Coronary Spasm and Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.1.48 www.e-kcj.org generation DES such as sirolimus-eluting (Cypher, Cordis, Miami La- kes, FL, USA) and paclitaxel-eluting stents (Taxus, Boston Scientific, Natick, MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.48 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
"52 Coronary Spasm and Drug-Eluting Stent http://dx.doi.org/10.4070/kcj.2013.43.1.48 www.e-kcj.org deed, Byrne et al.1 1) recently had demonstrated that a durable poly - mer carrier plays a significant role in the DES related hypersensitivi- ty reaction and delayed vessel healing and has pro-inflammatory and thrombogenic potential.",Non-OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.48 www.e-kcj.org atrioventricular block, and ventricular fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/af/7f/kcj-43-48.PMC3569567.pdf
"Here, we de - scribe a neonate with congenital HCMP without other congenital anomalies who was presented with severe congestive heart failure and respiratory failure, and whose condition proceeded rapidly to death during an early neonatal period.Case Report http://dx.doi.org/10.4070/kcj.2013.43.1.54 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Congenital Hypertrophic Cardiomyopathy Hyeon Seok Seo, MD, In Hak Lee, MD, Young Wooh Song, MD, Byung Min Choi, MD,   Gi Young Jang, MD, Chang Sung Son, MD, and Joo Won Lee, MD Department of Pediatrics, Korea University Hospital, Seoul, Korea Congenital hypertrophic cardiomyopathy (HCMP) is a very rare congenital heart disease.",Non-OADS,/arxiv_data1/oa_pdf/41/2a/kcj-43-54.PMC3569568.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 2726 g (<50 percentile) male newborn was delivered via cesare - an section at 38 weeks’ gestation as the first child of healthy, non- consanguineous parents.",Non-OADS,/arxiv_data1/oa_pdf/41/2a/kcj-43-54.PMC3569568.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.54 www.e-kcj.org kinase, cholesterol, triglycerides, glucose, and pyruvic acid.",Non-OADS,/arxiv_data1/oa_pdf/41/2a/kcj-43-54.PMC3569568.pdf
"56 Congenital Hypertrophic Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.1.54 www.e-kcj.org heart was not detected, except the already known dextrocardia.",Non-OADS,/arxiv_data1/oa_pdf/41/2a/kcj-43-54.PMC3569568.pdf
"57 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Wolff-Parkinson-White (WPW) syndrome is a preexcitation of the  heart, caused by an accessory pathway (AP) that bypasses the atrio - ventricular node, and is associated with supraventricular tachycar - dia.1) Incessant or recurrent AP-mediated supraventricular tachycar - dia can cause dilated cardiomyopathy (DCMP).2)3) However, overt  ventricular preexcitation in children can cause ventricular dysfunc -Case Report http://dx.doi.org/10.4070/kcj.2013.43.1.57 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Amiodarone and Catheter Ablation as Cardiac Resynchronization Therapy for Children with Dilated Cardiomyopathy and   Wolff-Parkinson-White Syndrome Sung Hoon Kim, MD1, Soo In Jeong, MD2, June Huh, MD3, I-Seok Kang, MD3, and Heung Jae Lee, MD3 1Department of Pediatrics, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon,  2Department of Pediatrics , Kangdong Sacred Heart Hospital, Hallym University School of Medicine, Seoul, 3Department of Pediatrics, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Preexcitation by accessory pathways (APs) is known to cause dyssynchrony of the ventricle, related to ventricular dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/82/bf/kcj-43-57.PMC3569569.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tion, even in the absence of recurrent and incessant tachyarrhy- thmia.4)5) Preexcitation by an AP is associated with decreased left ven- tricular function, depending on the location of the AP.5) Patients with  a right-sided AP, with preexcitation, have more severe cardiac dys - function.5-8) It is well known that in most patients, cardiac function  improves and reverse remodeling initiates after preexcitation st-ops.",Non-OADS,/arxiv_data1/oa_pdf/82/bf/kcj-43-57.PMC3569569.pdf
58 CRT for Pediatric DCMP with WPW Syndrome http://dx.doi.org/10.4070/kcj.2013.43.1.57 www.e-kcj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/bf/kcj-43-57.PMC3569569.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.57 www.e-kcj.org normal electrocardiography (ECG) at a routine check-up for a hydro- cele operation.,Non-OADS,/arxiv_data1/oa_pdf/82/bf/kcj-43-57.PMC3569569.pdf
60 CRT for Pediatric DCMP with WPW Syndrome http://dx.doi.org/10.4070/kcj.2013.43.1.57 www.e-kcj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/bf/kcj-43-57.PMC3569569.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.57 www.e-kcj.org high risk of complications of RFCA.,Non-OADS,/arxiv_data1/oa_pdf/82/bf/kcj-43-57.PMC3569569.pdf
"We made a diagnosis of ATS, based on dysmorphic features, ventricular arrhythmia, and periodic paralysis.Case Report http://dx.doi.org/10.4070/kcj.2013.43.1.62 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Ventricular Tachyarrhythmias in a Patient   with Andersen-Tawil Syndrome Jung Yoon Pyo, MD, Dong Hoo Joh, MD, Jin Su Park, MD, Seung-Jun Lee, MD,   Hancheol Lee, MD, Wonjin Kim, MD, and Boyoung Joung, MD Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea Andersen-Tawil syndrome (ATS), a rare autosomal dominant disorder, is characterized by periodic paralysis, dysmorphic features and car - diac arrhythmias.",Non-OADS,/arxiv_data1/oa_pdf/8d/e3/kcj-43-62.PMC3569570.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case An 18-year-old girl was transferred to our emergency room for  post-resuscitated status.",Non-OADS,/arxiv_data1/oa_pdf/8d/e3/kcj-43-62.PMC3569570.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.62 www.e-kcj.org acute respiratory difficulty.,Non-OADS,/arxiv_data1/oa_pdf/8d/e3/kcj-43-62.PMC3569570.pdf
"64 Andersen-Tawil Syndrome http://dx.doi.org/10.4070/kcj.2013.43.1.62 www.e-kcj.org potential in skeletal and cardiac muscle, and contribute significantly  to the most terminal repolarization phase of the cardiac action po - tential.3) The KCNJ2 gene mutation alters potassium channels in  such a way that it disrupts the flow of potassium ions in the skeletal and heart muscle.",Non-OADS,/arxiv_data1/oa_pdf/8d/e3/kcj-43-62.PMC3569570.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.62 www.e-kcj.org entry in this patient.,Non-OADS,/arxiv_data1/oa_pdf/8d/e3/kcj-43-62.PMC3569570.pdf
"However, with advance of endovascular skills Case Report http://dx.doi.org/10.4070/kcj.2013.43.1.66 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Hybrid Treatment for Thoracic Aortic Aneurysm Combined   with Aberrant Right Subclavian Artery Joong-Hee Lee, MD1, Young-Guk Ko, MD1, Young-Nam Yoon, MD2, Donghoon Choi, MD1, and Do-Yun Lee, MD3 1Division of Cardiology, Yonsei University College of Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, 2Division of Cardiovascular Surgery, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul,  3Department of Radiology, Yonsei University College of Medicine, Seoul, Korea An aberrant right subclavian artery (ARSA) is the most common vascular abnormality of the aortic arch and is associated with develop - ment of aneurysms in 3-8% of these anomalies.",Non-OADS,/arxiv_data1/oa_pdf/66/60/kcj-43-66.PMC3569571.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and devices, a hybrid procedure combining less-invasive surgery with  endovascular therapy using stent grafts to reduce the risk of pro - cedure-related morbidity and mortality is gaining attention.",Non-OADS,/arxiv_data1/oa_pdf/66/60/kcj-43-66.PMC3569571.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.66 www.e-kcj.org mal left anterior descending artery.,Non-OADS,/arxiv_data1/oa_pdf/66/60/kcj-43-66.PMC3569571.pdf
68 Hybrid Treatment of TAA http://dx.doi.org/10.4070/kcj.2013.43.1.66 www.e-kcj.org available from one vendor at that time.,OADS,/arxiv_data1/oa_pdf/66/60/kcj-43-66.PMC3569571.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.66 www.e-kcj.org plantation in the aortic arch.,Non-OADS,/arxiv_data1/oa_pdf/66/60/kcj-43-66.PMC3569571.pdf
"However, certain types of coronary artery abnormalities were related to sudden death, par -Original Article http://dx.doi.org/10.4070/kcj.2013.43.1.7 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Prevalence of Congenital Coronary Artery Anomalies of Korean Men Detected by Coronary Computed Tomography Jae Hyun Park, MD1, Nak Hyun Kwon, MD1, Jun Hwan Kim, MD1, Yu Jin Ko, MD1, Seo Hee Ryu, MD1,  Seok Jin Ahn, MD1, Young Jung Kim, MD1, Joo Yeong Baeg, MD1, and Jung Im Kim, MD2 1Department of Internal Medicine, National Police Hospital, Seoul, 2Chest Radiology, Human Medical Imaging & Intervention Center, Seoul, Korea Background and Objectives:  It has been demonstrated that the anomalous origin of coronary arteries (AOCA) are generally asymptom - atic and rare diseases.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ticularly in young athletes.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
"8 Prevalence of Congenital Coronary Artery http://dx.doi.org/10.4070/kcj.2013.43.1.7 www.e-kcj.org database which was performed from November 28, 2010 to June 3,  201 1.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.7 www.e-kcj.org normal origin of the coronary ostium arising from an opposite or  non-coronary sinus (n=1 1, 0.70%), and 7 out of 1 1 cases of abnor - mal origin were in the right coronary artery (RCA) arising from the left coronary sinus (0.44%) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
"10 Prevalence of Congenital Coronary Artery http://dx.doi.org/10.4070/kcj.2013.43.1.7 www.e-kcj.org ality with significant lower radiation doses when compared to 64- MDCT, using retrospective ECG-gating.15) The mean effective radia - tion dose was 2.1 ±0.9 mSv for the prospective 128-MDCT group,  which was significantly lower (p<0.01) than that for the retrospec - tive 64-MDCT group.14) The mean radiation doses were 350.0 ±149.7  mGy×cm in DLP (4.90 ±2.10 mSv) in our study.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.1.7 www.e-kcj.org An interarterial course is clinically important and carries a high risk  for sudden cardiac death in young adults.3)4) The possible mechanism  of myocardial ischaemia remain unclear, but the acute take-off an - gle, the slitlike ostium, compression of the RCA between the aorta and the pulmonary artery, and spasm of the anomalous RCA have been thought to be possible causes.",Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
12 Prevalence of Congenital Coronary Artery http://dx.doi.org/10.4070/kcj.2013.43.1.7 www.e-kcj.org coronary artery detected by multi-detector computed tomography at  one center.,Non-OADS,/arxiv_data1/oa_pdf/de/7c/kcj-43-7.PMC3569572.pdf
"Also, the fact that SVG calcifications occurred mainly within the wall, and not within the plaque, which suggest that SVG calcifications are not just Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2013.43.1.70 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Full Calcified Jacket of Saphenous Vein Graft Hyun Soo Kim, MD and Weon Kim, MD Division of Cardiovascular, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea Received:  April 12, 2012 / Revision Received: August 9, 2012 / Accepted: August 10, 2012 Correspondence: Weon Kim, MD, Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College  of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-702, KoreaTel: 82-2-958-8170, Fax: 82-2-958-8160, E-mail: mylovekw@hanmail.net • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/f9/61/kcj-43-70.PMC3569573.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.results of lesion formation, but also of hemodynamic changes that  are associated with arterializations of SVG.1) Increasing calcified  plaques of coronary artery are associated to angiographically severe stenosis, 4) but it’s not apparent that SVG calcifications is related to  stenosis in that the location of SVG calcium is more diffuse and con-centric in the vessel wall.",Non-OADS,/arxiv_data1/oa_pdf/f9/61/kcj-43-70.PMC3569573.pdf
http://dx.doi.org/10.4070/kcj.2013.43.1.70  www.e-kcj.org A   C  B   D   Fig.,Non-OADS,/arxiv_data1/oa_pdf/f9/61/kcj-43-70.PMC3569573.pdf
"Yusuf :K. Leung :K. J. Morris :E. V. Volpi ( *) Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive,OX3 7BN, Oxford, UKe-mail: emanuela.volpi@well.ox.ac.uk URL: http://www.ndm.ox.ac.uk/principal-investigators/researcher/ emanuela-volpi M. Yusuf London Centre for Nanotechnology,University College London,WC1E 6BT, London, UK Present Address: K. LeungCentre for Genetics and Genomics, Queens Medical Centre, University of Nottingham, NG7 2UH, Nottingham, UKNeurogenetics (2013) 14:63 –70 DOI 10.1007/s10048-012-0350-9",Non-OADS,/arxiv_data1/oa_pdf/26/2a/10048_2012_Article_350.PMC3569589.pdf
"Karyotyping by multiplex fluorescence in situ hybridiza- tion (M-FISH) was performed as recommended by the 24XCyte mFISH probe kit manufacturer (MetaSystems, Germany, http://www.metasystems-international.com ).",Non-OADS,/arxiv_data1/oa_pdf/26/2a/10048_2012_Article_350.PMC3569589.pdf
"FISH and M-FISHexperiments were analysed on a CytoVysion system (Genetix, UK, http://www.genetix.com ), consisting of an Olympus BX-51 epifluorescence microscope coupled to aJAI CVM4+ CCD camera.",OADS,/arxiv_data1/oa_pdf/26/2a/10048_2012_Article_350.PMC3569589.pdf
"Multi-colour mBand FISH imaging (MCM-banding) and analysis were performed as recommended by the XCyte1mBand probe kit manufacturer (MetaSystems, Germany, http://www.metasystems-international.com ), utilizing a Carl Zeiss AxioImager.Z2 epifluorescence microscope coupledto a MetaSystems CoolCube camera and MetaSystems ISIS software.",OADS,/arxiv_data1/oa_pdf/26/2a/10048_2012_Article_350.PMC3569589.pdf
All copy number changes observed were compared to CNVscatalogued in the Database of Genomic Variants (DGV) (http://projects.tcag.ca/variation/ ) and the UCSC genome browser ( http://genome.ucsc.edu/ ).,OADS,/arxiv_data1/oa_pdf/26/2a/10048_2012_Article_350.PMC3569589.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Denicol, A.C. et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/02/srep01266.PMC3569626.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/a7/srep01260.PMC3569627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Gopal, J., Hasan, N., Manikandan, M. & Wu, H. F. Bacterial toxicity/compatibility of platinum nanospheres, nanocuboids and nanoflowers.",Non-OADS,/arxiv_data1/oa_pdf/9f/a7/srep01260.PMC3569627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Mahajan, S., Machabeli, G., Osmanov, Z.",Non-OADS,/arxiv_data1/oa_pdf/14/68/srep01262.PMC3569628.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/f3/srep01264.PMC3569629.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yan, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/6f/f3/srep01264.PMC3569629.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cf/13/srep01265.PMC3569630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zhang, G.H.",Non-OADS,/arxiv_data1/oa_pdf/cf/13/srep01265.PMC3569630.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Tahir, M., Sabeeh, K. & Schwingenschlo ¨gl, U. Quantum capacitance of an ultrathin topological insulator film in a magnetic field.",Non-OADS,/arxiv_data1/oa_pdf/37/85/srep01261.PMC3569631.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/94 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"She was diagnosed as having RF complicated by SC, according to the modified Jones criteria, 7after having other causes of chorea ruled out (drug-induced, metabolic and toxic encephalopathies,other infectious choreas, systemic lupus erythematosus, post-vaccinalencephalitis, paraneoplastic choreas, and genetic such as benignhereditary chorea, ataxia–telangiectasia, and Huntington’s disease).Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Rheumatology (Oxford) 2010;49:1806–1814, http://dx.doi.org/ 10.1093/rheumatology/keq167.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Arthritis Rheum 1990;33:1129–1134, http://dx.doi.org/10.1002/art.1780330811.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Clin Cardiol 1988;11:123–125, http://dx.doi.org/10.1002/clc.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Am Hearto ˆJ1977;93:94–103, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Circulation 1967;35: 1141–1155, http://dx.doi.org/10.1161/01.CIR.35.6.1141.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Handb Clin Neurol 2011;100:221–229, http://dx.doi.org/10.1016/B978-0-444-52014-2.00014-8.",OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
Takayasu’s Arteritis and Sydenham’s Chorea Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"JAMA 1992;268:2069–2073, http://dx.doi.org/10.1001/jama.1992.03490150121036.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Pediatr Nephrol 2010;25:1037– 1048, http://dx.doi.org/10.1007/s00467-009-1312-9.9.Minagar A, Fowler M, Harris MK, et al.",OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"Neurol Clin 2010;28:171–184, http://dx.doi.org/10.1016/ j.ncl.2009.09.015.",OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
"1998;66:S85–90, http://dx.doi.org/10.1016/S0167- 5273(98)00155-7.Takayasu’s Arteritis and Sydenham’s Chorea Vale TC, Maciel ROH, Maia D, et al.",OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/4a/f4/tre-02-94-542-1.PMC3569897.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/ article/view/104 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
He noted problems getting on and off trains without holding aFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
SPG11 Presenting with Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"Curr Opin Neurol 2007; 20:674–680, http://dx.doi.org/10.1097/WCO.",OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"J Neurol Neurosurg Psychiatry 2009;80:1402–1404, http://dx.doi.org/10.1136/jnnp.2008.",Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"Brain 2010;133:591– 598, http://dx.doi.org/10.1093/brain/awp325.",OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"Brain 2008;131:772– 784, http://dx.doi.org/10.1093/brain/awm293.",OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"Brain 2008;131:772– 784, http://dx.doi.org/10.1093/brain/awm293.",OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"Nat Genet 2007;39:366–372, http://dx.doi.org/10.1038/ng1980.",Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
"Neurology 2008;70: 1384–1389, http://dx.doi.org/10.1212/01.wnl.0000294327.66106.3d.",Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/87/98/tre-02-104-666-1.PMC3569902.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/51 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Environmental factors may also play a role in ET.22 Here, we provide a concise summary of the link between LINGO-1 and neurodegeneration, and hypothesize its possible relevance to ETpathogenesis.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"This could contribute to activation of the EGFR-PI3K-Akt signaling pathway and improve-ment of Purkinje cell survival in cerebellum of ET.Zhou Z-d, Sathiyamoorthy S, Tan E-K LINGO-1 and Neurodegeneration Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"This is based on the presumption that the identifiedLINGO-1 and Neurodegeneration Zhou Z-d, Sathiyamoorthy S, Tan E-K Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Mov Disord 1998;13:5–10, http://dx.doi.org/10.1002/ mds.870130105.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Brain 2007;130:3297–307, http://dx.doi.org/10.1093/brain/awm266.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Parkinsonism Relat D 2011;17:406–409, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Mov Disord 2008;23:174–182, http://dx.doi.org/10.1002/mds.21731.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Brain 2006;129:2318–2331, http://dx.doi.org/10.1093/ brain/awl120.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Nat Genet 2009;41:277–279, http://dx.doi.org/10.1038/ng.299.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Parkinsonism Relat D 2010;16:109–111, http://dx.doi.org/10.1016/j.parkreldis.2009.08.006.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Neurogenetics 2010;11:401–408, http://dx.doi.org/10.1007/s10048-010-0241-x.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Neurology 2009;73:1161–1162, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Neurosci Lett 2010;481:69–72, http://dx.doi.org/10.1016/j.neulet.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Neuroepidemiology 2008;31:139–149, http://dx.doi.org/10.1159/000151523 Figure 1.Hypothetical mechanisms for LINGO-1 induced cerebellum Purkinje cell degeneration in ET.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"LINGO-1 might contribute to Purkinje cell degenerationin the cerebellum via regulation of the activity of the NgR1–p75 signaling pathwayand EGFR–PI3K–Akt signaling pathway:Zhou Z-d, Sathiyamoorthy S, Tan E-K LINGO-1 and Neurodegeneration Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"AMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembraneproteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs.Brain Res Rev 2006;51:265–274, http://dx.doi.org/10.1016/j.brainresrev.2005.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"JB i o lC h e m 2006;281:36378–36390, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Genomics 2003;81:411–421, http://dx.doi.org/10.1016/ S0888-7543(03)00030-2 27.Homma S, Shimada T, Hikake T, Yaginuma H. Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouseembryo.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Gene Expr Patterns 2009;9:1–26, http://dx.doi.org/10.1016/j.gep.2008.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Gene Expr Patterns 2008;8:79–86, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Dev Neurobiol 2008;68:521–541, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Nat Neurosci 2004;7:221–228, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Biol Chem 2009;284: 15717–15728, http://dx.doi.org/10.1074/jbc.M808751200 32.Inoue H, Lin L, Lee X, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Biol Chem 2009;284:le9, http://dx.doi.org/10.1074/jbc.L808751200 34.Trifunovski A, Josephson A, Ringman A, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Neuroreport 2004;15:2397–2400, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Neuron 2005;45:353–359, http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Nature 2002;420:74–78, http://dx.doi.org/10.1038/nature01176 37.Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Trends Neurosci 2003;26:193–8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Neurocytol 2002;31:93–120, http://dx.doi.org/10.1023/A:1023941421781 40.Mi S, Miller RH, Lee X, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Nat Neurosci 2005;8:745–751, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Neurosci 2007;27:220–225, http://dx.doi.org/10.1523/JNEUROSCI.4175-06.2007 42.Mi S, Hu B, Hahm K, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Nat Med 2007;13:1228–1233, http://dx.doi.org/10.1038/ nm1664 43.Zhao XH, Jin WL, Wu J, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Cell Mol Neurobiol 2008;28: 727–735, http://dx.doi.org/10.1007/s10571-007-9258-6 44.Jeon CY, Kim HJ, Morii H, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Cell Physiol 224:786–94, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Expert Opin Ther Targets 15:63–74, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Neuro-Oncol 2010;97:323–337, http://dx.doi.org/10.1007/s11060-009-0035-x 49.Sakanaka M, Peng H, Wen TC, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Regen Med 2006;1:15–28, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerveLINGO-1 and Neurodegeneration Zhou Z-d, Sathiyamoorthy S, Tan E-K Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Invest Ophthalmol Vis Sci 2008;49:975–985, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Int J Biochem Cell Biol 2008;40:1971–1978, http://dx.doi.org/10.1016/j.biocel.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Curr Opin Ophthalmol 2007;18:110–114, http://dx.doi.org/10.1097/ICU.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Mol Cell Neurosci 2006;33:311–320, http://dx.doi.org/10.1016/j.mcn.2006.08.003 58.Rudick RA, Mi S, Sandrock AW, Jr. LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Expert Opin Biol Ther 2008;8: 1561–1570, http://dx.doi.org/10.1517/14712598.8.10.1561 59.Wilkins A, Majed H, Layfield R, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Neurosci 30:2989–3001, http://dx.doi.org/10.1523/JNEUROSCI.3174-09.2010.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Front Neuroanat 2009;3:5, http://dx.doi.org/10.3389/neuro.05.005.2009 62.Baer AS, Syed YA, Kang SU, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Brain 2009;132:465– 481, http://dx.doi.org/10.1093/brain/awn334 63.Rajasekharan S, Baker KA, Horn KE, et al.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Development 2009;136:415–426, http://dx.doi.org/10.1242/dev.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Parkinsonism Relat D 16: 109–111, http://dx.doi.org/10.1016/j.parkreldis.2009.08.006.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Acta Neurol Scand 2011;125:1–7, http://dx.doi.org/10.1111/ j.1600-0404.2011.01516.x.2011 66.Wang GJ, Yang P, Xie HG.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Pharmacogenomics 2006;7:203–209, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Mol Psychiatr 2006;11:125–133, http://dx.doi.org/10.1038/sj.mp.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Genomics 2003;82:511–520, http://dx.doi.org/10.1016/S0888-7543(03)00142-3 69.Hoffstedt J, Wahlen K, Sjolin E. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis.J Lipid Res 2008;49:607–611, http://dx.doi.org/10.1194/jlr.M700448-JLR200 70.Rouleau GA, Xiong L, Catoire H, et al.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Hum Mol Genet 2009;18:1065–1074, http://dx.doi.org/10.1093/hmg/ ddn443 71.Ng CE, Tang BL.",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Neurosci Res 2002;67:559–565, http://dx.doi.org/ 10.1002/jnr.10134 72.Funahashi S, Hasegawa T, Nagano A, Sato K. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system.",OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"J Comp Neurol 2008;506:141–160, http://dx.doi.org/ 10.1002/cne.21541Zhou Z-d, Sathiyamoorthy S, Tan E-K LINGO-1 and Neurodegeneration Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/15/6e/tre-02-51-249-1.PMC3569903.pdf
"Tremor Other Hyperkinet Mov 2011;1: http://www.tremorjournal.org/article/ view/32 * To whom correspondence should be addressed: E-mail: ruth.walker@mssm.edu Editor: Elan D. Louis, Columbia University, United States of America Received: May 5, 2011 Accepted: May 27, 2011 Published: December 12, 2011 Copyright: ’2011 Walker.",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
The movements remained unchanged when he was first seen by the author.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
"Brain 2003;126:685–691, http://dx.doi.org/10.1093/brain/awg050.",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
"On a reduced- gluten diet, chorea is markedly reduced, although some facial movements arevisible, and mild upper limb dystonia is present.Video Segment 1Walker RH Chorea in Celiac Disease Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
"Mov Disord 2004;19:478– 482, http://dx.doi.org/10.1002/mds.10691.",OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
"J Neurol Neurosurg Psychiatry 2003;74:1221–1224, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
"Brain 1995;118:1087–1093, http://dx.doi.org/ 10.1093/brain/118.5.1087.",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
Neurology 2004;62:132–133.Chorea in Celiac Disease Walker RH Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/d7/ae/tre-01-32-96-3.PMC3569904.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: H.W.H., A.A.B., J.H.",Non-OADS,/arxiv_data1/oa_pdf/16/b8/srep01259.PMC3569917.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Hou, H.W.",Non-OADS,/arxiv_data1/oa_pdf/16/b8/srep01259.PMC3569917.pdf
http://www.futurlec.com/CO2_Sensor.shtml (December 1 2012).,OADS,/arxiv_data1/oa_pdf/c4/b4/srep01267.PMC3569919.pdf
http://www.gow-mac.com/products/prod_cat.cfm?cat_id 53 (December 1 2012).,Non-OADS,/arxiv_data1/oa_pdf/c4/b4/srep01267.PMC3569919.pdf
http://www.horiba.com/process- environmental/products/combustion/cems-stack-gas-emission/details/enda- 600-series-stack-gas-analyzer-system-1538 (December 1 2012).,Non-OADS,/arxiv_data1/oa_pdf/c4/b4/srep01267.PMC3569919.pdf
http://support.automation.siemens.com/ WW/llisapi.dll?func 5cslib.csinfo&lang 5en&objID 510807005&subtype 5 133300 (December 1 2012).24.,OADS,/arxiv_data1/oa_pdf/c4/b4/srep01267.PMC3569919.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/b4/srep01267.PMC3569919.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zhang, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/c4/b4/srep01267.PMC3569919.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/91 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
Botulinum toxin injections are curre ntly established as safe and effective in the treatment of CD4and can provide relief for up to 85% of patients.5Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
OnabotulinumtoxinA Efficacy in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Mov Disord 1991;6:119–126, http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Mov Disord 1988;3:188–194, http://dx.doi.org/10.1002/mds.870030302.",OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Neurology 2008;70(19):1699–706, doi: http://dx.doi.org/10.1212/01.wnl.0000311389.",Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
OnabotulinumtoxinA Efficacy in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Eur J Neurol 2006;13(Suppl 1):16–20, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Clin Ther 2007;29:683–690, http://dx.doi.org/10.1016/j.clinthera.2007.04.015.",OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Mov Disord 2008;23:1353–1360, http://dx.doi.org/10.1002/mds.22157.",OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"J Neurol 1992;239:9–15, http://dx.doi.org/10.1007/BF00839204.9.Dauer WT, Burke RE, Greene P, Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia.",OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Brain 1998; 121:547–560, http://dx.doi.org/10.1093/brain/121.4.547.",Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
"Muscle Nerve 2000;23:1752–1756, http://dx.doi.org/10.1002/1097- 4598(200011)23:11 ,1752::AID-MUS12 .3.0.CO;2-U.",Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/26/dd/tre-02-91-598-1.PMC3569932.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/77 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"They are currently managed through phar- macotherapy or surgery, consisting either of stereotactic thalamotomyFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Biomechanical Loading as an Alternative Treatment for Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Biomechanical Loading as an Alternative Treatment for Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Biomechanical Loading as an Alternative Treatment for Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Biomechanical Loading as an Alternative Treatment for Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Mov Disord 1998; 13:2–23, http://dx.doi.org/10.1002/mds.870131303 2.Wenning GK, Kiechl S, Seppi K, et al.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Lancet Neurol 2005;4:815–820, http://dx.doi.org/10.1016/S1474- 4422(05)70226-X.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Biomechanical Loading as an Alternative Treatment for Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Mov Disord 2006; 21(Suppl 14):S290–S304, http://dx.doi.org/10.1002/mds.20962.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Annu Rev Neurosci 2006; 29:229–257, http://dx.doi.org/10.1146/annurev.neuro.29.051605.112824.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Eur J Neurosci 2010;32:1100–1108, http://dx.doi.org/10.1111/j.1460-9568.2010.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Clin Neurophysiol 2011;122:1794–1801, http://dx.doi.org/10.1016/j.clinph.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"12.Aisen ML, Adelstein BD, Romero J, Morris A, Rosen M. Peripheral mechanical loading and the mechanism of the tremor of chronic alcoholism.Arch Neurol 1992;49:740–742, http://dx.doi.org/10.1001/archneur.1992.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Mov Disord 2005;20:1543–1549, http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Mult Scler 2003;9: 44–54, http://dx.doi.org/10.1191/1352458503ms863oa.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Neurology 1986;36:225–231, http://dx.doi.org/10.1212/WNL.36.2.225.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Neurol Neurosurg Psychiatry 1987;50:568–579, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Clin Neurophysiol 2009;120:1020–1029, http://dx.doi.org/10.1016/j.clinph.2009.03.012.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Clin Rehabil 2002; 26:481–492, http://dx.doi.org/10.1191/ 0269215502cr521oa.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Neurology 2003;61:919–925, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Mov Disord 2005;20:1038–1042, http://dx.doi.org/10.1002/mds.20487.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Neurol Neurosurg Psychiatry 1987;50:691–698, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Muscle loading as a method to isolate the underlying tremor components in essential tremor and Parkinson’s disease.Muscle Nerve 2004;30:347–355, http://dx.doi.org/10.1002/mus.20109.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Clin Neurophysiol 2010;121:233–239, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Correlation between tremor, voluntary contraction and firing pattern of motor units in Parkinson’s disease.J Neurol Neurosurg Psychiatry 1974;37:927–937, http://dx.doi.org/10.1136/jnnp.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Exp Neurol 2005;194:151–60, http://dx.doi.org/ 10.1016/j.expneurol.2005.02.008.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Brain 1979;102:509–526, http://dx.doi.org/10.1093/ brain/102.3.509.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Neurol Neurosurg Psychiatry 1988;51:934–943, http://dx.doi.org/10.1136/jnnp.51.7.934.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Clin Neurophysiol 1996;13:133– 144, http://dx.doi.org/10.1097/00004691-199603000-00004.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Nat Clin Pract Neurol 2006; 2:666–678, http://dx.doi.org/10.1038/ ncpneuro0347.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Cerebellum 2007; 6:73–78, http://dx.doi.org/ 10.1080/14734220601103037.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Ann Biomed Eng 1992;20:205–224, http://dx.doi.org/10.1007/BF02368521.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Ann Biomed Eng 1992;20: 225–236, http://dx.doi.org/10.1007/BF02368522.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Med Biol Eng Comput 2011;49:1187–1193, http://dx.doi.org/10.1007/s11517-011-0803-6.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Neurology 1993;43:1346– 1350, http://dx.doi.org/10.1212/WNL.43.7.1346.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Eur J Appl Physiol 2002;88:29–41, http://dx.doi.org/10.1007/s00421- 002-0677-2.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Neurol Neurosurg Psychiatry 1986;49:669–676, http://dx.doi.org/10.1136/jnnp.49.6.669.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Rehab Eng 2000;8:53–59, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Neural Syst Rehab Eng 2007;15:367–378, http://dx.doi.org/10.1109/TNSRE.2007.903917.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Artif Organs 2005;49:448–452, http://dx.doi.org/10.1111/j.1525-1594.2005.29075.x.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Ann Biomed Eng 1985;13:59–74, http://dx.doi.org/10.1007/BF02371250.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Neural Syst Rehabil Eng 2006;14:38–45, http://dx.doi.org/10.1109/ TNSRE.2006.870490.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Sensors 2010; 10:2129–2149, http://dx.doi.org/10.3390/s100302129.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Med Biol Eng Comput 2006;44:569–582, http://dx.doi.org/10.1007/s11517-006-0065-x.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Biomed Eng 1998;45: 839–846, http://dx.doi.org/10.1109/10.686791.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Syst Man Cyber – C , in press, http://dx.doi.org/10.1109/TSMCC.2012.2200101 67.Farina D, Merletti R, Enoka RM.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Appl Physiol 2004;96:1486–1495, http://dx.doi.org/ 10.1152/japplphysiol.01070.2003 68.Zwarts MJ, Stegeman DF.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Muscle Nerve 2003;28:1–17, http://dx.doi.org/10.1002/mus.10358.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Neural Syst Rehabil Eng 2003;11:407–415, http://dx.doi.org/10.1109/TNSRE.2003.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Biomechanical Loading as an Alternative Treatment for Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services12,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"IEEE Trans Neural Syst Rehab Eng 2001;9: 245–257, http://dx.doi.org/10.1109/7333.948452.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Lancet 2001;357:519–523, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Mov Disord 2002;17(Suppl 3): S28–S40, http://dx.doi.org/10.1002/mds.10140.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Neurologic Clinics 2009;27:679–695, http://dx.doi.org/10.1016/j.ncl.2009.04.",OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"Muscle Nerve 2001;24:716–735, http://dx.doi.org/10.1002/mus.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
"J Neurosci 2008;28:11165–11173, http://dx.doi.org/10.1523/JNEUROSCI.3099-08.2008.Biomechanical Loading as an Alternative Treatment for Tremor Rocon E, Gallego JA, Belda-Lois JM, et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services13,Non-OADS,/arxiv_data1/oa_pdf/e3/3b/tre-02-77-495-1.PMC3569933.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/64 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Methods Demographic, clinical and genetic data were analyzed, collected from 45 centers in the United States, Canada and Australia thatparticipated in the Cooperative Huntington’s Observational Research Trial (COHORT), a prospective observational study examiningFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"No differences in diagnostic confidence were detectedbetween the normal group and the intermediate (p 50.86) group, although there was a slightly higher proportion of subjects withHa AD, Beck CA, Jankovic J Huntington’s Disease Intermediate CAG Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"I) Age [years] 50.31 (13.29) 49.08 (13.13) 0.5828 48.80 (13.11) 0.8021 Female [%] 373 (57.8) 37 (74.0) 0.0256 708 (54.9) 0.0085White [%] 602 (93.2) 48 (96.0) 0.7652 1206 (93.5) 0.7667 Employment status [% currently in labor force]444 (68.8) 36 (72.0) 0.7513 429 (31.6) ,0.0001 Marital status [% currently married] 505 (78.3) 40 (80.0) 0.8600 777 (60.2) 0.0047 History of at least one suicide attempt [%] – Overall 9 (1.4) 3 (6.0) 0.0486 82 (6.4) 1.0000 – Females 7 (1.9) 3 (8.1) 0.0522 48 (6.8) 0.7346– Males 2 (0.7) 0 (0) 1.0000 34 (5.8) 1.0000 Body mass index [kg/m 2] – Overall 28.63 (6.47) 28.67 (7.00) 0.8787 25.69 (5.42) 0.0003– Females 28.28 (6.76) 28.91 (7.76) 0.5416 25.55 (6.07) 0.0008– Males 29.09 (6.03) 28.01 (4.45) 0.5391 25.87 (4.50) 0.1823 Motor assessment Total UHDRS motor assessment [0–124] 1.72 (2.91) 2.16 (3.14) 0.2581 30.11 (21.96) ,0.0001 Total maximal chorea score [0–28] 0.08 (0.41) 0.16 (0.59) 0.2245 7.72 (5.99) ,0.0001 Total maximal dystonia score [0–20] – Overall 0.01 (0.14) 0.10 (0.42) 0.0014 2.64 (3.60) ,0.0001 – Females 0.02 (0.18) 0.14 (0.49) 0.0001 2.56 (3.64) ,0.0001 – Males 0.004 (0.06) 0 (0) 0.9178 2.74 (3.56) 0.0103 Behavioral assessmentUHDRS Behavioral frequency [0–44] 4.39 (4.33) 5.06 (4.48) 6.94 (6.25) UHDRS Behavioral frequency x severity [0–176]6.27 (9.12) 8.28 (10.87) 0.1945 13.51 (15.87) 0.0186 Cognitive assessment Mini Mental State Examination [0–30] 29.12 (1.51) 28.96 (1.56) 0.3783 26.01 (4.30) ,0.0001 UHDRS Verbal fluency 40.25 (11.84) 38.44 (11.51) 0.1612 26.43 (14.88) ,0.0001 UHDRS Symbol digit modalities test 47.35 (10.91) 45.65 (9.79) 0.0734 30.11 (15.28) ,0.0001 UHDRS Stroop color naming 74.60 (15.32) 72.27 (12.58) 0.1264 52.05 (20.86) ,0.0001Huntington’s Disease Intermediate CAG Ha AD, Beck CA, Jankovic J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"3Based on two-sided Wilcoxon test for comparing median score for Intermediates vs. HD.Ha AD, Beck CA, Jankovic J Huntington’s Disease Intermediate CAG Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"*p ,0.05, **p ,0.01, RUE 5right upper extremity, LLE 5left lower extremityHuntington’s Disease Intermediate CAG Ha AD, Beck CA, Jankovic J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"In Figure 2.Diagnostic Confidence at Baseline between the Normal, Intermediate, ‘High-Intermediate’ and HD GroupsHa AD, Beck CA, Jankovic J Huntington’s Disease Intermediate CAG Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Lancet Neurol 2011;10:83–98, http://dx.doi.org/10.1016/ S1474-4422(10)70245-3.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"J Neurol Sci 2009;277:143–146, http://dx.doi.org/10.1016/j.jns.2008.11.005.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"J Neurol Neurosurg Psychiatry 2010; 81:228–230, http://dx.doi.org/10.1136/jnnp.2008.170902.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Mov Disord 2008;23:879–881, http://dx.doi.org/10.1002/ mds.21958.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Mov Disord 2007;22:127–130, http://dx.doi.org/ 10.1002/mds.21195.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Clin Genet 2006; 70:283–294, http://dx.doi.org/10.1111/j.1399-0004.2006.00668.x.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Mov Disord 1996;11:136–142, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Lancet 2010; 376(9750):1372–1373, http://dx.doi.org/10.1016/S0140-6736(10)60974-9.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Postgrad Med 2011;123:116–121, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Mov Disord 2011;26: 925–927, http://dx.doi.org/10.1002/mds.23623.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Clin Genet 2010;78:381–387, http://dx.doi.org/10.1111/j.1399-0004.2010.01388.x.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Am J Med Genet A 2009;149A:1375–1381, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Hum Mol Genet 1995;4:1911–1918, http://dx.doi.org/10.1093/hmg/4.10.1911.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Mov Disord 2009;24:2254–2259, http://dx.doi.org/10.1002/mds.22809.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Arch Neurol 2010;67:154– 160, http://dx.doi.org/10.1001/archneurol.2009.334.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Mov Disord 2011;26:877– 884, http://dx.doi.org/10.1002/mds.23574.",OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"Neurology 2008; 71:1506–1513, http://dx.doi.org/10.1212/01.wnl.0000334276.09729.0e.",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
"J Neurol Sci 2012 Feb 15;313(1-2):35-41.Huntington’s Disease Intermediate CAG Ha AD, Beck CA, Jankovic J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/f6/14/tre-02-64-287-4.PMC3569951.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/ article/view/61 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"9Persistence of ADHD and OCD is associated with poorer psychosocial functioning.10Family genetic studies strongly indicate a genetic component to tic disorders, with shared geneticFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Table 1.Epidemiological Studies on the Prevalence of Tic Disorders in Children First Author, YearCountry Age (Years)Screening Sample SizePoint Prevalence (%)Period Prevalence (%) Boncour, 191059France 2–13 Teacher observation 1759 23.7 – MacFarlane, 195426USA 1–14 Parent interview 116 – 25 Lapouse, 196427USA 6–12 Parent interview 482 12 – Pringle, 196728UK 7 Parent questionnaire, medical history and examination7949 7.7 – 7958 7965 Rutter, 197060UK 9–12 Parent and teacher interview 2057 Non psychiatric sample 1919 4Psychiatric sample 95 18 Non psychiatric epileptic sample 26 8 Psychiatric epileptic sample 17 24 Shepherd, 1971 61UK 5–15 Parent questionnaire 6290 – 20 Achenbach, 1978–930,31USA 6–16 Parent questionnaire 2200 Population sample 1100 7.7 Referral sample 1100 28.8 Kurlan, 200144USA 8.5–17.5 Parent questionnaire Technician exam Special education 341 29Regular education 1255 17.9 Khalifa, 2003 50Sweden 7–15 Parent questionnaire Medical examRegular education 4438 6.3 Special education 41 46.3 Lanzi, 2004 22Italy 6–11 Teacher observation 2347 2.9 Ooki, 200533Japan 3–15 Questionnaire 1986 6.8 (males) 4.1 (females) Linazasoro, 200662Spain 4–16 Parent and teacher questionnaire Observation867 6.5 Stefanoff, 200724Poland 12–15 Parent and teacher questionnaire Exam1579 6.7 9.9 Schlander, 200936Germany 0–50+ Database code 2.238.460 0.2Cubo E Prevalence of Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"39Table 1.Continued First Author, YearCountry Age (Years)Screening Sample SizePoint Prevalence (%)Period Prevalence (%) Cubo, 201148Spain 6–16 Parent, teacher questionnaire Observation Neurologist interviewRegular education 741 16.8Special education 54 20.3 Modified from Shapiro et al,22and Lanzi et al.25Prevalence of Tic Disorders Cubo E Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"92 (76.03–100) 72 (60.30–84.80) 44 (24.54–63.46) 97 (92.28–100) 3.33 (2.07–5.38) Data obtained from Cubo et al, study.48 Abbreviations: +LR ratio, likelihood ratio for a positive result; NPV, negative predictive value; ob., observation; PPV, positive predictive valu e; CI, confidence interval.Cubo E Prevalence of Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"45 (30.00–60.36) 22 (10.07–34.36) 12 (2.25–22.74) 62 (38.77–86.22) 0.58 (0.30–1.13) Data obtained from Cubo et al, study.48 Abbreviations: +LR ratio, likelihood ratio for a positive result; NPV, negative predictive value; ob., observation; PPV, positive predictive valu e; CI, confidence interval.Prevalence of Tic Disorders Cubo E Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Clin Pediatr (Phila) 2009;48:790–791, http://dx.doi.org/10.1177/0009922808316664.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Arch Neurol 1993;50:1013–1016, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Nervenarzt 2009;80:1377–1387, http://dx.doi.org/10.1007/s00115-009- 2807-0.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Psychosom Res 2008;65:473–486, http://dx.doi.org/10.1016/j.jpsychores.2008.03.007.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Brain 2000;123:425–462, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Am Acad Child Adolesc Psychiatry 2006;45:1354–1362, http://dx.doi.org/10.1097/01.chi.0000251211.36868.fe.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Soc Psychiatry Psychiatr Epidemiol 2011;46:291–297, http://dx.doi.org/10.1007/s00127-010- 0194-2.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Eur Child Adolesc Psychiatry 2011;20:155–171, http://dx.doi.org/10.1007/s00787-011- 0164-6.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Psychosom Res 2009;67:533–545, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
JCubo E Prevalence of Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Psychosom Res 2008;65:461–472, http://dx.doi.org/10.1016/j.jpsychores.2008.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Child Psychol Psychiatry 2001;42:1035–1039, http://dx.doi.org/10.1111/1469-7610.00802.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Pediatrics 2002;110:331–336, http://dx.doi.org/10.1542/peds.110.2.331.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Dev Med Child Neurol 2002;44:330–338, http://dx.doi.org/10.1111/j.1469-8749.2002.tb00820.x.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Brain Dev 2003; 25(Suppl 1):S29–31, http://dx.doi.org/10.1016/S0387-7604(03)90005-2.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Eur J Epidemiol 2005;20:925–927, http://dx.doi.org/10.1007/s10654-005-2953-z.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Dev Med Child Neurol 2003;45:315– 319, http://dx.doi.org/10.1111/j.1469-8749.2003.tb00402.x.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Am J Orthopsychiatry 1964;34:436–446, http://dx.doi.org/10.1111/j.1939-0025.1964.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Consult Clin Psychol 1978;46:478–488, http://dx.doi.org/10.1037/0022-006X.46.3.478.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Consult Clin Psychol 1979;47:223– 233, http://dx.doi.org/10.1037/0022-006X.47.2.223.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Pediatr Neurol 2011; 45:100–108, http://dx.doi.org/10.1016/j.pediatrneurol.2011.03.003.33.Ooki S. Genetic and environmental influences on stuttering and tics in Japanese twin children.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Twin Res Hum Genet 2005;8:69–75, http://dx.doi.org/ 10.1375/twin.8.1.69.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Eur Psychiatry 2011;26:370–374, http://dx.doi.org/10.1016/j.eurpsy.2009.10.003.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Am Acad Child Adolesc Psychiatry 2000;39:548– 555, http://dx.doi.org/10.1097/00004583-200005000-00007.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Autism 2007;11:19–28, http://dx.doi.org/10.1177/ 1362361307070992.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"J Child Psychol Psychiatry 1999;40:213–218, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Psychol Med 1999;29:1151–1159, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Eur Child Adolesc Psychiatry 2008;17: 171–178, http://dx.doi.org/10.1007/s00787-007-0651-y.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Mov Disord 2011; 26:520–526, http://dx.doi.org/10.1002/mds.23460.Prevalence of Tic Disorders Cubo E Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Acta Paediatr 2005;94:1608–1614, http://dx.doi.org/10.1111/j.1651-2227.2005.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Eur Child Adolesc Psychiatry 2011 Feb;20(2): 71–74, http://dx.doi.org/10.1007/s00787-010-0143-3.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome.Mov Disord 2001;16:693–697, http://dx.doi.org/10.1002/mds.1159.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Mov Disord 2008;23:2407–2411, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"54.Walkup JT, Ferrao Y, Leckman JF, Stein DJ, Singer H. Tic disorders: some key issues for DSM-V. Depress Anxiety 2010;27:600–610, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Br J Psychiatry 1994;164:263–266, http://dx.doi.org/10.1192/bjp.164.2.263.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Scand J Public Health 2010;38:648– 656, http://dx.doi.org/10.1177/1403494810374222.",Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
"Mov Disord 2006;21:2106–2109, http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
48Cubo E Prevalence of Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/90/90/tre-02-61-349-1.PMC3569952.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/ view/59 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Cincotta et al.4reported another case of a 15-year- old girl with strong and sustained congenital MM affecting both hands and forearms, who complained about a painful contraction ofFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"21,22,24,29,27,28MM in the more affected hand areCox BC, Cincotta M, Espay AJ Mirror Movements in Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"M 1more5more affected cortex; M1less 5less affected cortex (modified from Li et al., 2007.29)Mirror Movements in Movement Disorders Cox BC, Cincotta M, Espay AJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Moreover,interhemispheric inhibition of the MEP tested by paired-pulse TMS atlong interstimulus intervals (20–50 milliseconds) was more pronouncedCox BC, Cincotta M, Espay AJ Mirror Movements in Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Park et al.64described one CJDMirror Movements in Movement Disorders Cox BC, Cincotta M, Espay AJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"16:620–623, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Dev Med Child Neurol 2000;42:728–736, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2003;18:1294–1300, http://dx.doi.org/10.1002/mds.10545.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Dev Med Child Neurol 1968;10:49–56, http://dx.doi.org/10.1111/j.1469-8749.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2010; 25:1317–1334, http://dx.doi.org/10.1002/mds.22944.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Clin Neurophysiol 2008;119:744–762, http://dx.doi.org/ 10.1016/j.clinph.2007.11.047.Cox BC, Cincotta M, Espay AJ Mirror Movements in Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Neurology 2011;76:260– 264, http://dx.doi.org/10.1212/WNL.0b013e318207b1e0.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Brain 1997 (Pt 7):1199–1216, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Clin Neurophysiol 2008;119: 80–87, http://dx.doi.org/ 10.1016/j.clinph.2007.09.120.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:154–163, http://dx.doi.org/10.1080/ 14660820410019657.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Stroke 1998;29:1182– 1187, http://dx.doi.org/10.1161/01.STR.29.6.1182.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurol Neurosurg Psychiatry 2005;76: 276–279, http://dx.doi.org/10.1136/jnnp.2004.040949.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Neurophysiol Clin 1994;24:427–434, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Exp Brain Res 2000;134:174–186, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurol Neurosurg Psychiatry 2005;76:1355–1358, http://dx.doi.org/10.1136/jnnp.2005.062950.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurol Neurosurg Psychiatry 2003;74:1352–1353, http://dx.doi.org/10.1136/jnnp.74.9.1352.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2008;23:253–258, http://dx.doi.org/10.1002/ mds.21825.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2006;21:1461–1465, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurol Neurosurg Psychiatry 2006;77:1194–1195, http://dx.doi.org/10.1136/jnnp.2005.086892.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2007;22:813–821, http://dx.doi.org/10.1002/mds.21386.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2006;21:1019–1025, http://dx.doi.org/10.1002/mds.20850.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Transitions between dynamical states of differing stability in the human brain.Proc Natl Acad Sci U S A 2002;99:10948–10953, http://dx.doi.org/10.1073/ pnas.162114799.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Exp Brain Res 2006;175: 633–640, http://dx.doi.org/10.1007/s00221-006-0581-9.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J CognNeurosci 2007;19:204–213, http://dx.doi.org/10.1162/jocn.2007.19.2.204.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Exp Brain Res 2008;186:59–66, http://dx.doi.org/10.1007/s00221-007-1205-8.Mirror Movements in Movement Disorders Cox BC, Cincotta M, Espay AJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Physiol 2004;561:331–338, http://dx.doi.org/10.1113/jphysiol.2004.072843.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Eur J Neurosci 2008; 28: 364–371, http://dx.doi.org/10.1111/j.1460-9568.2008.06335.x.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Physiol 2009;587:5393–5410, http://dx.doi.org/ 10.1113/jphysiol.2009.175885.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Behav Cogn Neurosci Rev 2003;2:261–277, http://dx.doi.org/10.1177/1534582303260119.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Am J Phys Med Rehabil 1992;71:297–300, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2005;20:870–873, http://dx.doi.org/10.1002/mds.20451.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2004;12:518–528, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Clin Neurophysiol 2008; 25:304–312, http://dx.doi.org/10.1097/WNP.0b013e318182d304.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2009;24:2211–2217, http://dx.doi.org/10.1002/ mds.22749.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2008;23: 1602–1605, http://dx.doi.org/10.1002/mds.22161.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurophysiol 2007; 97:3219–3228, http://dx.doi.org/10.1152/jn.00477.2006.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurol Sci 2008;266:31–33, http://dx.doi.org/10.1016/j.jns.2007.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Parkinsonism Relat Disord 2007;13:421–424, http://dx.doi.org/ 10.1016/j.parkreldis.2007.01.009.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Trends Neurosci 1990;13:148– 153, http://dx.doi.org/10.1016/0166-2236(90)90007-W. 58.Merello M, Carpintiero S, Cammarota A, Meli F, Leiguarda R. Bilateral mirror writing movements (mirror dystonia) in a patient with writer’s cramp:Functional correlates.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Mov Disord 2006;2:683–689, http://dx.doi.org/10.1002/ mds.20736.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Neurosurg Psychiatry 2005;76;1608–1609, http://dx.doi.org/10.1136/jnnp.2004.062265.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Eur J Neurosci 2009;29: 1634–1640, http://dx.doi.org/10.1111/j.1460-9568.2009.06710.x.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Neurology 2010;75:441–447, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Neurol Neurosurg Psychiatry 1997;63:404–407, http://dx.doi.org/10.1136/jnnp.63.3.404.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Clin.Neurol.Neurosurg 2009;111:380–383, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"Clin Neurophysiol 2001;112:1612–1617, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"J Int Neuropsychol Soc 2005;11:855–862, http://dx.doi.org/10.1017/S1355617705051003.",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
"doi.org/10.1007/s00221-002-1101-1.Cox BC, Cincotta M, Espay AJ Mirror Movements in Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/f3/62/tre-02-59-398-1.PMC3569961.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/45 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"None of the affected family members was examined, and the nature of the tremors could thus not beFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Spiral drawings before (A) and after (B) initial programming, demonstratingimprovement in tremor with stimulation.Mammis A, Pourfar M, Feigin A, et al DBS for Tremor in Abetalipoproteinemia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"AMA Arch Ophthalmol 1958;59:818– 820, http://dx.doi.org/10.1001/archopht.1958.00940070032002.",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Lancet 1960;2:325–329, http://dx.doi.org/ 10.1016/S0140-6736(60)91478-1.Table 1.Motor Rating Scales pre- and post- DBS Pre-DBS Post-DBS TETRAS Head 3 2 Right upper extremity 3 2 Left upper extremity 3 2Standing 3 1 Spiral 3.5 1 BARSRight finger–nose 3 1 Left finger–nose 4 1 Gait 4 2 Abbreviations: BARS, brief ataxia rating scale; DBS, deep brain stimulation; TETRAS, The Essential Tremor Rating Assessment Scale.Video 1.",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"With the stimulator ‘‘ON’’, there aresignificant improvement in both the extremity and axial tremors, as well as gait.Video Segment 1DBS for Tremor in Abetalipoproteinemia Mammis A, Pourfar M, Feigin A, et al Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Hum Mol Genet 1993;2:2109–2116, http://dx.doi.org/10.1093/ hmg/2.12.2109.",OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Science 1992;258:999–1001, http://dx.doi.org/10.1126/science.1439810.",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Orphanet J Rare Dis 2008;3:19, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Arch Neurol 2011;68:165, http://dx.doi.org/10.1001/archneurol.2010.260.",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Mov Disord 2010;25: 1150–1559, http://dx.doi.org/10.1002/mds.23195.",OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"Neurosurgery 2010;67:646–651, http://dx.doi.org/10.1227/01.",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
"NEU.0000375506.18902.3E.Mammis A, Pourfar M, Feigin A, et al DBS for Tremor in Abetalipoproteinemia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/04/19/tre-02-45-228-1.PMC3569962.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/34 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
"He has triedseveral medicines; most recently, clonazepam 2 mg, which helpedFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
Visualization of themovements in this video is brief but identical movements were seen constantlythroughout the evaluation prior to treatment.Video Segment 1A Video Segment 2Video Segment 1BOndo WG Movements Mimicking Myoclonus Associated with Spinal Cord Pathology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
"Sleep Med 2003;4:101–119, http://dx.doi.org/10.1016/ S1389-9457(03)00010-8.",Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
"Mov Disord 1997;12:61–65, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
"Acta Neurolog Scand 1988; 77:418–421, http://dx.doi.org/10.1111/j.1600-0404.1988.tb05929.x.",OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
"JN e u r o p a t h o lE x pN e u r o l 2007;66:383–8, http://dx.doi.org/10.1097/nen.",Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
"Mov Disord 2000;15:752–753, http://dx.doi.org/10.1002/1531-8257(200007)15:4 ,752::AID-MDS1029 .3.",OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
0.CO;2-Q.Movements Mimicking Myoclonus Associated with Spinal Cord Pathology Ondo WG Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/7e/9c/tre-02-34-107-1.PMC3569967.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/38 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Charts were individually reviewed to assess eligibilitycriteria, which included 1) a unilateral thalamic DBS device implantedbetween October 2000 through October 2010 (Medtronic ActivaFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
Medication Reduction for ET Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
Medication Reduction for ET Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Neuropsychiatr Dis Treat 2010;6:401–408, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Neuroepidemiolog y 2009; 32:215–216, http://dx.doi.org/10.1159/000195692.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Update on the worldwide prevalence of essential tremor.Mov Disord 2010;25:534–541, http://dx.doi.org/10.1002/mds.22838.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists.Parkinsonism Relat Disord 2010;16:604–607, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"CNS Drugs 2008;22:1037–1045, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Expert Opin Pharmacother 2005;6:419–428, http://dx.doi.org/ 10.1517/14656566.6.3.419.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Curr Opin Neurol 2007;20:447–452, http://dx.doi.org/10.1097/WCO.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Curr Treat Options Neurol 2006;8:256–267, http://dx.doi.org/10.1007/s11940-006-0016-8.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Clin Neuropharmacol 1990;13:67–76, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 2007;22:139–141, http://dx.doi.org/ 10.1002/mds.21211.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 1986;1:235–237, http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Drug Saf 2003;26:461–481, http://dx.doi.org/10.2165/00002018-200326070-00003.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"J Clin Neurophysiol 2004;21:2–5, http://dx.doi.org/10.1097/00004691-200401000-00002.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension.J Gastroenterol Hepatol 2009;24:1852–1856, http://dx.doi.org/10.1111/j.1440- 1746.2009.05912.x.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 2002; 17:382–386, http://dx.doi.org/10.1002/mds.10083.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Lancet Neurol 2011;10:148–161, http://dx.doi.org/10.1016/ S1474-4422(10)70322-7.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Ther Adv Neurol Disord 2009;2:215–222, http://dx.doi.org/ 10.1177/1756285609104791.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 2010;25: 1550–1559, http://dx.doi.org/10.1002/mds.23195.34.Blomstedt P, Sandvik U, Tisch S. Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 2010;25:1350– 1356, http://dx.doi.org/10.1002/mds.22758.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"J Neurol Neurosurg Psychiatry 2003;74:305–311, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor.Mov Disord 2001;16:464–468, http://dx.doi.org/10.1002/mds.1089.",Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 2001; 16:140–143, http://dx.doi.org/10.1002/1531-8257(200101)16:1 ,140::AID- MDS1025 .3.0.CO;2-T. 39.Koller WC, Pahwa PR, Lyons KE, Wilkinson SB.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 1997;12:841, http://dx.doi.org/10.1002/mds.870120602.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Neurotherapeutics 2008;5:331–338, http://dx.doi.org/10.1016/j.nurt.2008.01.004.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"J Neurosurg 2006;104:506–512, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
"Mov Disord 2001;16:1137–1142, http://dx.doi.org/10.1002/mds.1249.Resnick AS, Okun MS, Malapira T, et al.",OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
Medication Reduction for ET Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/b5/91/tre-02-38-193-1.PMC3569968.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/113 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"His sensory examination was normal.Based on his history and examination, he was diagnosed with post-stroke HCHB syndrome.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"Hyperkinetic movements and dystonia are reduced after treatment.Umeh CC, Nichols P, Rosenthal LS, et al Dual Treatment of Hemichorea-Hemiballismus Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"Arch Neurol 1989;46:862–867, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"J Neurol 2004;251:725–729, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"JN e u r o l 1994;241:537–542, doi: http://dx.doi.org/10.1007/ BF00873516.",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"Brain 2001;124: 299–309, doi: http://dx.doi.org/10.1093/brain/124.2.299.Dual Treatment of Hemichorea-Hemiballismus Syndrome Umeh CC, Nichols P, Rosenthal LS, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"J Comput Assist Tomogr 1995;19:537–540, doi: http://dx.doi.org/10.1097/00004728- 199507000-00005.",OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"J Med Case Rep 2008;2:352–352, doi: http://dx.doi.org/10.1186/ 1752-1947-2-352.8.Jankovic J, Beach J.",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"Neurology 1997;48:358–362, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"Cleve Clin J Med 2012;79:S25–29, doi: http://dx.doi.org/10.3949/ccjm.79.",OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
"s2a.05.Umeh CC, Nichols P, Rosenthal LS, et al Dual Treatment of Hemichorea-Hemiballismus Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/1d/25/tre-02-113-791-3.PMC3569969.pdf
Tremor Other Hyperkinet Mov 2011;1: http://www.tremorjournal.,Non-OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"Since the patient was completely refractory to medications, he underwent a bilateral Vim thalamic DBS implantation (Soletra,Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"J Neurol 2003;250(2):212–215, http://dx.doi.org/10.1007/s00415-003-0980-9.",Non-OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"MovDisord 2004;19(7):788–795, http://dx.doi.org/10.1002/mds.20132.",OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"J Neurol Neurosurg Psychiatry 2006;77(9):1013–1016, http://dx.doi.org/10.1136/jnnp.2005.086132.",Non-OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"Mov Disord 2008;23(13):1808– 1811, http://dx.doi.org/10.1002/mds.22001.",Non-OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"Mov Disord 2008;23(16):2357–2362, http://dx.doi.org/10.1002/mds.22271.Video 1.Patient 4 Months Prior to DBS Implantation and 6 Months After DBS Implantation Segment 1 of the video shows the patient 4 months prior to DBS implantation.",OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
"There is significantimprovement in his hand tremor while standing and the leg tremor is not visible.The patient is able to stand for several minutes without difficulty.Table 1.Surgical Treatment of Orthostatic Tremor Reference Patient Disease Duration (Years)Age at Surgery (Years)Surgery Sustained Clinical Improvement Krauss et al.41 10 58 Spinal cord stimulation Yes 2 8 72 Spinal cord stimulation Yes Guridi et al.53 11 55 Bilateral Vim DBS Yes Espay et al.64 28 73 Bilateral Vim DBS Yes 5 30 67 Unilateral Vim DBS No Current patient 6 9 82 Bilateral Vim DBS YesToby C. Yaltho, William G. Ondo Thalamic Deep Brain Stimulation for Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/21/44/tre-01-26-56-2.PMC3569971.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/58 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
He was alert and orientedFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Diffusion weighted imaging and ADC imaging revealed no evidence of associated ischemia.Guerrero W, Okun MS, McFarland NR Bilateral Chorea–Ballism and Diabetic Ketoacidosis Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Mov Disord 2004;19:475–478, http://dx.doi.org/10.1002/ mds.10676.",OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"J Clin Neurosci 2011;2:293–294, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Stroke 1997;28:584– 587, http://dx.doi.org/10.1161/01.STR.28.3.584.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Arch Neurol 1984;41:341–342, http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Mov Disord 1990;5:176–177, http://dx.doi.org/10.1002/mds.870050217.",OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Eur Neurol 1993;33:244–247, http://dx.doi.org/10.1159/ 000116946.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"J Neurol Neurosurg Psychiatry 1996;61:194–195, http://dx.doi.org/10.1136/jnnp.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Stroke 1997;28:584– 587, http://dx.doi.org/10.1161/01.STR.28.3.584.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Neurology 2001; 57:933–935, http://dx.doi.org/10.1212/WNL.57.5.933-a.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"J Neurol Neurosurg Psychiatry 2002;72:329–333, http://dx.doi.org/10.1136/jnnp.72.3.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Metabolism 1975;24:665– 679, http://dx.doi.org/10.1016/0026-0495(75)90146-8.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Arch Intern Med 1982;142:154–155, http://dx.doi.org/10.1001/archinte.1982.00340140156029.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"J Neurol 2004;251: 1486–1490, http://dx.doi.org/10.1007/s00415-004-0571-4.Bilateral Chorea–Ballism and Diabetic Ketoacidosis Guerrero W, Okun MS, McFarland NR Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Intern Med 2009;48:1135–1141, http://dx.doi.org/10.2169/internalmedicine.48.1996.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Neurol Sci 2009;30:179–183, http://dx.doi.org/10.1007/s10072-009-0039-5.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Stroke 1999;30:1043–1046, http://dx.doi.org/10.1161/01.STR.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Mov Disord 2010;25:966–968, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"Diabetes Res Clin Pract 2011;2:e80–83, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
"1016/j.diabres.2011.05.003.Guerrero W, Okun MS, McFarland NR Bilateral Chorea–Ballism and Diabetic Ketoacidosis Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/52/3d/tre-02-58-235-1.PMC3569973.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/86 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"4 Olanzapine treatment in HD patients showed a 35% improvement in gait, tandem gait, and pull test subscores of the Unified Huntington Disease Rating Scale (UHDRS).5In another study, involving 11 patients with HD, tetrabenazine was associated with improvement in lifting of large, light objects.6 We designed a study to measure the functional effects of tetrabenazine on various cognitive, behavioral, and motor domainsusing validated scales.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
Effect of Tetrabenazine and Huntington Disease Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Abbreviations: CI, confidence interval; MoCA, Montreal Cognitive Assessment; SD, standard deviation; UHDRS, Unified Huntington Disease Rating S cale.Effect of Tetrabenazine and Huntington Disease Fekete R, Davidson A, Jankovic J. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Lancet Neurol 2009;8:844–856, http://dx.doi.org/10.1016/S1474-4422(09)70183-8.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Expert Rev Neurotherap 2011;11: 1509–1523, http://dx.doi.org/10.1586/ern.11.149.3.Huntington Study Group.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Neurology 2006;66:366–372, http://dx.doi.org/10.1212/01.wnl.0000198586.85250.13.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Neurology 1985;35:1450–1454, http://dx.doi.org/10.1212/WNL.35.10.1450.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Clin Neuropharmacol 2002;25:263–5, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Mov Disord 2010;25:401–404, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Mov Disord 1996;11:136–142, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Arch Neurol 2001;58:961–967, http://dx.doi.org/10.1001/archneur.58.6.961.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"J Bone Joint Surg Am 2005;87:1038–1046, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Neurology 1992;42:1232–1238, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Mov Disord 2010;25: 2428–2433, http://dx.doi.org/10.1002/mds.23309.",OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Neuropsychopharmacology 2007;32:1600–1610, http://dx.doi.org/10.1038/ sj.npp.1301262.Fekete R, Davidson A, Jankovic J.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
Effect of Tetrabenazine and Huntington Disease Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Neurology 2000;54:119–125, http://dx.doi.org/10.1212/WNL.54.1.119.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Nature 2000;403:544– 549, http://dx.doi.org/10.1038/35000576.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Clin Neuropharmacol 2008;31: 127–133, http://dx.doi.org/10.1097/WNF.0b013e3180ca77ea.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"BMC Neurology 2009;9:62, http://dx.doi.org/10.1186/1471- 2377-9-62.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Exp Toxicol Pathol 2001;53:303–308, http://dx.doi.org/ 10.1078/0940-2993-00195.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"Arch Clin Neuropsychol 2004;19:555–567, http://dx.doi.org/10.1016/j.acn.2003.",OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
"08.004.Effect of Tetrabenazine and Huntington Disease Fekete R, Davidson A, Jankovic J. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/tre-02-86-476-4.PMC3569975.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/30 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
He could only stand inFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
DBS for Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"Acta Neurol Scand 1990;81:113–117, http://dx.doi.org/ 10.1111/j.1600-0404.1990.tb00944.x.",OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"Mov Disord 2004;19:788–795, http://dx.doi.org/10.1002/mds.20132.",OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"Clin Neuropharmacol 1991;14: 438–441, http://dx.doi.org/10.1097/00002826-199110000-00008.",Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"J Neurol 2003;250:212–215, http://dx.doi.org/ 10.1007/s00415-003-0980-9.",Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"Mov Disord 2008;23:2357–2362, http://dx.doi.org/ 10.1002/mds.22271.",OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"Brain 2001;124:322–330, http://dx.doi.org/10.1093/brain/124.2.322.",Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
"J Neurol Neurosurg Psychiatry 2006;77: 1013–1016, http://dx.doi.org/10.1136/jnnp.2005.086132.Lyons MK, Behbahani M, Boucher OK, et al.",OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
DBS for Orthostatic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/0c/85/tre-02-30-85-9.PMC3569976.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/ 28 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Previous reports in the stroke literature have documented rare instances of unilateral resolution of tremor in ET cases caused by cerebellar, thalamic, cortical infarcts and hemorrhages.14,15These acute lesions, many of which are sizable, grossly disrupt the cerebellar– thalamic–cortical fiber tracts that are implicated in the propagation of action tremor in ET.14Whether smaller scattered lesions (e.g., diffuseFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
White Matter Hyperintensities in Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
White Matter Hyperintensities in Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
White Matter Hyperintensities in Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
White Matter Hyperintensities in Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"J Neurol 2005;252:570–574, http://dx.doi.org/10.1007/s00415-005-0700-8.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Mov Disord 2003;18:389– 394, http://dx.doi.org/10.1002/mds.10376.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Essential tremor prevalence is low in Arabic villages in Israel: door-to-door neurological examination s.J Neurol 2006;253:1557–1560, http://dx.doi.org/10.1007/s00415-006-0253-5.White Matter Hyperintensities in Tremor Oliveira AP, Brickman AM, Provenzano FA, et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Neurology 2008;70:1452– 1455, http://dx.doi.org/10.1212/01.wnl.0000310425.76205.02.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Neurology 2005;64:1721–1725, http://dx.doi.org/10.1212/01.WNL.0000161852.70374.01.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Arch Neurol 2008;65:1053–1061, http://dx.doi.org/10.1001/ archneur.65.8.1053.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Lancet 1999; 354:919–920, http://dx.doi.org/10.1016/S0140-6736(99)02355-7.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"J Neurol 2003;250:354–355, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Parkinsonism Relat Disord 2008;14:373–375, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Mov Disord 2004;19:630–640, http://dx.doi.org/10.1002/mds.20083.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Arch Neurol 1992;49:453–460, http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Neurology 2009;73: 621–625, http://dx.doi.org/10.1212/WNL.0b013e3181b389f1.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Application of the Trail Making Test in differentiating neuropsychological impairment of elderly perso ns.Percept Mot Skills 1985;61:1283–1289, http://dx.doi.org/10.2466/pms.1985.61.3f.1283 .",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"JN e u r o l Neurosurg Psychiatry 1993;56:868–873, http://dx.doi.org/10.1136/jnnp.56.8.868.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Arch Neurol 1998;55:823–828, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Neuroepidemiology 1997;16:124–133, http://dx.doi.org/10.1159/ 000109681.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Brain 2007;130:3297– 3307, http://dx.doi.org/10.1093/brain/awm266.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Neurobiol Aging 2005;26:491–510, http://dx.doi.org/10.1016/j.neurobiolaging.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"J Neurolog Sci 2005; 232:23–27, http://dx.doi.org/10.1016/j.jns.2004.12.017.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Arch Neurol 2008;65:1649–1654, http://dx.doi.org/10.1001/archneurol.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Stroke 1994;25:2280–2282, http://dx.doi.org/10.1161/01.STR.25.11.2280.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Arch Neurol 1995;52:299–305, http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Neurosci Lett 2002;333:17–20, http://dx.doi.org/ 10.1016/S0304-3940(02)00966-7.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Mov Disord 2008;23:174–182, http://dx.doi.org/10.1002/mds.21731.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"Update on the worldwide prevalence of essential tremo r. Mov Disord 2010;25:534–541, http://dx.doi.org/10.1002/mds.22838.Oliveira AP, Brickman AM, Provenzano FA, et al.",OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
White Matter Hyperintensities in Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/fe/cd/tre-02-28-95-3.PMC3569979.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)CCN2 inhibits lung cancer metastasis through DAPK C-C Chang et al 455 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/35/72/cdd2012136a.PMC3569983.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Differentiation of human embryonic stem cells DA Brafman et al 381 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/08/15/cdd2012138a.PMC3569984.pdf
The emission intensity of GCaMP2.0 was calculated by using the ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/15/3d/cdd2012142a.PMC3569987.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)PMR1 regulates a-synuclein toxicity SB u¨ttner et al 477 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/15/3d/cdd2012142a.PMC3569987.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Clearance of infection-activated T cells by SARM P Panneerselvam et al 489 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/87/ed/cdd2012144a.PMC3569988.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/44 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
He wasFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
Cerebellar Ataxia from Multiple Potential Causes Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Diabetes Metab 2008;34:386–388, http://dx.doi.org/10.1016/ j.diabet.2008.02.002.",Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Mov Disord 2009;24:2358–2362, http://dx.doi.org/10.1002/mds.22660.",OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Brain 2008;131:2553–2563, http://dx.doi.org/10.1093/brain/ awn183.",OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Neurologist 2010;16:115–116, http://dx.doi.org/10.1097/NRL.",Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"J Neurol Neurosurg Psych 2001;71: 81–87, http://dx.doi.org/10.1136/ jnnp.71.1.81.",Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Neurology 2008;70:1452– 1455, http://dx.doi.org/10.1212/01.wnl.0000310425.76205.02.",Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"‘‘Hairy baskets’’ associated with degenerative Purkinje cell changes in essential tremor.J Neuropathol Exp Neurol 2010;69:262–271, http://dx.doi.org/10.1097/NEN.",Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Mov Disord 2009;24:386–391, http://dx.doi.org/10.1002/mds.22356.14.Pahwa R, Lyons KE, Wilkinson SB, et al.",OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"J Neurosurg 2006;104:506–512, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"J Clin Neurol 2005;1: 76–80, http://dx.doi.org/10.3988/jcn.2005.1.1.76.",Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Brain 2001;124:2278–2286, http://dx.doi.org/10.1093/ brain/124.11.2278.",OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
"Mov Disord 2009;11:1629–1635, http://dx.doi.org/10.1002/mds.22633.Shneyder N, Lyons MK, Driver-Dunckley E, et al.",OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
Cerebellar Ataxia from Multiple Potential Causes Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/72/7f/tre-02-44-309-2.PMC3569994.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/36 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
We are unaware of prior studies that have attempted to address this issue.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Finally, the measures of cognitiveLouis ED, Gillman A Mirror Movements in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"5Potential range 0–80 (maximum).Mirror Movements in Essential Tremor Louis ED, Gillman A Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Mov Disord 2009;24:2211–2217, http://dx.doi.org/10.1002/ mds.22749.",OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Neurology 2009;73: 621–625, http://dx.doi.org/10.1212/WNL.0b013e3181b389f1.",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Mov Disord 2007;22:1573–1580, http://dx.doi.org/10.1002/mds.21553.5.Troster AI, Woods SP, Fields JA, et al.",OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Brain 2007;130:3297– 3307, http://dx.doi.org/10.1093/brain/awm266.",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Mov Disord 2005;20:1361–1365, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"J Psychiatr Res 1975;12:189–198, http://dx.doi.org/10.1016/0022-3956(75)90026-6.",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"J Neurol Neurosurg Psychiatry 2005; 76:1355–1358, http://dx.doi.org/10.1136/jnnp.2005.062950.",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
"Neuroepidemiology 1997;16:124–133, http://dx.doi.org/10.1159/ 000109681.Louis ED, Gillman A Mirror Movements in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/ca/99/tre-02-36-147-1.PMC3570028.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/82 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
The neuropathology and the differences between the pedigrees are discussed in the generalFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
FCMTE: A Third Pathology Case and Review Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
FCMTE: A Third Pathology Case and Review Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
FCMTE: A Third Pathology Case and Review Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 2003;60: 1381–1385, http://dx.doi.org/10.1212/01.WNL.0000055874.24000.4A.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsy Res 2005;65:147–152, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 2010;74: 2000–2003, http://dx.doi.org/10.1212/WNL.0b013e3181e396a8.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Brain 2001;124:2459–2475, http://dx.doi.org/10.1093/brain/ 124.12.2459.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 2002;58:941–944, http://dx.doi.org/10.1212/WNL.58.6.941.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurogenetics 2008;9:139–142, http://dx.doi.org/ 10.1007/s10048-008-0118-4.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Am J Hum Genet 1999;65:745–751, http://dx.doi.org/10.1086/302535.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 1999;53:1180–1183, http://dx.doi.org/10.1212/WNL.53.6.1180.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsia 2004;45:190–192, http://dx.doi.org/10.1111/j.0013- 9580.2004.39903.x.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"10.Striano P, Madia F, Minetti C, Striano S, Zara F. Electroclinical and genetic findings in a family with cortical tremor, myoclonus, and epilepsy.Epilepsia 2005;46:1993–1995, http://dx.doi.org/10.1111/j.1528-1167.2005.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Autosomal dominant early-onset cortical myoclonus, photic-induced myoclonus, and epilepsy in a large pedigree.Epilepsia 2006;47:1643–1649, http://dx.doi.org/10.1111/j.1528-1167.2006.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"J Neurol 2002;249:829– 834, http://dx.doi.org/10.1007/s00415-002-0729-x.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Rev Neurol (Paris) 2009;165:812–820, http://dx.doi.org/10.1016/j.neurol.2009.05.014.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 2004;19:213–217, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 2005;20:665–673, http://dx.doi.org/10.1002/ mds.20413.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 2006;21:215–222, http://dx.doi.org/10.1002/mds.20703.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Acta Neurol Scand 2005;111:211–217, http://dx.doi.org/10.1111/j.1600-0404.2005.00385.x.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsia 2005; 46(Suppl 9):57–66, http://dx.doi.org/10.1111/j.1528-1167.2005.00314.x.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Brain 2008;131:2295–2303, http://dx.doi.org/10.1093/brain/awn177.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Hum Brain Mapp 2008;29:1430–1441, http://dx.doi.org/10.1002/hbm.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 2007;22:2378–2385, http://dx.doi.org/10.1002/ mds.21738.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 1979;29:1107–1125, http://dx.doi.org/10.1212/WNL.29.8.1107.Sharifi S, Aronica E, Koelman JHTM, et al.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
FCMTE: A Third Pathology Case and Review Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 1990;40:1561– 1565, http://dx.doi.org/10.1212/WNL.40.10.1561.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Clin Neurol Neurosurg 1998;100: 75–78, http://dx.doi.org/10.1016/S0303-8467(98)00003-1.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 1997;12:370–377, http://dx.doi.org/10.1002/mds.870120316.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 2005;20:1610–1614, http://dx.doi.org/10.1002/mds.20530.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Clinical analysis in familial cortical myoclonic tremor allows differential diagnosis with essential tremor.Mov Disord 2006;21:599–608, http://dx.doi.org/10.1002/mds.20725.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsia 2007;48:1995–1998, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsy Behav 2010;19:669, http://dx.doi.org/10.1016/j.yebeh.2010.09.032.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Seizure 2000;9:344–346, http://dx.doi.org/10.1053/seiz.2000.0402.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Seizure 2002;11:266–268, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Arch Neurol 1998;55:1569– 1573, http://dx.doi.org/10.1001/archneur.55.12.1569.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsia 2009;50:1491–1497, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsia 2011;52:1245–1250, http://dx.doi.org/10.1111/j.1528- 1167.2011.03017.x.41.Striano P, Striano S, Zara F. Re: Fame 3: a novel form of progressive myoclonus and epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 2008;70:85–86, http://dx.doi.org/10.1212/ 01.wnl.0000295707.90283.e6.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Mov Disord 2005;20:1076– 1077, http://dx.doi.org/10.1002/mds.20558.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Ann Neurol 1996;40:367–378, http://dx.doi.org/10.1002/ ana.410400306.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Clin Neurophysiol 2004;115:1717–1729, http://dx.doi.org/10.1016/j.clinph.2004.03.006.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Acta Neuropathol (Berl) 2000;100:371– 376, http://dx.doi.org/10.1007/s004010000201.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Parkinsonism Relat Disord 2011;17:406–409, http://dx.doi.org/ 10.1016/j.parkreldis.2011.05.004.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Brain 1995;118:1087–1093, http://dx.doi.org/ 10.1093/brain/118.5.1087.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 1980;30:245–249, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Brain 1921;44:490–538, http://dx.doi.org/10.1093/brain/44.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Neurology 2000;54:1350–1356, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Toxicon 1998;36: 645–655, http://dx.doi.org/10.1016/S0041-0101(97)00084-6.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Hum Brain Mapp 2007;28:1117–1127, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Curr Opin Neurol 2004;17:147–153, http://dx.doi.org/10.1097/00019052-200404000- 00011.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Epilepsia 2002;43 Suppl 9:16–20, http://dx.doi.org/10.1046/j.1528-1157.43.s.9.5.x.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Curr Opin Neurol 2003;16:171–176, http://dx.doi.org/ 10.1097/00019052-200304000-00009.",OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"60.Crooks R, Mitchell T, Thom M. Patterns of cerebellar atrophy in patients with chronic epilepsy: a quantitative neuropathological study.Epilepsy Res 2000;41:63–73, http://dx.doi.org/10.1016/S0920-1211(00)00133- 9.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"J Neurol Sci 1997;145:113–118, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"J Med Genet 1996;33:80– 81, http://dx.doi.org/10.1136/jmg.33.1.80.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
"Eur Neurol 1995;35:63–64, http://dx.doi.org/10.1159/000117093.",Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
FCMTE: A Third Pathology Case and Review Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/04/df/tre-02-82-472-2.PMC3570033.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/85 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Each botulinum product is purified and manufactured using proprietary processes, resulting in unique agentsthat differ in such features as molecular weight, uniformity of toxin complex size, protein content, and the presence of inactive ingredients, all of which can impact performance characteristics including potency,duration of effect, and adverse event (AE), and diffusion or migration profile.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"10,15,27Brodsky MA, Swope DM, Grimes D Diffusion of Botulinum Toxins Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Protein composition No Molecular size No Injection volume Yes Injection dose YesInjection concentration Yes Injection method MaybeDiffusion of Botulinum Toxins Brodsky MA, Swope DM, Grimes D Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"In a multicenter, randomized, double-blind, parallel-arm study comparing ONAA and RIMAB forBrodsky MA, Swope DM, Grimes D Diffusion of Botulinum Toxins Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"References 1.Wohlfarth K, Muller C, Sassin I, Comes G, Grafe S. Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins.Clin Neuropharmacol 2007;30:86–94, http://dx.doi.org/10.1097/01.WNF.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Neurotox Res 2006;9:133–140, http://dx.doi.org/10.1007/ BF03033931.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Neurol Neurosurg Psychiatry 1997;62:198, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Neurol Neurosurg Psychiatry 1999;67:90–93, http://dx.doi.org/10.1136/jnnp.67.1.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
2009 [cited 2011 December 29]; Available from: http://www.fda.gov/Safety/MedWatch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm164255.htm.,OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Neurology 1996;46:1158–1160, http://dx.doi.org/10.1212/WNL.46.4.1158.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Mov Disord 2004;19(Suppl 8):S53–59, http://dx.doi.org/10.1002/mds.20010.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Dermatol Surg 2003;29:519–522, http://dx.doi.org/10.1046/j.1524- 4725.2003.29124.x.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Biomech 2008; 41:897–902, http://dx.doi.org/10.1016/j.jbiomech.2007.11.016.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Laryngoscope 1991;101:960– 964, http://dx.doi.org/10.1288/00005537-199109000-00006.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Head Neck 1990;12:392–399, http://dx.doi.org/10.1002/hed.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Mov Disord 1994;9:31–39, http://dx.doi.org/10.1002/mds.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Quantitative electromyographic analysis of changes in muscle activity followingDiffusion of Botulinum Toxins Brodsky MA, Swope DM, Grimes D Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Clin Neuropharmacol 1993;16:205– 210, http://dx.doi.org/10.1097/00002826-199306000-00003.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Muscle Nerve 2009;40:374–380, http://dx.doi.org/10.1002/mus.21343.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Toxicon 2003;42:461–469, http://dx.doi.org/ 10.1016/S0041-0101(03)00196-X.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Cosmet Laser Ther 2008;10:181–183, http://dx.doi.org/ 10.1080/14764170802094282.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Dermatol Surg 2003;29:533–538, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Cosmet Laser Ther 2007;9(Suppl 1):17–22, http://dx.doi.org/10.1080/ 17429590701523794.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Am J Phys Med Rehabil 2004;83:S59–64, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Toxicon 2009;54: 697–701, http://dx.doi.org/10.1016/j.toxicon.2009.03.010.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Curr Med Res Opin 2009;25:1573–1584, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Neural Transm 2010;117:317–319, http://dx.doi.org/10.1007/s00702-010- 0372-0.33.Brin MF, Lyons KE, Doucette J, et al.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Neurology 2001;56:1523–1528, http://dx.doi.org/10.1212/WNL.56.11.1523.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Neurol Neurosurg Psychiatry 2009;80:380–385, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Neurology 2002;58:805–807, http://dx.doi.org/10.1212/WNL.58.5.805.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Clin Neurol Neurosurg 2004;106: 93–96, http://dx.doi.org/10.1016/j.clineuro.2003.10.012.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Toxicon 2001;39:1815–1820, http://dx.doi.org/ 10.1016/S0041-0101(01)00101-5.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Toxicon 2002;40:923–928, http://dx.doi.org/10.1016/S0041- 0101(02)00086-7.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Graefes Arch Clin Exp Ophthalmol 1997;235:197–199, http://dx.doi.org/10.1007/BF00941758.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Neurol Neurosurg Psychiatry 1998;64:6–12, http://dx.doi.org/10.1136/jnnp.64.1.6.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Am Acad Dermatol 2006;55:975–980, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"J Neural Transm 2006;113:303–312, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"org/10.1007/s00702-005-0323-3.Brodsky MA, Swope DM, Grimes D Diffusion of Botulinum Toxins Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Neurology 2005;64:1949–1951, http://dx.doi.org/10.1212/01.WNL.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"49.Frevert J. Xeomin: an innovative new botulinum toxin type A. Eur J Neurol 2009;16(Suppl 2):11–13, http://dx.doi.org/10.1111/j.1468-1331.2009.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Future Neurol 2007;2:485–493, http://dx.doi.org/10.2217/14796708.2.5.485.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Neurology 2005;65: 1423–1429, http://dx.doi.org/10.1212/01.wnl.0000183055.81056.5c.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Mov Disord 2008;23:510–517, http://dx.doi.org/10.1002/mds.21724.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Clin Ther 2007;29:1325–1337, http://dx.doi.org/10.1016/j.clinthera.2007.07.020.",OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
"Acta Neurol Taiwan 2004;13:71–76.Diffusion of Botulinum Toxins Brodsky MA, Swope DM, Grimes D Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/3f/13/tre-02-85-417-1.PMC3570036.pdf
Tremor Other Hyperkinet Mov 2012;2: http://tremorjournal.org/article/view/68 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
UnlikeFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
Clinical Trials in ET: Methodological Issues Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Update on the worldwide prevalence of essential tremor.Mov Disord 2010;25:534–541, http://dx.doi.org/10.1002/mds.22838.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 2009;24:2033– 2041, http://dx.doi.org/10.1002/mds.22755.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Lancet Neurol 2011;10:148–161, http://dx.doi.org/10.1016/ S1474-4422(10)70322-7.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Neurology 1986;36:1001–1004, http://dx.doi.org/10.1212/WNL.36.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"J Neurol Neurosurg Psychiatry 1993;56:868–87, http://dx.doi.org/10.1136/jnnp.56.8.868.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Neurology 1989;39:1587–1588, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"J Neurol 2000;247:955–959, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Arch Neurol 2006;63:1100–1104, http://dx.doi.org/10.1001/archneur.63.8.1100.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Nat Clin Pract Neurol 2006;2:666–78, http://dx.doi.org/10.1038/ ncpneuro0347.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 2011;26:18–23, http://dx.doi.org/10.1002/ mds.23289.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 2011;26: 1096–1105, http://dx.doi.org/10.1002/mds.23579.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 2010;25:679–686, http://dx.doi.org/10.1002/mds.22870.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Acta Neurol Scand 2012;125:332–337, http://dx.doi.org/10.1111/j.1600-0404.2011.01573.x.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 1997;12:973– 976, http://dx.doi.org/10.1002/mds.870120621.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Neuroepidemiology 1997;16:124–133, http://dx.doi.org/10.1159/ 000109681.Clinical Trials in ET: Methodological Issues Carranza MA, Snyder MR, Elble RJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 1998;13:465–467, http://dx.doi.org/ 10.1002/mds.870130315.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"A randomized placebo- controlled comparative trial of gabapentin and propranolol in essential tremor.Arch Neurol 1999;56:475–480, http://dx.doi.org/10.1001/archneur.56.4.475.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 2000;15:678– 682, http://dx.doi.org/10.1002/1531-8257(200007)15:4 ,678::AID- MDS1012 .3.0.CO;2-0.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"J Neurol 1993;241:54–61, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Neurology 2011;77: 1752–1755, http://dx.doi.org/10.1212/WNL.0b013e318236f0fd.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Neurology 2001;56:1523–1528, http://dx.doi.org/10.1212/WNL.56.11.1523.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 1996;11:250–256, http://dx.doi.org/10.1002/mds.870110306.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Neurology 2006;66:672–677, http://dx.doi.org/10.1212/01.wnl.0000200779.03748.0f.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Clin Neurophysiol 2005;116:1638–1643, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"A double-blind placebo- controlled trial of zonisamide (Zonegram) in the treatment of essential tremor.Mov Disord 2007;22:279–282, http://dx.doi.org/10.1002/mds.21282.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.Mov Disord 2007;22:1660–1663, http://dx.doi.org/10.1002/mds.21629.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Mov Disord 2011;26:2073–2080, http://dx.doi.org/10.1002/mds.23808.33.Elble RJ, Pullman SL, Matsumoto JY, et al.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Brain 2006; 129:2660–2666, http://dx.doi.org/10.1093/brain/awl190.",OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
"Clin Neuropharmacol 1990;13:67–76, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/tre-02-68-402-1.PMC3570037.pdf
